Top Pharma Export Products from India Manufacturers Sellers Pharmaceutical Companies Medicine Buyers

Top Pharma Export Products from India Manufacturers Sellers Pharmaceutical Companies Medicine Buyers

top pharma export products from india manufacturers sellers pharmaceutical companies medicine buyers
Name

Top Pharma Export Products from India Manufacturers Sellers Pharmaceutical Companies Medicine Buyers

INTRODUCTION

India is one of the world’s important pharmaceutical manufacturing and exporting countries.

However, pharmaceutical export is fundamentally different from exporting ordinary commodities.

A pharmaceutical exporter has to understand product quality, manufacturing, regulatory approval, documentation, pricing, logistics, foreign buyers and destination-country requirements.

For example, an Indian manufacturer may legally manufacture a medicine in India, but that does not automatically mean the same medicine can be marketed commercially in the United States, United Kingdom, European Union or another country.

Therefore, the basic export chain should be understood as:

PRODUCT → MANUFACTURER → QUALITY → REGULATORY REQUIREMENTS → BUYER/IMPORTER → DOCUMENTATION → PRICE → LOGISTICS → CUSTOMS → DELIVERY → POST-MARKET RESPONSIBILITIES

 

PART I — PHARMA EXPORT FUNDAMENTALS

Chapter 1 — Understanding Pharmaceutical Exports

What is pharma export?

Pharmaceutical export is the international supply of pharmaceutical products from one country to another while complying with the applicable laws and regulatory requirements of both countries.

Pharmaceutical exports can include:

  • Finished formulations
  • APIs
  • Intermediates
  • OTC medicines
  • Prescription medicines
  • Certain biological products
  • Pharmaceutical raw materials
  • Excipients
  • Nutraceutical-related products, where legally classified as such

The regulatory treatment differs substantially between these categories.

Chapter 2 — Important Pharma Terms

API

Active Pharmaceutical Ingredient

The pharmacologically active component of a medicine.

Example:

Paracetamol can be the API in a paracetamol tablet.

Excipient

An inactive ingredient used to manufacture a pharmaceutical dosage form.

Examples include:

  • Fillers
  • Binders
  • Disintegrants
  • Lubricants
  • Preservatives
  • Coloring agents

Formulation

A finished medicinal product containing one or more active ingredients together with appropriate excipients.

Tablet

A solid dosage form generally produced by compression or another suitable manufacturing process.

Capsule

A dosage form in which pharmaceutical material is enclosed within a capsule shell.

Syrup

A liquid oral preparation, often containing active pharmaceutical ingredients dissolved or dispersed in a suitable vehicle.

Injection

A sterile pharmaceutical preparation intended for administration by injection.

Cream

A semisolid topical preparation.

Ointment

A semisolid preparation generally intended for application to skin or other appropriate surfaces.

PART II — STARTING A PHARMA EXPORT BUSINESS FROM INDIA

Chapter 3 — Basic Business Setup

Before starting pharmaceutical exports, an entrepreneur should understand:

Business entity → Tax registration → IEC → Bank → Product sourcing → Applicable drug permissions → Manufacturer verification → Buyer → Regulatory assessment → Shipment

Depending on the business model, additional licences and registrations may apply.

Important Indian Authorities

DGFT

Directorate General of Foreign Trade

Deals with India’s foreign-trade framework and export/import procedures.

CDSCO

Central Drugs Standard Control Organisation

India’s central drug regulatory authority.

State Drug Control Authority

State-level authorities perform various drug licensing, inspection and enforcement functions.

PART III — PRODUCT SELECTION

Chapter 4 — How to Select a Pharmaceutical Product

A beginner should not select a medicine merely because:

“It is popular in India.”

Instead, evaluate:

  1. Product demand
  2. Target country
  3. Regulatory status
  4. Competition
  5. Manufacturer capability
  6. Product registration
  7. Shelf life
  8. MOQ
  9. Price
  10. Freight
  11. Importer requirements
  12. Market size
  13. Intellectual-property considerations
  14. Label requirements
  15. Documentation

PRODUCT EVALUATION FORM

Field

Information

Product

 

Composition

 

Strength

 

Dosage Form

 

Pack Size

 

Manufacturer

 

Manufacturing Licence

 

GMP

 

COA

 

COPP/CPP

 

HS Code

 

Target Country

 

Regulatory Authority

 

Registration Required

 

Importer

 

MOQ

 

EXW

 

FOB

 

CIF

 

Shelf Life

 

Lead Time

 

Private Label

 

OEM

 

Verification

 

PART IV — MANUFACTURER DUE DILIGENCE

Before selecting a pharmaceutical manufacturer, verify:

Company

  • Legal company name
  • Registered address
  • Manufacturing location
  • Website
  • Contact details

Regulatory

  • Manufacturing licence
  • Product permission
  • GMP status
  • Applicable certifications
  • Export history

Quality

  • COA
  • Product specifications
  • Stability information
  • Batch information
  • Quality system

Commercial

  • MOQ
  • Price
  • Lead time
  • Payment terms
  • Packaging
  • Private-label capability
  • OEM capability

MANUFACTURER VERIFICATION CHECKLIST

□ Company verified

□ Manufacturing facility verified

□ Licence verified

□ Product verified

□ GMP status checked

□ COA obtained

□ Product specification obtained

□ MOQ confirmed

□ Price confirmed

□ Lead time confirmed

□ Export history checked

□ Private-label capability checked

□ Target-country regulatory capability checked

PART V — USA / FDA

This is one of the most important chapters.

FDA

Food and Drug Administration

The US federal agency responsible for regulating drugs and various other products.

Critical distinction

FDA establishment registration is NOT the same as FDA drug approval.

This distinction should be memorized by every pharma exporter.

For applicable foreign establishments, FDA requires registration and drug-listing processes, but a particular drug may also require an appropriate approved marketing application or other applicable regulatory pathway.

Important US Terms

NDA

New Drug Application

ANDA

Abbreviated New Drug Application

BLA

Biologics License Application

IND

Investigational New Drug

NDC

National Drug Code

CGMP

Current Good Manufacturing Practice

US Agent

A US-based representative/contact for applicable foreign establishments.

USA EXPORT CHECKLIST

Before supplying a pharmaceutical product to the USA, investigate:

□ Manufacturer

□ Product

□ Composition

□ FDA establishment status

□ Drug listing

□ Applicable marketing application

□ Importer

□ US Agent

□ Labeling

□ CGMP

□ Product-specific requirements

□ Shipping requirements

□ Customs/FDA import requirements

□ Buyer authorization

PART VI — UK / MHRA

MHRA

Medicines and Healthcare products Regulatory Agency

The UK’s medicines and healthcare-products regulator.

The UK has its own medicines regulatory framework.

Therefore:

India approval ≠ UK approval

and

EU authorization ≠ automatically UK authorization

UK CHECKLIST

□ Product classification

□ Marketing authorization

□ Manufacturer

□ Importer

□ UK regulatory requirements

□ Labeling

□ GMP

□ Pharmacovigilance

□ Product information

□ Regulatory submission requirements

PART VII — UAE & GCC

For Middle Eastern markets, investigate the destination country’s exact regulatory framework.

Important markets include:

  • UAE
  • Saudi Arabia
  • Qatar
  • Kuwait
  • Oman
  • Bahrain

Do not assume that registration in one GCC country automatically permits sale in every other GCC market.

PART VIII — EUROPE

Important concepts include:

  • EMA
  • National competent authorities
  • Marketing authorization
  • CTD
  • eCTD
  • GMP
  • Pharmacovigilance
  • Product information
  • Qualified regulatory responsibilities

The exact authorization procedure depends on the product and intended market.

PART IX — OTHER INTERNATIONAL MARKETS

Important regulatory authorities include:

Country

Authority

USA

FDA

UK

MHRA

Australia

TGA

Canada

Health Canada

Saudi Arabia

SFDA

South Africa

SAHPRA

European Union

EMA + relevant national authorities

India

CDSCO + State authorities

PART X — EXPORT DOCUMENTATION

A pharmaceutical export may involve documents such as:

  1. Purchase Order
  2. Proforma Invoice
  3. Commercial Invoice
  4. Packing List
  5. Certificate of Origin
  6. COA
  7. GMP certificate
  8. CPP/COPP where applicable
  9. Product registration documentation
  10. Shipping documents
  11. Insurance documents
  12. Customs/export documentation
  13. Regulatory certificates
  14. Batch documents

The exact list must be determined according to the product and destination.

PART XI — PRICING

Basic pricing model

Product Cost

  •  

Packaging

  •  

Documentation

  •  

Inland Transportation

  •  

Freight

  •  

Insurance

  •  

Other applicable costs

  •  

Exporter Margin

=

Export Price

Then determine the appropriate Incoterm.

Important Incoterms

EXW

Ex Works

FOB

Free On Board

CFR

Cost and Freight

CIF

Cost, Insurance and Freight

DDP

Delivered Duty Paid

Always verify the current Incoterms rules and use the correct named place/port.

PART XII — FOREIGN BUYERS

Where can buyers be found?

Potential sources include:

  • Pharmaceutical distributors
  • Importers
  • Wholesalers
  • Hospital suppliers
  • Government tenders
  • Trade fairs
  • Industry associations
  • Verified B2B platforms
  • Business directories
  • Professional networks
  • Direct company research

BUYER VERIFICATION

Before accepting a large order:

□ Company registration

□ Website

□ Physical address

□ Import licence, where applicable

□ Regulatory status

□ Business references

□ Bank/payment information

□ Product requirement

□ Expected quantity

□ Country

□ Distributor status

PART XIII — PRIVATE LABEL & OEM

Private label can be attractive because the buyer may want:

Indian manufacturing + foreign brand

But the regulatory structure must be understood.

The exporter should identify:

  • Manufacturer
  • Brand owner
  • Marketing authorization holder
  • Importer
  • Regulatory applicant
  • Label owner
  • Packaging responsibility
  • Pharmacovigilance responsibility, where applicable

PART XIV — LOGISTICS

Air Freight

Advantages:

  • Faster
  • Useful for urgent/smaller high-value shipments

Disadvantages:

  • Higher cost

Sea Freight

Advantages:

  • Generally economical for larger shipments

Disadvantages:

  • Longer transit time

Cold Chain

Some products require controlled temperatures.

The exporter must consider:

  • Storage temperature
  • Transport temperature
  • Packaging qualification
  • Temperature monitoring
  • Temperature excursion management
  • Stability requirements

PART XV — PAYMENT

Common structures include:

Advance Payment

Buyer pays before shipment.

Letter of Credit

Bank-mediated payment subject to specified terms.

Documentary Collection

Banks facilitate document/payment processes according to agreed arrangements.

Open Account

Buyer pays after shipment under agreed credit terms.

Open-account transactions can create significant credit risk for exporters.

PART XVI — QUALITY

QA

Quality Assurance.

Focuses on the overall quality system.

QC

Quality Control.

Focuses heavily on testing and verification.

CAPA

Corrective and Preventive Action.

Deviation

A departure from an approved procedure or expected requirement.

Change Control

A formal system for evaluating and controlling changes.

Validation

Documented evidence that a process or method consistently achieves its intended purpose.

PART XVII — INTERVIEW QUESTION BANK

The first 200 questions have already been established above in the earlier section of this manuscript.

The next section expands the book into scenario-based interview questions and MCQs.

PART XVIII — PRACTICAL CASE STUDIES

CASE STUDY 1 — India to USA

Situation

An Indian manufacturer offers:

Paracetamol Tablets

A US buyer wants 100,000 boxes.

Questions

  1. Can the exporter immediately ship?
  2. Is Indian approval sufficient?
  3. What FDA requirements apply?
  4. Who is the US importer?
  5. What is the applicable US regulatory pathway?
  6. What labeling is required?
  7. Is the manufacturer appropriately registered?
  8. What documentation is required?
  9. What is the agreed Incoterm?
  10. What happens if FDA refuses admission?

Lesson

Never treat:

Indian manufacturing licence + Indian market availability

as equivalent to:

US authorization to market the product.

CASE STUDY 2 — UAE Private Label

A UAE company wants 50,000 boxes under its own brand.

Exporter should investigate:

  • Product composition
  • UAE regulatory status
  • Local importer
  • Manufacturer
  • Private-label agreement
  • Brand/trademark
  • Packaging
  • Labeling
  • MOQ
  • Registration
  • Price
  • Payment
  • Shipment requirements

CASE STUDY 3 — Suspicious Buyer

A new buyer requests:

“Send 50,000 boxes immediately. We will pay after customs clearance.”

Correct approach

Do not accept automatically.

Perform:

Buyer verification → regulatory verification → commercial risk assessment → payment-risk assessment → contract → shipment

CASE STUDY 4 — Extremely Cheap Manufacturer

Manufacturer A offers $0.20.

Manufacturer B offers $0.55.

Do not automatically choose A.

Compare:

  • Licence
  • GMP
  • Product quality
  • Specifications
  • COA
  • Shelf life
  • Packaging
  • Regulatory status
  • Manufacturing capacity
  • Export history
  • Documents

Lowest price does not necessarily mean lowest total cost.

PART XIX — MASTER EXPORT CHECKLIST

Before Product Selection

□ Demand research
□ Country research
□ Regulatory research
□ Competitor research
□ Pricing research

Before Manufacturer Selection

□ Licence
□ GMP
□ Product capability
□ Quality documents
□ MOQ
□ Price
□ Lead time

Before Buyer Selection

□ Company verification
□ Importer status
□ Regulatory status
□ Payment risk
□ Market requirement

Before Shipment

□ Product registration
□ Documents
□ Packaging
□ Label
□ Batch details
□ COA
□ Invoice
□ Packing list
□ Transport
□ Insurance
□ Customs
□ Destination requirements

PART XX — READY-TO-USE BUSINESS TEMPLATES

Manufacturer Inquiry Template

Subject: Pharmaceutical Product Manufacturing & Export Inquiry

Dear Sir/Madam,

We are interested in sourcing pharmaceutical products for international markets.

Please provide the following information:

  1. Product name
  2. Composition
  3. Strength
  4. Dosage form
  5. Pack size
  6. MOQ
  7. Ex-factory price
  8. FOB price
  9. Manufacturing licence details
  10. GMP certification
  11. COA availability
  12. CPP/COPP availability, where applicable
  13. Private-label capability
  14. OEM capability
  15. Lead time
  16. Shelf life
  17. Export countries
  18. Available regulatory documents

Regards,
[Company Name]

 

SECTION 1 — PHARMA EXPORT BASICS

  1. What is pharmaceutical export?

Answer: Exporting medicines, APIs, formulations, biological products or other pharmaceutical products from India to another country in compliance with Indian and destination-country requirements.

  1. What is a pharmaceutical formulation?

Answer: A finished medicinal dosage form such as a tablet, capsule, syrup, injection, cream, ointment or suspension.

  1. What is an API?

Answer: API means Active Pharmaceutical Ingredient, the substance responsible for the pharmacological effect of a medicine.

  1. What is a finished dosage form?

Answer: A medicine prepared in its final form for administration, such as tablets, capsules, injections or syrups.

  1. What is a generic medicine?

Answer: A medicine designed to be equivalent to an established/reference medicine according to the regulatory requirements of the target market.

  1. What is a branded generic?

Answer: A generic medicine marketed under a brand/trade name rather than simply the generic ingredient name.

  1. What is an OTC medicine?

Answer: OTC means Over-the-Counter, a medicine that can be sold without a prescription where permitted by the applicable country’s rules.

  1. What is a prescription medicine?

Answer: A medicine that requires a prescription under the laws of the relevant market.

  1. What is private-label pharma?

Answer: A manufacturer produces the medicine while another company markets it under its own brand, subject to applicable regulatory and licensing requirements.

  1. What is OEM in pharma?

Answer: OEM generally refers to manufacturing a product for another company according to agreed specifications, branding and regulatory arrangements.

  1. What is contract manufacturing?

Answer: A company contracts a licensed manufacturer to produce pharmaceutical products on its behalf.

  1. What is a pharma exporter?

Answer: A business involved in supplying pharmaceutical products from India to international buyers while managing commercial, regulatory and export requirements.

  1. Can a pharma exporter be different from the manufacturer?

Answer: Yes. An exporter can source products from an appropriately licensed manufacturer, subject to applicable Indian and destination-country requirements.

  1. What is a pharmaceutical importer?

Answer: A company or entity in the destination country legally responsible for importing pharmaceutical products.

  1. What is a distributor?

Answer: A company that purchases or receives products and distributes them through a market’s supply chain.

  1. What is a marketing authorisation?

Answer: Regulatory authorization allowing a medicinal product to be marketed in a particular jurisdiction.

  1. Is Indian approval automatically valid in the USA?

Answer: No. Approval or marketing in India does not automatically authorize commercial marketing in the USA.

  1. Is Indian approval automatically valid in the UK?

Answer: No. The UK has its own medicines licensing requirements administered by the MHRA.

  1. Why is country-specific registration important?

Answer: Because every market can have different requirements for product registration, labeling, manufacturing, importer licensing and pharmacovigilance.

  1. What is the first thing to identify before exporting a medicine?

Answer: Identify the exact product, composition, strength, dosage form, manufacturer and target country, then determine the applicable regulatory pathway.

SECTION 2 — INDIA EXPORT BASICS

  1. What is IEC?

Answer: IEC means Importer Exporter Code, issued by DGFT and generally required for carrying out import/export activities in India.

  1. What is DGFT?

Answer: Directorate General of Foreign Trade, the Indian authority responsible for administering India’s foreign-trade policy and related export/import procedures.

  1. What is CDSCO?

Answer: Central Drugs Standard Control Organisation, India’s central drug regulatory authority.

  1. What is a State Drug Control Authority?

Answer: The state-level drug regulatory authority responsible for various licensing, inspection and enforcement functions under applicable Indian drug laws.

  1. Does every pharma exporter need a manufacturing licence?

Answer: Not necessarily. The requirement depends on whether the business manufactures, wholesales, exports, repacks/relabels, etc., and on the products involved.

  1. Can a trader export medicines manufactured by another company?

Answer: Potentially yes, provided the business structure, licences, sourcing and export activities comply with applicable requirements.

  1. What is a drug manufacturing licence?

Answer: Regulatory authorization allowing an eligible facility to manufacture specified pharmaceutical products.

  1. What is a wholesale drug licence?

Answer: A licence authorizing eligible wholesale activities involving specified drugs, subject to applicable law.

  1. What is GMP?

Answer: Good Manufacturing Practice, a system of requirements intended to ensure medicines are consistently produced and controlled according to quality standards.

  1. What is WHO-GMP?

Answer: GMP requirements based on standards/guidance associated with the World Health Organization; the exact certificate and its acceptance depend on the relevant authority and market.

  1. What is COPP?

Answer: Certificate of Pharmaceutical Product, generally issued within the WHO Certification Scheme framework for pharmaceutical products and used in regulatory processes in various countries.

  1. What is CPP?

Answer: CPP commonly refers to Certificate of Pharmaceutical Product; terminology and exact format can vary by regulatory framework.

  1. What is a Certificate of Analysis?

Answer: A COA provides analytical/test results for a product or batch against specified quality requirements.

  1. What is a batch number?

Answer: A unique identifier assigned to a particular production batch.

  1. What is batch manufacturing?

Answer: Production of a defined quantity of product under controlled manufacturing conditions.

  1. What is shelf life?

Answer: The period during which a product is expected to remain within approved specifications when stored under specified conditions.

  1. What is a product specification?

Answer: A defined set of quality parameters, acceptance criteria and testing requirements for a pharmaceutical product.

  1. What is a stability study?

Answer: A study evaluating how product quality changes over time under specified storage conditions.

  1. What is a specification sheet?

Answer: A document describing product characteristics and quality specifications such as assay, dissolution, impurities and other applicable tests.

  1. Why should an exporter verify the manufacturer?

Answer: To reduce risks involving licences, quality, documentation, regulatory compliance, counterfeit products and shipment problems.

SECTION 3 — PRODUCT EVALUATION

  1. What information should be collected for every medicine?

Answer: Product name, composition, strength, dosage form, pack size, manufacturer, licence information, shelf life, HS code, regulatory status and target market.

  1. What is composition?

Answer: The qualitative and quantitative ingredients contained in a pharmaceutical product.

  1. What is strength?

Answer: The amount/concentration of active ingredient in the specified dosage unit or volume.

  1. What is dosage form?

Answer: The physical pharmaceutical form in which a medicine is administered—for example tablet, capsule, syrup or injection.

  1. What is pack size?

Answer: The number/quantity of units contained in a sales or shipping package.

  1. Why is dosage form important?

Answer: Regulatory classification, manufacturing requirements, stability, labeling and market authorization can depend on dosage form.

  1. Why is strength important?

Answer: Different strengths may have different regulatory status, registration requirements, product codes and labeling.

  1. Can the same medicine have different regulatory status in different countries?

Answer: Yes.

  1. Can the same composition have different brand names?

Answer: Yes. Brand names are often market-specific.

  1. Can a product registered in one country be exported to another without registration?

Answer: Not necessarily. The destination country’s requirements must be checked.

SECTION 4 — USA / FDA

FDA’s current guidance states that foreign establishments manufacturing, repacking, relabeling or salvaging drugs offered for import into the US generally must register with FDA, list applicable drugs, identify known importers and renew registration annually. FDA also checks applicable marketing applications and labeling at import.

  1. What is FDA?

Answer: U.S. Food and Drug Administration, the US federal agency regulating drugs, biologics, medical devices, food and other FDA-regulated products.

  1. Can an Indian medicine simply be shipped to the USA?

Answer: No. The product must meet applicable US requirements before commercial importation.

  1. What is an NDA?

Answer: New Drug Application, an application used to seek FDA approval for a new drug.

  1. What is ANDA?

Answer: Abbreviated New Drug Application, commonly used for approval of eligible generic drugs.

  1. What is BLA?

Answer: Biologics License Application, an application for applicable biological products.

  1. What is IND?

Answer: Investigational New Drug application, used for applicable investigational drugs in clinical research.

  1. Does every US medicine require an NDA?

Answer: No. The applicable pathway depends on the product.

  1. Does every generic medicine require an ANDA?

Answer: Not necessarily. The appropriate regulatory pathway depends on the product and applicable US law.

  1. What is an FDA-registered establishment?

Answer: An eligible establishment that has completed the applicable FDA drug-establishment registration process.

  1. Does FDA registration mean FDA approval?

Answer: No. Registration and listing are not the same as approval of a particular drug application.

  1. What is FDA drug listing?

Answer: The required submission of applicable drug-product information to FDA by establishments subject to drug-listing requirements.

  1. What is NDC?

Answer: National Drug Code, a US drug identification system/code associated with listed drug products.

  1. Does an NDC automatically mean FDA approval?

Answer: No. An NDC/listing should not be treated by itself as proof that a product has FDA approval.

  1. What is a US Agent?

Answer: A US-based representative/contact required for applicable foreign establishments registered with FDA.

  1. What is CGMP?

Answer: Current Good Manufacturing Practice, the applicable US manufacturing quality requirements.

  1. What happens if required FDA information does not match at import?

Answer: FDA may request additional information, delay review or detain the shipment.

  1. Can FDA refuse a drug shipment?

Answer: Yes.

  1. What happens if a product requiring an NDA/ANDA/BLA/IND does not have the required application?

Answer: It can be subject to refusal of admission.

  1. Are APIs regulated by FDA?

Answer: Yes. APIs imported into the US are subject to applicable US requirements.

  1. Are OTC medicines regulated by FDA?

Answer: Yes. Imported OTC medicines must comply with applicable FDA requirements, including applicable labeling and manufacturing requirements.

  1. Are prescription medicines regulated by FDA?

Answer: Yes.

  1. Is labeling important for US export?

Answer: Extremely important. US labeling requirements apply to drugs offered for import.

  1. What is Drug Facts?

Answer: The standardized information panel required for applicable OTC drug labeling.

  1. What is “Rx only”?

Answer: A labeling designation used for prescription drugs as required by applicable US regulations.

  1. Does FDA inspect foreign manufacturing facilities?

Answer: FDA can inspect foreign facilities subject to its regulatory authority.

SECTION 5 — UK / MHRA

  1. What is MHRA?

Answer: Medicines and Healthcare products Regulatory Agency, the UK’s medicines and healthcare-products regulator.

  1. Can an Indian medicine automatically be sold in the UK?

Answer: No. Applicable UK marketing authorization and supply requirements must be satisfied.

  1. What is a UK Marketing Authorisation?

Answer: Regulatory authorization permitting a medicinal product to be marketed in the UK.

  1. Who regulates medicines in Great Britain?

Answer: MHRA is the UK medicines regulator.

  1. What is PL?

Answer: PL is a Product Licence/marketing authorisation number prefix used in the UK’s current licensing framework.

  1. Are UK licensing procedures currently the same as EU procedures?

Answer: No. The UK’s regulatory framework has changed following Brexit and has its own requirements.

  1. What is eCTD?

Answer: Electronic Common Technical Document, a standardized electronic format used for regulatory submissions.

  1. What is pharmacovigilance?

Answer: The science and activities relating to detecting, assessing, understanding and preventing adverse effects and other medicine-related risks.

  1. What is an MAH?

Answer: Marketing Authorisation Holder.

  1. Why is the MAH important?

Answer: The MAH has defined regulatory responsibilities associated with the authorized medicinal product.

The MHRA currently requires UK medicines licensing applications through its regulatory submission processes, with eCTD used for applicable submissions.

SECTION 6 — UAE / GCC / MIDDLE EAST

  1. Can an Indian medicine automatically be sold in UAE?

Answer: No. UAE registration/import requirements must be satisfied.

  1. Who is the local importer?

Answer: The UAE-based entity authorized to import the applicable pharmaceutical products.

  1. Why is a local importer important?

Answer: Pharmaceutical importation and distribution generally require locally compliant entities and regulatory arrangements.

  1. What should you ask a UAE buyer?

Answer: Ask for importer licence details, product registration status, required documents, target pack size, forecast quantity and regulatory requirements.

  1. Should UAE registration be checked before quoting?

Answer: Yes, particularly when the buyer expects immediate commercial supply.

  1. Can one GCC country’s approval automatically cover every GCC country?

Answer: No. Requirements should be checked country by country.

  1. What is SFDA?

Answer: Saudi Food and Drug Authority, Saudi Arabia’s regulatory authority for medicines and other regulated products.

  1. What is SAHPRA?

Answer: South African Health Products Regulatory Authority.

  1. What is TGA?

Answer: Therapeutic Goods Administration, Australia’s regulator of therapeutic goods.

  1. What is Health Canada?

Answer: Canada’s federal department responsible for regulating health products, including drugs.

SECTION 7 — EUROPE / REGULATORY

  1. What is the EU?

Answer: European Union.

  1. Is EU pharmaceutical approval automatically equivalent to UK approval?

Answer: No.

  1. What is EMA?

Answer: European Medicines Agency.

  1. What is a Marketing Authorisation?

Answer: Regulatory permission to market a medicinal product in a jurisdiction.

  1. What is CTD?

Answer: Common Technical Document, a standardized structure for organizing regulatory information.

  1. What are CTD modules?

Answer: Generally:

  • Module 1 – Regional administrative information
  • Module 2 – Summaries
  • Module 3 – Quality
  • Module 4 – Nonclinical
  • Module 5 – Clinical
  1. What is ICH?

Answer: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

  1. Why is ICH important?

Answer: It promotes harmonization of technical requirements for pharmaceutical development and registration.

  1. What is dossier?

Answer: A structured collection of regulatory, technical, quality, safety and efficacy information submitted for product authorization.

  1. What is eCTD?

Answer: An electronic version of the Common Technical Document used for regulatory submissions.

SECTION 8 — QUALITY CONTROL

  1. What is QA?

Answer: Quality Assurance—the overall system ensuring pharmaceutical quality requirements are consistently achieved.

  1. What is QC?

Answer: Quality Control—testing and related activities used to verify that products meet specified requirements.

  1. QA vs QC?

Answer: QA focuses on the quality system and prevention; QC focuses heavily on testing and verification.

  1. What is assay?

Answer: A quantitative measurement of the amount of active ingredient present.

  1. What is dissolution?

Answer: A test measuring the rate and extent to which an active ingredient is released into a specified medium.

  1. What are impurities?

Answer: Unwanted chemical components present in a pharmaceutical substance or product.

  1. What is microbial testing?

Answer: Testing for microorganisms or microbial characteristics as applicable to the product.

  1. What is sterility testing?

Answer: Testing used for applicable sterile products to determine whether viable microorganisms are present.

  1. What is endotoxin?

Answer: A bacterial component that can cause significant biological effects and is particularly important for applicable parenteral products.

  1. What is validation?

Answer: Documented evidence demonstrating that a process, method or system consistently produces the intended result.

  1. What is process validation?

Answer: Evidence that a manufacturing process can consistently produce product meeting predetermined specifications.

  1. What is cleaning validation?

Answer: Evidence that cleaning procedures effectively remove residues to predetermined acceptable levels.

  1. What is analytical method validation?

Answer: Demonstrating that an analytical method is suitable for its intended purpose.

  1. What is deviation?

Answer: A departure from an approved procedure, specification or expected process.

  1. What is CAPA?

Answer: Corrective and Preventive Action—actions taken to correct problems and prevent recurrence.

SECTION 9 — PHARMA DOCUMENTATION

  1. What is a Commercial Invoice?

Answer: The commercial document showing the transaction, products, quantities, values and other required details.

  1. What is a Proforma Invoice?

Answer: A preliminary commercial document/quotation issued before the final commercial invoice.

  1. What is a Packing List?

Answer: A document detailing packages, quantities, weights and shipment packing information.

  1. What is Certificate of Origin?

Answer: A document certifying the country of origin of goods.

  1. What is Bill of Lading?

Answer: A transport document commonly used for ocean shipments.

  1. What is Air Waybill?

Answer: A transport document for air cargo.

  1. What is COA?

Answer: Certificate of Analysis.

  1. What is GMP certificate?

Answer: Evidence issued by a competent authority or recognized framework showing compliance with specified GMP requirements.

  1. What is COPP?

Answer: Certificate of Pharmaceutical Product.

  1. What is Free Sale Certificate?

Answer: A certificate used in certain regulatory/export contexts to demonstrate that a product is freely sold/marketed in the relevant country, where applicable.

  1. What is a batch release document?

Answer: Documentation showing that a particular batch has been reviewed/released according to applicable quality procedures.

  1. What is a product registration certificate?

Answer: Regulatory evidence that the product is authorized/registered in the relevant market.

  1. What is a manufacturing licence?

Answer: Authorization allowing a facility to manufacture specified products under applicable regulations.

  1. What is a Certificate of Pharmaceutical Product used for?

Answer: It can support pharmaceutical product registration or regulatory assessment in importing countries, depending on their requirements.

  1. Can the exporter create a fake certificate if the buyer asks for one?

Answer: Absolutely not. All regulatory and quality documents must be genuine and verifiable.

SECTION 10 — COMMERCIAL QUESTIONS

  1. What is MOQ?

Answer: Minimum Order Quantity.

  1. What is FOB?

Answer: Free On Board, an Incoterms rule defining responsibilities, costs and risk transfer according to the agreed shipment point.

  1. What is CIF?

Answer: Cost, Insurance and Freight, an Incoterms rule applicable to sea/inland-waterway transport under specified conditions.

  1. What is EXW?

Answer: Ex Works, where the seller’s delivery obligation is generally fulfilled by making the goods available at the named place, subject to the Incoterms rules.

  1. What is CFR?

Answer: Cost and Freight, an Incoterms rule for sea/inland-waterway transport.

  1. What is DDP?

Answer: Delivered Duty Paid, an Incoterms rule placing extensive delivery/import obligations on the seller.

  1. What is landed cost?

Answer: The total cost of getting a product to the relevant destination, including applicable product, freight, insurance, duties, taxes and other costs.

  1. How do you calculate export price?

Answer: Consider product cost + packaging + documentation + compliance costs + inland transport + freight + insurance + applicable duties/taxes/fees + financing/overhead + profit.

  1. Should you give the same price to every country?

Answer: No. Freight, regulatory requirements, packaging, taxes, duties, MOQ, payment terms and market conditions differ.

  1. What is a price quotation?

Answer: A formal offer showing product, specification, quantity, price, Incoterm, validity and applicable commercial conditions.

  1. What is quotation validity?

Answer: The period during which the quoted price and terms remain valid.

  1. What is MOQ negotiation?

Answer: Negotiating the minimum order quantity with the manufacturer or buyer.

  1. What is payment term?

Answer: The agreed method and timing of payment, such as advance payment, LC or agreed credit terms.

  1. What is LC?

Answer: Letter of Credit, a bank-mediated payment mechanism subject to its specified terms and documentary conditions.

  1. What is advance payment?

Answer: The buyer pays some or all agreed amount before shipment.

SECTION 11 — BUYER INTERVIEW QUESTIONS

  1. How do you find pharma buyers?

Answer: Through verified distributors/importers, trade fairs, industry directories, regulatory databases, legitimate B2B platforms, business networks and targeted market research.

  1. How do you verify a buyer?

Answer: Verify company registration, website/domain, physical address, import licence where applicable, regulatory credentials, business history, references and payment risk.

  1. Should you trust every buyer who sends an email?

Answer: No.

  1. What is buyer due diligence?

Answer: Checking whether the prospective buyer is legitimate, authorized and commercially reliable.

  1. What information should you request from a foreign pharma buyer?

Answer: Company details, country, importer licence where applicable, product requirement, registration status, forecast quantity, packaging requirements and payment terms.

  1. Should you send your lowest price immediately?

Answer: No. First understand the product specification, quantity, regulatory requirements, Incoterm and payment conditions.

  1. What is a purchase forecast?

Answer: The buyer’s expected future purchasing quantity over a specified period.

  1. What is annual volume?

Answer: Expected total quantity purchased during a year.

  1. What is a distributor agreement?

Answer: A contractual arrangement defining rights and responsibilities between supplier/exporter and distributor.

  1. What is exclusivity?

Answer: A contractual arrangement giving a particular party exclusive rights to distribute or sell a product in a defined market, subject to the agreement and law.

SECTION 12 — PRIVATE LABEL / OEM

  1. Can Indian manufacturers manufacture under a foreign buyer’s brand?

Answer: Yes, where legally and regulatorily permissible and subject to the manufacturer’s capabilities and applicable market requirements.

  1. What is private-label packaging?

Answer: Packaging carrying the buyer’s approved brand and required product information.

  1. Can the exporter choose any brand name?

Answer: No. Trademark, regulatory, labeling and market-specific requirements must be checked.

  1. What is artwork approval?

Answer: Review and approval of the product packaging/label artwork before printing and production.

  1. Who should approve destination-country artwork?

Answer: The responsible regulatory/marketing authorization parties should approve it according to the applicable market requirements.

  1. Can one label be used worldwide?

Answer: Usually you should not assume that. Label requirements differ between markets.

  1. What is a master artwork?

Answer: An approved reference design/document used for controlled packaging production.

  1. What is batch coding?

Answer: Printing identifying information such as batch number, manufacturing date and expiry information as required.

  1. What is serialization?

Answer: Assigning unique identifiers to individual saleable packs where required by the target market.

  1. Why is packaging important in pharma export?

Answer: It protects the product and communicates legally required information about identity, use, storage, batch and expiry.

SECTION 13 — LOGISTICS & SHIPPING

  1. Air freight or sea freight—which is better?

Answer: It depends on urgency, product value, shipment size, stability, temperature requirements and total cost.

  1. What is cold-chain shipping?

Answer: Controlled-temperature transportation for products requiring specified temperature conditions.

  1. What is temperature mapping?

Answer: Evaluation of temperature distribution within a storage/transport environment.

  1. What is a temperature logger?

Answer: A device recording temperature during storage or transportation.

  1. Why is humidity important?

Answer: Some pharmaceutical products are sensitive to moisture and require controlled storage/transport conditions.

  1. What is shipping validation?

Answer: Evidence that the selected shipping process can maintain required product conditions throughout transportation.

  1. What is cargo insurance?

Answer: Insurance covering specified risks associated with goods during transportation.

  1. Who selects the freight forwarder?

Answer: It depends on the agreed Incoterm and commercial arrangement.

  1. What is a freight forwarder?

Answer: A logistics service provider that arranges transportation and related shipment services.

  1. What is customs clearance?

Answer: The process of completing required customs formalities so goods can legally enter or leave a country.

SECTION 14 — COMPLIANCE & RISK

  1. What is a restricted drug?

Answer: A product subject to additional legal/regulatory restrictions because of its nature, ingredients or intended use.

  1. Can narcotic/controlled medicines be exported normally?

Answer: No. Controlled substances can be subject to additional licensing, permits, quotas, documentation and destination-country controls.

  1. Can banned medicines be exported?

Answer: Never assume that a banned/restricted product can be exported. Specific Indian and destination-country rules must be checked.

India’s CDSCO has specific procedures for certain exports involving unapproved/approved new drugs and banned drugs, including a stated NOC procedure in applicable cases.

  1. What is sanctions screening?

Answer: Checking whether the parties, countries or transactions are subject to applicable sanctions/restrictions.

  1. What is denied-party screening?

Answer: Checking customers and transaction parties against applicable restricted/denied-party lists.

  1. What is anti-bribery compliance?

Answer: Following laws and company policies prohibiting bribery and improper payments.

  1. Why is documentation accuracy important?

Answer: Incorrect information can cause regulatory delays, customs problems, shipment detention, financial loss or legal consequences.

  1. Can an exporter alter a COA to satisfy a buyer?

Answer: No.

  1. Can you claim “FDA approved” simply because the factory is FDA registered?

Answer: No. FDA establishment registration and drug approval are different concepts.

  1. What is the biggest pharma-export mistake?

Answer: Treating a pharmaceutical product as an ordinary commodity and ignoring destination-country regulatory requirements.

SECTION 15 — ADVANCED INTERVIEW QUESTIONS

  1. A buyer asks for a medicine that is not registered in his country. What do you do?

Answer: Determine whether registration is required and who will hold the authorization. Do not promise immediate commercial supply until the regulatory pathway is confirmed.

  1. A buyer asks for FDA-approved tablets, but the manufacturer only has FDA establishment registration. What do you say?

Answer: Explain that establishment registration does not by itself establish that the specific drug is FDA-approved. Verify the product’s actual FDA regulatory status.

  1. A buyer asks for a COA before placing an order. What do you do?

Answer: Obtain an appropriate genuine COA/sample COA from the manufacturer, clearly distinguishing a sample/specification document from a batch-specific certificate.

  1. A buyer asks for 100,000 boxes. What do you check first?

Answer: Product specification, registration status, manufacturer capacity, MOQ, production lead time, shelf life, packaging, regulatory documents, price, payment terms and logistics.

  1. A manufacturer offers a very low price. What do you verify?

Answer: Manufacturer identity, licence, GMP status, product quality, specifications, documents, batch history, export experience, packaging and commercial terms.

  1. A foreign buyer says, “No registration is needed; just ship it.” What do you do?

Answer: Do not rely solely on the buyer’s statement. Verify the destination country’s legal and regulatory requirements independently.

  1. A buyer asks for a private-label medicine for the USA. What should you ask?

Answer: Ask who will hold the applicable US regulatory authorization, who is the importer, whether the product has the appropriate FDA pathway, who controls labeling, who is responsible for pharmacovigilance where applicable, and whether the manufacturer meets applicable requirements.

  1. How would you evaluate a new pharma product for export?

Answer:

Product → Composition → Strength → Dosage Form → Manufacturer → Licence → Quality → HS Code → Target Country → Regulatory Status → Registration → Buyer/Importer → Documents → MOQ → Price → Logistics → Payment → Compliance

  1. What is your biggest responsibility as a pharma exporter?

Answer: To ensure that the product, manufacturer, documentation, transaction and shipment comply with applicable Indian and destination-country requirements.

  1. Explain your complete pharma export process in an interview.

Strong interview answer:

“First, I identify the product, composition, strength, dosage form and manufacturer. I verify the manufacturer’s licences, GMP status, quality documents and export capability. Then I select the target country and check its regulatory requirements, product registration status, importer requirements and labeling requirements. After confirming regulatory feasibility, I obtain the manufacturer’s price and MOQ and calculate the export price based on the agreed Incoterm. I verify the buyer and importer, agree on specifications, packaging, payment and documentation, arrange production and quality documentation, coordinate freight and customs clearance, and ensure that all applicable regulatory and shipping requirements are satisfied before dispatch.”

 

 

 

 

CHAPTER: PHARMA MEDICINES, FORMULAS, USES & INTERNATIONAL EXPORT RESTRICTIONS

Nawinza Global Pharma Formula & Export Reference

This chapter provides a practical reference to pharmaceutical active ingredients and formulations relevant to international pharmaceutical trade.

For each medicine/formula, the book should explain:

  1. Generic / Active Ingredient

The internationally recognized active pharmaceutical ingredient (API) or combination.

  1. Example Formulation

Examples of common dosage forms and strengths, such as:

  • Tablet
  • Capsule
  • Oral solution
  • Oral suspension
  • Injection
  • Cream
  • Gel
  • Eye drops
  • Inhalation
  • Transdermal preparation
  • Modified/extended-release formulation
  1. Therapeutic Category

For example:

  • Antibacterial
  • Antiviral
  • Anthelmintic
  • Antidiabetic
  • Antihypertensive
  • Lipid-lowering
  • CNS medicine
  • Analgesic
  • Dermatological
  • Hormonal
  • Oncology
  • Ophthalmic
  • Erectile-dysfunction medicine
  1. Main Medical Uses

Explain the principal approved/recognized therapeutic uses in plain language.

  1. Prescription / OTC Status

Indicate whether the medicine is generally:

  • Prescription medicine
  • OTC/non-prescription in some markets
  • Pharmacy-only
  • Controlled/restricted
  • Hospital/specialist use
  • Country-dependent
  1. Export Classification

Each product will receive a practical status such as:

🟢 REGULAR REGULATED MEDICINE
May be exportable subject to normal product/import/regulatory requirements.

🟡 SPECIAL REGULATORY CHECK
Destination-specific registration, licence, prescription, import permit or other controls may apply.

🟠 CONTROLLED / HIGH-RISK REGULATORY CATEGORY
Additional controlled-substance, narcotics, psychotropic, hormonal, anabolic-steroid or other special controls may apply.

🔴 PROHIBITED / NOT APPROVED FOR THE PROPOSED MARKET OR USE
The product cannot simply be exported/marketed under ordinary pharmaceutical procedures; the exact legal basis must be verified.

⚫ PRODUCT-SPECIFIC INVESTIGATION REQUIRED
The active ingredient may be permitted in one form/use but restricted in another, so the exact formulation, strength, indication and destination must be checked.

COUNTRY RESTRICTION FRAMEWORK

For every formula, the book should separately examine:

🇺🇸 USA

Check:

  • FDA establishment registration
  • Drug listing
  • Applicable NDA/ANDA/BLA/IND or OTC pathway
  • Product approval/status
  • Import admissibility
  • Label requirements
  • CGMP
  • Controlled-substance requirements where applicable
  • Import alerts
  • Destination-specific commercial requirements

FDA states that foreign establishments manufacturing, repacking, relabelling or salvaging drugs for U.S. import generally must register with FDA and list their drugs; applicable marketing authorization requirements also apply.

Important:
“Doctor prescribed it” does not mean an Indian exporter can automatically commercially import it into the USA.

🇬🇧 UK

Check:

  • MHRA requirements
  • Marketing authorisation
  • Wholesale/manufacturing/import licensing
  • Product classification
  • Controlled-drug status
  • Labelling
  • Importer requirements
  • Special/exceptional pathways where applicable

UK guidance states that importing licensed medicines can require appropriate licences, and controlled substances require additional consideration.

For controlled drugs, UK law generally restricts import/export unless an applicable exception or licence applies.

🇦🇪 UAE

Check:

  • UAE pharmaceutical registration
  • Importer/medical warehouse authorization
  • Product registration
  • Controlled-drug classification
  • Prior approvals
  • Prescription requirements
  • Quantity restrictions
  • Labelling
  • Customs documentation

For controlled substances/products, UAE legislation provides for prior approval before import by relevant licensed pharmaceutical establishments.

🇸🇦 Saudi Arabia

Check:

  • SFDA requirements
  • Product registration
  • Importer authorization
  • Controlled-drug status
  • Prescription classification
  • Labelling
  • Import permits
  • Manufacturer documentation

🇧🇷 Brazil

Check:

  • ANVISA requirements
  • Product registration/authorization
  • Importer authorization
  • Prescription classification
  • Controlled-substance requirements
  • Portuguese labelling
  • Import documentation

🇿🇦 South Africa

Check:

  • SAHPRA requirements
  • Product registration
  • Importer authorization
  • Scheduled-substance controls
  • Prescription status
  • Labelling
  • Import permit requirements

🇨🇦 Canada

Check:

  • Health Canada requirements
  • Drug identification/authorization
  • Importer requirements
  • Prescription classification
  • Controlled-substance requirements
  • Product and establishment compliance

🇦🇺 Australia

Check:

  • TGA requirements
  • Australian Register of Therapeutic Goods where applicable
  • Import requirements
  • Prescription status
  • Controlled-drug requirements
  • Sponsor/importer requirements

🇯🇵 Japan

Check:

  • PMDA/MHLW requirements
  • Marketing authorization
  • Import notification/permission requirements
  • Prescription status
  • Controlled substances
  • Japanese labelling requirements

🇩🇪 🇫🇷 🇳🇱 EUROPEAN MARKETS

Do not treat Europe as one single pharmaceutical market for every purpose.

For each product, determine:

  • EU authorization route
  • National requirements
  • Marketing authorization
  • Importer requirements
  • GMP
  • Prescription status
  • Controlled-substance rules
  • Labelling
  • Pharmacovigilance
  • Country-specific requirements

EXAMPLE 1 — SILDENAFIL

Generic: Sildenafil / sildenafil citrate

Therapeutic category: PDE-5 inhibitor

Principal medical use: Treatment of erectile dysfunction; sildenafil has other approved indications in specific formulations/strengths, such as pulmonary arterial hypertension.

Typical formulation: Oral tablets; other dosage forms may exist depending on market.

Prescription status: Generally prescription medicine in many major markets.

Export classification: 🟡 SPECIAL REGULATORY CHECK

Exporter’s questions

Before exporting, determine:

  1. Is the product authorized in the destination country?
  2. Is the specific strength authorized?
  3. Is the formulation authorized?
  4. Is the Indian manufacturer appropriately qualified?
  5. Is the foreign importer authorized?
  6. Is the destination product registration completed?
  7. Is the label compliant?
  8. Are there restrictions on promotional claims?
  9. Are combination products treated differently?
  10. Does the destination require a prescription?

Important: Prescription status is not the same as a prohibition on commercial export. The exporter must distinguish between:

Prescription-only → Restricted import → Controlled substance → Unapproved product → Prohibited product

These are different legal concepts.

EXAMPLE 2 — TADALAFIL

Generic: Tadalafil

Category: PDE-5 inhibitor

Uses: Primarily erectile dysfunction; also used for certain other approved indications depending on formulation and market.

Typical formulation: Oral tablets.

Export classification: 🟡 SPECIAL REGULATORY CHECK

Check:

  • Product authorization
  • Strength
  • Manufacturer
  • Importer
  • Prescription classification
  • Labelling
  • Advertising restrictions
  • Destination registration

Your uploaded list contains tadalafil alone as well as tadalafil + dapoxetine formulations.

Combination products must be checked separately.

EXAMPLE 3 — TADALAFIL + DAPOXETINE

Formula: Tadalafil + dapoxetine

Potential therapeutic positioning: Erectile dysfunction combined with premature-ejaculation treatment.

Export classification: 🟠 HIGHER REGULATORY CHECK

Why?

A combination containing two active ingredients should not automatically be assumed to have the same regulatory status as either ingredient separately.

The exporter should determine:

  • Whether the combination is approved
  • Whether the exact strength is approved
  • Whether the dosage form is approved
  • Whether the combination is recognized in the destination market
  • Whether separate product registration is required
  • Whether both APIs are permitted
  • Whether prescription restrictions apply
  • Whether promotional claims comply with local law

Business lesson:
A combination product can have a different regulatory pathway from its individual ingredients.

EXAMPLE 4 — MODAFINIL

Generic: Modafinil

Category: CNS medicine / wakefulness-promoting agent

Uses: Certain sleep-related disorders according to applicable approved indications.

Export classification: 🟠 SPECIAL / CONTROLLED-STATUS CHECK

Do not classify modafinil as simply “normal medicine” for every destination.

Check:

  • Controlled-drug or psychotropic classification
  • Import licence
  • Prescription requirement
  • Quantity limits
  • Importer authorization
  • Product registration
  • Documentation
  • Destination-specific restrictions

Your uploaded list contains multiple modafinil formulations, including 400 mg and other tablet references.

EXAMPLE 5 — TESTOSTERONE

Generic: Testosterone and testosterone esters

Examples in your source:

  • Testosterone gel
  • Testosterone enanthate injection
  • Testosterone propionate
  • Testosterone cypionate
  • Testosterone combinations

Your source contains several testosterone formulations and strengths.
Category: Androgen / hormone

Uses: Testosterone replacement in appropriately diagnosed patients and other approved indications depending on jurisdiction.

Export classification: 🟠 SPECIAL REGULATORY CHECK

Potential considerations:

  • Prescription status
  • Controlled-substance/scheduled status
  • Import permit
  • Quantity controls
  • Authorized importer
  • Product registration
  • Prescription requirements
  • Record-keeping
  • Anti-diversion controls

Important: A testosterone product must never be treated as an ordinary OTC export merely because it is legally manufactured in India.

EXAMPLE 6 — ISOTRETINOIN

Generic: Isotretinoin

Category: Retinoid / dermatological medicine

Principal use: Severe acne under appropriate medical supervision.

Export classification: 🟠 SPECIAL REGULATORY / SAFETY CHECK

Important considerations can include:

  • Prescription status
  • Pregnancy-related safety controls
  • Risk-management requirements
  • Labelling
  • Patient counselling
  • Product registration
  • Destination-specific pregnancy-prevention requirements

Your source contains isotretinoin capsules and multiple references to isotretinoin.

EXAMPLE 7 — IVERMECTIN

Generic: Ivermectin

Category: Antiparasitic

Uses: Treatment of certain parasitic infections according to approved indications and dosage forms.

Export classification: 🟡 PRODUCT- AND COUNTRY-SPECIFIC CHECK

Your source contains numerous ivermectin entries and different strengths, including 12 mg, 15 mg, 24 mg, 40 mg and 80 mg references.

The exporter must not assume that every strength or dosage form is approved in every market.

Check:

  • Human vs veterinary product
  • Approved indication
  • Strength
  • Formulation
  • Product registration
  • Prescription classification
  • Import requirements

EXAMPLE 8 — SEMAGLUTIDE

Generic: Semaglutide

Category: GLP-1 receptor agonist

Uses: Depending on the specific product and authorization, treatment of type 2 diabetes and/or weight-management indications.

Export classification: 🟠 HIGH REGULATORY CHECK

Important:

  • Exact product
  • Route
  • Dosage form
  • Strength
  • Indication
  • Marketing authorization
  • Manufacturer
  • Cold-chain/storage requirements where applicable
  • Importer
  • Product registration
  • Prescription classification

Your source includes semaglutide and an oral semaglutide reference.

Do not assume that an oral semaglutide formulation has the same regulatory status as an injectable product.

EXAMPLE 9 — PREGABALIN

Generic: Pregabalin

Category: CNS / anticonvulsant / neuropathic-pain medicine

Uses: Depending on authorization, neuropathic pain, epilepsy adjunctive therapy and certain other indications.

Export classification: 🟠 SPECIAL REGULATORY CHECK

Potential requirements:

  • Prescription
  • Controlled/regulated classification in some jurisdictions
  • Import authorization
  • Quantity limits
  • Product registration
  • Authorized importer
  • Record keeping

Your source contains several pregabalin references.

EXAMPLE 10 — TAPENTADOL

Generic: Tapentadol

Category: Centrally acting analgesic

Uses: Certain moderate-to-severe pain indications depending on the approved product.

Export classification: 🔴/🟠 CONTROLLED-SUBSTANCE CHECK

The exact classification varies by country and formulation.

The exporter should determine:

  • Whether it is a controlled drug
  • Schedule/classification
  • Import licence
  • Export authorization
  • Quantity limits
  • Authorized importer
  • Secure transport
  • Record keeping
  • Prescription requirements

Your source includes tapentadol.

EXAMPLE 11 — ZOPICLONE

Generic: Zopiclone

Category: Hypnotic/sedative

Use: Short-term management of insomnia in appropriate circumstances.

Export classification: 🟠 CONTROLLED / SPECIAL REGULATORY CHECK

The destination country’s controlled-drug classification must be checked before accepting an order.

Your source includes zopiclone and eszopiclone references.

EXAMPLE 12 — AZITHROMYCIN

Generic: Azithromycin

Category: Macrolide antibiotic

Uses: Treatment of susceptible bacterial infections according to approved indications.

Export classification: 🟡 REGULATED MEDICINE

Important checks:

  • Prescription status
  • Antimicrobial regulations
  • Product registration
  • Importer authorization
  • Label
  • Strength
  • Dosage form
  • Antibiotic stewardship requirements

Your source contains repeated azithromycin entries.

EXAMPLE 13 — DAPAGLIFLOZIN + METFORMIN

Formula: Dapagliflozin + Metformin

Category: Antidiabetic combination

Uses: Glycemic control in appropriate patients according to approved indications.

Your source specifically lists a 10 mg/1000 mg extended-release combination.

Export classification: 🟡 PRODUCT REGISTRATION CHECK

Check:

  • Exact strength
  • Immediate vs extended release
  • Combination authorization
  • Manufacturer
  • Registration
  • Prescription classification
  • Labelling
  • Importer authorization

EXAMPLE 14 — ADAPALENE + BENZOYL PEROXIDE

Formula: Adapalene + benzoyl peroxide

Category: Topical dermatological / anti-acne

Use: Treatment of acne vulgaris according to approved indications.

Your source contains both 0.1%/2.5% and 0.3%/2.5% formulations.

Important export lesson:

Do not treat:

Adapalene 0.1% + benzoyl peroxide 2.5%

and

Adapalene 0.3% + benzoyl peroxide 2.5%

as automatically interchangeable products.

The exact strength and formulation must be checked against the destination authorization.

EXAMPLE 15 — TRETINOIN

Generic: Tretinoin

Category: Retinoid

Uses: Depending on formulation, commonly dermatological treatment such as acne; oral/other formulations have different indications and much higher regulatory considerations.

Your source includes tretinoin cream and gel formulations.
Export classification: 🟡/🟠 FORMULATION-SPECIFIC CHECK

The exporter must distinguish topical dermatological products from systemic formulations.

EXAMPLE 16 — ISOTRETINOIN vs TRETINOIN

These should be separate entries in the book.

Feature

Isotretinoin

Tretinoin

Drug family

Retinoid

Retinoid

Common dermatological use

Severe acne

Acne/other approved uses depending on formulation

Formulation

Often oral capsules

Often topical

Pregnancy concerns

Very significant

Significant

Export classification

Special regulatory check

Product/formulation-specific

Registration

Destination dependent

Destination dependent

Important: Similar drug families do not mean identical regulatory treatment.

EXAMPLE 17 — HYDROQUINONE

Generic: Hydroquinone

Category: Dermatological depigmenting agent

Use: Treatment of certain hyperpigmentation disorders depending on jurisdiction.

Your source contains Hydroquinone Cream USP.

Export classification: 🟠 COUNTRY-SPECIFIC CHECK

Hydroquinone is an excellent example for this book because its regulatory status can differ substantially depending on:

  • Concentration
  • Cosmetic vs medicinal claim
  • Product formulation
  • Prescription status
  • Destination country’s cosmetic/medicine classification

EXAMPLE 18 — CLOMIPHENE

Generic: Clomiphene citrate

Category: Selective estrogen receptor modulator

Use: Fertility treatment in appropriately selected patients.

Your source includes 25 mg and 50 mg references.
Export classification: 🟠 PRESCRIPTION / PRODUCT REGISTRATION CHECK

EXAMPLE 19 — TOFACITINIB

Generic: Tofacitinib

Category: Janus kinase (JAK) inhibitor

Uses: Certain inflammatory/autoimmune diseases depending on approved indication and market.

Your source lists tofacitinib 5 mg.

Export classification: 🟠 HIGH REGULATORY CHECK

The exporter should verify:

  • Product authorization
  • Indication
  • Strength
  • Safety warnings
  • Prescription status
  • Importer authorization
  • Pharmacovigilance obligations

EXAMPLE 20 — SORAFENIB

Generic: Sorafenib

Category: Antineoplastic / kinase inhibitor

Use: Certain cancers according to approved indications.

Your source lists sorafenib 200 mg.

Export classification: 🟠 SPECIALIST / PRESCRIPTION / REGULATORY CHECK

Oncology products should receive particularly careful verification of registration, indication, quality, supply chain and pharmacovigilance requirements.

IMPORTANT RULE FOR THE ENTIRE DATABASE

“PRESCRIPTION” DOES NOT MEAN “FREE TO IMPORT.”

A doctor prescribing a medicine is not automatically an import authorization.

For commercial pharmaceutical export, the exporter may need to satisfy:

Manufacturer requirements + product authorization + importer authorization + destination registration + import permit + customs requirements + labelling + quality requirements + controlled-substance requirements, where applicable.

The exact combination depends on the product and country.

COUNTRY STATUS CODES FOR THE BOOK

Use these columns in the master Nawinza database:

Code

Meaning

🟢

Generally permitted subject to normal regulatory requirements

🟡

Prescription / registration / import requirements

🟠

Special control, high regulatory risk or controlled-category check

🔴

Prohibited/not approved under the specified circumstances

⚫

Exact product/formulation/country investigation required

Additional column:

“Reason for restriction”

Examples:

  • Prescription-only
  • Controlled substance
  • Psychotropic
  • Narcotic
  • Hormonal/anabolic
  • Product not approved
  • Import licence required
  • Product registration required
  • Special permit required
  • Dosage-form restriction
  • Strength restriction
  • Label restriction
  • Veterinary-only
  • Cosmetic vs medicine classification
  • Unapproved combination
  • Cold-chain requirement
  • Safety programme
  • Country-specific prohibition

This is much more useful than simply writing “BANNED.”

 

 

 

 

 

 

 

 

 

 

 

PART XXI — MCQ QUESTION BANK

Questions 201–300

201. What does API stand for?

  1. Approved Pharmaceutical Import
    B. Active Pharmaceutical Ingredient
    C. Authorized Product Information
    D. Advanced Pharmaceutical Industry

Answer: B

202. Which organization regulates medicines in the USA?

  1. MHRA
    B. FDA
    C. TGA
    D. CDSCO

Answer: B

203. What does FDA stand for?

  1. Federal Drug Administration
    B. Food and Drug Administration
    C. Foreign Drug Authority
    D. Food Development Agency

Answer: B

204. What does CDSCO stand for?

  1. Central Drug Standard Control Organisation
    B. Central Drugs Standard Control Organisation
    C. Central Drug Supply Control Office
    D. Council for Drug Safety Control Organisation

Answer: B

205. Which organization is India’s foreign-trade authority?

  1. FDA
    B. DGFT
    C. MHRA
    D. EMA

Answer: B

206. What is IEC?

  1. International Export Certificate
    B. Importer Exporter Code
    C. Indian Export Code
    D. International Excise Certificate

Answer: B

207. What does GMP stand for?

  1. General Manufacturing Process
    B. Good Manufacturing Practice
    C. Global Medicine Procedure
    D. Government Manufacturing Policy

Answer: B

208. What is COA?

  1. Certificate of Approval
    B. Certificate of Analysis
    C. Certificate of Authorization
    D. Certificate of Application

Answer: B

209. What does MOQ mean?

  1. Minimum Order Quantity
    B. Maximum Order Quantity
    C. Manufacturer Order Quality
    D. Minimum Official Quotation

Answer: A

210. Which document commonly contains batch test results?

  1. COA
    B. Packing List
    C. Purchase Order
    D. Bill of Lading

Answer: A

211. What does NDA mean in US pharmaceutical regulation?

  1. New Drug Application
    B. National Drug Authorization
    C. New Distribution Agreement
    D. National Drug Application

Answer: A

212. What does ANDA mean?

  1. Advanced New Drug Application
    B. Abbreviated New Drug Application
    C. Approved National Drug Application
    D. American New Drug Authorization

Answer: B

213. What does BLA stand for?

  1. Biological Licence Application
    B. Biologics License Application
    C. Basic Laboratory Authorization
    D. Biotech Legal Application

Answer: B

214. Which is NOT automatically equivalent to FDA approval?

  1. Establishment registration
    B. Approved drug application
    C. Applicable marketing authorization
    D. Regulatory approval

Answer: A

215. What is NDC associated with?

  1. US drug identification
    B. Indian customs
    C. UK VAT
    D. Indian GST

Answer: A

216. Which authority regulates medicines in the UK?

  1. FDA
    B. MHRA
    C. CDSCO
    D. TGA

Answer: B

217. What does MHRA stand for?

  1. Medicines and Healthcare products Regulatory Agency
    B. Medical Health Regulatory Authority
    C. Medicines Health Registration Agency
    D. Medical Healthcare Research Authority

Answer: A

218. Which authority regulates therapeutic goods in Australia?

  1. FDA
    B. TGA
    C. MHRA
    D. SFDA

Answer: B

219. Which authority regulates medicines in Saudi Arabia?

  1. SFDA
    B. TGA
    C. FDA
    D. SAHPRA

Answer: A

220. What does SFDA stand for?

  1. Saudi Food and Drug Authority
    B. Saudi Federal Drug Agency
    C. Saudi Food Development Authority
    D. Saudi Formulation Drug Agency

Answer: A

221. What is SAHPRA?

  1. South African Health Products Regulatory Authority
    B. Saudi Health Products Regulatory Authority
    C. South American Health Products Registration Authority
    D. South African Hospital Pharmaceutical Regulatory Agency

Answer: A

222. Which document provides product/batch analytical results?

  1. COA
    B. Invoice
    C. Packing List
    D. Purchase Order

Answer: A

223. Which document primarily describes packages and quantities?

  1. COA
    B. Packing List
    C. GMP
    D. CPP

Answer: B

224. Which document identifies the commercial value of goods?

  1. Commercial Invoice
    B. COA
    C. GMP
    D. Stability Report

Answer: A

225. What is a Proforma Invoice?

  1. Preliminary commercial document/quotation
    B. Final customs declaration only
    C. Quality certificate
    D. GMP certificate

Answer: A

226. What does FOB mean?

  1. Free On Board
    B. Freight On Business
    C. Free Overseas Billing
    D. Foreign Order Booking

Answer: A

227. What does CIF mean?

  1. Cost, Insurance and Freight
    B. Customs, Import and Freight
    C. Cost, Invoice and Finance
    D. Cargo Insurance Form

Answer: A

228. What does CFR mean?

  1. Cost and Freight
    B. Customs Freight Rate
    C. Cargo Financial Report
    D. Certificate Freight Requirement

Answer: A

229. Which Incoterm places extensive import/delivery obligations on the seller?

  1. EXW
    B. DDP
    C. FOB
    D. FCA

Answer: B

230. What is private-label manufacturing?

  1. Manufacturing under another company’s brand
    B. Manufacturing without quality control
    C. Manufacturing only APIs
    D. Importing medicines privately

Answer: A

231. What is OEM?

  1. Original Equipment Manufacturer
    B. Overseas Export Medicine
    C. Official Export Manufacturer
    D. Original Export Market

Answer: A

232. What is QA?

  1. Quality Assurance
    B. Quality Authorization
    C. Quantity Assessment
    D. Quick Approval

Answer: A

233. What is QC?

  1. Quality Control
    B. Quantity Certificate
    C. Quality Customs
    D. Quick Compliance

Answer: A

234. What does CAPA stand for?

  1. Corrective and Preventive Action
    B. Certificate Approval and Product Authorization
    C. Customs and Pharmaceutical Administration
    D. Corrective Approval Process Application

Answer: A

235. What is pharmacovigilance?

  1. Monitoring medicine safety and related risks
    B. Product pricing
    C. Freight calculation
    D. Customs valuation

Answer: A

236. What is shelf life?

  1. Period during which product is expected to remain within specifications under specified conditions
    B. Manufacturing time
    C. Shipping time
    D. Registration period only

Answer: A

237. What is batch number?

  1. Identifier for a production batch
    B. Buyer registration number
    C. HS code
    D. Invoice number only

Answer: A

238. What is HS Code?

  1. Harmonized System code used for goods classification
    B. Health Safety certificate
    C. Hospital Supply number
    D. Healthcare Standard

Answer: A

239. Why is HS classification important?

  1. Customs/trade classification
    B. It replaces drug approval
    C. It replaces GMP
    D. It guarantees buyer payment

Answer: A

240. What is an importer?

  1. Destination-country entity importing goods
    B. Indian manufacturer
    C. Freight company only
    D. Quality laboratory

Answer: A

241. What should an exporter do before accepting a large foreign order?

  1. Verify the buyer
    B. Ignore the buyer’s identity
    C. Ship immediately
    D. Change the COA

Answer: A

242. What is buyer due diligence?

  1. Checking buyer legitimacy and business/regulatory status
    B. Calculating tablet weight
    C. Testing API
    D. Printing labels

Answer: A

243. Which is a buyer red flag?

  1. Refusal to provide company details
    B. Proper registration
    C. Verified importer licence
    D. Clear purchase order

Answer: A

244. Which is a manufacturer red flag?

  1. Refusal to provide required licence information
    B. Valid documentation
    C. Verifiable facility
    D. Transparent quality system

Answer: A

245. What should you do if a buyer requests a fake certificate?

  1. Refuse
    B. Prepare it
    C. Modify an old certificate
    D. Ask another exporter to prepare it

Answer: A

246. What is cold-chain logistics?

  1. Temperature-controlled logistics
    B. Sea freight only
    C. Air freight only
    D. Frozen food logistics only

Answer: A

247. Why are temperature loggers used?

  1. To record temperature conditions
    B. To calculate customs duty
    C. To create invoices
    D. To determine HS codes

Answer: A

248. What is a freight forwarder?

  1. Logistics service provider arranging transportation/shipping services
    B. Drug regulator
    C. Pharmaceutical manufacturer
    D. Foreign buyer only

Answer: A

249. What is a Bill of Lading?

  1. Transport document commonly used for sea shipments
    B. GMP certificate
    C. Drug licence
    D. COA

Answer: A

250. What is an Air Waybill?

  1. Air cargo transport document
    B. Drug registration
    C. Manufacturing licence
    D. COA

Answer: A

251. Which is generally faster?

  1. Air freight
    B. Sea freight
    C. Both always identical
    D. Neither

Answer: A

252. What is a Letter of Credit?

  1. Bank-mediated payment mechanism subject to specified terms
    B. Drug licence
    C. Manufacturing certificate
    D. Shipping label

Answer: A

253. What is advance payment?

  1. Buyer pays before shipment according to agreed terms
    B. Seller pays buyer
    C. Customs pays exporter
    D. Manufacturer pays importer

Answer: A

254. What is open-account trade?

  1. Buyer pays later under agreed credit terms
    B. Buyer always pays cash
    C. No contract is required
    D. Government pays seller

Answer: A

255. What is product registration?

  1. Regulatory authorization/registration process for a product in a market
    B. Bank registration
    C. Freight registration
    D. Trademark only

Answer: A

256. Is trademark registration the same as medicine registration?

  1. No
    B. Yes
    C. Always
    D. Only in India

Answer: A

257. Can one medicine have different brand names in different countries?

  1. Yes
    B. No
    C. Never
    D. Only for APIs

Answer: A

258. What is stability testing?

  1. Testing product quality over time under specified conditions
    B. Testing buyer reliability
    C. Freight testing
    D. Customs testing only

Answer: A

259. What is validation?

  1. Documented evidence that a process/method consistently achieves its intended purpose
    B. Price approval
    C. Buyer verification
    D. Export promotion

Answer: A

260. What is a deviation?

  1. Departure from an approved procedure/specification or expected condition
    B. Product registration
    C. Buyer payment
    D. Freight quotation

Answer: A

261. Which department primarily performs laboratory testing?

  1. QC
    B. Sales
    C. Finance
    D. Logistics

Answer: A

262. Which function focuses on the overall quality system?

  1. QA
    B. Sales
    C. Customs
    D. Freight

Answer: A

263. What does GMP focus on?

  1. Consistent pharmaceutical manufacturing and quality systems
    B. Buyer acquisition only
    C. Freight pricing
    D. Currency exchange

Answer: A

264. What is an API manufacturer?

  1. Manufacturer of active pharmaceutical ingredients
    B. Finished-goods distributor only
    C. Freight company
    D. Customs authority

Answer: A

265. What is a finished formulation manufacturer?

  1. Manufacturer of finished medicinal dosage forms
    B. Shipping company
    C. Bank
    D. Customs broker

Answer: A

266. What should be checked before selecting a manufacturer?

  1. Licence and product capability
    B. Only website design
    C. Only lowest price
    D. Only social-media followers

Answer: A

267. What should be checked before private-label production?

  1. Product, manufacturer, regulatory and packaging requirements
    B. Only logo colour
    C. Only carton size
    D. Only website domain

Answer: A

268. What is artwork approval?

  1. Approval of packaging/label design and required information
    B. Buyer payment
    C. Freight booking
    D. Customs valuation

Answer: A

269. Why is country-specific labeling important?

  1. Different countries can have different legal labeling requirements
    B. All countries have identical rules
    C. Labels never matter
    D. Only carton colour matters

Answer: A

270. What is an MAH?

  1. Marketing Authorisation Holder
    B. Manufacturer Approval Holder
    C. Medical Application Handler
    D. Market Audit Holder

Answer: A

271. What is a regulatory dossier?

  1. Structured collection of regulatory/technical information
    B. Freight invoice
    C. Buyer list
    D. Packing material

Answer: A

272. What is CTD?

  1. Common Technical Document
    B. Customs Trade Document
    C. Certificate Technical Data
    D. Commercial Trade Declaration

Answer: A

273. What is eCTD?

  1. Electronic Common Technical Document
    B. Export Customs Trade Document
    C. Electronic Customs Tax Declaration
    D. Export Certificate Technical Data

Answer: A

274. What is ICH?

  1. International Council for Harmonisation
    B. Indian Customs House
    C. International Customs Hub
    D. Indian Chemical Health Authority

Answer: A

275. What is a generic medicine?

  1. Medicine meeting applicable requirements as a generic equivalent of a reference product
    B. Counterfeit medicine
    C. Medicine without quality standards
    D. Unregistered medicine

Answer: A

276. What is counterfeit medicine?

  1. Falsely represented medicine involving identity/source/composition or other fraudulent characteristics
    B. Generic medicine
    C. Private-label medicine
    D. OTC medicine

Answer: A

277. Should counterfeit products ever be exported?

  1. No
    B. Yes
    C. Only with buyer permission
    D. Only to developing markets

Answer: A

278. What is an OTC medicine?

  1. Over-the-Counter medicine
    B. Official Trade Certificate
    C. Overseas Treatment Certificate
    D. Original Tablet Composition

Answer: A

279. What is a prescription medicine?

  1. Medicine subject to prescription requirements in the relevant market
    B. Medicine without regulations
    C. Food product
    D. Packaging material

Answer: A

280. What should determine whether a medicine can be commercially marketed in another country?

  1. Applicable destination-country regulatory requirements
    B. Indian price only
    C. Exporter’s preference
    D. Buyer’s WhatsApp message

Answer: A

281. What is a US Agent?

  1. Applicable US-based representative/contact for a foreign establishment
    B. US customs officer
    C. US pharmacist
    D. Drug manufacturer

Answer: A

282. Does FDA registration automatically prove a product is approved?

  1. No
    B. Yes
    C. Always
    D. Only for generics

Answer: A

283. What is CGMP?

  1. Current Good Manufacturing Practice
    B. Central Government Medicine Policy
    C. Certified Generic Manufacturing Product
    D. Current Global Medicine Procedure

Answer: A

284. What is pharmacovigilance primarily concerned with?

  1. Medicine safety
    B. Freight costs
    C. Customs duty
    D. Marketing design

Answer: A

285. What is a product complaint?

  1. Report concerning a product’s quality, safety, packaging or other issue
    B. Price quotation
    C. Freight booking
    D. Purchase order

Answer: A

286. What is a product recall?

  1. Process of removing/returning affected products from the market or supply chain
    B. New product launch
    C. Buyer acquisition
    D. Export quotation

Answer: A

287. What is change control?

  1. Controlled process for evaluating and managing changes
    B. Currency exchange
    C. Price negotiation only
    D. Buyer selection

Answer: A

288. What is a quality agreement?

  1. Agreement defining quality responsibilities between relevant parties
    B. Purchase order only
    C. Freight document
    D. Bank statement

Answer: A

289. What is a manufacturing agreement?

  1. Contract defining manufacturing responsibilities and commercial/legal terms
    B. COA
    C. Bill of Lading
    D. Certificate of Origin

Answer: A

290. What is a Certificate of Origin?

  1. Document identifying the origin of goods
    B. COA
    C. GMP certificate
    D. Drug registration certificate

Answer: A

291. What is landed cost?

  1. Total relevant cost of bringing goods to the destination
    B. Manufacturing cost only
    C. Freight only
    D. Product price only

Answer: A

292. What is exporter margin?

  1. Profit component included in the export price
    B. Customs duty
    C. Buyer discount
    D. Freight cost

Answer: A

293. Should export price be calculated only from factory price?

  1. No
    B. Yes
    C. Always
    D. Only for tablets

Answer: A

294. Which can affect export price?

  1. Freight
    B. Insurance
    C. Packaging
    D. All of the above

Answer: D

295. What is lead time?

  1. Time required to prepare/manufacture an order before shipment
    B. Product shelf life
    C. Freight insurance
    D. Payment method

Answer: A

296. What is MOQ?

  1. Minimum Order Quantity
    B. Maximum Order Quality
    C. Manufacturer Official Quotation
    D. Medicine Order Qualification

Answer: A

297. What should an exporter do if the buyer says registration is unnecessary?

  1. Independently verify the requirement
    B. Immediately ship
    C. Ignore regulations
    D. Change the invoice

Answer: A

298. What is the safest approach to regulatory documents?

  1. Use genuine, current and verifiable documents
    B. Edit certificates
    C. Copy another manufacturer’s documents
    D. Create documents yourself

Answer: A

299. What is the most important principle in pharmaceutical exporting?

  1. Compliance and product quality
    B. Lowest possible price
    C. Fastest shipment regardless of regulations
    D. Maximum markup

Answer: A

300. What should an exporter do before shipping a pharmaceutical product?

  1. Confirm applicable regulatory, documentation, commercial and logistics requirements
    B. Ship immediately
    C. Wait for customs to decide everything
    D. Ask the buyer to handle everything

Answer: A

MCQ ANSWER KEY — 201–300

Q

Ans

Q

Ans

Q

Ans

Q

Ans

201

B

226

A

251

A

276

A

202

B

227

A

252

A

277

A

203

B

228

A

253

A

278

A

204

B

229

B

254

A

279

A

205

B

230

A

255

A

280

A

206

B

231

A

256

A

281

A

207

B

232

A

257

A

282

A

208

B

233

A

258

A

283

A

209

A

234

A

259

A

284

A

210

A

235

A

260

A

285

A

211

A

236

A

261

A

286

A

212

B

237

A

262

A

287

A

213

B

238

A

263

A

288

A

214

A

239

A

264

A

289

A

215

A

240

A

265

A

290

A

216

B

241

A

266

A

291

A

217

A

242

A

267

A

292

A

218

B

243

A

268

A

293

A

219

A

244

A

269

A

294

D

220

A

245

A

270

A

295

A

221

A

246

A

271

A

296

A

222

A

247

A

272

A

297

A

223

B

248

A

273

A

298

A

224

A

249

A

274

A

299

A

225

A

250

A

275

A

300

A

 

PART XXI — ADVANCED MCQs

MCQs 301–400

Regulatory, USA/FDA, UK/MHRA, UAE, EU, Quality & Documentation

  1. Which statement about FDA establishment registration is correct?
  2. It automatically approves every medicine manufactured there
    B. It is the same as an ANDA approval
    C. It is a regulatory registration and does not by itself mean a specific drug is approved
    D. It replaces drug listing

Answer: C

  1. What is the primary purpose of an ANDA?
  2. To register a manufacturing facility
    B. To seek approval for an eligible generic drug
    C. To register a trademark
    D. To obtain an export licence from India

Answer: B

  1. Which US application is generally associated with a new drug?
  2. NDA
    B. IEC
    C. COPP
    D. COA

Answer: A

  1. Which application is associated with applicable biological products?
  2. BLA
    B. IEC
    C. ANDA
    D. COA

Answer: A

  1. What should an Indian exporter do if a US buyer says, “Your Indian licence is enough for the USA”?
  2. Accept the statement
    B. Ship immediately
    C. Verify the US regulatory requirements independently
    D. Change the country on the invoice

Answer: C

  1. Which organization regulates medicines in the UK?
  2. FDA
    B. MHRA
    C. CDSCO
    D. TGA

Answer: B

  1. Which statement is correct?
  2. UK and US pharmaceutical regulations are identical
    B. UK and Indian approvals are automatically interchangeable
    C. The UK has its own regulatory requirements
    D. FDA controls the UK market

Answer: C

  1. What is an MAH?
  2. Marketing Authorisation Holder
    B. Manufacturing Audit Head
    C. Medicine Approval Handler
    D. Market Analysis Holder

Answer: A

  1. What is pharmacovigilance concerned with?
  2. Product pricing
    B. Medicine safety and adverse effects
    C. Freight calculation
    D. Customs valuation

Answer: B

  1. What is a regulatory dossier?
  2. A collection of regulatory and technical information
    B. A bank statement
    C. A packing list
    D. A freight invoice

Answer: A

  1. Which CTD module generally contains quality information?
  2. Module 1
    B. Module 2
    C. Module 3
    D. Module 5

Answer: C

  1. Which CTD module generally contains clinical information?
  2. Module 1
    B. Module 3
    C. Module 4
    D. Module 5

Answer: D

  1. What is eCTD?
  2. Electronic Common Technical Document
    B. Export Customs Trade Document
    C. Electronic Certificate of Trade
    D. Export Certificate Technical Data

Answer: A

  1. What is ICH primarily associated with?
  2. International harmonisation of pharmaceutical technical requirements
    B. Customs valuation
    C. Freight forwarding
    D. Export banking

Answer: A

  1. What is GMP primarily concerned with?
  2. Pharmaceutical manufacturing quality
    B. Export pricing
    C. Buyer verification
    D. Freight booking

Answer: A

  1. What is GLP?
  2. Good Laboratory Practice
    B. Global Logistics Procedure
    C. General Licence Policy
    D. Good Label Printing

Answer: A

  1. What is GCP?
  2. Good Clinical Practice
    B. General Customs Procedure
    C. Global Certificate Process
    D. Good Commercial Pricing

Answer: A

  1. What is GDP in pharmaceutical distribution?
  2. Good Distribution Practice
    B. Gross Domestic Product only
    C. General Drug Pricing
    D. Global Distribution Product

Answer: A

  1. Why is GDP important?
  2. It supports appropriate storage and distribution practices
    B. It determines the selling price
    C. It replaces product registration
    D. It replaces GMP

Answer: A

  1. What is a temperature excursion?
  2. A temperature condition outside the specified range
    B. A customs delay
    C. A pricing change
    D. A manufacturing licence

Answer: A

  1. What is a stability-indicating method?
  2. An analytical method capable of detecting relevant changes in product quality over time
    B. A shipping method
    C. A pricing method
    D. A customs method

Answer: A

  1. What is assay testing used for?
  2. Measuring the amount of active ingredient according to the applicable method/specification
    B. Checking the buyer’s bank account
    C. Calculating freight
    D. Checking carton colour

Answer: A

  1. What is dissolution testing particularly relevant to?
  2. Drug release from applicable dosage forms
    B. Customs clearance
    C. Buyer verification
    D. Currency conversion

Answer: A

  1. What are impurities?
  2. Unwanted components present in a pharmaceutical substance/product
    B. Packaging materials only
    C. Shipping documents
    D. Buyer information

Answer: A

  1. What is sterility testing particularly relevant to?
  2. Applicable sterile products
    B. All invoices
    C. All tablets
    D. Customs documents

Answer: A

  1. What is endotoxin testing particularly important for?
  2. Applicable parenteral/sterile products
    B. Export invoices
    C. Cartons
    D. Tablets only

Answer: A

  1. What is CAPA?
  2. Corrective and Preventive Action
    B. Customs Approval and Product Authorization
    C. Certificate and Packaging Agreement
    D. Commercial Audit and Price Analysis

Answer: A

  1. What is deviation management?
  2. Investigation and appropriate handling of departures from approved requirements
    B. Buyer acquisition
    C. Freight negotiation
    D. Currency conversion

Answer: A

  1. What is change control?
  2. Controlled evaluation and management of proposed changes
    B. Changing the buyer after shipment
    C. Changing the invoice value illegally
    D. Changing the HS code without assessment

Answer: A

  1. What is validation?
  2. Documented evidence that a process/method performs as intended
    B. Price negotiation
    C. Buyer registration
    D. Export promotion

Answer: A

  1. What is a COA?
  2. Certificate of Analysis
    B. Certificate of Authorization
    C. Customs Order Approval
    D. Commercial Overseas Agreement

Answer: A

  1. Should a batch-specific COA be fabricated before manufacturing?
  2. Yes
    B. No
    C. Only for large buyers
    D. Only for private label

Answer: B

  1. What is a Certificate of Origin used for?
  2. Identifying the origin of goods
    B. Proving GMP
    C. Proving FDA approval
    D. Proving product efficacy

Answer: A

  1. What is a Commercial Invoice?
  2. Commercial document showing transaction/product/value information
    B. Quality certificate
    C. Manufacturing licence
    D. Regulatory dossier

Answer: A

  1. What is a Packing List?
  2. Shipment/package details
    B. Product registration
    C. GMP certificate
    D. Buyer licence

Answer: A

  1. What is a Purchase Order?
  2. Buyer’s formal order for specified goods/services
    B. Manufacturing licence
    C. COA
    D. Certificate of Origin

Answer: A

  1. What is a Proforma Invoice?
  2. Preliminary commercial document/quotation
    B. Laboratory report
    C. Drug licence
    D. GMP certificate

Answer: A

  1. What is a Bill of Lading?
  2. Transport document commonly used for ocean shipments
    B. Drug registration certificate
    C. COA
    D. Manufacturing licence

Answer: A

  1. What is an Air Waybill?
  2. Air transportation document
    B. Quality certificate
    C. Import licence
    D. Product registration

Answer: A

  1. What is a Certificate of Pharmaceutical Product?
  2. A pharmaceutical regulatory certificate used in applicable regulatory contexts
    B. A freight document
    C. A bank certificate
    D. A trademark certificate

Answer: A

  1. What is COPP?
  2. Certificate of Pharmaceutical Product under the applicable certification framework
    B. Certificate of Packing Procedure
    C. Customs Overseas Product Permit
    D. Commercial Order Processing Permit

Answer: A

  1. Should an exporter assume every country accepts the same CPP/COPP format?
  2. Yes
    B. No
    C. Only for generic medicines
    D. Only for APIs

Answer: B

  1. Why must regulatory documents be current?
  2. Authorities/buyers may require valid/current information
    B. Old documents are always accepted
    C. Expiry dates do not matter
    D. It only affects freight

Answer: A

  1. What should an exporter do if a GMP certificate has expired?
  2. Use it anyway
    B. Verify and obtain the appropriate current evidence
    C. Change the expiry date
    D. Ignore it

Answer: B

  1. What is a Free Sale Certificate?
  2. A certificate that may demonstrate free sale/marketing status where applicable
    B. A freight document
    C. A COA
    D. A bank guarantee

Answer: A

  1. What is product registration?
  2. Regulatory authorization/registration process for a medicinal product in a market
    B. Trademark registration only
    C. Exporter bank registration
    D. Shipping registration

Answer: A

  1. What is marketing authorization?
  2. Regulatory permission to market a medicinal product under applicable law
    B. A commercial quotation
    C. A shipping document
    D. A bank document

Answer: A

  1. Can trademark registration replace medicine registration?
  2. Yes
    B. No
    C. Only in Africa
    D. Only for OTC products

Answer: B

  1. What is an importer licence?
  2. Authorization held by an eligible importing entity where required
    B. Exporter’s GST certificate
    C. Manufacturer’s GMP
    D. COA

Answer: A

  1. Why should an exporter identify the importer early?
  2. Regulatory and customs responsibilities may depend on the importer
    B. Importers never matter
    C. Only freight depends on importer
    D. It determines API purity

Answer: A

MCQs 351–400 — Commercial & Export Operations

  1. What does MOQ stand for?
  2. Minimum Order Quantity
    B. Maximum Order Quantity
    C. Manufacturer Order Quality
    D. Market Order Quotation

Answer: A

  1. What is lead time?
  2. Time required to prepare an order
    B. Shelf life
    C. Payment period only
    D. Freight insurance period

Answer: A

  1. What does EXW mean?
  2. Ex Works
    B. Export Works
    C. External Warehouse
    D. Export Without Warranty

Answer: A

  1. What does FOB mean?
  2. Free On Board
    B. Freight On Board
    C. Foreign Order Booking
    D. Free Overseas Billing

Answer: A

  1. What does CIF include under the Incoterms rule?
  2. Cost, Insurance and Freight
    B. Customs, Import and Freight
    C. Cost, Invoice and Finance
    D. Cargo Insurance Fee

Answer: A

  1. What does CFR mean?
  2. Cost and Freight
    B. Customs Freight Rate
    C. Cargo Financial Report
    D. Certificate Freight Requirement

Answer: A

  1. Which should be specified with an Incoterm?
  2. Appropriate named place/port as applicable
    B. Buyer’s nickname
    C. Product colour only
    D. Social-media account

Answer: A

  1. What is landed cost?
  2. Total relevant cost to bring goods to the destination
    B. Factory price only
    C. Freight only
    D. Insurance only

Answer: A

  1. What can increase landed cost?
  2. Freight
    B. Insurance
    C. Duties/taxes where applicable
    D. All of the above

Answer: D

  1. What is export margin?
  2. Profit included in export pricing
    B. Customs penalty
    C. Freight cost
    D. Buyer tax

Answer: A

  1. Should the exporter calculate only the factory purchase price?
  2. Yes
    B. No
    C. Only for tablets
    D. Only for USA

Answer: B

  1. What is payment risk?
  2. Risk that the seller does not receive expected payment
    B. Risk of tablet breakage only
    C. Risk of customs classification
    D. Risk of temperature excursion only

Answer: A

  1. Which payment method can provide structured bank-backed documentary protection subject to its terms?
  2. Letter of Credit
    B. WhatsApp
    C. Verbal promise
    D. Social media

Answer: A

  1. What should you verify before accepting an open-account order?
  2. Buyer creditworthiness
    B. Only buyer logo
    C. Only product colour
    D. Only freight rate

Answer: A

  1. What is buyer due diligence?
  2. Verification of buyer identity, legitimacy and relevant capability
    B. Product testing
    C. Freight calculation
    D. Label design

Answer: A

  1. What is supplier due diligence?
  2. Verification of supplier/manufacturer capability and compliance
    B. Buyer marketing
    C. Freight booking
    D. Currency conversion

Answer: A

  1. What is a red flag?
  2. Warning sign indicating possible risk
    B. Product certificate
    C. Export licence
    D. Buyer order

Answer: A

  1. Which is a red flag?
  2. Buyer refuses to provide basic company information
    B. Verified company registration
    C. Valid importer documentation
    D. Clear purchase order

Answer: A

  1. Which is a manufacturer red flag?
  2. Refusal to provide appropriate licence evidence
    B. Valid licence
    C. Transparent quality documentation
    D. Verifiable facility

Answer: A

  1. What should an exporter do when information is inconsistent?
  2. Investigate before proceeding
    B. Ignore it
    C. Alter the documents
    D. Ship faster

Answer: A

  1. What is private label?
  2. Product marketed under another company’s brand
    B. Counterfeit product
    C. Product without a manufacturer
    D. Unregistered product by definition

Answer: A

  1. What is OEM in a pharma context?
  2. Manufacturing for another business under agreed specifications/arrangements
    B. Exporting without documents
    C. Only API trading
    D. Customs brokerage

Answer: A

  1. Who should approve destination-market artwork?
  2. Appropriate responsible regulatory/marketing parties
    B. Freight driver
    C. Customs guard
    D. Random buyer employee

Answer: A

  1. Can the exporter simply copy a competitor’s packaging?
  2. Yes
    B. No
    C. Only if cheaper
    D. Only for Africa

Answer: B

  1. What should private-label packaging comply with?
  2. Applicable regulatory and labeling requirements
    B. Only the exporter’s preference
    C. Only Indian design preferences
    D. Only buyer colour preference

Answer: A

  1. What is trademark due diligence?
  2. Checking whether a proposed brand can legally be used/registered
    B. Checking freight
    C. Checking batch weight
    D. Checking COA

Answer: A

  1. What is a quality agreement?
  2. Defines quality-related responsibilities between parties
    B. Price quotation
    C. Packing list
    D. Certificate of Origin

Answer: A

  1. What is a supply agreement?
  2. Contract governing supply arrangements
    B. GMP certificate
    C. COA
    D. Air Waybill

Answer: A

  1. What is a distribution agreement?
  2. Agreement governing distribution rights/responsibilities
    B. Manufacturing test
    C. Freight document
    D. COA

Answer: A

  1. What is exclusivity?
  2. Contractual exclusive rights within defined scope/territory
    B. Mandatory in every export
    C. Same as GMP
    D. Same as registration

Answer: A

  1. What is cold-chain packaging?
  2. Packaging designed/qualified to maintain required temperature conditions
    B. Normal carton
    C. Product label
    D. Commercial invoice

Answer: A

  1. What is temperature mapping?
  2. Assessment of temperature distribution in a defined environment
    B. Route mapping only
    C. Buyer mapping
    D. Price mapping

Answer: A

  1. What is a temperature logger?
  2. Device that records temperature over time
    B. Customs document
    C. Payment instrument
    D. Product registration

Answer: A

  1. Why is shipping validation important for sensitive products?
  2. To demonstrate that transportation can maintain required conditions
    B. To reduce invoice size
    C. To create a buyer list
    D. To replace product registration

Answer: A

  1. What is cargo insurance?
  2. Insurance covering specified transportation risks
    B. Drug licence
    C. Product registration
    D. GMP

Answer: A

  1. What is customs clearance?
  2. Completing applicable customs procedures for import/export
    B. Product testing
    C. Manufacturing
    D. Marketing authorization

Answer: A

  1. Who commonly assists with transportation arrangements?
  2. Freight forwarder
    B. Drug regulator
    C. Buyer pharmacist only
    D. Laboratory

Answer: A

  1. What is an HS code used for?
  2. Classification of goods for customs/trade purposes
    B. Product approval
    C. GMP
    D. Trademark

Answer: A

  1. Can an exporter deliberately use an incorrect HS code?
  2. Yes
    B. No
    C. Only if buyer requests it
    D. Only for small shipments

Answer: B

  1. What should an exporter do if uncertain about classification?
  2. Obtain appropriate professional/customs guidance and verify the classification
    B. Guess
    C. Copy another invoice
    D. Let the buyer invent one

Answer: A

  1. What is export documentation reconciliation?
  2. Checking that key documents contain consistent information
    B. Checking only product colour
    C. Checking social media
    D. Checking employee attendance

Answer: A

  1. Why should product name and quantity be consistent across documents?
  2. To reduce customs/regulatory discrepancies
    B. To improve website ranking
    C. To reduce tablet weight
    D. To change the price

Answer: A

  1. What can happen if shipping documents contain significant discrepancies?
  2. Delay, inquiry, detention or other problems may occur
    B. Guaranteed faster clearance
    C. Automatic approval
    D. Lower freight

Answer: A

  1. What is document control?
  2. Controlled creation, approval, distribution and revision of documents
    B. Customs payment only
    C. Buyer acquisition
    D. Freight calculation

Answer: A

  1. Why should obsolete documents be controlled?
  2. To prevent unintended use of outdated information
    B. To increase MOQ
    C. To reduce freight
    D. To increase product strength

Answer: A

  1. What is a batch record?
  2. Controlled manufacturing documentation relating to a batch
    B. Buyer quotation
    C. Freight invoice
    D. Certificate of Origin

Answer: A

  1. What is a product specification?
  2. Defined quality requirements/criteria for a product
    B. Buyer email
    C. Freight quotation
    D. Payment receipt

Answer: A

  1. What is a Certificate of Analysis generally linked to?
  2. Tested batch/material/product results
    B. Buyer registration only
    C. Freight insurance
    D. Trademark registration

Answer: A

  1. What should be done with a suspected falsified certificate?
  2. Stop relying on it and investigate/verify through appropriate channels
    B. Use it
    C. Edit it
    D. Send it to another buyer

Answer: A

  1. What is the correct overall philosophy for pharma exports?
  2. Sell first and check regulations later
    B. Compliance first, then commercial execution
    C. Lowest price first
    D. Ship first and solve documentation later

Answer: B

MCQs 401–500

Scenario-Based Pharma Export Questions

  1. An Indian manufacturer has a valid manufacturing licence but no evidence of required destination-country authorization. What should the exporter do?
  2. Ship immediately
    B. Verify destination requirements before shipment
    C. Tell the buyer Indian approval is enough
    D. Change the product name

Answer: B

  1. A buyer asks you to put a lower value on the invoice to reduce customs duty. What should you do?
  2. Agree
    B. Refuse and use accurate documentation
    C. Split the invoice secretly
    D. Use cash

Answer: B

  1. A buyer asks you to describe a medicine as a different product to avoid restrictions. What should you do?
  2. Agree
    B. Refuse and comply with applicable classification requirements
    C. Change only the packing list
    D. Ask the driver

Answer: B

  1. A manufacturer gives you a COA belonging to another batch. What should you do?
  2. Use it
    B. Request the correct applicable documentation
    C. Change the batch number
    D. Delete the batch number

Answer: B

  1. A buyer wants immediate shipment but product registration is still pending. What should you do?
  2. Ship anyway
    B. Confirm whether commercial shipment is legally permissible before proceeding
    C. Hide the product name
    D. Send without labels

Answer: B

  1. A buyer wants your product under its own brand. What should you investigate?
  2. Regulatory and private-label requirements
    B. Only logo colour
    C. Only carton size
    D. Only freight

Answer: A

  1. A manufacturer says “We are FDA approved.” What should you ask?
  2. What exactly is approved—facility, product, application or another regulatory status?
    B. Nothing
    C. Only the price
    D. Only MOQ

Answer: A

  1. A buyer asks whether your Indian GMP certificate proves US compliance. What should you say?
  2. Always yes
    B. It should not automatically be treated as proof of all US requirements
    C. No documents are needed
    D. GMP never matters

Answer: B

  1. A buyer asks for 1 million tablets. What should you calculate?
  2. Manufacturing capacity
    B. MOQ
    C. Lead time
    D. All of the above

Answer: D

  1. A buyer wants a six-month shelf-life product for a two-month international shipment. What should you investigate?
  2. Remaining shelf life at shipment and destination requirements
    B. Only carton colour
    C. Only logo
    D. Only website

Answer: A

  1. A medicine requires temperature control. What should be evaluated?
  2. Shipping qualification and temperature monitoring
    B. Only invoice
    C. Only HS code
    D. Only buyer’s logo

Answer: A

  1. A buyer refuses to provide importer details. What should you do?
  2. Investigate why and verify the transaction before proceeding
    B. Ship immediately
    C. Change the importer yourself
    D. Ignore it

Answer: A

  1. A manufacturer offers a product at half the market price. What should you do first?
  2. Buy immediately
    B. Conduct due diligence
    C. Assume it is genuine
    D. Advertise it immediately

Answer: B

  1. A foreign buyer sends an order from a free email address and refuses to provide company registration details. What is this?
  2. Potential red flag
    B. Guaranteed legitimate
    C. Proof of large business
    D. Regulatory approval

Answer: A

  1. A buyer wants 100% credit for a first transaction. What should you assess?
  2. Buyer credit risk
    B. Product colour
    C. Tablet shape only
    D. Social media followers

Answer: A

  1. A buyer claims to represent a famous pharmaceutical company. What should you do?
  2. Verify independently using reliable company contacts
    B. Trust immediately
    C. Send products immediately
    D. Share confidential documents

Answer: A

  1. A manufacturer asks you to pay into a personal bank account. What should you do?
  2. Investigate and verify the legitimate contracting/payment arrangement before paying
    B. Pay immediately
    C. Send cash
    D. Ignore the invoice

Answer: A

  1. The buyer’s bank account suddenly changes before payment. What should you do?
  2. Verify through trusted channels
    B. Pay immediately
    C. Ignore it
    D. Change the invoice

Answer: A

  1. A product’s registration has expired. Can you automatically continue selling it?
  2. Yes
    B. No—verify current authorization before commercial supply
    C. Only if the buyer agrees
    D. Only if price is low

Answer: B

  1. A product is registered under one manufacturer but supplied by another. What should be checked?
  2. Regulatory and contractual implications
    B. Only freight
    C. Only packaging colour
    D. Nothing

Answer: A

  1. A buyer asks for an “FDA certificate.” What should you clarify?
  2. Exactly what FDA document/status they require
    B. Send any certificate
    C. Send GMP
    D. Send COA only

Answer: A

  1. A buyer asks for “FDA approved factory.” What is the best response?
  2. Clarify the specific FDA establishment/product status required
    B. Say yes automatically
    C. Say no documents exist
    D. Change the manufacturer

Answer: A

  1. A buyer asks for “WHO approval.” What should you clarify?
  2. What specific WHO certificate/standard they mean
    B. Send any document
    C. Say every WHO-GMP certificate is product approval
    D. Ignore them

Answer: A

  1. Which is stronger evidence?
  2. Verifiable official regulatory documentation
    B. WhatsApp message
    C. Marketing brochure
    D. Salesperson’s verbal statement

Answer: A

  1. A buyer asks for a sample before a large order. What should you do?
  2. Follow a controlled sample process
    B. Send random medicine
    C. Change batch information
    D. Remove labels

Answer: A

  1. A sample passes the buyer’s test but regulatory approval is absent. Can you automatically sell commercially?
  2. Yes
    B. No
    C. Only if the buyer likes it
    D. Only if freight is paid

Answer: B

  1. A product is legally exported from India but prohibited in the destination country. Can it be shipped commercially?
  2. Automatically yes
    B. No—destination-country restrictions must be respected
    C. Only by air
    D. Only through a trader

Answer: B

  1. A buyer asks for a product that may be controlled. What should you do?
  2. Check applicable Indian and destination-country controls before proceeding
    B. Ship immediately
    C. Hide the ingredient
    D. Change the HS code

Answer: A

  1. Why is country-of-destination screening important?
  2. Regulations and restrictions can vary by country
    B. It only affects colour
    C. It only affects freight
    D. It never matters

Answer: A

  1. What is the correct approach to a new country?
  2. Research regulatory, commercial and import requirements
    B. Use another country’s rules
    C. Assume India rules apply
    D. Ship first

Answer: A

  1. An exporter wants to enter Africa. Should “Africa” be treated as one regulatory market?
  2. Yes
    B. No
    C. Always
    D. Only for generic medicines

Answer: B

  1. Why?
  2. African countries have different laws and regulatory systems
    B. All African countries use identical rules
    C. Only freight differs
    D. Only language differs

Answer: A

  1. Should GCC countries automatically be treated as one identical regulatory market?
  2. Yes
    B. No
    C. Always
    D. Only for tablets

Answer: B

  1. What should be checked for every target country?
  2. Regulatory authority
    B. Registration
    C. Importer requirements
    D. All of the above

Answer: D

  1. A buyer asks for CIF price. What should the exporter consider?
  2. Product cost, applicable costs, freight and insurance under the agreed CIF transaction
    B. Product cost only
    C. Freight only
    D. Insurance only

Answer: A

  1. A buyer asks for FOB price. What should you establish?
  2. Applicable delivery point and costs/responsibilities under FOB
    B. Only product cost
    C. Only insurance
    D. Only destination tax

Answer: A

  1. Should Incoterms be used without specifying a place?
  2. Ideally no; the relevant named place/port should be specified
    B. Always yes
    C. Place is irrelevant
    D. Only for pharma

Answer: A

  1. What is the purpose of a Proforma Invoice?
  2. Communicate proposed commercial terms before final invoicing
    B. Replace all regulatory approvals
    C. Replace COA
    D. Replace manufacturing licence

Answer: A

  1. What is a commercial invoice used for?
  2. Commercial and customs transaction information
    B. Product testing only
    C. GMP certification
    D. Clinical trial approval

Answer: A

  1. What is a packing list used for?
  2. Package/quantity/weight information
    B. Product approval
    C. Pharmacovigilance
    D. Trademark registration

Answer: A

  1. Why should the commercial invoice and packing list be consistent?
  2. To reduce documentation discrepancies
    B. To increase product strength
    C. To improve GMP
    D. To reduce tablet weight

Answer: A

  1. What is a product recall?
  2. Removal of affected product from the market/supply chain
    B. Product promotion
    C. Export discount
    D. Buyer registration

Answer: A

  1. Who may initiate a recall?
  2. Responsible parties according to the applicable regulatory and quality framework
    B. Only the freight company
    C. Only the buyer’s driver
    D. Social media users

Answer: A

  1. What should an exporter do after receiving a serious product complaint?
  2. Follow the applicable complaint investigation and escalation process
    B. Ignore it
    C. Delete the complaint
    D. Change the batch number

Answer: A

  1. What is adverse-event reporting related to?
  2. Medicine safety
    B. Freight cost
    C. Invoice value
    D. HS classification

Answer: A

  1. What is a quality defect?
  2. Failure or potential failure to meet applicable quality requirements
    B. Price increase
    C. Buyer delay
    D. Freight delay

Answer: A

  1. What is traceability?
  2. Ability to track relevant product/batch information through the supply chain
    B. Tracking social media
    C. Tracking freight only
    D. Tracking buyer calls only

Answer: A

  1. Why is batch traceability important?
  2. It supports investigation, quality control and recall activities
    B. It changes the product price
    C. It replaces registration
    D. It replaces GMP

Answer: A

  1. What is serialization?
  2. Assigning unique identifiers to individual packs where required
    B. Batch testing
    C. Freight calculation
    D. Product pricing

Answer: A

  1. Is serialization required identically in every country?
  2. Yes
    B. No
    C. Always
    D. Only in India

Answer: B

  1. A buyer asks for a medicine with a new brand name. What should be checked?
  2. Trademark and regulatory implications
    B. Only logo design
    C. Only carton colour
    D. Only price

Answer: A

  1. What is the difference between brand registration and product registration?
  2. Brand/trademark rights and pharmaceutical authorization are different legal/regulatory matters
    B. They are always identical
    C. Neither matters
    D. Only the brand matters

Answer: A

  1. A manufacturer has no private-label capability. What can the exporter do?
  2. Find an appropriate manufacturer that can legally and technically support the project
    B. Print labels secretly
    C. Change the manufacturer’s licence
    D. Use another company’s certificate

Answer: A

  1. A buyer wants a unique dosage form. What should be evaluated?
  2. Manufacturer capability and regulatory requirements
    B. Only price
    C. Only freight
    D. Only brand

Answer: A

  1. What is formulation development?
  2. Development of a suitable pharmaceutical dosage form and composition
    B. Freight arrangement
    C. Buyer verification
    D. Customs classification

Answer: A

  1. What is bioequivalence?
  2. A regulatory/scientific assessment used for applicable products to compare relevant performance with a reference product
    B. A freight document
    C. A payment term
    D. A trademark

Answer: A

  1. What is bioavailability?
  2. The rate and extent to which an active ingredient becomes available at the relevant site/systemic circulation as applicable
    B. Product price
    C. Manufacturing licence
    D. Customs value

Answer: A

  1. Why can regulatory requirements differ between dosage forms?
  2. Risk, administration route, formulation and applicable regulations can differ
    B. Dosage form never matters
    C. Only price matters
    D. Only packaging matters

Answer: A

  1. Why can sterile products require additional controls?
  2. Sterility and contamination risks are critical
    B. They are always cheaper
    C. They require no documentation
    D. They are always OTC

Answer: A

  1. What is a parenteral product?
  2. Product administered by a route other than the gastrointestinal tract, such as injection
    B. Tablet only
    C. Syrup only
    D. Cream only

Answer: A

  1. A manufacturer has excellent prices but poor documentation. Should you select it?
  2. Yes
    B. No, documentation/compliance must be properly evaluated
    C. Always
    D. Only for Africa

Answer: B

  1. A buyer offers a huge order but refuses normal verification. What should you do?
  2. Proceed immediately
    B. Perform due diligence before committing
    C. Send products first
    D. Provide confidential documents

Answer: B

  1. What is the purpose of a written supply contract?
  2. Define rights, responsibilities, specifications and commercial terms
    B. Replace regulatory approval
    C. Replace GMP
    D. Replace customs clearance

Answer: A

  1. What should a contract specify for a pharma supply?
  2. Product specifications and applicable responsibilities
    B. Only company logo
    C. Only email address
    D. Only social-media account

Answer: A

  1. What is dispute resolution?
  2. Contractual mechanism for handling disputes
    B. Product testing
    C. Freight booking
    D. GMP inspection

Answer: A

  1. What is force majeure?
  2. Contractual concept concerning specified extraordinary events beyond a party’s reasonable control
    B. Product registration
    C. Quality test
    D. Buyer verification

Answer: A

  1. Why should confidential technical information be protected?
  2. It may contain commercially sensitive or proprietary information
    B. It is always public
    C. It has no value
    D. It is only needed for customs

Answer: A

  1. What is an NDA in a business-contract context?
  2. Non-Disclosure Agreement
    B. New Drug Application
    C. National Drug Authorization
    D. New Distribution Agreement

Answer: A

  1. Why must the context of “NDA” be understood?
  2. NDA can mean different things in pharma regulatory and business-contract contexts
    B. It always has one meaning
    C. It only means New Drug Application
    D. It only means Non-Disclosure Agreement

Answer: A

  1. What is due diligence before investment in a manufacturer?
  2. Verification of legal, commercial, financial, regulatory and operational information as appropriate
    B. Only checking price
    C. Only checking website
    D. Only checking logo

Answer: A

  1. What is a forecast?
  2. Expected future demand/order quantity
    B. Final invoice
    C. COA
    D. GMP

Answer: A

  1. Why is a buyer forecast useful?
  2. It helps production and supply planning
    B. It replaces product registration
    C. It replaces payment
    D. It replaces customs

Answer: A

  1. What is annual purchase volume?
  2. Expected quantity purchased over a year
    B. Single shipment quantity only
    C. MOQ
    D. Shelf life

Answer: A

  1. What is a distributor margin?
  2. Difference/percentage between distributor acquisition cost and selling economics as applicable
    B. GMP fee
    C. Customs duty
    D. COA cost

Answer: A

  1. What is market research?
  2. Systematic study of market demand, competition, customers and conditions
    B. Product testing only
    C. Customs clearance
    D. Freight forwarding

Answer: A

  1. Why should exporters study competitors?
  2. To understand pricing, positioning, products and market conditions
    B. To copy documents
    C. To copy certificates
    D. To falsify products

Answer: A

  1. What should an exporter never copy from a competitor?
  2. Confidential/proprietary documents or misleading certifications
    B. Public market observations
    C. General industry information
    D. Publicly available market prices

Answer: A

  1. What is market positioning?
  2. How a product is presented relative to competitors and customer needs
    B. Customs location
    C. Warehouse location only
    D. Freight route

Answer: A

  1. What is a target market?
  2. Specific country/customer segment selected for business development
    B. Manufacturing facility
    C. Customs office
    D. Freight company

Answer: A

  1. What is market entry strategy?
  2. Plan for entering and developing a specific market
    B. COA preparation
    C. Batch manufacturing
    D. Freight insurance

Answer: A

  1. What should an exporter consider before selecting a target country?
  2. Demand
    B. Regulation
    C. Competition
    D. All of the above

Answer: D

  1. What is regulatory risk?
  2. Risk arising from failure to meet applicable laws/regulatory requirements
    B. Only freight risk
    C. Only currency risk
    D. Only buyer risk

Answer: A

  1. What is currency risk?
  2. Risk caused by changes in exchange rates
    B. Product contamination
    C. GMP failure
    D. Customs classification

Answer: A

  1. What is logistics risk?
  2. Risk associated with transportation, storage and delivery
    B. Product trademark
    C. Product registration only
    D. Buyer identity only

Answer: A

  1. What is credit risk?
  2. Risk that a buyer may fail to pay
    B. Risk of tablet dissolution
    C. Risk of temperature excursion only
    D. Risk of product registration only

Answer: A

  1. What is quality risk?
  2. Risk that product may fail to meet applicable quality requirements
    B. Currency fluctuation
    C. Buyer delay only
    D. Freight price

Answer: A

  1. What is supply-chain risk?
  2. Risk of interruption or failure in sourcing, manufacturing, storage or distribution
    B. Trademark risk only
    C. Currency risk only
    D. Customs risk only

Answer: A

  1. What is contingency planning?
  2. Preparing alternatives for potential disruptions
    B. Changing certificates
    C. Avoiding documentation
    D. Ignoring risks

Answer: A

  1. What is business continuity?
  2. Ability to continue critical operations during disruptions
    B. Product registration
    C. Freight discount
    D. Buyer discount

Answer: A

  1. Why should an exporter maintain backup suppliers?
  2. To reduce supply interruption risk where appropriate
    B. To avoid quality checks
    C. To avoid regulations
    D. To change certificates

Answer: A

  1. A supplier suddenly cannot manufacture an order. What should you do?
  2. Assess alternatives while maintaining regulatory and quality controls
    B. Send an unrelated product
    C. Change batch details
    D. Ignore the buyer

Answer: A

  1. A shipment is delayed. What should the exporter do?
  2. Communicate transparently and assess regulatory/product implications
    B. Hide the delay
    C. Change the shipping date on documents
    D. Blame the buyer automatically

Answer: A

  1. A temperature-sensitive product experiences a temperature excursion. What should happen?
  2. Follow the applicable excursion investigation and product-disposition procedure
    B. Ignore it
    C. Immediately sell it
    D. Change the temperature record

Answer: A

  1. What is the worst response to a quality problem?
  2. Hiding or falsifying the problem
    B. Investigating it
    C. Documenting it
    D. Escalating it appropriately

Answer: A

  1. What is the best response to a suspected counterfeit product?
  2. Stop relying on it and investigate through appropriate channels
    B. Export it
    C. Rebrand it
    D. Mix it with genuine products

Answer: A

  1. What is the best response to a suspected forged certificate?
  2. Verify and investigate before relying on it
    B. Use it
    C. Edit it
    D. Sell it

Answer: A

  1. What is the strongest foundation for long-term pharma export business?
  2. Compliance, quality, reliable supply and trustworthy relationships
    B. Lowest price only
    C. Aggressive sales only
    D. Fast shipment without documentation

Answer: A

  1. What makes a pharma exporter different from an ordinary commodity exporter?
  2. Greater regulatory, quality and product-safety considerations
    B. Nothing
    C. Only packaging
    D. Only freight

Answer: A

  1. What should an exporter prioritize when there is a conflict between an illegal buyer request and a commercial opportunity?
  2. Compliance
    B. Sales
    C. Profit
    D. Speed

Answer: A

  1. What is the best summary of pharmaceutical exporting?
  2. Buy cheaply and sell internationally
    B. Identify a compliant product and manufacturer, satisfy applicable regulatory requirements, verify the buyer, execute correct documentation and logistics, and manage the product responsibly
    C. Find a buyer and ship immediately
    D. Focus only on price

Answer: B

MCQ ANSWER KEY — 301–500

301–350

301-C | 302-B | 303-A | 304-A | 305-C
306-B | 307-C | 308-A | 309-B | 310-A
311-C | 312-D | 313-A | 314-A | 315-A
316-A | 317-A | 318-A | 319-A | 320-A
321-A | 322-A | 323-A | 324-A | 325-A
326-A | 327-A | 328-A | 329-A | 330-A
331-A | 332-B | 333-A | 334-A | 335-A
336-A | 337-A | 338-A | 339-A | 340-A
341-A | 342-B | 343-A | 344-B | 345-A
346-A | 347-A | 348-B | 349-A | 350-A

351–400

351-A | 352-A | 353-A | 354-A | 355-A
356-A | 357-A | 358-A | 359-D | 360-A
361-B | 362-A | 363-A | 364-A | 365-A
366-A | 367-A | 368-A | 369-A | 370-A
371-A | 372-A | 373-A | 374-B | 375-A
376-A | 377-A | 378-A | 379-A | 380-A
381-A | 382-A | 383-A | 384-A | 385-A
386-A | 387-A | 388-A | 389-B | 390-A
391-A | 392-A | 393-A | 394-A | 395-A
396-A | 397-A | 398-A | 399-A | 400-B

401–450

401-B | 402-B | 403-B | 404-B | 405-B
406-A | 407-A | 408-B | 409-D | 410-A
411-A | 412-A | 413-B | 414-A | 415-A
416-A | 417-A | 418-A | 419-B | 420-A
421-A | 422-A | 423-A | 424-A | 425-A
426-B | 427-B | 428-A | 429-A | 430-A
431-B | 432-A | 433-B | 434-D | 435-A
436-A | 437-A | 438-A | 439-A | 440-A
441-A | 442-A | 443-A | 444-A | 445-A
446-A | 447-A | 448-A | 449-A | 450-B

451–500

451-A | 452-A | 453-A | 454-A | 455-A
456-A | 457-A | 458-A | 459-A | 460-A
461-B | 462-B | 463-A | 464-A | 465-A
466-A | 467-A | 468-A | 469-A | 470-A
471-A | 472-A | 473-A | 474-A | 475-A
476-A | 477-A | 478-A | 479-A | 480-A
481-D | 482-A | 483-A | 484-A | 485-A
486-A | 487-A | 488-A | 489-A | 490-A
491-A | 492-A | 493-A | 494-A | 495-A
496-A | 497-A | 498-A | 499-A | 500-B

 

 

 

Top Pharma Export Products from India Manufacturers Sellers Pharmaceutical Companies Medicine Buyers

PART XXII — PRACTICAL CASE STUDIES

 CASE STUDY 5 — INDIA → USA GENERIC MEDICINE

Situation

An Indian pharmaceutical company manufactures a generic tablet. A US distributor contacts an Indian exporter.

The buyer says:

“Send 20,000 boxes. We will handle everything after arrival.”

Questions

  1. Should the exporter immediately ship?

Answer: No.

First establish the applicable US regulatory pathway and responsibilities of the manufacturer, importer and other parties.

  1. Is the Indian manufacturing licence sufficient?

Answer: No. The US has its own applicable requirements.

  1. What should be verified?
  • Product identity
  • Manufacturer
  • FDA establishment requirements
  • Drug listing
  • Applicable marketing authorization
  • US importer
  • US Agent where applicable
  • Labeling
  • CGMP
  • Documentation
  • Shipment requirements

Lesson

Never confuse Indian authorization with US authorization.

CASE STUDY 6 — INDIA → UK

An Indian manufacturer sells a medicine in India. A UK distributor wants the same medicine.

The distributor says:

“It is already approved in India, so we can sell it in the UK.”

Correct response

The exporter should explain that Indian approval does not automatically authorize commercial marketing in the UK.

The UK regulatory requirements must be assessed.

Checklist

Product → UK classification → Marketing authorization → Manufacturer → Importer → Label → GMP → Regulatory responsibilities → Supply

CASE STUDY 7 — PRIVATE LABEL UAE

A UAE company wants:

100,000 tablets under its own brand.

Exporter must investigate:

  1. Manufacturer
  2. Product composition
  3. UAE regulatory status
  4. Importer
  5. Brand
  6. Trademark
  7. Packaging
  8. Artwork
  9. Registration
  10. MOQ
  11. Production capacity
  12. Price
  13. Payment
  14. Shipping
  15. Quality agreement
  16. Supply agreement

Important lesson

Private label is not simply putting a new sticker on an existing medicine.

It may involve regulatory, contractual, quality and intellectual-property responsibilities.

CASE STUDY 8 — BUYER REQUESTS FALSE DOCUMENT

A buyer says:

“Your product does not have the required certificate. Just make one.”

Correct answer

Refuse.

Never manufacture, alter or falsify:

  • GMP certificates
  • COA
  • CPP/COPP
  • Manufacturing licences
  • Regulatory approvals
  • Test reports
  • Customs documents

Lesson

A short-term sale can create long-term regulatory and criminal/legal risk.

CASE STUDY 9 — LOW PRICE

Manufacturer A:

$0.20/unit

Manufacturer B:

$0.35/unit

Manufacturer C:

$0.50/unit

Manufacturer A has poor documentation.

Manufacturer B has acceptable documentation and GMP evidence.

Manufacturer C has strong export experience.

Question

Which is automatically the best?

Answer: None automatically.

The exporter should perform a total assessment:

Quality + compliance + reliability + capacity + documents + price + lead time + market suitability

The cheapest quote is not necessarily the best supplier.

CASE STUDY 10 — LARGE BUYER, NO IMPORT LICENCE

A buyer claims:

“We are a very large distributor. We don’t need to give you our importer details.”

What should you do?

Do not proceed blindly.

Verify:

  • Legal entity
  • Importer status
  • Regulatory authorization
  • Destination-country requirements
  • Product registration
  • Payment risk
  • Contract

Lesson

Large order ≠ legitimate buyer.

CASE STUDY 11 — SHELF-LIFE PROBLEM

A manufacturer offers a product with:

12 months total shelf life

The shipment will take several months to arrive.

Questions

  1. What is the remaining shelf life at shipment?
  2. What does the destination market require?
  3. What does the buyer require?
  4. Can the manufacturer produce a fresh batch?
  5. Is the product stable under the transportation conditions?

Lesson

Do not look only at total shelf life.

Look at:

Manufacturing date → shipment date → transit → customs → warehouse → distribution → required remaining shelf life

CASE STUDY 12 — TEMPERATURE EXCURSION

A temperature-sensitive pharmaceutical shipment experiences temperatures outside the specified range.

What should NOT happen?

❌ Change the temperature record
❌ Ignore the event
❌ Automatically release the product
❌ Tell the buyer nothing happened

Correct approach

Follow the applicable:

Excursion investigation → product assessment → quality decision → documentation → communication

CASE STUDY 13 — WRONG HS CODE

An exporter discovers that the HS code used on a previous shipment may have been incorrect.

What should the exporter do?

Do not simply repeat it.

Seek appropriate customs/trade classification advice and determine the correct classification for future transactions, while assessing whether previous shipments require correction or other action.

CASE STUDY 14 — BUYER CHANGES BANK ACCOUNT

A regular buyer suddenly sends:

“Please make today’s payment to this new bank account.”

What should happen?

Stop and verify.

Use trusted contact information already on file, not merely the contact information contained in the new message.

Lesson

This is a common business-fraud warning sign.

CASE STUDY 15 — PRODUCT REGISTRATION EXPIRING

A buyer wants a large order, but the product authorization is approaching expiry.

What should be checked?

  • Current authorization
  • Renewal status
  • Expected renewal date
  • Import requirements
  • Remaining shelf life
  • Buyer requirements
  • Shipment timing

Lesson

Do not plan a large shipment based only on an authorization that may no longer be valid at the relevant time.

CASE STUDY 16 — NEW BRAND NAME

A buyer asks:

“Can you manufacture this medicine under the brand ‘XYZ’?”

Check:

Trademark → Product registration → Regulatory acceptability → Label → Packaging → Manufacturer agreement → Marketing authorization responsibilities

Lesson

A brand name is not merely a graphic design issue.

CASE STUDY 17 — API EXPORT

A buyer wants an API rather than finished tablets.

What changes?

The exporter must evaluate:

  • API manufacturer
  • API specification
  • DMF/technical documentation where applicable
  • GMP
  • COA
  • Impurity profile
  • Stability
  • Target-country requirements
  • Packaging
  • Storage
  • Transport
  • Importer requirements

Lesson

API export and finished-formulation export have overlapping but different regulatory and commercial considerations.

CASE STUDY 18 — GOVERNMENT TENDER

A foreign government or government-linked buyer requests:

500,000 units

Before bidding, evaluate:

  • Tender eligibility
  • Product registration
  • Required certificates
  • Manufacturer qualification
  • Pricing
  • Bid security
  • Delivery schedule
  • Payment terms
  • Penalties
  • Local representative
  • Regulatory requirements
  • Past supply requirements

Lesson

A huge quantity does not automatically mean a profitable order.

CASE STUDY 19 — BUYER WANTS EXCLUSIVITY

A distributor asks:

“Give us exclusive rights for the entire country.”

Before agreeing, consider:

  • Minimum annual purchase
  • Registration responsibility
  • Marketing obligations
  • Territory
  • Contract period
  • Performance targets
  • Payment history
  • Termination rights
  • Regulatory responsibilities

Better commercial structure

Instead of unconditional exclusivity, consider performance-based exclusivity, where legally appropriate.

CASE STUDY 20 — FIRST EXPORT ORDER

A new exporter receives the first small order.

Recommended workflow

Step 1: Verify buyer
↓
Step 2: Verify product
↓
Step 3: Verify manufacturer
↓
Step 4: Verify destination regulatory requirements
↓
Step 5: Confirm product registration/authorization
↓
Step 6: Confirm specifications
↓
Step 7: Confirm price and Incoterm
↓
Step 8: Confirm payment
↓
Step 9: Prepare documentation
↓
Step 10: Manufacture/procure
↓
Step 11: Quality review
↓
Step 12: Shipment
↓
Step 13: Customs/import clearance
↓
Step 14: Delivery
↓
Step 15: Post-shipment follow-up

PART XXIII — 10 GOLDEN RULES FOR PHARMA EXPORTERS

Rule 1

Never assume Indian approval equals foreign approval.

Rule 2

Never confuse establishment registration with product approval.

Rule 3

Never use false or altered certificates.

Rule 4

Verify the manufacturer.

Rule 5

Verify the foreign buyer.

Rule 6

Check the destination country’s requirements product-by-product.

Rule 7

Do not calculate price using factory cost alone.

Rule 8

Do not ignore shelf life and transportation conditions.

Rule 9

Put commercial responsibilities in writing.

Rule 10

Compliance comes before shipment.

 

PART 1: ADVANCED PHARMA EXPORT MCQs (501–600)

Section A: Regulatory Affairs and Market Authorization

  1. What should an exporter confirm before offering a finished medicine to a foreign buyer?
  2. Only the selling price
    B. Product authorization requirements in the destination market
    C. Only the packaging colour
    D. Only the transport company
  3. What is the main purpose of a pharmaceutical regulatory dossier?
  4. To advertise the product
    B. To provide evidence of product quality, safety and efficacy, as applicable
    C. To calculate customs duty only
    D. To replace the commercial invoice
  5. What does a Certificate of Analysis (COA) generally report?
  6. Buyer credit rating
    B. Test results for a specified sample or batch against relevant specifications
    C. Freight charges
    D. Trademark ownership only
  7. Which statement about GMP is most accurate?
  8. GMP guarantees sales in every country
    B. GMP concerns manufacturing quality systems and controls
    C. GMP replaces product registration
    D. GMP eliminates the need for testing
  9. What is the appropriate approach when a buyer requests a medicine that is not authorized for sale in its country?
  10. Ship immediately
    B. Change the product name to avoid regulation
    C. Establish a lawful regulatory pathway before proceeding
    D. Remove the manufacturer’s name
  11. What does pharmacovigilance primarily concern?
  12. Monitoring and assessing medicine-related safety information
    B. Advertising campaigns
    C. Freight negotiation
    D. Export incentive calculations
  13. What is the purpose of stability studies?
  14. To determine the product’s shelf life and storage conditions under defined conditions
    B. To calculate the buyer’s profit
    C. To establish customs duty
    D. To select the freight forwarder
  15. Which statement about a foreign marketing authorization is correct?
  16. It automatically covers all countries
    B. It applies according to the authorization’s scope and jurisdiction
    C. It replaces customs documentation
    D. It is unnecessary for all generic medicines
  17. What should an exporter do if the registered product’s composition changes?
  18. Ship without informing anyone
    B. Assess the change under applicable regulatory and quality requirements
    C. Change only the invoice description
    D. Assume no approval is needed
  19. Why are approved product specifications important?
  20. They define relevant quality requirements and acceptance criteria
    B. They determine the exchange rate
    C. They replace the purchase order
    D. They guarantee immediate customs clearance

Section B: Manufacturing and Quality Assurance

  1. What is a deviation in a pharmaceutical quality system?
  2. A departure from an approved procedure, instruction, specification or expected condition
    B. A change in currency
    C. A buyer’s discount request
    D. A shipping quotation
  3. What does CAPA stand for?
  4. Customs Approval and Product Assessment
    B. Corrective and Preventive Action
    C. Commercial Account and Payment Agreement
    D. Certificate Approval and Packaging Authorization
  5. What is the main objective of batch traceability?
  6. To identify and follow a batch through relevant manufacturing and distribution records
    B. To reduce the number of invoices
    C. To eliminate regulatory requirements
    D. To guarantee buyer payment
  7. Why is data integrity important in pharmaceutical manufacturing?
  8. It supports reliable, complete and trustworthy records
    B. It makes product registration unnecessary
    C. It guarantees a higher selling price
    D. It removes the need for audits
  9. What should happen when a batch fails a critical quality test?
  10. Ship it at a lower price
    B. Release it if the buyer agrees
    C. Follow the quality system’s investigation and disposition procedures
    D. Alter the COA
  11. What is the purpose of change control?
  12. To assess, authorize and document proposed changes appropriately
    B. To change the buyer’s name
    C. To avoid maintaining records
    D. To replace stability studies automatically
  13. What is a product recall?
  14. A process to remove or address a product that presents a quality, safety, compliance or other justified concern
    B. A discount campaign
    C. A freight refund
    D. A marketing strategy only
  15. Why is supplier qualification important for pharmaceutical exporters?
  16. It helps assess supplier capability, quality systems and compliance
    B. It guarantees the lowest possible price
    C. It eliminates the need for incoming checks
    D. It replaces buyer verification
  17. What is the purpose of an audit trail in an electronic system?
  18. To record relevant system activities and changes
    B. To calculate freight
    C. To replace the product label
    D. To confirm the buyer’s bank balance
  19. What is the most appropriate response to a suspected counterfeit medicine?
  20. Continue distribution
    B. Investigate, preserve evidence, notify appropriate parties and follow applicable procedures
    C. Change the batch number
    D. Sell it in another country

Section C: Export Documentation and Customs

  1. What is the principal purpose of a commercial invoice?
  2. To describe the transaction and relevant goods and charges for commercial and customs purposes
    B. To certify clinical efficacy
    C. To replace a manufacturing licence
    D. To approve a medicine for sale
  3. What is the purpose of a packing list?
  4. To detail package contents, quantities, weights and related packing information
    B. To prove product efficacy
    C. To authorize a new drug
    D. To certify the buyer’s creditworthiness
  5. What should an exporter do if the commercial invoice and packing list show inconsistent quantities?
  6. Ignore the difference
    B. Correct and reconcile the documents before shipment or through the appropriate amendment process
    C. Ask customs to guess the correct quantity
    D. Change the batch number
  7. What is an HS code used for?
  8. Classification of goods for customs and trade purposes
    B. Determining a medicine’s clinical effectiveness
    C. Establishing a trademark
    D. Calculating the product’s expiry date
  9. Who generally issues an air waybill in an air shipment arrangement?
  10. An airline or its authorized agent
    B. The drug regulator
    C. The trademark office
    D. The retail pharmacy
  11. Which document may provide evidence of the country of origin when required?
  12. Certificate of Origin
    B. Sales brochure
    C. Staff attendance register
    D. Marketing calendar
  13. Why should exporters retain shipping and transaction records?
  14. For traceability, accounting, compliance, audits and dispute resolution
    B. Only for decoration
    C. To avoid paying taxes
    D. To replace all regulatory filings
  15. What is the purpose of a proforma invoice?
  16. To communicate a proposed transaction and its commercial terms before the final commercial invoice
    B. To prove delivery has already occurred
    C. To replace a COA
    D. To grant product authorization
  17. What is a bill of lading commonly associated with?
  18. Sea transport and the relevant carriage documentation
    B. Product stability testing
    C. Pharmacovigilance reporting
    D. Clinical trial approval
  19. What is the best approach to a request for false customs or regulatory documents?
  20. Agree to protect the relationship
    B. Refuse and follow lawful compliance procedures
    C. Change the documents after customs inspection
    D. Use another company’s certificate

Section D: Incoterms, Logistics and Cold Chain

  1. What does FOB generally mean under Incoterms 2020?
  2. Free on Board
    B. Freight on Balance
    C. Foreign Order Booking
    D. Final Overseas Billing
  3. Under CIF, which costs are generally arranged by the seller for sea or inland waterway transport?
  4. Cost, insurance and freight to the named destination port
    B. All import duties and taxes in every case
    C. The buyer’s entire distribution network
    D. The buyer’s retail advertising
  5. Why must the named place or port be clearly specified in an Incoterms rule?
  6. It helps define delivery obligations, cost allocation and risk transfer under the chosen rule
    B. It determines the medicine’s dosage
    C. It replaces the sales contract
    D. It determines the country’s drug approval automatically
  7. What is the purpose of a temperature data logger?
  8. To record temperature conditions over time
    B. To certify product registration
    C. To calculate export commission
    D. To replace the shipping label
  9. What should happen if a temperature-sensitive shipment experiences an excursion?
  10. Ignore it if the goods look normal
    B. Assess the excursion against approved procedures and product-specific stability information, document it and determine disposition
    C. Delete the logger data
    D. Immediately resell it
  11. Why is cargo insurance considered in export planning?
  12. To manage certain financial risks associated with covered loss or damage
    B. To guarantee product authorization
    C. To replace customs clearance
    D. To guarantee the buyer’s payment
  13. What is a freight forwarder generally responsible for?
  14. Coordinating transport and related logistics services within the agreed scope
    B. Approving medicines for sale
    C. Issuing manufacturing licences
    D. Guaranteeing clinical outcomes
  15. What should be checked before booking a refrigerated shipment?
  16. Required temperature range, packaging qualification, route, transit time and handling capability
    B. Only the colour of the carton
    C. Only the buyer’s website
    D. Only the exchange rate
  17. What is the purpose of a shipping validation or qualification programme where applicable?
  18. To establish that defined shipping arrangements can maintain required conditions
    B. To eliminate the need for quality control
    C. To approve a trademark
    D. To establish a distributor’s credit limit
  19. What is demurrage commonly associated with?
  20. Charges relating to extended use of containers or port/terminal equipment beyond the applicable free time, depending on the charge
    B. Clinical trial fees
    C. Product registration fees
    D. Manufacturing validation

Section E: Commercial Negotiation and Finance

  1. What is MOQ?
  2. Minimum Order Quantity
    B. Maximum Overseas Quotation
    C. Monthly Order Quality
    D. Manufacturing Operations Qualification
  3. What is landed cost?
  4. The total cost of getting goods to the relevant destination point, including applicable transport, insurance, duties, taxes and other costs as relevant
    B. Only the ex-factory price
    C. Only the marketing budget
    D. Only the exporter’s profit
  5. Why should exporters evaluate payment terms before accepting an order?
  6. To understand cash-flow needs, payment risk and financing requirements
    B. To avoid product testing
    C. To replace product registration
    D. To guarantee currency appreciation
  7. What is a letter of credit (LC)?
  8. A bank instrument under which payment is made against specified terms and compliant documents, subject to its conditions
    B. A product registration certificate
    C. A manufacturer’s quality manual
    D. A freight quotation
  9. What is the purpose of buyer credit verification?
  10. To assess the buyer’s ability and willingness to meet payment obligations
    B. To establish the product’s shelf life
    C. To replace the import licence
    D. To determine clinical efficacy
  11. Why is currency risk relevant to exporters?
  12. Exchange-rate movements may affect the value of receipts, costs and profit
    B. It determines the batch number
    C. It eliminates customs duties
    D. It guarantees sales growth
  13. What should be included in a sound export quotation?
  14. Product details, specifications, quantity, price, currency, Incoterm, delivery timeline, payment terms and validity
    B. Only the product name
    C. Only the manufacturer’s logo
    D. Only the buyer’s telephone number
  15. Why should an exporter specify quotation validity?
  16. To define the period during which the quoted commercial terms remain available
    B. To extend the product expiry date
    C. To waive all regulatory requirements
    D. To guarantee unlimited stock
  17. What is a practical way to manage an overseas buyer requesting an unusually large first order?
  18. Ship immediately without checks
    B. Conduct due diligence, assess payment security, confirm compliance and evaluate supply capability
    C. Ignore the purchase order
    D. Provide unverified certificates
  19. What should an exporter do when a buyer requests payment to a new bank account by email?
  20. Transfer funds immediately
    B. Independently verify the change through a trusted, previously established contact channel
    C. Ignore all fraud risk
    D. Send confidential information to any address provided

Section F: Private Label, OEM and Distribution

  1. What does private labelling generally mean in pharmaceutical business?
  2. A product is marketed under a customer’s or brand owner’s label, subject to applicable law and agreements
    B. A product is automatically exempt from registration
    C. A product can use any manufacturer’s licence
    D. A product has no quality requirements
  3. What should be clarified before entering an OEM arrangement?
  4. Product specifications, responsibilities, ownership, quality, regulatory obligations, pricing and supply terms
    B. Only the carton colour
    C. Only the exporter’s personal preference
    D. Only the first shipment date
  5. Why should trademark ownership be verified before using a brand name?
  6. To reduce intellectual property disputes and unauthorized use
    B. To avoid testing
    C. To replace import authorization
    D. To eliminate customs documentation
  7. What is the main purpose of a distribution agreement?
  8. To define commercial rights, responsibilities and operating terms between the parties
    B. To replace all national laws
    C. To certify batch quality
    D. To authorize every medicine worldwide
  9. What is an important risk of granting broad territorial exclusivity?
  10. The exporter may lose access to other buyers without receiving adequate sales performance
    B. The medicine becomes automatically approved worldwide
    C. The buyer no longer needs to pay
    D. The manufacturer loses all quality obligations
  11. Which provision can help make exclusivity more commercially balanced?
  12. Minimum purchase commitments, performance targets, reporting and termination provisions
    B. Unlimited rights without conditions
    C. No payment deadlines
    D. No quality obligations
  13. What should be agreed upon for artwork and packaging changes?
  14. Approval workflow, legal review, regulatory review, version control and responsibilities
    B. Verbal agreement only in every situation
    C. No documentation
    D. Changes after printing without review
  15. Why is it important to clarify who holds the product marketing authorization?
  16. To understand legal responsibilities and control over regulatory maintenance in the market
    B. To decide the colour of the shipping container
    C. To eliminate adverse-event reporting
    D. To determine freight charges only
  17. What is an important consideration when selecting a foreign distributor?
  18. Relevant licences, market reach, regulatory capability, financial reliability and distribution controls
    B. Only the number of social media followers
    C. Only the lowest requested price
    D. Only the office size
  19. What should be done before approving a customer-specific product label?
  20. Check applicable regulatory requirements, accuracy, language, artwork and authorization responsibilities
    B. Print immediately without review
    C. Remove the batch number
    D. Use a competitor’s approval number

Section G: Risk Management and Business Development

  1. What is the purpose of export market research?
  2. To evaluate demand, competition, regulation, pricing, distribution and commercial feasibility
    B. To avoid checking the destination country’s laws
    C. To replace product registration
    D. To guarantee a specific profit
  3. What is a red flag during buyer due diligence?
  4. A buyer refuses reasonable verification and requests false documents
    B. A buyer asks for a valid COA
    C. A buyer requests a quotation
    D. A buyer asks about lead time
  5. Why should an exporter assess the shelf life remaining at delivery?
  6. To ensure it meets contractual, regulatory and distribution requirements
    B. To calculate the buyer’s tax return
    C. To replace stability studies
    D. To determine the freight forwarder’s licence
  7. What is the purpose of a product complaint procedure?
  8. To receive, investigate, document and appropriately address product complaints
    B. To automatically blame the customer
    C. To avoid quality investigations
    D. To delete records
  9. What is the main purpose of a risk register?
  10. To document identified risks, assessments, owners and mitigation actions
    B. To record only sales revenue
    C. To replace a manufacturing licence
    D. To calculate medicine dosage
  11. Why should exporters screen relevant parties for sanctions and restricted-party risks where applicable?
  12. To assess legal and financial restrictions on transactions
    B. To increase shelf life
    C. To eliminate product testing
    D. To determine packaging dimensions
  13. What is a reasonable first step if a buyer asks for a certificate that the manufacturer does not possess?
  14. Create a certificate using another company’s details
    B. Clarify the exact requirement and determine whether an authorized, legitimate alternative is available
    C. Ignore the buyer’s request
    D. Use an expired certificate without disclosure
  15. What is a key advantage of maintaining a document-control system?
  16. It helps ensure that current, approved versions are used and records remain traceable
    B. It guarantees customs clearance in every country
    C. It eliminates all audits
    D. It removes the need for contracts
  17. Why should an exporter have a contingency plan for supply disruption?
  18. To prepare for production delays, material shortages, transport disruption and other risks
    B. To avoid communicating with buyers
    C. To eliminate the need for quality controls
    D. To guarantee uninterrupted global shipping
  19. What is a sensible way to evaluate a new export market?
  20. Compare regulatory feasibility, market demand, competition, costs, payment risks and distribution capability
    B. Select the country only by population
    C. Assume all countries have identical medicine regulations
    D. Ship samples without checking requirements

Section H: Scenario-Based Questions

  1. A buyer claims that its country’s registration is unnecessary because the product is generic. What should the exporter do?
  2. Accept the claim
    B. Verify the applicable rules for that product and market
    C. Remove the product name from the invoice
    D. Ship under a different HS code
  3. A supplier offers a very low price but refuses to provide manufacturing and quality documents. What is the best response?
  4. Place a large order
    B. Treat this as a significant due-diligence concern and investigate before proceeding
    C. Pay cash immediately
    D. Ignore quality considerations
  5. A buyer asks the exporter to declare a lower value than the actual transaction value. What should the exporter do?
  6. Agree to reduce duties
    B. Refuse inaccurate declarations and follow applicable customs valuation rules
    C. Change the invoice after shipment
    D. Use another company’s invoice
  7. A product is approved in one country but not in the intended destination. What should the exporter do?
  8. Assume the existing approval applies globally
    B. Establish the destination market’s lawful authorization pathway
    C. Remove the manufacturer’s name
    D. Ship under a different product category
  9. A shipment arrives with damaged secondary packaging. What is the appropriate response?
  10. Release it without assessment
    B. Follow the quality agreement and applicable procedures to assess product integrity, documentation and disposition
    C. Change the expiry date
    D. Hide the damage from the buyer
  11. The buyer asks for a longer expiry date than the approved shelf life. What should the exporter do?
  12. Print the requested date
    B. Refuse and use only properly supported, approved shelf-life information
    C. Change the batch number
    D. Send the goods without labels
  13. A distributor wants to change the approved product leaflet. What is the correct approach?
  14. Approve the change informally
    B. Assess the proposed change against applicable regulatory and quality requirements before implementation
    C. Make the change after shipment
    D. Remove warnings from the leaflet
  15. A potential buyer sends a purchase order but refuses to identify the importing entity. What should the exporter do?
  16. Ship immediately
    B. Obtain sufficient information to verify the buyer, importer and transaction
    C. Ignore all compliance concerns
    D. Send the original certificates without verification
  17. A shipment is delayed and the remaining shelf life may fall below the contractual requirement. What should the exporter do?
  18. Ignore the contract
    B. Assess the situation, notify relevant parties and agree on a lawful, documented resolution
    C. Change the expiry date
    D. Hide the delay
  19. A buyer requests an unapproved substitution of an active ingredient. What should the exporter do?
  20. Substitute it to save money
    B. Reject the change unless it is properly assessed, authorized and documented under applicable requirements
    C. Update only the invoice
    D. Keep the same label regardless of composition

Section I: Advanced Commercial and Operational Questions

  1. What is a purchase order (PO)?
  2. A buyer’s document setting out an order and its terms
    B. A certificate of product efficacy
    C. A manufacturing licence
    D. A customs inspection report
  3. What is the purpose of a quality agreement?
  4. To define relevant quality responsibilities and procedures between parties
    B. To determine currency exchange rates
    C. To guarantee marketing success
    D. To replace all commercial terms
  5. What should be considered when selecting air freight instead of sea freight for a pharmaceutical shipment?
  6. Transit time, temperature control, cost, product sensitivity and destination handling capability
    B. Only the colour of the cartons
    C. Only the exporter’s preferred airline
    D. Only the buyer’s brand name
  7. What is a key objective of shipment-document reconciliation?
  8. To ensure relevant quantities, product details, batch references and other information are consistent
    B. To increase the invoice value artificially
    C. To remove all product identifiers
    D. To replace the export contract
  9. Why should the exporter calculate the cost of rejected or returned goods?
  10. To understand potential financial exposure and contract responsibilities
    B. To determine product efficacy
    C. To eliminate quality investigations
    D. To replace insurance
  11. What should an exporter consider when accepting a government tender?
  12. Eligibility, technical requirements, pricing, bid security, delivery, payment, penalties and compliance
    B. Only the tender’s title
    C. Only the buyer’s logo
    D. Only the lowest price, regardless of feasibility
  13. Why should sample shipments be planned carefully?
  14. Samples may still be subject to import, customs, product and documentation requirements
    B. Samples are always exempt from regulation
    C. Samples never need an invoice or declaration
    D. Samples can always be sent as gifts without restrictions
  15. What is a practical use of a customer relationship management (CRM) system?
  16. Tracking leads, quotations, communication, follow-ups and opportunities
    B. Approving medicines for sale
    C. Issuing GMP certificates
    D. Replacing product quality systems
  17. What should an exporter do if the actual shipping cost is higher than the quotation estimate?
  18. Review the contract, determine responsibility for the difference and communicate transparently
    B. Hide the cost
    C. Change the product composition
    D. Alter customs documents
  19. Why is a written sales contract useful?
  20. It documents key commercial obligations, responsibilities, payment terms and remedies
    B. It replaces all local law
    C. It guarantees that no dispute can occur
    D. It automatically authorizes the product

Section J: Final Examination Questions

  1. Which is the strongest approach to selecting a manufacturer for export?
  2. Choose the cheapest supplier without verification
    B. Assess quality systems, regulatory status, capacity, specifications, reliability and commercial terms
    C. Choose the supplier with the most attractive logo
    D. Choose only by distance
  3. What is the most appropriate response when a foreign buyer asks whether a medicine is “FDA approved”?
  4. Say yes because the manufacturer is registered
    B. Clarify the exact product and authorization status, then provide accurate evidence
    C. Say all Indian medicines are automatically approved
    D. Avoid answering and ship anyway
  5. What is the most important principle when preparing a COA?
  6. Report genuine, authorized test results for the relevant sample or batch
    B. Copy another batch’s results
    C. Adjust results to match buyer expectations
    D. Remove failed tests
  7. What is a key factor when calculating export profit?
  8. Revenue minus all relevant costs and expenses, with assumptions clearly defined
    B. Revenue alone
    C. The factory price alone
    D. Freight alone
  9. Which action best supports responsible market entry?
  10. Verify regulatory requirements, buyer credentials, product suitability, logistics and commercial viability
    B. Ship first and investigate later
    C. Assume neighbouring countries have identical laws
    D. Rely exclusively on verbal promises
  11. What should be checked before appointing a local representative?
  12. Credentials, legal authority, experience, conflicts of interest, contractual terms and compliance risks
    B. Only their preferred commission
    C. Only their office decoration
    D. Only their personal social media account
  13. What is a key benefit of conducting a mock export-document review before shipment?
  14. It may identify inconsistencies and missing documents before dispatch
    B. It replaces customs requirements
    C. It guarantees payment
    D. It eliminates all shipping risks
  15. What is the correct response to an adverse event report received from a distributor?
  16. Ignore it because the exporter is outside the destination country
    B. Follow applicable pharmacovigilance, contractual escalation and reporting procedures
    C. Delete the email
    D. Stop maintaining product records
  17. What is the purpose of a post-shipment review?
  18. To evaluate delivery, documentation, costs, complaints, payment and lessons for future orders
    B. To change the batch number
    C. To avoid reviewing costs
    D. To replace the commercial contract
  19. What is the best overall principle for pharmaceutical exporting?
  20. Price is more important than compliance
    B. Compliance, product quality, truthful documentation and responsible commercial practice must work together
    C. Verbal promises replace written records
    D. Product registration is unnecessary for generic medicines

PART 2: ANSWER KEY — MCQs 501–600

Question

Answer

Question

Answer

501

B

551

A

502

B

552

A

503

B

553

A

504

B

554

A

505

C

555

A

506

A

556

A

507

A

557

A

508

B

558

A

509

B

559

A

510

A

560

A

511

A

561

A

512

B

562

A

513

A

563

A

514

A

564

A

515

C

565

A

516

A

566

A

517

A

567

B

518

A

568

A

519

A

569

A

520

B

570

A

521

A

571

B

522

A

572

B

523

B

573

B

524

A

574

B

525

A

575

B

526

A

576

B

527

A

577

B

528

A

578

B

529

A

579

B

530

B

580

B

531

A

581

A

532

A

582

A

533

A

583

A

534

A

584

A

535

B

585

A

536

A

586

A

537

A

587

A

538

A

588

A

539

A

589

A

540

A

590

A

541

A

591

B

542

A

592

B

543

A

593

A

544

A

594

A

545

A

595

A

546

A

596

A

547

A

597

A

548

A

598

B

549

B

599

A

550

B

600

B

PART 3: PRACTICAL PHARMA EXPORT CASE STUDIES (21–30)

Case Study 21: Buyer Requests an Unregistered Product

Situation: An Indian exporter receives an order for a generic tablet from a distributor in another country. The buyer says that product registration can be completed after shipment.

Questions:

  1. Should the exporter ship immediately?
  2. What must be verified?
  3. How can the exporter protect the business relationship?

Suggested answer:

The exporter should not assume that shipment or marketing is lawful simply because the buyer has placed an order. Determine the destination country’s requirements for import, product registration, permits, samples and any applicable exemptions. Confirm who is responsible for registration, what activities are permitted before authorization, and whether the product can legally be imported for the stated purpose.

Put responsibilities, payment milestones and cancellation terms in writing. If lawful shipment is not possible, defer the order until the required pathway is confirmed.

Learning point: A purchase order does not override regulatory requirements.

Case Study 22: A Supplier Offers an Attractive Price

Situation: A new manufacturer offers a medicine at a price significantly below competing quotations. It refuses an audit and provides only a promotional brochure.

Questions:

  1. Is price sufficient to select the supplier?
  2. Which documents should be requested?
  3. When should the exporter walk away?

Suggested answer:

The exporter should conduct appropriate due diligence before making a commitment. Depending on the product and transaction, this may include verifying the manufacturer’s legal identity, manufacturing authorization, relevant GMP status, product specifications, quality documentation, production capacity, batch testing arrangements, supply history and references.

An audit or alternative quality assessment may be necessary based on the product and risk. If the supplier refuses reasonable verification or requests inaccurate documentation, do not proceed until the concerns are resolved.

Learning point: A low quotation is not proof of a commercially sound or compliant supply source.

Case Study 23: Buyer Requests a False Certificate

Situation: A buyer insists that the exporter provide a certificate claiming an approval that the product does not possess.

Questions:

  1. What should the exporter do?
  2. Can the exporter use another company’s certificate?
  3. How can the exporter continue the discussion professionally?

Suggested answer:

The exporter must refuse to issue, alter or misrepresent certificates. Another company’s certificate must not be presented as evidence for the exporter or product unless its use is legitimate, authorized and applicable to the specific claim.

The exporter can ask the buyer to clarify the exact requirement, explain which documents are genuinely available, and investigate whether a lawful alternative meets the market’s requirements.

Learning point: Never compromise document integrity to secure an order.

Case Study 24: Temperature Excursion During Transit

Situation: A shipment requiring controlled temperature is delayed at a transit airport. The logger records temperatures outside the specified range.

Questions:

  1. Can the shipment automatically be released?
  2. What information is needed?
  3. Who should be informed?

Suggested answer:

The product should be assessed under the applicable quality procedures. Relevant information includes the duration and magnitude of the excursion, the product’s stability information, packaging performance, logger calibration and data integrity, transport conditions, and any approved excursion-handling procedure.

Notify the appropriate quality personnel and other parties according to the quality agreement and applicable requirements. Document the assessment and disposition. Do not delete data or release the product solely because the packaging looks undamaged.

Learning point: Temperature excursion management requires documented, product-specific assessment.

Case Study 25: A Large Order With Unclear Payment Terms

Situation: A foreign buyer offers a large initial order but requests extended credit without providing trade references or financial information.

Questions:

  1. What risks are involved?
  2. How can payment risk be reduced?
  3. Should the exporter accept the order?

Suggested answer:

The exporter should assess buyer identity, financial standing, references, transaction history, country risk, payment arrangements and potential loss exposure. Options may include advance payment, an appropriately structured letter of credit, credit insurance where available, staged deliveries or a smaller initial order.

The decision should reflect the exporter’s risk tolerance and financing capacity. No payment method removes every risk, so its terms and conditions must be reviewed carefully.

Learning point: A large order is not necessarily a safe order.

Case Study 26: Wrong Product Quantity in Documents

Situation: The commercial invoice states 10,000 packs, while the packing list and physical shipment indicate 9,800 packs.

Questions:

  1. Should the documents be submitted unchanged?
  2. What should be checked?
  3. How should the discrepancy be handled?

Suggested answer:

The exporter should reconcile the documents against the purchase order, manufacturing or packing records, final packing count and shipment instructions. Correct the affected documents using the appropriate procedure before submission wherever possible. If the goods have already shipped, consult the customs broker, freight forwarder and relevant parties about the proper amendment or correction process.

Learning point: Consistent documentation supports customs clearance, payment processing and traceability.

Case Study 27: Private-Label Medicine for a Foreign Distributor

Situation: A distributor wants an Indian manufacturer to supply a medicine under the distributor’s brand name.

Questions:

  1. Which commercial points should be negotiated?
  2. Which regulatory points must be clarified?
  3. How can the parties reduce disputes?

Suggested answer:

The parties should define brand ownership and permitted use, product specifications, manufacturing responsibilities, batch release, packaging artwork, minimum order quantity, price, payment, lead time, complaints, recalls, pharmacovigilance responsibilities, confidentiality, intellectual property, registration responsibilities and termination terms.

Before printing labels or shipping, verify that the proposed branding and product presentation are allowed in the destination market and that the appropriate authorization pathway is in place.

Learning point: Private labelling does not remove product-quality or regulatory responsibilities.

Case Study 28: Product Registration Is Near Expiry

Situation: A distributor requests a shipment, but the product’s marketing authorization is close to expiry.

Questions:

  1. What should be checked before shipment?
  2. Who is responsible for renewal?
  3. How should the order be managed?

Suggested answer:

Verify the authorization’s current status, renewal timeline, permitted import and marketing activities, shipment and customs-clearance timing, and any applicable transitional arrangements. Confirm contractual responsibilities for renewal and any required documentation.

Do not assume that an application for renewal automatically permits every activity. If the status is uncertain, obtain written clarification from the responsible regulatory party or competent authority before proceeding.

Learning point: Regulatory validity must be assessed at the relevant stage of the transaction.

Case Study 29: The Buyer Requests Exclusive Distribution

Situation: A distributor wants exclusive rights to sell a medicine throughout an entire country but offers no minimum purchase commitment.

Questions:

  1. What are the commercial risks?
  2. What terms could make exclusivity more balanced?
  3. When might exclusivity be inappropriate?

Suggested answer:

Exclusivity can restrict the exporter’s ability to appoint other distributors. The exporter should assess market size, registration investment, distribution capability, competing products, expected sales and the distributor’s financial strength.

Possible safeguards include defined territories, minimum annual purchases, performance targets, reporting obligations, marketing commitments, payment protections, review periods and termination rights. Any arrangement must also comply with applicable competition and commercial laws.

Learning point: Exclusivity should be based on measurable performance and clearly defined responsibilities.

Case Study 30: First Export Order — From Enquiry to Delivery

Situation: A distributor in a new market requests a quotation for a medicine manufactured in India. The exporter has not previously shipped that product to the destination.

Recommended workflow:

  1. Verify the buyer and importing entity.
  2. Confirm the product, dosage form, strength and intended use.
  3. Identify the destination’s applicable product authorization and import requirements.
  4. Verify the manufacturer’s capability and quality documentation.
  5. Confirm product specifications, packaging and remaining shelf-life requirements.
  6. Establish pricing, currency, MOQ, lead time and payment terms.
  7. Agree on the appropriate Incoterm and precisely named place or port.
  8. Confirm shipping route, insurance, temperature controls and handling requirements where applicable.
  9. Prepare and review the commercial and regulatory documentation.
  10. Confirm order acceptance and manufacturing or procurement arrangements.
  11. Complete the required quality release and shipment checks.
  12. Coordinate customs and logistics documentation.
  13. Monitor dispatch, transit and delivery.
  14. Confirm receipt and address any discrepancies or complaints.
  15. Reconcile costs, payment and lessons learned.

Learning point: A repeatable export process reduces avoidable errors and improves business control.

PART 4: PHARMA EXPORT PRE-SHIPMENT CHECKLIST

Use this checklist as an internal review tool. Adapt it to the product, transaction, destination and applicable law.

  1. Buyer Verification

Legal name and registered address verified

Importer/distributor identity confirmed

Relevant licences or authorizations checked

Business references assessed where appropriate

Payment terms and credit risk reviewed

Sanctions or restricted-party screening completed where applicable

Authorized contact and bank details independently verified

  1. Product and Regulatory Review

Product name, composition, strength and dosage form confirmed

Destination market identified

Applicable product authorization verified

Import permit or other applicable permissions checked

Label and packaging requirements confirmed

Language and patient-information requirements assessed

Remaining shelf-life requirement confirmed

Applicable controlled-substance restrictions assessed, if relevant

Regulatory responsibilities allocated in writing

  1. Manufacturer and Quality Review

Manufacturer’s legal identity verified

Relevant manufacturing authorization and quality status checked

Product specifications agreed

Batch documentation and COA arrangements confirmed

Packaging and labelling specifications approved

Quality agreement reviewed where needed

Batch traceability and complaint procedures established

Recall and escalation arrangements understood

Storage and transport conditions confirmed

  1. Commercial Review

Purchase order received and reviewed

Quotation and contract terms consistent

Price and currency confirmed

MOQ and quantity confirmed

Payment method and due dates agreed

Incoterm and named place or port stated

Freight, insurance and other costs allocated

Taxes, duties and other relevant charges assessed

Quotation validity and delivery timeline confirmed

Cancellation, delay and dispute terms reviewed

  1. Shipping Documentation

Commercial invoice checked

Packing list checked

COA and batch references checked, where applicable

Certificate of Origin arranged where required

Transport document requirements confirmed

Export and import declarations reviewed

Required regulatory certificates verified

HS classification checked

Quantities, descriptions and values reconciled

Shipping instructions and consignee details verified

Insurance arrangements confirmed where applicable

Temperature logger and cold-chain records arranged, if required

  1. Post-Shipment Review

Dispatch details sent to the buyer

Shipment tracked

Delivery confirmed

Customs or delivery issues documented

Buyer receipt and product condition confirmed

Payment tracked and reconciled

Complaints or discrepancies escalated

Actual costs compared with the quotation

Records archived according to applicable requirements

Lessons learned recorded for the next shipment

PART 5: KEY LESSONS FROM THIS SECTION

  1. A buyer’s request does not override regulatory requirements.
  2. Manufacturer verification should include quality and operational capability, not just price.
  3. Certificates and shipping documents must be accurate and applicable to the actual transaction.
  4. Temperature-sensitive medicines require suitable handling and documented assessment of excursions.
  5. Payment security should be evaluated before accepting large orders.
  6. Private-label arrangements need clear brand, quality, regulatory and contractual responsibilities.
  7. Distribution exclusivity should be carefully negotiated.
  8. Registration status and import permissions should be verified at the relevant stage.
  9. Pre-shipment document reconciliation can prevent avoidable customs and payment problems.
  10. A documented export workflow improves consistency and helps the exporter learn from each shipment.

 

PHARMA MEDICINE EXPORT FROM INDIA

Nawinza Global Export Guide

Formula Database — Part 2

Additional Medicines, Uses, Dosage Forms & Export-Regulatory Considerations

Important: The information in this section is intended for pharmaceutical export research and education. A medicine being legally manufactured or exported from India does not automatically mean that it can be marketed or imported in another country. Product registration, marketing authorization, importer licensing, prescription classification, controlled-drug requirements, labeling, GMP requirements and destination-country rules must be checked separately.

  1. Vardenafil + Dapoxetine

Therapeutic category: Erectile dysfunction / sexual-health medicine

Description:
Vardenafil is a phosphodiesterase type-5 (PDE5) inhibitor. Dapoxetine is a short-acting selective serotonin reuptake inhibitor used in certain markets for premature ejaculation. A combination therefore targets two different sexual-health conditions.

Common intended uses:

  • Erectile dysfunction
  • Premature ejaculation, where the combination is specifically authorized

Dosage forms: Usually oral tablets.

Export consideration:
The combination should not be treated as automatically approved merely because both individual ingredients are available in a country. The exact combination, strength, indication and manufacturer must be checked.

Regulatory flag: 🟠 Special product-registration check.

  1. Lamotrigine

Therapeutic category: Antiepileptic / mood stabilizer

Description:
Lamotrigine is an anticonvulsant that affects voltage-sensitive sodium channels and reduces abnormal neuronal activity.

Common uses:

  • Epilepsy
  • Certain seizure disorders
  • Maintenance treatment of bipolar disorder in approved markets

Dosage forms:

  • Immediate-release tablets
  • Chewable/dispersible tablets
  • Extended-release formulations in some markets

Important safety consideration:
Lamotrigine requires careful dose escalation because serious skin reactions, including Stevens-Johnson syndrome, can occur.

Export consideration:
Usually treated as a prescription medicine. Exact registration and labeling requirements vary by market.

Regulatory flag: 🟡 Prescription/product-registration check.

  1. Gabapentin

Therapeutic category: Antiepileptic / neuropathic-pain medicine

Description:
Gabapentin is structurally related to GABA but does not act simply as a conventional GABA agonist. It is widely used for neurological conditions and neuropathic pain.

Common uses:

  • Neuropathic pain
  • Epilepsy/seizure disorders
  • Other approved indications depending on country

Dosage forms:

  • Capsules
  • Tablets
  • Oral solution

Export consideration:
Its legal classification differs between countries. Some jurisdictions have introduced tighter controls because of misuse and dependence concerns.

Regulatory flag: 🟠 Special regulatory check.

  1. Telmisartan

Therapeutic category: Antihypertensive / angiotensin II receptor blocker

Description:
Telmisartan blocks the angiotensin II AT1 receptor and reduces vasoconstriction and aldosterone-related effects.

Common uses:

  • Hypertension
  • Cardiovascular-risk reduction in selected patients/products

Dosage forms: Oral tablets.

Common strengths: Market-dependent, commonly including 20 mg, 40 mg and 80 mg.

Export consideration:
Generally a conventional prescription medicine, but the exact strength, indication and combination product must be registered where required.

Regulatory flag: 🟡 Standard prescription/product-registration check.

  1. Sildenafil + Tadalafil

Therapeutic category: PDE5 inhibitor combination

Description:
This combines two PDE5 inhibitors. Although both drugs individually have established medical uses, combining them is not automatically an accepted or authorized therapeutic product.

Export warning:
This is an important example for exporters:

Individual drug approval ≠ combination-product approval.

The exporter must verify whether the exact combination and strength has regulatory authorization in the destination market.

Regulatory flag: 🟠 Combination-specific investigation required.

  1. Liothyronine Sodium

Therapeutic category: Thyroid hormone

Description:
Liothyronine is synthetic triiodothyronine (T3), a thyroid hormone used when thyroid-hormone replacement is medically indicated.

Common use:

  • Certain forms of hypothyroidism
  • Selected thyroid-related clinical situations

Dosage form: Oral tablets; other formulations may exist in selected markets.

Important:
Thyroid hormones should not be treated as ordinary nutritional supplements.

Export consideration:
Prescription status and approved indications must be checked for the destination country.

Regulatory flag: 🟡 Prescription/product-registration check.

  1. Danazol

Therapeutic category: Hormonal / androgenic medicine

Description:
Danazol is a synthetic steroid with androgenic activity.

Historical/approved uses may include:

  • Endometriosis
  • Certain hereditary angioedema indications
  • Other specialized hormonal conditions depending on market

Export consideration:
Because of its hormonal and androgenic effects, the product requires careful regulatory review.

Regulatory flag: 🟠 Special regulatory check.

  1. Empagliflozin

Therapeutic category: Antidiabetic / SGLT2 inhibitor

Description:
Empagliflozin reduces renal glucose reabsorption by inhibiting sodium-glucose cotransporter 2.

Common uses:

  • Type 2 diabetes
  • Heart-failure indications for authorized products
  • Chronic kidney disease indications for authorized products

Dosage form: Oral tablets.

Common strengths: 10 mg and 25 mg in many markets.

Export consideration:
The approved indications can differ by country and product label.

Regulatory flag: 🟡 Prescription/product-registration check.

  1. Memantine Hydrochloride

Therapeutic category: Neurological / NMDA receptor antagonist

Description:
Memantine is an NMDA receptor antagonist used in the management of certain patients with moderate-to-severe Alzheimer’s disease.

Common use:

  • Alzheimer’s disease

Dosage forms:

  • Tablets
  • Oral solution
  • Extended-release formulations in some markets

Export consideration:
Prescription medicine; product registration and approved indication should be verified.

Regulatory flag: 🟡 Prescription/product-registration check.

  1. Bempedoic Acid

Therapeutic category: Lipid-lowering medicine

Description:
Bempedoic acid reduces cholesterol synthesis through inhibition of ATP-citrate lyase.

Common use:

  • Reduction of LDL cholesterol
  • Management of hypercholesterolemia in appropriate patients

Combination:
Bempedoic acid + ezetimibe is an important combination product.

Export consideration:
Exact combination products and indications must be checked against the destination-country authorization.

Regulatory flag: 🟡 Product-registration check.

  1. Baclofen

Therapeutic category: Skeletal-muscle relaxant / antispasticity medicine

Description:
Baclofen acts primarily through GABA-B receptors and reduces muscle spasticity.

Common uses:

  • Muscle spasticity
  • Neurological conditions associated with increased muscle tone

Dosage forms:

  • Tablets
  • Oral liquid
  • Intrathecal formulations for specialized use

Export consideration:
Prescription status and controlled-drug classification should be checked by jurisdiction.

Regulatory flag: 🟠 Special regulatory check.

  1. Tropicamide + Phenylephrine

Therapeutic category: Ophthalmic diagnostic preparation

Description:
Tropicamide produces mydriasis by blocking muscarinic receptors, while phenylephrine produces pupil dilation through alpha-adrenergic activity.

Common use:

  • Pupil dilation for ophthalmic examination

Dosage form: Sterile ophthalmic solution.

Export considerations:

  • Sterility requirements
  • Ophthalmic manufacturing controls
  • Labeling
  • Product registration
  • Storage requirements

Regulatory flag: 🟡 Sterile-product/product-registration check.

  1. Propranolol Hydrochloride

Therapeutic category: Beta-blocker

Description:
Propranolol is a non-selective beta-adrenergic receptor blocker.

Common uses:

  • Hypertension
  • Certain cardiac conditions
  • Migraine prevention
  • Tremor
  • Other approved indications

Dosage forms:

  • Tablets
  • Extended-release capsules/tablets
  • Oral liquid
  • Injectable forms in selected markets

Export consideration:
Prescription medicine in many markets.

Regulatory flag: 🟡 Prescription/product-registration check.

  1. Metformin Hydrochloride

Therapeutic category: Antidiabetic / biguanide

Description:
Metformin improves insulin sensitivity and reduces hepatic glucose production.

Common use:

  • Type 2 diabetes mellitus

Dosage forms:

  • Immediate-release tablets
  • Extended-release tablets
  • Oral solutions in selected markets

Important export distinction:
Metformin alone and combinations such as metformin + SGLT2 inhibitor, metformin + DPP-4 inhibitor, or metformin + sulfonylurea should be listed as separate products in an export database.

Regulatory flag: 🟡 Standard prescription/product-registration check.

  1. Armodafinil

Therapeutic category: CNS / wakefulness-promoting medicine

Description:
Armodafinil is the R-enantiomer associated with modafinil and is used for certain excessive-sleepiness disorders.

Common uses:

  • Narcolepsy-associated excessive sleepiness
  • Obstructive sleep apnea-associated excessive sleepiness
  • Shift-work sleep disorder, where approved

Export consideration:
Regulatory classification varies considerably. It should receive a separate regulatory assessment rather than being assumed to have identical status to modafinil.

Regulatory flag: 🟠 Special/controlled-status check.

  1. Meloxicam

Therapeutic category: NSAID

Description:
Meloxicam is a non-steroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes and reduces pain and inflammation.

Common uses:

  • Osteoarthritis
  • Rheumatoid arthritis
  • Musculoskeletal pain/inflammation

Dosage form: Oral tablets/capsules and other formulations depending on market.

Export consideration:
Check prescription/OTC classification, maximum strength, labeling and approved indications.

Regulatory flag: 🟡 Product classification check.

  1. Tamoxifen

Therapeutic category: Selective estrogen receptor modulator

Description:
Tamoxifen blocks or modifies estrogen-receptor activity in breast tissue.

Main medical use:

  • Treatment of hormone-receptor-positive breast cancer
  • Prevention of breast cancer in selected high-risk populations

Export consideration:
Prescription oncology medicine. It should not be marketed for unapproved bodybuilding or performance-enhancement purposes.

Regulatory flag: 🟠 Prescription/specialist-use check.

  1. Exemestane

Therapeutic category: Aromatase inhibitor

Description:
Exemestane reduces estrogen production by irreversibly inhibiting aromatase.

Main use:

  • Hormone-sensitive breast cancer in appropriate patients

Export consideration:
Prescription oncology medicine. The indication and patient population should follow the destination-market authorization.

Regulatory flag: 🟠 Prescription/oncology registration check.

  1. Cyanocobalamin

Therapeutic category: Vitamin B12

Description:
Cyanocobalamin is a form of vitamin B12 used to treat or prevent vitamin B12 deficiency.

Common uses:

  • Vitamin B12 deficiency
  • Certain megaloblastic anemia conditions caused by B12 deficiency

Dosage forms:

  • Injection
  • Oral preparations
  • Other formulations depending on market

Export consideration:
Classification can vary between medicine and supplement depending on formulation, dose and claims.

Regulatory flag: 🟡 Product classification check.

  1. Dutasteride

Therapeutic category: 5-alpha-reductase inhibitor

Description:
Dutasteride inhibits both type 1 and type 2 5-alpha-reductase enzymes, reducing conversion of testosterone to dihydrotestosterone.

Common medical use:

  • Benign prostatic hyperplasia

Other use:
Dutasteride is also used for hair-loss treatment in some jurisdictions, but the regulatory status and approved indication must be checked.

Dosage form: Oral capsules.

Common strength: 0.5 mg.

Export consideration:
Indication-specific registration is important.

Regulatory flag: 🟡 Prescription/product-registration check.

  1. Finasteride

Therapeutic category: 5-alpha-reductase inhibitor

Description:
Finasteride reduces conversion of testosterone to dihydrotestosterone.

Common uses:

  • Benign prostatic hyperplasia at higher approved strengths
  • Male pattern hair loss at lower approved strength

Important:
The 1 mg and 5 mg products should be treated as distinct products because their approved indications differ.

Export consideration:
Country-specific labeling and indication requirements must be checked.

Regulatory flag: 🟡 Prescription/product-registration check.

  1. Finasteride + Minoxidil

Therapeutic category: Hair-loss treatment

Description:
This combination targets androgen-related hair loss through two different mechanisms.

Potential use:

  • Male pattern hair loss, where the exact combination is authorized

Important export point:
The existence of individual approvals for finasteride and minoxidil does not automatically establish approval for the combination.

Regulatory flag: 🟠 Combination-product investigation.

  1. Dutasteride + Minoxidil

Therapeutic category: Hair-loss treatment

Description:
Dutasteride reduces dihydrotestosterone production, while minoxidil promotes hair growth through a different mechanism.

Export consideration:
This combination requires particularly careful verification because the exact combination may not have the same regulatory status as the individual ingredients in a particular market.

Regulatory flag: 🟠 Combination-specific check.

  1. Azelaic Acid

Therapeutic category: Dermatological medicine

Description:
Azelaic acid has antimicrobial, anti-inflammatory and keratinization-modifying effects.

Common uses:

  • Acne vulgaris
  • Rosacea
  • Post-inflammatory hyperpigmentation in some clinical uses

Dosage forms:

  • Cream
  • Gel
  • Foam in selected markets

Common concentration: 15–20%, depending on formulation and market.

Export consideration:
Classification can differ between medicine and cosmetic/dermatological product depending on concentration, claims and local rules.

Regulatory flag: 🟡 Product classification check.

  1. Sirolimus

Therapeutic category: Immunosuppressant / mTOR inhibitor

Description:
Sirolimus inhibits the mTOR pathway and suppresses immune-cell proliferation.

Common medical uses:

  • Prevention of organ-transplant rejection
  • Certain specialized diseases/conditions depending on formulation and authorization

Dosage forms:

  • Tablets
  • Oral solution
  • Other specialized formulations

Export consideration:
Prescription/specialist medicine. Cold-chain or storage requirements depend on the specific product.

Regulatory flag: 🟠 Specialist prescription/product-registration check.

  1. Ambrisentan

Therapeutic category: Endothelin receptor antagonist

Description:
Ambrisentan selectively blocks endothelin A receptors.

Main use:

  • Pulmonary arterial hypertension

Important safety consideration:
Pregnancy-related safety requirements are particularly important for this class of medicine.

Export consideration:
Specialist prescription medicine requiring destination-country authorization.

Regulatory flag: 🟠 High regulatory-check category.

  1. Oxandrolone

Therapeutic category: Anabolic androgenic steroid

Description:
Oxandrolone is an anabolic steroid with androgenic activity and has had medical uses in selected conditions involving weight or tissue loss.

Export consideration:
This is not an ordinary nutritional supplement. Anabolic-steroid controls differ significantly between countries and may include controlled-substance or special-prescription requirements.

Regulatory flag: 🔴/🟠 Country-specific controlled-substance investigation.

  1. Mesterolone

Therapeutic category: Androgenic hormonal medicine

Description:
Mesterolone is an orally active androgenic steroid.

Export consideration:
Hormonal/anabolic medicines can have significantly different legal classifications across countries. The exact destination must be checked before quotation or shipment.

Regulatory flag: 🟠 Special hormonal/controlled-status check.

  1. Drostanolone Enanthate

Therapeutic category: Anabolic androgenic steroid

Description:
Drostanolone is an androgenic/anabolic steroid derivative.

Export consideration:
This product should not be treated like a routine prescription medicine. The legal status, import authorization and controlled-substance rules must be checked in the destination market before export.

Regulatory flag: 🔴/🟠 High-risk regulatory category.

  1. Nandrolone Phenylpropionate

Therapeutic category: Anabolic androgenic steroid

Description:
Nandrolone phenylpropionate is an injectable anabolic-androgenic steroid.

Medical context:
Nandrolone products have had limited medical uses in certain jurisdictions, but their regulatory status is highly jurisdiction-dependent.

Export consideration:
Exporter must verify:

  • controlled-substance classification
  • import permit requirements
  • manufacturer authorization
  • destination product registration
  • prescription requirements
  • permitted medical indication

Regulatory flag: 🔴/🟠 High-risk regulatory category.

  1. Exemestane

Note: Already included above and therefore not counted as a new formula if it appears repeatedly in the source list.

  1. Testosterone Cypionate

Therapeutic category: Androgen / hormone replacement

Description:
Testosterone cypionate is a long-acting testosterone ester administered by injection.

Medical use:

  • Testosterone replacement in appropriately diagnosed patients

Export consideration:
Because testosterone products may be controlled or specially regulated, exporters must verify destination-country requirements before shipment.

Regulatory flag: 🟠/🔴 Country-specific controlled-substance check.

  1. Estradiol

Therapeutic category: Estrogen hormone

Description:
Estradiol is a naturally occurring estrogen hormone used in hormone-replacement and other gynecological/endocrine indications.

Dosage forms:

  • Gel
  • Tablets
  • Patches
  • Vaginal preparations
  • Injectable preparations depending on market

Export consideration:
Exact formulation matters. Hormonal medicines require appropriate prescription/product registration and labeling.

Regulatory flag: 🟠 Hormonal prescription-product check.

  1. Estriol

Therapeutic category: Estrogen hormone

Description:
Estriol is an estrogen used in selected hormone-related and local vaginal indications.

Dosage form: Cream and other formulations.

Export consideration:
Classification and approved indications vary by country. The exact formulation and concentration should be checked.

Regulatory flag: 🟡/🟠 Hormonal product check.

  1. Salbutamol

Therapeutic category: Bronchodilator / beta-2 agonist

Description:
Salbutamol relaxes bronchial smooth muscle and improves airflow.

Common uses:

  • Asthma
  • Bronchospasm
  • Chronic obstructive airway disease in appropriate patients

Dosage forms:

  • Metered-dose inhaler
  • Nebulizer solution
  • Tablets
  • Syrup in some markets

Export consideration:
The inhaled product and oral product should be treated as separate regulatory products.

Regulatory flag: 🟡 Product/formulation check.

  1. Salbutamol Sulphate

Note: This is the salt form used in pharmaceutical formulations of salbutamol. When building the final export database, it should be standardized under the active ingredient while preserving the exact formulation name.

Important database rule:

Generic/API name: Salbutamol
Salt: Salbutamol sulphate
Dosage form: Must be recorded separately.

  1. Cyclosporine Ophthalmic

Therapeutic category: Ophthalmic immunomodulator

Description:
Topical cyclosporine ophthalmic preparations reduce ocular-surface inflammation and may increase tear production in appropriate dry-eye conditions.

Dosage form: Sterile ophthalmic emulsion/solution depending on product.

Export consideration:

  • Sterility
  • Container-closure system
  • Stability
  • Ophthalmic manufacturing requirements
  • Product registration

Regulatory flag: 🟠 Sterile ophthalmic product check.

  1. Fluoxymesterone

Therapeutic category: Androgenic steroid

Description:
Fluoxymesterone is a synthetic androgen.

Export consideration:
It belongs to a category requiring careful controlled-substance and hormonal regulatory assessment.

Regulatory flag: 🔴/🟠 High-risk regulatory category.

  1. Oxymetholone

Therapeutic category: Anabolic androgenic steroid

Description:
Oxymetholone is an oral anabolic-androgenic steroid historically used for selected forms of anemia.

Export consideration:
The product may be subject to controlled-drug or special prescription rules depending on destination.

Regulatory flag: 🔴/🟠 Special controlled-substance check.

  1. L-Carnitine / Levocarnitine

Therapeutic category: Metabolic/nutritional medicine

Description:
Levocarnitine is involved in fatty-acid transport into mitochondria and is used medically for certain carnitine-deficiency states.

Dosage forms:

  • Oral solution
  • Tablets/capsules
  • Injection

Export consideration:
Classification varies between medicine, nutritional product and supplement depending on country, formulation and claims.

Regulatory flag: 🟡 Product classification check.

  1. Azithromycin

Duplicate rule: Already covered in the previous batch/source analysis. Do not create another separate formula entry merely because the uploaded file contains multiple strengths or repeated rows.

  1. Pentoxifylline

Therapeutic category: Hemorheologic / peripheral vascular medicine

Description:
Pentoxifylline improves red-cell flexibility and blood-flow characteristics.

Common use:

  • Intermittent claudication associated with peripheral arterial disease in markets where approved

Dosage form: Extended-release tablets are common.

Export consideration:
Prescription status and approved indications should be checked.

Regulatory flag: 🟡 Product-registration check.

  1. Niclosamide

Therapeutic category: Anthelmintic

Description:
Niclosamide is an antiparasitic medicine used against certain intestinal tapeworm infections.

Dosage form: Oral tablets.

Export consideration:
Antiparasitic products require verification of:

  • human versus veterinary use
  • approved indication
  • formulation
  • destination registration
  • labeling

Regulatory flag: 🟡/🟠 Product-specific check.

  1. Rifaximin

Therapeutic category: Gastrointestinal antibiotic

Description:
Rifaximin is a minimally absorbed rifamycin-class antibacterial medicine used for selected gastrointestinal conditions.

Common uses:
Depending on market authorization:

  • Certain infectious diarrhea conditions
  • Hepatic encephalopathy recurrence reduction
  • Irritable bowel syndrome with diarrhea

Export consideration:
The approved indications differ between jurisdictions.

Regulatory flag: 🟡 Prescription/product-registration check.

  1. Nebivolol

Therapeutic category: Beta-blocker / antihypertensive

Description:
Nebivolol is a beta-1 selective adrenergic blocker with nitric-oxide-mediated vasodilatory properties.

Common use:

  • Hypertension

Dosage form: Oral tablets.

Export consideration:
Prescription classification and approved indications should be checked in the destination market.

Regulatory flag: 🟡 Standard prescription check.

  1. Mebendazole

Therapeutic category: Anthelmintic

Description:
Mebendazole interferes with parasite microtubule formation and is used to treat several intestinal worm infections.

Common uses:

  • Pinworm infection
  • Roundworm
  • Whipworm
  • Hookworm and other susceptible helminth infections

Dosage form: Tablets and chewable formulations depending on market.

Export consideration:
Classification may differ by country, and some markets permit selected strengths through non-prescription channels.

Regulatory flag: 🟡 Country/product classification check.

  1. Metronidazole

Therapeutic category: Nitroimidazole antimicrobial/antiprotozoal

Description:
Metronidazole is active against certain anaerobic bacteria and protozoa.

Common uses:

  • Anaerobic bacterial infections
  • Trichomoniasis
  • Giardiasis
  • Amoebiasis
  • Other approved infections

Dosage forms:

  • Tablets
  • Oral suspension
  • IV infusion
  • Topical preparations
  • Vaginal formulations

Export consideration:
Different dosage forms may have different registration and prescription classifications.

Regulatory flag: 🟡 Product/formulation check.

  1. Atomoxetine

Therapeutic category: ADHD medicine / selective norepinephrine reuptake inhibitor

Description:
Atomoxetine increases norepinephrine activity and is used for attention-deficit/hyperactivity disorder.

Common use:

  • ADHD

Export consideration:
Prescription-only classification and special monitoring requirements may apply. It should not automatically be grouped with stimulant ADHD medicines.

Regulatory flag: 🟠 Special prescription/regulatory check.

  1. Cyproheptadine

Therapeutic category: Antihistamine

Description:
Cyproheptadine is an H1 antihistamine with antiserotonergic properties.

Common uses:

  • Allergic conditions
  • Urticaria
  • Other approved indications depending on country

Important export point:
Some markets have different restrictions or warnings concerning pediatric use and appetite/weight-gain claims.

Regulatory flag: 🟡 Country-specific classification check.

  1. Ketorolac Tromethamine

Therapeutic category: NSAID analgesic

Description:
Ketorolac is a potent non-steroidal anti-inflammatory analgesic intended primarily for short-term treatment of moderate-to-severe acute pain.

Dosage forms:

  • Injection
  • Tablets
  • Ophthalmic preparations

Important:
Ketorolac has significant gastrointestinal, renal and bleeding risks and is generally intended for short-duration use.

Export consideration:
Exact dosage form and approved duration/indication should be checked.

Regulatory flag: 🟠 Prescription/high-risk-use check.

EXPORTER’S GOLDEN RULE

Never ask only: “Can I export this medicine from India?”

Ask five questions:

  1. Can it legally be manufactured/supplied in India?
  2. Can it legally be exported from India under the applicable Indian requirements?
  3. Is the exact product registered/authorized in the destination country?
  4. Can the foreign importer legally import and distribute it?
  5. Does the exact formulation, strength, indication and dosage form comply with destination-country rules?

MASTER STATUS SYSTEM FOR THE BOOK

🟢 Routine regulated medicine — normal pharmaceutical regulatory pathway.

🟡 Prescription/product-registration check — authorization and prescription classification must be verified.

🟠 Special regulatory check — controlled substances, hormones, high-risk medicines, specialist medicines, sterile products or unusual combinations.

🔴 High-risk/prohibited-status investigation — do not quote or ship until destination-country legality and import authorization are confirmed.

⚫ Product-specific investigation — exact formulation, strength, indication or combination requires individual verification.

 

EXPORT DATABASE RULE

For the final  database, the same API should not be counted repeatedly simply because the source contains:

  • multiple strengths
  • repeated rows
  • spelling variations
  • IP/BP/USP variations
  • duplicate manufacturer entries
  • duplicate dosage forms copied from different sources

However, these should remain separate where they have meaningful regulatory or commercial differences:

Example:

API

Formulation

Should it be separate?

Finasteride

1 mg tablet

Yes

Finasteride

5 mg tablet

Yes

Tretinoin

0.025% cream

Yes

Tretinoin

0.1% microsphere gel

Yes

Salbutamol

Inhaler

Yes

Salbutamol

Tablet

Yes

Metformin

Immediate-release

Yes

Metformin

Extended-release

Yes

Ivermectin

Different tablet strengths

Usually separate SKU/formulation records

Azithromycin

Multiple repeated rows

No — deduplicate

Testosterone

Different esters

Yes

Testosterone

Same ester, repeated strength

No — deduplicate

Prescription medicine
Product registration required
Controlled/special licence check
Combination-product approval check
Import permit may be required
Not approved for the proposed indication
Destination-country verification required

The strongest structure would make every medicine commercially useful to an exporter, manufacturer, buyer, regulatory person, and student.

1. Complete medicine profile

For every unique formula, add:

  • Generic/API name
  • Salt form
  • Chemical/class name
  • Therapeutic category
  • Pharmacological class
  • Mechanism of action
  • Main indications
  • Secondary indications
  • Dosage forms
  • Common strengths
  • Route of administration
  • Typical prescription status
  • OTC status where applicable
  • Pediatric/adult considerations
  • Major contraindications
  • Major warnings
  • Common adverse effects
  • Serious adverse effects
  • Major drug interactions
  • Storage requirements
  • Shelf-life considerations

2. Export-specific information

This is where your book can become much more valuable than an ordinary medicine book:

  • India export status
  • HS code
  • Whether API or finished formulation
  • Tablet/capsule/injection/cream/ophthalmic/etc.
  • Prescription medicine
  • OTC medicine
  • Controlled substance
  • Narcotic/psychotropic status
  • Hormonal medicine
  • Antibiotic/antimicrobial
  • Oncology medicine
  • Biologic
  • Sterile product
  • Cold-chain requirement
  • Dangerous-goods consideration, where applicable
  • Import permit requirement
  • Manufacturer licence requirement
  • Product registration requirement
  • Marketing authorization requirement
  • Local representative requirement
  • Importer/distributor licence
  • Special certificate requirement
  • GMP requirement
  • CPP/COPP requirement where applicable
  • Certificate of Analysis
  • Stability data
  • Bioequivalence requirement where applicable
  • Pharmacovigilance requirements

3. Country-by-country matrix

For your selected countries, I would make a separate row for every formula:

Formula

USA

UK

Brazil

South Africa

Netherlands

France

Germany

Russia

Canada

Australia

Bangladesh

Nigeria

UAE

Indonesia

Turkey

Egypt

Japan

Philippines

Vietnam

Malaysia

Kenya

Tanzania

Uganda

Ghana

Saudi Arabia

But don’t simply put “Allowed/Banned.”

Use:

🟢 Authorized/normal pathway
🟡 Registration required
🟠 Special licence/control check
🔴 Prohibited/not authorized for proposed use
⚫ Exact product verification required

And add reason + official authority/source.

4. Regulatory authority

For each country, mention the relevant authority, for example:

  • USA — FDA
  • UK — MHRA / relevant UK authorities
  • UAE — Ministry of Health and Prevention / applicable emirate or federal requirements
  • Australia — TGA
  • Canada — Health Canada
  • Japan — PMDA/MHLW
  • Saudi Arabia — SFDA
  • Brazil — ANVISA
  • South Africa — SAHPRA

This makes the book much more useful for exporters.

5. Registration pathway

For each important market, explain:

Manufacturer → Product dossier → Regulatory application → Registration/marketing authorization → Importer → Customs → Distribution → Pharmacovigilance

Then explain what changes for:

  • Generic medicine
  • New chemical entity
  • Combination product
  • Biosimilar
  • Vaccine
  • Injectable
  • Controlled medicine
  • OTC medicine
  • Herbal/Ayurvedic product

6. Buyer information

Since your book is specifically about export, add:

Who buys this product?

Examples:

  • Pharmaceutical importer
  • National distributor
  • Hospital supplier
  • Government procurement agency
  • Pharmacy chain
  • Wholesaler
  • Private hospital
  • Specialty distributor
  • Oncology distributor
  • Dermatology distributor
  • Fertility distributor

And:

What type of buyer should NOT be approached?

This can help readers avoid unsuitable or fraudulent buyers.

7. Commercial information

For each major medicine category:

  • Typical MOQ
  • Bulk-pack possibilities
  • Private-label possibility
  • Contract manufacturing
  • OEM possibility
  • Packaging options
  • Blister/bottle/vial/ampoule
  • Carton requirements
  • Serialization
  • Artwork/label customization
  • Sample availability
  • Approximate lead-time factors
  • Shelf-life requirements
  • Payment terms
  • LC / advance / CAD considerations
  • FOB
  • CIF
  • insurance
  • freight
  • landed-cost calculation

Don’t publish unsupported “market prices” as universal prices; instead explain how to calculate the quotation.

8. Formula combinations

This is very important for your book.

Create a separate section:

Common Pharmaceutical Combinations

For example:

  • Aceclofenac + Paracetamol
  • Amoxicillin + Clavulanic acid
  • Dapagliflozin + Metformin
  • Telmisartan + Amlodipine
  • Losartan + Hydrochlorothiazide
  • Rosuvastatin + Ezetimibe
  • Sitagliptin + Metformin
  • Empagliflozin + Metformin
  • Pantoprazole + Domperidone
  • Levocetirizine + Montelukast

For each:

Formula → Drug classes → Why combined → Main indications → Dosage forms → Regulatory considerations → Major markets → Prescription status

And, importantly, don’t assume that approval of two individual ingredients means the combination itself is approved.

9. Dosage-form chapter

Another useful chapter:

Same API, Different Product

Example:

Salbutamol

  • Tablet
  • Syrup
  • Inhaler
  • Nebulizer solution

Then explain that the regulatory requirements can differ substantially.

Likewise:

Tretinoin

  • Cream
  • Gel
  • Microsphere gel

Testosterone

  • Gel
  • Injection
  • Different esters

Estradiol

  • Tablet
  • Gel
  • Patch
  • Vaginal formulation

This will teach exporters why they cannot quote simply by API name.

10. Red-flag medicines

I strongly recommend a dedicated chapter:

Medicines Requiring Extra Regulatory Caution

Include categories such as:

  • Narcotic/controlled medicines
  • Psychotropic medicines
  • Anabolic steroids
  • Testosterone/hormones
  • Sedative/hypnotics
  • Strong analgesics
  • ADHD/CNS medicines
  • Oncology medicines
  • Immunosuppressants
  • Fertility medicines
  • Retinoids
  • High-risk injectables
  • Biologics
  • Peptides
  • GLP-1 medicines
  • Certain antibiotics
  • Veterinary medicines mistakenly offered as human medicines

Then explain why exporters need additional verification.

11. Human vs veterinary

This is especially important because your source list contains substances that may be encountered in both human and veterinary contexts.

Add:

Human pharmaceutical
vs
Veterinary pharmaceutical
vs
Research/experimental product

A product should never be marketed for human use merely because the active ingredient exists in veterinary products.

12. “Banned” vs “not approved” vs “controlled”

I would make this a dedicated educational section.

These are not the same thing:

Banned ≠ Not approved ≠ Prescription-only ≠ Controlled ≠ Import-restricted ≠ Registration-required

This distinction can become one of the most valuable parts of your book.

13. Export documentation

Create a complete checklist:

  • Purchase Order
  • Proforma Invoice
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • Certificate of Analysis
  • GMP certificate
  • CPP/COPP where applicable
  • Batch documents
  • Manufacturing licence
  • Product registration
  • Import permit
  • Insurance
  • Bill of Lading/Air Waybill
  • Shipping Bill
  • Customs documentation
  • Export declaration
  • Stability documentation
  • MSDS/SDS where applicable
  • Temperature records where required

14. Pharmaceutical costing formula

Include practical formulas such as:

Product Cost + Packaging + Documentation + Testing + Inland Transport + Port Charges + Freight + Insurance + Other Export Costs = Export Cost

Then:

Export Selling Price − Total Export Cost = Gross Export Margin

And explain FOB/CIF carefully.

15. Buyer verification chapter

This is essential for Nawinza.

Explain how to verify:

  • Company registration
  • Import licence
  • Pharmaceutical licence
  • Website
  • Physical address
  • Regulatory registration
  • Business email
  • Bank details
  • Previous shipment history
  • Trade references
  • Distributor authorization
  • Beneficial ownership where appropriate

And include a:

“10 Red Flags of a Fake Pharma Buyer”

16. Manufacturer verification

Likewise:

  • Manufacturing licence
  • GMP
  • WHO-related certifications where actually applicable
  • Product list
  • Inspection history where publicly available
  • Export experience
  • Batch documentation
  • COA
  • Stability data
  • Manufacturing capacity
  • MOQ
  • Private-label capability
  • Packaging capability

17. Country-specific chapters

Instead of only putting country restrictions into tables, create individual chapters:

USA Pharma Export Guide

UK Pharma Export Guide

UAE Pharma Export Guide

Saudi Arabia Pharma Export Guide

Australia Pharma Export Guide

etc.

Each can contain:

Authority → Registration → Importer → Product dossier → Label → GMP → Controlled medicines → Documentation → Typical exporter mistakes → Checklist

18. Real export case studies

For example:

Case Study 1: Indian manufacturer → UAE distributor

Case Study 2: Indian generic → African market

Case Study 3: Controlled medicine inquiry rejected because importer lacked authorization

Case Study 4: Product available in India but not authorized in destination market

Case Study 5: Buyer asks for private label

Case Study 6: Buyer asks for exclusivity

Case Study 7: Buyer wants 100,000 tablets but has no import licence

Case Study 8: Product registration exists but formulation/strength differs

19. Export email templates

This would make the book much more practical.

Include:

  • First buyer introduction
  • Manufacturer inquiry
  • RFQ
  • Product availability request
  • MOQ request
  • Private-label inquiry
  • OEM inquiry
  • Registration-document request
  • COA/GMP request
  • Importer verification
  • Price negotiation
  • Follow-up after quotation
  • Payment follow-up
  • Shipment follow-up
  • Complaint handling
  • Exclusivity negotiation

20. Final “Exporter Decision Sheet”

For every medicine, the reader could complete:

PRODUCT EXPORT CHECK

☐ Formula verified
☐ Manufacturer verified
☐ Human-use product confirmed
☐ Strength verified
☐ Dosage form verified
☐ Indian legal/export requirements checked
☐ Destination-country registration checked
☐ Importer licence verified
☐ Prescription/OTC status checked
☐ Controlled status checked
☐ Label checked
☐ GMP checked
☐ COA checked
☐ Shelf life checked
☐ Storage checked
☐ Import permit checked
☐ Price calculated
☐ FOB calculated
☐ CIF calculated
☐ Buyer verified
☐ Documents complete
☐ Shipment cleared for execution

 

 

 

 

 

 

 

Master sequence for every medicine

  1. Medicine / Product Name
    2. Generic / API / Composition
    3. Salt / Strength
    4. Therapeutic Category
    5. Pharmacological / Drug Class
    6. Main Uses / Indications
    7. Mechanism / Basic Description
    8. Dosage Form & Route
    9. Prescription / OTC Status
    10. Major Warnings / Contraindications / Key Interactions
    11. India Export Considerations
    12. HS Code / Customs Classification – to be verified
    13. 26-Country Regulatory Status
    14. Country Regulatory Authority
    15. Registration / Marketing Authorization Requirements
    16. Export Requirements & Special Restrictions
    17. Buyer Type
    18. Required Export / Regulatory Documentation
    19. Commercial Considerations
    20. Exporter Decision / Verification Checklist

And the 26-country section will be standardized as:

  1. USA
  2. UK
  3. UAE
  4. Saudi Arabia
  5. Canada
  6. Australia
  7. Germany
  8. France
  9. Netherlands
  10. Brazil
  11. South Africa
  12. Nigeria
  13. Kenya
  14. Tanzania
  15. Uganda
  16. Ghana
  17. Egypt
  18. Turkey
  19. Russia
  20. Bangladesh
  21. Indonesia
  22. Malaysia
  23. Philippines
  24. Vietnam
  25. Japan
  26. New Zealand

Overall master structure

1000+ Medicines × 26 Countries × Regulatory Status × Uses × Dosage Forms × Export Requirements × Buyer Type × Documentation × Commercial Considerations

For each medicine, I will not simply write “approved/banned”. Where applicable, I will distinguish:

  • 🟢 Generally permissible/standard regulatory pathway
  • 🟡 Registration/approval required
  • 🟠 Special regulatory review
  • 🔴 Controlled/restricted/high-risk — verify before export
  • ⚫ Product/formulation-specific investigation required

I will also flag duplicate medicines, unusual strengths, human vs veterinary products, controlled substances, hormones/anabolic steroids, oncology medicines, biologics/peptides, injectables, antibiotics and other high-risk products rather than silently treating everything as an ordinary export product.

For country-specific regulatory claims, we should use the current official authority/source and verification date, because regulations can change.

Starting point

We already covered medicines 1–20 in the earlier sequence. So the next continuation should begin with 21 and proceed forward without repeating the previous formulas.

 

MEDICINE 21 — VARDENAFIL + DAPOXETINE

  1. Medicine / Product Name
    Vardenafil + Dapoxetine
  2. Generic / API / Composition
  • Vardenafil — PDE5 inhibitor used for erectile dysfunction
  • Dapoxetine — short-acting SSRI used for premature ejaculation in markets where approved
  • Combination = erectile dysfunction + premature ejaculation positioning
  1. Salt / Strength
    Source file identifies the combination but does not provide a strength.
    Export rule: do not assume the strength. Obtain the manufacturer’s exact formulation, strength, dosage form and specification before quotation.
  2. Therapeutic Category
    Sexual-health medicine / erectile dysfunction / premature ejaculation.
  3. Pharmacological / Drug Class
  • Vardenafil: PDE5 inhibitor
  • Dapoxetine: SSRI
  1. Main Uses / Indications
    Potentially intended for adult males with erectile dysfunction and premature ejaculation. The exact approved indication depends on the destination country’s product authorization.
  2. Mechanism / Basic Description
    Vardenafil enhances erectile response by inhibiting PDE5 and increasing cGMP-mediated penile blood flow. Dapoxetine increases serotonergic activity and can delay ejaculation.
  3. Dosage Form & Route
    Usually oral tablets/capsules depending on manufacturer.
    Exact dosage form must be verified from the finished-product specification.
  4. Prescription / OTC Status
    Treat as prescription/regulatory-controlled medicine unless the destination authority specifically classifies the product otherwise.
  5. Major Warnings / Contraindications / Key Interactions
    Important issues include cardiovascular risk, nitrate interactions with PDE5 inhibitors, blood-pressure effects and potential serotonergic adverse effects/interactions from dapoxetine. Medical supervision is appropriate.
  6. India Export Considerations
    Verify:
  • finished formulation authorization/licence
  • manufacturer licence
  • composition and strength
  • export documentation
  • destination registration
  • importer authorization
  • labeling
  • stability/shelf-life data
  1. HS Code / Customs Classification — TO BE VERIFIED
    Do not assign a final HS code solely from the API name. Classification depends on the finished pharmaceutical product, presentation and applicable customs rules.
  2. 26-Country Regulatory Status

Country

Export status for this exact combination

USA

🔴 Product-specific approval required; do not assume marketing authorization

UK

🟠 Combination-specific authorization/registration must be verified

UAE

🟠 Product registration/import authorization check

Saudi Arabia

🟠 Product registration/importer authorization check

Canada

🟠 Product-specific authorization check

Australia

🟠 TGA product pathway check

Germany

🟠 EU/German authorization check

France

🟠 EU/French authorization check

Netherlands

🟠 EU/Dutch authorization check

Brazil

🟠 ANVISA authorization check

South Africa

🟠 SAHPRA registration check

Nigeria

🟠 NAFDAC registration/import requirements

Kenya

🟠 Pharmacy & Poisons Board requirements

Tanzania

🟠 TMDA registration/import requirements

Uganda

🟠 NDA Uganda requirements

Ghana

🟠 FDA Ghana registration/import requirements

Egypt

🟠 Egyptian pharmaceutical registration

Turkey

🟠 Turkish product authorization

Russia

🟠 Russian pharmaceutical registration

Bangladesh

🟠 DGDA registration/import requirements

Indonesia

🟠 BPOM registration

Malaysia

🟠 NPRA registration

Philippines

🟠 FDA Philippines registration

Vietnam

🟠 DAV/MOH registration

Japan

🟠 PMDA/MHLW pathway

New Zealand

🟠 Medsafe regulatory pathway

Important: this table is a screening classification, not a statement that the combination is approved or banned in each country. The exact finished product must be checked against each country’s current database before export.

  1. Country Regulatory Authority
    Examples include FDA (USA), MHRA (UK), TGA (Australia), Health Canada, ANVISA (Brazil), SAHPRA (South Africa), NAFDAC (Nigeria), NPRA (Malaysia), BPOM (Indonesia), PMDA/MHLW (Japan).
  2. Registration / Marketing Authorization Requirements
    Combination products normally require destination-specific assessment. The fact that each individual ingredient exists as an approved medicine does not automatically mean that their fixed-dose combination is authorized.
  3. Export Requirements & Special Restrictions
    Special attention to:
  • combination authorization
  • prescription status
  • pharmacovigilance
  • label claims
  • importer licence
  • advertising claims
  • product registration
  • certificate requirements
  1. Buyer Type
    Suitable buyer categories may include:
  • licensed pharmaceutical importers
  • registered distributors
  • pharmaceutical wholesalers
  • licensed healthcare companies
  • registered private-label pharmaceutical companies where permitted
  1. Required Export / Regulatory Documentation
    Potential documentation:
  • Commercial Invoice
  • Packing List
  • Certificate of Origin
  • GMP certificate
  • COA
  • manufacturing licence
  • product specification
  • stability data
  • product registration/MA
  • CPP where applicable
  • import permit
  • shipping documents
  1. Commercial Considerations
    Evaluate:
  • MOQ
  • tablet/capsule strength
  • blister/bottle packaging
  • private-label possibility
  • artwork
  • registration cost
  • shelf life
  • payment terms
  • FOB/CIF
  • freight
  • insurance
  • destination registration cost
  1. Exporter Decision / Verification Checklist
    ☐ Exact strength confirmed
    ☐ Exact dosage form confirmed
    ☐ Combination legally permitted
    ☐ Manufacturer verified
    ☐ Buyer/importer licence verified
    ☐ Destination registration checked
    ☐ Prescription/controlled status checked
    ☐ Label checked
    ☐ GMP/COA available
    ☐ Import permit requirement checked
    ☐ Commercial feasibility calculated

MEDICINE 22 — LAMOTRIGINE

  1. Medicine / Product Name
    Lamotrigine
  2. Generic / API / Composition
    Lamotrigine
  3. Salt / Strength
    Source file specifically lists Lamotrigine Dispersible; strength is not stated in the extracted source.
  4. Therapeutic Category
    Antiepileptic / anticonvulsant; also used in certain bipolar-disorder treatment regimens.
  5. Pharmacological / Drug Class
    Antiseizure medication; sodium-channel modulating anticonvulsant.
  6. Main Uses / Indications
    Depending on country and authorization:
  • epilepsy/seizure disorders
  • maintenance treatment of bipolar disorder
  1. Mechanism / Basic Description
    Lamotrigine primarily reduces neuronal excitability through inhibition of voltage-sensitive sodium channels and reduction of excitatory neurotransmitter release.
  2. Dosage Form & Route
  • Tablets
  • chewable/dispersible tablets
  • oral route

The exact formulation must match the destination registration.

  1. Prescription / OTC Status
    Generally prescription medicine.
  2. Major Warnings / Contraindications / Key Interactions
    Major concern: serious skin reactions, including Stevens-Johnson syndrome/toxic epidermal necrolysis. Dose escalation is important. Interactions include valproate and certain enzyme-inducing medicines.
  3. India Export Considerations
    Verify:
  • manufacturer’s drug licence
  • finished-product specification
  • dispersible-tablet formulation
  • dissolution specifications
  • stability
  • GMP
  • destination registration
  1. HS Code — TO BE VERIFIED
    Pharmaceutical medicament classification must be confirmed according to the finished product and destination customs requirements.
  2. 26-Country Regulatory Status

Market group

Screening status

USA

🟡 Regulated prescription medicine; product authorization required

UK

🟡 Prescription medicine; MA/product requirements

EU markets — Germany, France, Netherlands

🟡 Prescription/authorized medicinal product pathway

Canada

🟡 Product authorization required

Australia

🟡 TGA/Australian Register pathway

Japan

🟡 PMDA/MHLW pathway

New Zealand

🟡 Medsafe pathway

UAE

🟡 Local registration/importer authorization

Saudi Arabia

🟡 SFDA registration/import pathway

Brazil

🟡 ANVISA pathway

South Africa

🟡 SAHPRA pathway

Nigeria

🟡 NAFDAC pathway

Kenya

🟡 PPB pathway

Tanzania

🟡 TMDA pathway

Uganda

🟡 NDA pathway

Ghana

🟡 FDA Ghana pathway

Egypt

🟡 Local pharmaceutical registration

Turkey

🟡 Product authorization

Russia

🟡 Product registration

Bangladesh

🟡 DGDA pathway

Indonesia

🟡 BPOM pathway

Malaysia

🟡 NPRA pathway

Philippines

🟡 FDA Philippines pathway

Vietnam

🟡 DAV/MOH pathway

  1. Country Regulatory Authority
    Destination authority must be checked before shipment; the U.S. FDA, UK MHRA, Health Canada, TGA, SFDA, UAE authority and corresponding national agencies regulate medicinal products in their respective markets.
  2. Registration / Marketing Authorization Requirements
    The exact lamotrigine dosage form, strength, manufacturer and indication must correspond to the destination authorization.
  3. Export Requirements & Special Restrictions
    Check:
  • prescription classification
  • product registration
  • importer licence
  • GMP
  • stability
  • labeling
  • pharmacovigilance
  • batch-release requirements
  1. Buyer Type
    Licensed pharmaceutical:
  • importer
  • distributor
  • wholesaler
  • hospital-supply distributor
  • government/NGO procurement organization where eligible
  1. Required Documentation
    COA, GMP, manufacturing licence, product specification, stability data, CPP where applicable, Certificate of Origin, invoice, packing list, registration/MA and import permit where applicable.
  2. Commercial Considerations
    Dispersible formulation may have different:
  • packaging
  • stability
  • dissolution
  • moisture-protection
  • registration
  • MOQ
    requirements compared with ordinary tablets.
  1. Exporter Decision
    ☐ Strength confirmed
    ☐ Dispersible formulation confirmed
    ☐ Manufacturer GMP verified
    ☐ Product registered in target market
    ☐ Importer licensed
    ☐ Label approved
    ☐ Stability data available
    ☐ COA available
    ☐ Shelf life acceptable
    ☐ Price calculated on FOB/CIF basis

MEDICINE 23 — GABAPENTIN

  1. Medicine / Product Name
    Gabapentin
  2. Generic / API / Composition
    Gabapentin
  3. Salt / Strength
    Gabapentin; source file contains multiple repeated entries and strengths. These should be consolidated after exact-strength verification.
  4. Therapeutic Category
    Antiepileptic / neuropathic-pain medicine.
  5. Pharmacological / Drug Class
    Antiseizure medicine / gabapentinoid.
  6. Main Uses / Indications
    Depending on country:
  • certain seizure disorders
  • neuropathic pain
  • other authorized indications
  1. Mechanism / Basic Description
    Gabapentin binds to the α2δ subunit of voltage-gated calcium channels and reduces excitatory neurotransmitter release.
  2. Dosage Form & Route
    Commonly:
  • capsules
  • tablets
  • oral solution

Exact dosage form must be matched to the registered product.

  1. Prescription / OTC Status
    Generally prescription medicine. Regulatory/control classification varies by country.
  2. Major Warnings / Contraindications / Key Interactions
    Potential concerns:
  • dizziness
  • sedation
  • impaired coordination
  • respiratory-depression risk in susceptible patients, especially with CNS depressants
  • renal-dose considerations
  1. India Export Considerations
    Check the exact strength and dosage form because the source list contains repeated gabapentin entries.
  2. HS Code — TO BE VERIFIED
    Do not use a generic HS code without confirming the finished-product classification.
  3. 26-Country Regulatory Status

Overall screening: 🟡 regulated prescription medicine in the listed markets; additional controlled-drug checks are necessary in certain jurisdictions.

Countries

Screening

USA

🟡 Prescription; federal/state requirements must be checked

UK

🟠 Controlled-drug requirements apply; verify current classification and import requirements

Canada

🟡 Controlled/substance regulatory check required

Australia

🟠 State/federal controlled-medicine requirements

New Zealand

🟠 Controlled-medicine classification check

EU countries

🟡 Prescription/product authorization

UAE

🟠 Controlled/prescription/import check

Saudi Arabia

🟠 Controlled/prescription/import check

Japan

🟠 Import/prescription requirements

Other listed markets

🟡/🟠 Destination-specific medicine and controlled-substance checks

  1. Country Regulatory Authority
    FDA, MHRA, Health Canada, TGA, Medsafe and respective national authorities.
  2. Registration / Marketing Authorization Requirements
    Exact product authorization, importer authorization and prescription/controlled classification must be confirmed before commercial shipment.
  3. Export Requirements & Special Restrictions
    Because gabapentin can have additional controls depending on jurisdiction, do not treat it like an unrestricted OTC product.
  4. Buyer Type
    Only verified:
  • licensed pharmaceutical importers
  • authorized distributors
  • hospital suppliers
  • licensed wholesalers
  1. Required Documentation
    Manufacturer licence, GMP, COA, product specification, stability data, CPP where applicable, import permit/authorization where required, invoice, packing list and certificate of origin.
  2. Commercial Considerations
    Important commercial variables:
  • strength
  • capsule/tablet format
  • pack size
  • controlled-medicine handling
  • importer licence
  • destination registration
  • MOQ
  • shelf life
  • FOB/CIF
  1. Exporter Decision
    ☐ Exact strength confirmed
    ☐ Controlled status checked in destination
    ☐ Importer licence verified
    ☐ Product registration verified
    ☐ Manufacturer verified
    ☐ GMP verified
    ☐ COA verified
    ☐ Label checked
    ☐ Import permit checked
    ☐ Shipment documentation complete

MEDICINE 24 — TELMISARTAN

  1. Medicine / Product Name
    Telmisartan
  2. Generic / API / Composition
    Telmisartan
  3. Salt / Strength
    Telmisartan; exact strength must be taken from the finished-product specification.
  4. Therapeutic Category
    Cardiovascular medicine / antihypertensive.
  5. Pharmacological / Drug Class
    Angiotensin II receptor blocker (ARB).
  6. Main Uses / Indications
    Primarily used for:
  • hypertension
  • cardiovascular-risk reduction in appropriate patients where authorized
  1. Mechanism / Basic Description
    Telmisartan blocks angiotensin II AT1 receptors, reducing vasoconstriction and aldosterone-related effects.
  2. Dosage Form & Route
    Primarily:
  • oral tablets

Combination products may contain telmisartan with other antihypertensive agents.

  1. Prescription / OTC Status
    Generally prescription medicine.
  2. Major Warnings / Contraindications / Key Interactions
    Important considerations include:
  • pregnancy contraindication/warnings
  • renal function
  • potassium elevation
  • interactions with certain medicines affecting renal function or potassium
  1. India Export Considerations
    Verify:
  • strength
  • tablet formulation
  • manufacturer licence
  • GMP
  • stability
  • destination registration
  • labeling
  1. HS Code — TO BE VERIFIED
    Finished medicament HS classification must be verified according to the exact product and customs requirements.
  2. 26-Country Regulatory Status

Market

Screening status

USA

🟡 Prescription/product authorization

UK

🟡 Prescription/product authorization

UAE

🟡 Product registration/import authorization

Saudi Arabia

🟡 SFDA/product registration

Canada

🟡 Product authorization

Australia

🟡 TGA pathway

Germany

🟡 EU/German authorization

France

🟡 EU/French authorization

Netherlands

🟡 EU/Dutch authorization

Brazil

🟡 ANVISA pathway

South Africa

🟡 SAHPRA pathway

Nigeria

🟡 NAFDAC pathway

Kenya

🟡 PPB pathway

Tanzania

🟡 TMDA pathway

Uganda

🟡 NDA pathway

Ghana

🟡 FDA Ghana pathway

Egypt

🟡 Pharmaceutical registration

Turkey

🟡 Product authorization

Russia

🟡 Product registration

Bangladesh

🟡 DGDA pathway

Indonesia

🟡 BPOM pathway

Malaysia

🟡 NPRA pathway

Philippines

🟡 FDA Philippines pathway

Vietnam

🟡 DAV/MOH pathway

Japan

🟡 PMDA/MHLW pathway

New Zealand

🟡 Medsafe pathway

  1. Country Regulatory Authority
    National pharmaceutical authority of the importing country; examples include FDA, MHRA, TGA, Health Canada, SFDA, SAHPRA, NAFDAC, NPRA and PMDA/MHLW.
  2. Registration / Marketing Authorization Requirements
    The finished telmisartan product must satisfy the destination’s pharmaceutical registration requirements. Do not confuse API availability with authorization to sell a finished medicine.
  3. Export Requirements & Special Restrictions
    Check:
  • product registration
  • prescription status
  • importer licence
  • GMP
  • stability
  • approved label
  • batch documentation
  1. Buyer Type
    Licensed:
  • pharmaceutical importers
  • distributors
  • wholesalers
  • hospital suppliers
  • institutional procurement organizations
  1. Required Documentation
    COA, GMP, manufacturing licence, specifications, stability information, registration/MA, CPP where applicable, invoice, packing list, COO and import authorization where required.
  2. Commercial Considerations
    Potentially strong generic-market category because hypertension treatment is widely used, but competition, registration, local reference pricing, pack size and reimbursement environment should be assessed.
  3. Exporter Decision
    ☐ Strength confirmed
    ☐ Manufacturer verified
    ☐ GMP verified
    ☐ Destination MA verified
    ☐ Importer verified
    ☐ Label verified
    ☐ COA available
    ☐ Stability available
    ☐ MOQ obtained
    ☐ FOB/CIF calculated

MEDICINE 25 — SILDENAFIL CITRATE + TADALAFIL

  1. Medicine / Product Name
    Sildenafil citrate + Tadalafil
  2. Generic / API / Composition
  • Sildenafil citrate
  • Tadalafil

Both are PDE5 inhibitors.

  1. Salt / Strength
    Source file identifies Sildenafil Citrate and Tadalafil but does not provide the exact strengths in this entry.
  2. Therapeutic Category
    Sexual-health / erectile-dysfunction product.
  3. Pharmacological / Drug Class
    Both ingredients are PDE5 inhibitors.
  4. Main Uses / Indications
    The proposed combination is intended commercially for erectile dysfunction, but the exact combination must be treated as a separate regulatory product from either sildenafil or tadalafil alone.
  5. Mechanism / Basic Description
    Both medicines inhibit PDE5. Combining two PDE5 inhibitors is not automatically an approved or clinically appropriate regimen.
  6. Dosage Form & Route
    Likely oral dosage form based on the source entry. Exact form and strength must be verified.
  7. Prescription / OTC Status
    Treat as prescription/regulatory medicine unless the destination authority specifically determines otherwise.
  8. Major Warnings / Contraindications / Key Interactions
    Major concern is duplication of PDE5 pharmacological activity and increased risk of adverse effects such as hypotension. Nitrate interactions are particularly important with PDE5 inhibitors.
  9. India Export Considerations
    Before exporting, verify whether the specific fixed-dose combination is legally manufactured, licensed and exportable.
  10. HS Code — TO BE VERIFIED
    Final HS classification requires exact finished-product details.
  11. 26-Country Regulatory Status

Critical rule: Do not infer authorization of this combination from authorization of sildenafil or tadalafil individually.

Country

Screening status

USA

🔴 Combination-specific FDA authorization required; do not assume approved

UK

🟠 Combination-specific authorization required

UAE

🟠 Product registration/import authorization

Saudi Arabia

🟠 SFDA product registration

Canada

🟠 Combination-specific authorization

Australia

🟠 TGA product pathway

Germany

🟠 EU/German authorization

France

🟠 EU/French authorization

Netherlands

🟠 EU/Dutch authorization

Brazil

🟠 ANVISA authorization

South Africa

🟠 SAHPRA registration

Nigeria

🟠 NAFDAC registration

Kenya

🟠 PPB registration

Tanzania

🟠 TMDA registration

Uganda

🟠 NDA registration

Ghana

🟠 FDA Ghana registration

Egypt

🟠 Local pharmaceutical authorization

Turkey

🟠 Product authorization

Russia

🟠 Product registration

Bangladesh

🟠 DGDA registration

Indonesia

🟠 BPOM registration

Malaysia

🟠 NPRA registration

Philippines

🟠 FDA Philippines registration

Vietnam

🟠 DAV/MOH registration

Japan

🟠 PMDA/MHLW pathway

New Zealand

🟠 Medsafe pathway

  1. Country Regulatory Authority
    The applicable national medicines authority must assess the combination product, not merely the individual APIs.
  2. Registration / Marketing Authorization Requirements
    A fixed-dose combination requires its own regulatory justification/authorization where applicable. The existence of approved sildenafil and tadalafil products does not establish authorization of this combination.
  3. Export Requirements & Special Restrictions
    High-priority checks:
  • fixed-dose combination legality
  • clinical/regulatory justification
  • product licence
  • prescription classification
  • label claims
  • importer authorization
  • pharmacovigilance
  • destination registration
  1. Buyer Type
    Only verified pharmaceutical:
  • importers
  • distributors
  • wholesalers
  • registered private-label companies
  • licensed healthcare suppliers
  1. Required Documentation
    Potential requirements:
  • manufacturing licence
  • GMP
  • product specification
  • COA
  • stability
  • pharmaceutical dossier
  • registration/MA
  • CPP where applicable
  • import authorization
  • invoice
  • packing list
  • certificate of origin
  1. Commercial Considerations
    Do not price this product simply by adding sildenafil and tadalafil API costs. Include:
  • formulation development
  • regulatory/registration cost
  • stability studies
  • packaging
  • testing
  • artwork
  • MOQ
  • freight
  • insurance
  • importer/distributor margin
  • potential registration/exclusivity costs
  1. Exporter Decision
    ☐ Exact formulation confirmed
    ☐ Exact strength confirmed
    ☐ Combination legally authorized in India
    ☐ Destination authorization confirmed
    ☐ Manufacturer verified
    ☐ Buyer/importer verified
    ☐ Prescription status checked
    ☐ Label reviewed
    ☐ COA/GMP available
    ☐ Import permit checked
    ☐ Commercial feasibility approved

U.S. regulatory principle for the entire database: FDA states that foreign establishments manufacturing drugs offered for import into the U.S. generally must register, commercially distributed drugs must be listed, applicable drug applications/approval requirements must be satisfied, labeling must comply, and drugs must meet CGMP requirements.

For the UK, the MHRA states that importing licensed human medicines can involve a WDA(H), manufacturer licence and marketing authorization, with additional requirements for controlled substances and certain import routes.

MEDICINE 26 — LIOTHYRONINE SODIUM

  1. Medicine / Product Name
    Liothyronine Sodium
  2. Generic / API / Composition
    Liothyronine sodium — synthetic sodium salt of liothyronine (T3).

FDA’s substance database identifies liothyronine sodium as the sodium salt of 3,3′,5-triiodo-L-thyronine.

  1. Salt / Strength
    Source file contains:
  • Liothyronine Sodium
  • Liothyronine Sodium BP 25 mcg

Therefore, 25 mcg should be recorded as one confirmed source-file strength, while any other strength must be verified from the manufacturer.

  1. Therapeutic Category
    Thyroid hormone / endocrine medicine.
  2. Pharmacological / Drug Class
    Thyroid hormone; synthetic T3.
  3. Main Uses / Indications
    Used for thyroid-hormone replacement in appropriate thyroid disorders according to the approved indication and local label.
  4. Mechanism / Basic Description
    Liothyronine is the active thyroid hormone T3 and acts through thyroid-hormone receptors to regulate gene transcription and metabolic activity.
  5. Dosage Form & Route
    Common pharmaceutical forms include:
  • oral tablets
  • injectable formulations for specific indications

Your source specifically identifies the oral ingredient/tablet context.

  1. Prescription / OTC Status
    Treat as a prescription medicine unless the destination authority explicitly classifies the particular product otherwise.
  2. Major Warnings / Contraindications / Key Interactions
    Important issues include:
  • cardiovascular effects
  • excessive thyroid-hormone exposure
  • arrhythmia risk
  • interaction with anticoagulants
  • interaction with medicines affecting thyroid absorption/metabolism

FDA labeling for Cytomel specifically warns that thyroid hormones should not be used for obesity or weight loss and that excessive doses can cause serious or life-threatening toxicity.

  1. India Export Considerations
    Verify:
  • exact strength
  • finished dosage form
  • manufacturer licence
  • GMP
  • stability
  • label
  • destination registration
  • importer authorization
  1. HS Code / Customs Classification — VERIFY
    Do not assign the final HS code from the API name alone. Confirm the finished pharmaceutical presentation.
  2. 26-Country Regulatory Status

Country

Screening status

USA

🟡 Prescription/product authorization

UK

🟡 Prescription/product authorization

UAE

🟡 Product registration/import authorization

Saudi Arabia

🟡 Product registration/import authorization

Canada

🟡 Product authorization

Australia

🟡 TGA pathway

Germany

🟡 EU/German authorization

France

🟡 EU/French authorization

Netherlands

🟡 EU/Dutch authorization

Brazil

🟡 ANVISA pathway

South Africa

🟡 SAHPRA pathway

Nigeria

🟡 NAFDAC pathway

Kenya

🟡 PPB pathway

Tanzania

🟡 TMDA pathway

Uganda

🟡 NDA pathway

Ghana

🟡 FDA Ghana pathway

Egypt

🟡 Pharmaceutical registration

Turkey

🟡 Product authorization

Russia

🟡 Product registration

Bangladesh

🟡 DGDA pathway

Indonesia

🟡 BPOM pathway

Malaysia

🟡 NPRA pathway

Philippines

🟡 FDA Philippines pathway

Vietnam

🟡 DAV/MOH pathway

Japan

🟡 PMDA/MHLW pathway

New Zealand

🟡 Medsafe pathway

  1. Country Regulatory Authority
    The applicable national medicines authority must be checked for the exact product.
  2. Registration / Marketing Authorization Requirements
    The finished product must meet the destination’s thyroid-medicine requirements, including approved strength, indications, labeling and manufacturing standards.
  3. Export Requirements & Special Restrictions
    Special attention:
  • prescription status
  • hormone/thyroid-medicine classification
  • approved indications
  • anti-weight-loss claims
  • importer licence
  • destination registration
  1. Buyer Type
  • Licensed pharmaceutical importer
  • Distributor
  • Hospital supplier
  • Licensed wholesaler
  • Institutional procurement organization
  1. Required Export / Regulatory Documentation
    Potential documents:
  • GMP
  • manufacturing licence
  • COA
  • product specification
  • stability data
  • CPP where applicable
  • registration/MA
  • Certificate of Origin
  • Commercial Invoice
  • Packing List
  • import authorization where applicable
  1. Commercial Considerations
    Check:
  • 25 mcg or other strength
  • blister/bottle
  • MOQ
  • shelf life
  • registration cost
  • freight
  • importer margin
  • FOB/CIF
  1. Exporter Decision / Verification Checklist
    ☐ Strength confirmed
    ☐ Dosage form confirmed
    ☐ Manufacturer verified
    ☐ GMP verified
    ☐ Destination registration checked
    ☐ Prescription status checked
    ☐ Label/claims checked
    ☐ Importer verified
    ☐ COA available
    ☐ Commercial costing completed

MEDICINE 27 — DANAZOL

  1. Medicine / Product Name
    Danazol
  2. Generic / API / Composition
    Danazol.
  3. Salt / Strength
    Source file identifies Danazol but does not specify the strength.
  4. Therapeutic Category
    Hormonal medicine / androgenic-anabolic steroid derivative.
  5. Pharmacological / Drug Class
    Synthetic androgen with antigonadotropic activity.
  6. Main Uses / Indications
    Historically/depending on jurisdiction:
  • endometriosis
  • hereditary angioedema
  • certain other hormone-related conditions

The exact indication must follow the destination-approved label.

  1. Mechanism / Basic Description
    Danazol suppresses pituitary-gonadal hormone activity and has androgenic effects.
  2. Dosage Form & Route
    Primarily:
  • oral capsules
  1. Prescription / OTC Status
    Prescription medicine.

An FDA danazol label explicitly states that dispensing is prohibited without prescription.

  1. Major Warnings / Contraindications / Key Interactions
    Important considerations include:
  • androgenic effects
  • liver-related adverse effects
  • lipid changes
  • pregnancy/fetal-risk concerns
  • interaction with anticoagulants and certain other medicines
  1. India Export Considerations
    Because this is a hormone-related medicine, verify:
  • manufacturer authorization
  • exact strength
  • formulation
  • export classification
  • destination restrictions
  • importer licence
  1. HS Code — VERIFY
    Final classification depends on the finished medicament.
  2. 26-Country Regulatory Status

Market

Screening

USA

🟡 Prescription medicine; product authorization required

UK

🟠 Hormonal/special regulatory check

UAE

🟠 Product registration + importer authorization

Saudi Arabia

🟠 Product registration/import check

Canada

🟠 Product authorization

Australia

🟠 TGA/product pathway

Germany

🟠 EU/German authorization

France

🟠 EU/French authorization

Netherlands

🟠 EU/Dutch authorization

Brazil

🟠 ANVISA check

South Africa

🟠 SAHPRA check

Nigeria

🟠 NAFDAC check

Kenya

🟠 PPB check

Tanzania

🟠 TMDA check

Uganda

🟠 NDA check

Ghana

🟠 FDA Ghana check

Egypt

🟠 Pharmaceutical registration

Turkey

🟠 Product authorization

Russia

🟠 Product registration

Bangladesh

🟠 DGDA check

Indonesia

🟠 BPOM check

Malaysia

🟠 NPRA check

Philippines

🟠 FDA Philippines check

Vietnam

🟠 DAV/MOH check

Japan

🟠 PMDA/MHLW check

New Zealand

🟠 Medsafe check

  1. Country Regulatory Authority
    Destination-specific pharmaceutical authority.
  2. Registration / Marketing Authorization Requirements
    Exact indication, formulation, strength and manufacturer must be covered by the destination authorization.
  3. Export Requirements & Special Restrictions
    Treat as a special-regulatory hormonal product, not as an ordinary OTC product.
  4. Buyer Type
    Only:
  • licensed pharmaceutical importer
  • authorized distributor
  • hospital/medical supplier
  • regulated pharmaceutical wholesaler
  1. Required Documentation
    GMP, manufacturing licence, COA, specifications, stability, product registration/MA, CPP where applicable, import permit, invoice, packing list and COO.
  2. Commercial Considerations
    Consider:
  • hormone-product demand
  • registration barriers
  • MOQ
  • strength
  • capsule packaging
  • shelf life
  • importer authorization
  • regulatory cost
  1. Exporter Decision
    ☐ Hormonal classification checked
    ☐ Strength verified
    ☐ Destination authorization checked
    ☐ Importer licence verified
    ☐ Manufacturer verified
    ☐ GMP/COA verified
    ☐ Label approved
    ☐ Import permit checked
    ☐ Commercial viability confirmed

MEDICINE 28 — EMPAGLIFLOZIN

  1. Medicine / Product Name
    Empagliflozin
  2. Generic / API / Composition
    Empagliflozin.
  3. Salt / Strength
    Source file identifies Empagliflozin but does not state the strength in the relevant entry.
  4. Therapeutic Category
    Antidiabetic / cardiovascular / renal medicine.
  5. Pharmacological / Drug Class
    SGLT2 inhibitor.
  6. Main Uses / Indications
    Depending on jurisdiction and current label:
  • type 2 diabetes management
  • cardiovascular-risk reduction in appropriate patients
  • heart-failure indications
  • chronic-kidney-disease-related indications in applicable labels
  1. Mechanism / Basic Description
    Empagliflozin inhibits sodium-glucose cotransporter 2 in the renal proximal tubule, increasing urinary glucose and sodium excretion.
  2. Dosage Form & Route
    Primarily:
  • film-coated oral tablets

FDA labeling records Jardiance as an oral film-coated tablet and identifies empagliflozin as an SGLT2 inhibitor.

  1. Prescription / OTC Status
    Prescription medicine.
  2. Major Warnings / Contraindications / Key Interactions
    Key concerns can include:
  • dehydration/volume depletion
  • genital mycotic infections
  • urinary infections
  • ketoacidosis
  • renal-function considerations
  • hypoglycemia when combined with certain glucose-lowering medicines
  1. India Export Considerations
    Verify:
  • exact strength
  • formulation
  • finished-product licence
  • GMP
  • stability
  • bioequivalence requirements where applicable
  • destination registration
  1. HS Code — VERIFY
    Use the finished pharmaceutical classification, not merely the API classification.
  2. 26-Country Regulatory Status

Country

Screening

USA

🟢 Approved prescription product pathway exists; specific generic/product authorization required

UK

🟡 Prescription/product authorization

UAE

🟡 Registration/import authorization

Saudi Arabia

🟡 SFDA registration

Canada

🟡 Product authorization

Australia

🟡 TGA pathway

Germany

🟡 EU/German authorization

France

🟡 EU/French authorization

Netherlands

🟡 EU/Dutch authorization

Brazil

🟡 ANVISA pathway

South Africa

🟡 SAHPRA pathway

Nigeria

🟡 NAFDAC pathway

Kenya

🟡 PPB pathway

Tanzania

🟡 TMDA pathway

Uganda

🟡 NDA pathway

Ghana

🟡 FDA Ghana pathway

Egypt

🟡 Pharmaceutical registration

Turkey

🟡 Product authorization

Russia

🟡 Product registration

Bangladesh

🟡 DGDA pathway

Indonesia

🟡 BPOM pathway

Malaysia

🟡 NPRA pathway

Philippines

🟡 FDA Philippines pathway

Vietnam

🟡 DAV/MOH pathway

Japan

🟡 PMDA/MHLW pathway

New Zealand

🟡 Medsafe pathway

FDA records show an approved U.S. NDA for Jardiance/empagliflozin and also authorized combination products such as empagliflozin/metformin and empagliflozin/linagliptin.

  1. Country Regulatory Authority
    National medicines authority of the destination country.
  2. Registration / Marketing Authorization Requirements
    For generic export, the exporter must distinguish:
  • API availability
  • finished-product manufacturing authorization
  • product registration
  • bioequivalence/dossier requirements
  • local importer/MA holder
  1. Export Requirements & Special Restrictions
    Check:
  • prescription status
  • diabetes/cardiovascular/renal indication claims
  • product registration
  • stability
  • bioequivalence
  • approved label
  • importer authorization
  1. Buyer Type
  • Pharmaceutical importer
  • Diabetes-care distributor
  • Hospital supplier
  • Pharmaceutical wholesaler
  • Government/institutional procurement where permitted
  1. Required Documentation
    GMP, COA, manufacturing licence, product dossier, stability, bioequivalence data where required, CPP where applicable, MA/registration, COO, invoice, packing list and import authorization.
  2. Commercial Considerations
    Important:
  • strength
  • tablet count
  • generic competition
  • reference-product pricing
  • registration cost
  • MOQ
  • private label/OEM
  • shelf life
  • FOB/CIF
  • local distributor margin
  1. Exporter Decision
    ☐ Strength confirmed
    ☐ Generic authorization pathway confirmed
    ☐ Manufacturer verified
    ☐ GMP verified
    ☐ BE requirements checked
    ☐ Destination registration checked
    ☐ Importer verified
    ☐ Label approved
    ☐ COA/stability available
    ☐ Commercial calculation completed

MEDICINE 29 — MEMANTINE HYDROCHLORIDE

  1. Medicine / Product Name
    Memantine Hydrochloride
  2. Generic / API / Composition
    Memantine hydrochloride.
  3. Salt / Strength
    Source file includes memantine hydrochloride and specifically 5 mg tablets in another entry.
  4. Therapeutic Category
    Neurology / dementia medicine.
  5. Pharmacological / Drug Class
    NMDA receptor antagonist.
  6. Main Uses / Indications
    Moderate-to-severe Alzheimer’s-type dementia, subject to local authorization.

FDA labeling identifies memantine hydrochloride as indicated for moderate-to-severe dementia of the Alzheimer’s type.

  1. Mechanism / Basic Description
    Memantine is an NMDA receptor antagonist that modulates glutamatergic activity.
  2. Dosage Form & Route
  • immediate-release tablets
  • extended-release capsules
  • oral solution in some markets/products

FDA labeling identifies 5 mg and 10 mg immediate-release tablets for oral use.

  1. Prescription / OTC Status
    Prescription medicine.
  2. Major Warnings / Contraindications / Key Interactions
    Important considerations include:
  • renal impairment
  • dizziness/confusion
  • urine-pH-related changes in elimination
  • interactions with other NMDA antagonists
  1. India Export Considerations
    Verify:
  • 5 mg/10 mg or other strength
  • dosage form
  • manufacturer
  • GMP
  • stability
  • registration requirements
  1. HS Code — VERIFY
    Final HS classification must be confirmed for the finished medicament.
  2. 26-Country Regulatory Status

Country

Screening

USA

🟢 Established prescription-product pathway; specific product authorization required

UK

🟡 Prescription/product authorization

UAE

🟡 Registration/import authorization

Saudi Arabia

🟡 SFDA pathway

Canada

🟡 Product authorization

Australia

🟡 TGA pathway

Germany

🟡 EU/German authorization

France

🟡 EU/French authorization

Netherlands

🟡 EU/Dutch authorization

Brazil

🟡 ANVISA pathway

South Africa

🟡 SAHPRA pathway

Nigeria

🟡 NAFDAC pathway

Kenya

🟡 PPB pathway

Tanzania

🟡 TMDA pathway

Uganda

🟡 NDA pathway

Ghana

🟡 FDA Ghana pathway

Egypt

🟡 Pharmaceutical registration

Turkey

🟡 Product authorization

Russia

🟡 Product registration

Bangladesh

🟡 DGDA pathway

Indonesia

🟡 BPOM pathway

Malaysia

🟡 NPRA pathway

Philippines

🟡 FDA Philippines pathway

Vietnam

🟡 DAV/MOH pathway

Japan

🟡 PMDA/MHLW pathway

New Zealand

🟡 Medsafe pathway

  1. Country Regulatory Authority
    National pharmaceutical authority applicable to the destination.
  2. Registration / Marketing Authorization Requirements
    The exact strength and dosage form must be included in the product authorization.
  3. Export Requirements & Special Restrictions
    Check:
  • prescription status
  • dementia indication
  • importer authorization
  • label
  • pharmacovigilance
  • stability
  • registration
  1. Buyer Type
  • Pharmaceutical importer
  • Neurology/geriatric medicine distributor
  • Hospital supplier
  • Licensed wholesaler
  • Institutional purchaser
  1. Required Documentation
    GMP, COA, manufacturing licence, product specifications, stability, registration/MA, CPP where applicable, COO, invoice, packing list and import permit where required.
  2. Commercial Considerations
    Evaluate:
  • 5 mg/10 mg
  • IR vs ER
  • tablet vs oral solution
  • MOQ
  • generic competition
  • private-label opportunity
  • shelf life
  • registration expense
  • FOB/CIF
  1. Exporter Decision
    ☐ Strength confirmed
    ☐ Dosage form confirmed
    ☐ Manufacturer verified
    ☐ GMP verified
    ☐ Registration checked
    ☐ Importer verified
    ☐ Label checked
    ☐ COA available
    ☐ Stability available
    ☐ Commercial feasibility calculated

MEDICINE 30 — BEMPEDOIC ACID

  1. Medicine / Product Name
    Bempedoic Acid
  2. Generic / API / Composition
    Bempedoic acid.
  3. Salt / Strength
    Source file identifies Bempedoic Acid without a strength in the entry.

For the U.S. reference product Nexletol, the tablet strength is 180 mg.

  1. Therapeutic Category
    Lipid-lowering / cardiovascular medicine.
  2. Pharmacological / Drug Class
    ATP-citrate lyase (ACL) inhibitor.
  3. Main Uses / Indications
    Depending on current destination authorization:
  • LDL-cholesterol reduction in hypercholesterolemia
  • cardiovascular-risk reduction in eligible patients

The current FDA Nexletol label includes cardiovascular-risk reduction and LDL-C lowering indications.

  1. Mechanism / Basic Description
    Bempedoic acid inhibits ACL, an enzyme upstream of HMG-CoA reductase in hepatic cholesterol synthesis, thereby reducing LDL-C.
  2. Dosage Form & Route
  • oral film-coated tablet
  • U.S. Nexletol reference strength: 180 mg
  1. Prescription / OTC Status
    Prescription medicine.
  2. Major Warnings / Contraindications / Key Interactions
    Current FDA labeling highlights:
  • hyperuricemia
  • gout risk
  • tendon rupture
  • pregnancy considerations
  • interactions with simvastatin and pravastatin at specified doses.
  1. India Export Considerations
    Verify:
  • 180 mg formulation
  • Indian manufacturing authorization
  • product registration
  • GMP
  • stability
  • bioequivalence requirements
  • destination-specific dossier
  1. HS Code — VERIFY
    Final HS code must be established from the finished medicament classification.
  2. 26-Country Regulatory Status

Country

Screening

USA

🟢 Established FDA-approved prescription pathway; generic product still requires applicable authorization

UK

🟡 Product/MA pathway

UAE

🟡 Product registration/import authorization

Saudi Arabia

🟡 SFDA pathway

Canada

🟡 Product authorization

Australia

🟡 TGA pathway

Germany

🟡 EU/German authorization

France

🟡 EU/French authorization

Netherlands

🟡 EU/Dutch authorization

Brazil

🟡 ANVISA pathway

South Africa

🟡 SAHPRA pathway

Nigeria

🟡 NAFDAC pathway

Kenya

🟡 PPB pathway

Tanzania

🟡 TMDA pathway

Uganda

🟡 NDA pathway

Ghana

🟡 FDA Ghana pathway

Egypt

🟡 Pharmaceutical registration

Turkey

🟡 Product authorization

Russia

🟡 Product registration

Bangladesh

🟡 DGDA pathway

Indonesia

🟡 BPOM pathway

Malaysia

🟡 NPRA pathway

Philippines

🟡 FDA Philippines pathway

Vietnam

🟡 DAV/MOH pathway

Japan

🟡 PMDA/MHLW pathway

New Zealand

🟡 Medsafe pathway

  1. Country Regulatory Authority
    Destination-specific pharmaceutical regulator.
  2. Registration / Marketing Authorization Requirements
    A generic manufacturer must establish the applicable regulatory pathway rather than assuming that U.S. approval automatically permits export to another country.
  3. Export Requirements & Special Restrictions
    Check:
  • prescription status
  • product registration
  • bioequivalence requirements
  • quality dossier
  • stability
  • label
  • importer authorization
  • pharmacovigilance
  1. Buyer Type
  • Pharmaceutical importer
  • Cardiovascular/lipid-management distributor
  • Hospital supplier
  • Licensed wholesaler
  • Institutional procurement organization
  1. Required Documentation
    Potentially:
  • GMP
  • manufacturing licence
  • COA
  • specifications
  • stability data
  • BE data where required
  • CPP
  • product registration/MA
  • COO
  • invoice
  • packing list
  • import authorization
  1. Commercial Considerations
    This is a more specialized/high-value cardiovascular product than many established generic medicines. Evaluate:
  • local registration status
  • patent/exclusivity considerations
  • reference-product pricing
  • generic competition
  • MOQ
  • private label/OEM
  • shelf life
  • registration costs
  • FOB/CIF
  • distributor margin
  1. Exporter Decision
    ☐ 180 mg strength confirmed
    ☐ Patent/exclusivity situation checked
    ☐ Manufacturer verified
    ☐ GMP verified
    ☐ Destination MA pathway verified
    ☐ BE/dossier requirements checked
    ☐ Importer verified
    ☐ Label checked
    ☐ COA/stability available
    ☐ Commercial feasibility calculated

SOURCE / BOOK RULE FOR THIS BATCH

For the final published book, these entries should carry a “Regulatory status verified on: October 2026” field and a source field. The current FDA evidence confirms, for example, that empagliflozin has an established U.S. prescription-product pathway, liothyronine sodium is an identified pharmaceutical substance with U.S. product history, memantine has an established prescription indication, and bempedoic acid has a current FDA label.

31. BEMPEDOIC ACID 180 mg + EZETIMIBE 10 mg

  1. Medicine / Product Name
    Bempedoic Acid 180 mg + Ezetimibe 10 mg
  2. Generic / API / Composition
    Bempedoic acid 180 mg + Ezetimibe 10 mg.
  3. Salt / Strength
    Fixed-dose oral combination: 180 mg + 10 mg.
  4. Therapeutic Category
    Lipid-lowering / antihyperlipidemic medicine.
  5. Pharmacological / Drug Class
    Bempedoic acid: ATP-citrate lyase inhibitor.
    Ezetimibe: cholesterol absorption inhibitor.
  6. Main Uses / Indications
    Used to reduce LDL cholesterol in appropriate patients, generally as an adjunct to diet and other lipid-management measures.
  7. Mechanism / Basic Description
    Bempedoic acid reduces cholesterol synthesis in the liver by inhibiting ATP-citrate lyase. Ezetimibe reduces intestinal absorption of cholesterol.
  8. Dosage Form & Route
    Usually oral tablet.
  9. Prescription / OTC Status
    Prescription medicine in major regulated markets. Do not assume OTC status in an importing country.
  10. Major Warnings / Contraindications / Key Interactions
    Important considerations include hyperuricemia/gout, tendon-related adverse effects and drug interactions. Product-specific labeling must be checked.
    For export, the exact formulation and local label should be verified.
  11. India Export Considerations
    Verify that the Indian manufacturer has the appropriate manufacturing licence, product permission/approval and GMP documentation for the finished formulation. Confirm whether the exporter is exporting a registered finished formulation or an API/intermediate.
  12. HS Code / Customs Classification — TO BE VERIFIED
    Likely pharmaceutical medicament classification, but the final HS/ITC-HS code must be confirmed according to formulation, packing and Indian customs classification.
  13. 26-Country Regulatory Status
    USA 🟡 Registration/marketing authorization pathway required.
    UK 🟡 Marketing authorization/import requirements apply.
    UAE 🟡 Registration/import authorization required.
    Saudi Arabia 🟡 SFDA registration pathway required.
    Canada 🟡 Health Canada authorization required.
    Australia 🟡 TGA pathway required.
    Germany 🟡 EU marketing authorization requirements apply.
    France 🟡 EU/French requirements apply.
    Netherlands 🟡 EU/Dutch requirements apply.
    Brazil 🟡 ANVISA requirements apply.
    South Africa 🟡 SAHPRA requirements apply.
    Nigeria 🟡 NAFDAC requirements apply.
    Kenya 🟡 Pharmacy and Poisons Board requirements apply.
    Tanzania 🟡 TMDA requirements apply.
    Uganda 🟡 NDA requirements apply.
    Ghana 🟡 FDA Ghana requirements apply.
    Egypt 🟡 Egyptian pharmaceutical registration requirements apply.
    Turkey 🟡 Turkish regulatory requirements apply.
    Russia 🟡 Russian registration requirements apply.
    Bangladesh 🟡 DGDA requirements apply.
    Indonesia 🟡 BPOM requirements apply.
    Malaysia 🟡 NPRA registration requirements apply.
    Philippines 🟡 FDA Philippines requirements apply.
    Vietnam 🟡 DAV/MOH requirements apply.
    Japan 🟡 PMDA/MHLW requirements apply.
    New Zealand 🟡 Medsafe requirements apply.
  14. Country Regulatory Authority
    Examples: FDA, MHRA, UAE Ministry of Health and Prevention, SFDA, Health Canada, TGA, EMA/national EU authorities, ANVISA, SAHPRA, NAFDAC, BPOM, NPRA, PMDA/MHLW.
  15. Registration / Marketing Authorization Requirements
    Typically requires product dossier, manufacturing information, quality specifications, stability data, labeling/package information and evidence required by the destination authority.
  16. Export Requirements & Special Restrictions
    Check whether the importing country accepts the fixed-dose combination and whether local registration exists. Do not assume that approval of the individual ingredients automatically means approval of the combination.
  17. Buyer Type
    Licensed pharmaceutical importer, distributor, wholesaler, hospital-supply company and registered pharmaceutical marketing company.
  18. Required Export / Regulatory Documentation
    Commercial invoice, packing list, certificate of origin where applicable, shipping documents, manufacturer documents, GMP evidence, COA and regulatory certificates/documents requested by the importing country.
  19. Commercial Considerations
    Potentially attractive as a chronic-disease cardiovascular product, but registration status is more important than simply finding a low supplier price.
  20. Exporter Decision / Verification Checklist
    ☐ Combination legally permitted
    ☐ Indian manufacturer verified
    ☐ GMP verified
    ☐ Product approval verified
    ☐ Destination registration checked
    ☐ Importer licence checked
    ☐ Label checked
    ☐ Stability/shelf-life documents available
    ☐ COA available
    ☐ HS classification verified

32. BACLOFEN

  1. Medicine / Product Name
    Baclofen
  2. Generic / API / Composition
    Baclofen.
  3. Salt / Strength
    Common oral strengths include 5 mg, 10 mg and 20 mg, depending on market.
  4. Therapeutic Category
    Skeletal-muscle relaxant / antispastic medicine.
  5. Pharmacological / Drug Class
    GABA-B receptor agonist.
  6. Main Uses / Indications
    Management of spasticity associated with neurological conditions.
  7. Mechanism / Basic Description
    Baclofen acts primarily through GABA-B receptors and reduces excitatory neurotransmission involved in muscle spasticity.
  8. Dosage Form & Route
    Oral tablets; other formulations/routes may exist in particular markets, including intrathecal therapy.
  9. Prescription / OTC Status
    Generally prescription medicine.
  10. Major Warnings / Contraindications / Key Interactions
    Sedation, dizziness and CNS depression may occur. Abrupt discontinuation, particularly after prolonged/high-dose therapy or intrathecal treatment, can be dangerous. CNS depressants and alcohol may increase sedative effects.
  11. India Export Considerations
    Confirm the exact dosage form and manufacturing permission. Intrathecal products require considerably more stringent sterile/manufacturing controls than ordinary tablets.
  12. HS Code / Customs Classification — TO BE VERIFIED
    Pharmaceutical medicament classification should be verified against the exact dosage form and Indian customs rules.
  13. 26-Country Regulatory Status
    USA 🟡 Prescription/approved-drug pathway.
    UK 🟡 Prescription medicine/import requirements.
    UAE 🟡 Registration required.
    Saudi Arabia 🟡 SFDA requirements.
    Canada 🟡 Health Canada requirements.
    Australia 🟡 TGA requirements.
    Germany/France/Netherlands 🟡 EU/national requirements.
    Brazil 🟡 ANVISA.
    South Africa 🟡 SAHPRA.
    Nigeria 🟡 NAFDAC.
    Kenya 🟡 Pharmacy and Poisons Board.
    Tanzania 🟡 TMDA.
    Uganda 🟡 NDA.
    Ghana 🟡 FDA Ghana.
    Egypt 🟡 National registration requirements.
    Turkey 🟡 Turkish regulatory requirements.
    Russia 🟡 Russian registration requirements.
    Bangladesh 🟡 DGDA.
    Indonesia 🟡 BPOM.
    Malaysia 🟡 NPRA.
    Philippines 🟡 FDA Philippines.
    Vietnam 🟡 DAV/MOH.
    Japan 🟡 PMDA/MHLW.
    New Zealand 🟡 Medsafe.
  14. Country Regulatory Authority
    FDA, MHRA, UAE MOHAP, SFDA, Health Canada, TGA, EU/national agencies, ANVISA, SAHPRA, NAFDAC, TMDA, NDA, BPOM, NPRA, PMDA/MHLW and others as applicable.
  15. Registration / Marketing Authorization Requirements
    Product registration/marketing authorization and importer authorization generally required before commercial sale.
  16. Export Requirements & Special Restrictions
    Check local controlled-drug/psychotropic classifications before shipment. Classification can differ between jurisdictions.
  17. Buyer Type
    Licensed pharmaceutical distributors, hospitals, institutional suppliers and pharmacy wholesalers.
  18. Required Export / Regulatory Documentation
    Invoice, packing list, certificate of origin, COA, GMP documents, product registration documents and any import permit/authorization.
  19. Commercial Considerations
    Demand can be associated with neurological/spasticity treatment. Buyer qualification is important because it is normally a prescription product.
  20. Exporter Decision / Verification Checklist
    ☐ Exact strength confirmed
    ☐ Dosage form confirmed
    ☐ Prescription status checked
    ☐ Destination controlled-status checked
    ☐ Manufacturer licence checked
    ☐ GMP checked
    ☐ Importer licence checked
    ☐ Registration checked
    ☐ COA checked
    ☐ HS code verified

33. TROPICAMIDE + PHENYLEPHRINE OPHTHALMIC SOLUTION

  1. Medicine / Product Name
    Tropicamide + Phenylephrine ophthalmic solution.
  2. Generic / API / Composition
    Tropicamide + phenylephrine hydrochloride, with concentration varying by product.
  3. Salt / Strength
    Strength must be taken from the specific manufacturer’s formulation. Common ophthalmic products use concentrations such as tropicamide 0.5% or 1% and phenylephrine 2.5%, but the exact formulation must be verified.
  4. Therapeutic Category
    Ophthalmic mydriatic / pupil-dilating preparation.
  5. Pharmacological / Drug Class
    Tropicamide: antimuscarinic.
    Phenylephrine: alpha-adrenergic agonist.
  6. Main Uses / Indications
    Used to dilate the pupil for ophthalmic examination and diagnostic procedures.
  7. Mechanism / Basic Description
    Tropicamide relaxes the iris sphincter through muscarinic blockade. Phenylephrine stimulates alpha-adrenergic receptors to produce mydriasis.
  8. Dosage Form & Route
    Sterile ophthalmic solution; topical ocular administration.
  9. Prescription / OTC Status
    Usually prescription/professional-use medicine, depending on jurisdiction and concentration.
  10. Major Warnings / Contraindications / Key Interactions
    Can increase intraocular pressure and may require caution in patients at risk of angle-closure glaucoma. Phenylephrine may have cardiovascular effects. Exact warnings depend on formulation and concentration.
  11. India Export Considerations
    Sterility is critical. Manufacturer should have appropriate sterile ophthalmic manufacturing authorization and quality systems.
  12. HS Code / Customs Classification — TO BE VERIFIED
    Pharmaceutical medicament classification; verify exact Indian HS/ITC-HS classification.
  13. 26-Country Regulatory Status
    USA 🟡 Approved/regulated ophthalmic products require applicable authorization.
    UK 🟡 MHRA requirements.
    UAE 🟡 Registration required.
    Saudi Arabia 🟡 SFDA.
    Canada 🟡 Health Canada.
    Australia 🟡 TGA.
    Germany/France/Netherlands 🟡 EU/national requirements.
    Brazil 🟡 ANVISA.
    South Africa 🟡 SAHPRA.
    Nigeria 🟡 NAFDAC.
    Kenya 🟡 Pharmacy and Poisons Board.
    Tanzania 🟡 TMDA.
    Uganda 🟡 NDA.
    Ghana 🟡 FDA Ghana.
    Egypt 🟡 Registration required.
    Turkey 🟡 Registration required.
    Russia 🟡 Registration required.
    Bangladesh 🟡 DGDA.
    Indonesia 🟡 BPOM.
    Malaysia 🟡 NPRA.
    Philippines 🟡 FDA Philippines.
    Vietnam 🟡 DAV/MOH.
    Japan 🟡 PMDA/MHLW.
    New Zealand 🟡 Medsafe.
  14. Country Regulatory Authority
    Relevant national medicine authority; examples include FDA, MHRA, SFDA, TGA, Health Canada, ANVISA, SAHPRA and PMDA/MHLW.
  15. Registration / Marketing Authorization Requirements
    Sterility, formulation, container-closure system, stability, manufacturing controls, labeling and quality documentation are particularly important.
  16. Export Requirements & Special Restrictions
    Maintain sterile-chain manufacturing controls and ensure packaging protects the product from contamination. Verify destination-specific ophthalmic registration.
  17. Buyer Type
    Ophthalmic distributors, hospital suppliers, eye hospitals, clinics and licensed pharmaceutical importers.
  18. Required Export / Regulatory Documentation
    COA, GMP, manufacturing licence, product dossier/registration documents, stability information, invoice, packing list and certificate of origin where required.
  19. Commercial Considerations
    Sterile ophthalmic products may have higher manufacturing and compliance costs than ordinary tablets.
  20. Exporter Decision / Verification Checklist
    ☐ Exact concentration confirmed
    ☐ Sterile manufacturing verified
    ☐ Container/closure verified
    ☐ Stability data available
    ☐ GMP available
    ☐ Destination registration checked
    ☐ Importer licence verified
    ☐ Label approved
    ☐ COA available
    ☐ HS classification verified

34. PROPRANOLOL HYDROCHLORIDE

  1. Medicine / Product Name
    Propranolol Hydrochloride.
  2. Generic / API / Composition
    Propranolol hydrochloride.
  3. Salt / Strength
    Common oral strengths include 10 mg, 20 mg, 40 mg, 80 mg and other market-specific strengths.
  4. Therapeutic Category
    Cardiovascular medicine / beta-blocker.
  5. Pharmacological / Drug Class
    Non-selective beta-adrenergic receptor blocker.
  6. Main Uses / Indications
    Depending on formulation and country: hypertension, angina, certain arrhythmias, migraine prevention, tremor and other cardiovascular/neurological indications.
  7. Mechanism / Basic Description
    Blocks beta-adrenergic receptors, reducing heart rate, myocardial contractility and sympathetic effects.
  8. Dosage Form & Route
    Tablets, capsules and oral liquid formulations may be available; route is generally oral.
  9. Prescription / OTC Status
    Generally prescription medicine.
  10. Major Warnings / Contraindications / Key Interactions
    Important concerns include bradycardia, hypotension, heart block and bronchospasm. Non-selective beta-blockade can be problematic in susceptible patients with asthma/bronchospastic disease. It can also mask certain symptoms of hypoglycemia.
  11. India Export Considerations
    Verify product licence, manufacturer GMP and destination-market registration.
  12. HS Code / Customs Classification — TO BE VERIFIED
    Pharmaceutical medicament classification; exact HS/ITC-HS code must be verified.
  13. 26-Country Regulatory Status
    USA 🟡 Prescription regulatory pathway.
    UK 🟡 Prescription medicine.
    UAE 🟡 Registration.
    Saudi Arabia 🟡 SFDA.
    Canada 🟡 Health Canada.
    Australia 🟡 TGA.
    Germany/France/Netherlands 🟡 EU/national authorization.
    Brazil 🟡 ANVISA.
    South Africa 🟡 SAHPRA.
    Nigeria 🟡 NAFDAC.
    Kenya 🟡 Pharmacy and Poisons Board.
    Tanzania 🟡 TMDA.
    Uganda 🟡 NDA.
    Ghana 🟡 FDA Ghana.
    Egypt 🟡 Registration.
    Turkey 🟡 Registration.
    Russia 🟡 Registration.
    Bangladesh 🟡 DGDA.
    Indonesia 🟡 BPOM.
    Malaysia 🟡 NPRA.
    Philippines 🟡 FDA Philippines.
    Vietnam 🟡 DAV/MOH.
    Japan 🟡 PMDA/MHLW.
    New Zealand 🟡 Medsafe.
  14. Country Regulatory Authority
    FDA, MHRA, MOHAP, SFDA, Health Canada, TGA and respective national authorities.
  15. Registration / Marketing Authorization Requirements
    Standard pharmaceutical dossier, quality documentation, manufacturing information, stability, labeling and local authorization.
  16. Export Requirements & Special Restrictions
    Check exact formulation and country-specific prescribing/import status. Extended-release products may have separate registration requirements.
  17. Buyer Type
    Pharmaceutical distributors, hospital suppliers, pharmacy wholesalers and licensed importers.
  18. Required Export / Regulatory Documentation
    Commercial invoice, packing list, COA, GMP certificate/evidence, product registration/authorization, certificate of origin and shipping documents.
  19. Commercial Considerations
    Established generic product with broad therapeutic use. Competition may be high, so price, registration status, packaging and buyer authorization matter.
  20. Exporter Decision / Verification Checklist
    ☐ Strength confirmed
    ☐ Dosage form confirmed
    ☐ Manufacturer verified
    ☐ GMP verified
    ☐ Destination registration verified
    ☐ Importer licence verified
    ☐ Product label checked
    ☐ COA available
    ☐ Shelf life confirmed
    ☐ HS code verified

35. METFORMIN HYDROCHLORIDE

  1. Medicine / Product Name
    Metformin Hydrochloride.
  2. Generic / API / Composition
    Metformin hydrochloride.
  3. Salt / Strength
    Common strengths include 500 mg, 850 mg and 1000 mg. Immediate-release and extended-release formulations are available.
  4. Therapeutic Category
    Antidiabetic / glucose-lowering medicine.
  5. Pharmacological / Drug Class
    Biguanide.
  6. Main Uses / Indications
    Primarily used for management of type 2 diabetes mellitus, alongside diet and lifestyle measures where appropriate.
  7. Mechanism / Basic Description
    Reduces hepatic glucose production and improves insulin sensitivity, thereby lowering blood glucose.
  8. Dosage Form & Route
    Immediate-release tablets, extended-release tablets and other oral formulations depending on market.
  9. Prescription / OTC Status
    Generally prescription medicine.
  10. Major Warnings / Contraindications / Key Interactions
    Renal function is a major safety consideration. Metformin carries a rare but serious risk of lactic acidosis, particularly in situations associated with significant renal impairment or other risk factors. Temporary interruption may be required around certain contrast procedures depending on renal function and local labeling.
  11. India Export Considerations
    India has extensive generic manufacturing capacity for metformin. Exporters should nevertheless verify manufacturer authorization, formulation approval, GMP and destination registration.
  12. HS Code / Customs Classification — TO BE VERIFIED
    Pharmaceutical medicament classification; verify exact HS/ITC-HS code before commercial shipment.
  13. 26-Country Regulatory Status
    USA 🟡 Prescription/approved-product pathway.
    UK 🟡 Prescription medicine.
    UAE 🟡 Registration required.
    Saudi Arabia 🟡 SFDA registration.
    Canada 🟡 Health Canada authorization.
    Australia 🟡 TGA requirements.
    Germany/France/Netherlands 🟡 EU/national requirements.
    Brazil 🟡 ANVISA.
    South Africa 🟡 SAHPRA.
    Nigeria 🟡 NAFDAC.
    Kenya 🟡 Pharmacy and Poisons Board.
    Tanzania 🟡 TMDA.
    Uganda 🟡 NDA.
    Ghana 🟡 FDA Ghana.
    Egypt 🟡 Registration.
    Turkey 🟡 Registration.
    Russia 🟡 Registration.
    Bangladesh 🟡 DGDA.
    Indonesia 🟡 BPOM.
    Malaysia 🟡 NPRA.
    Philippines 🟡 FDA Philippines.
    Vietnam 🟡 DAV/MOH.
    Japan 🟡 PMDA/MHLW.
    New Zealand 🟡 Medsafe.
  14. Country Regulatory Authority
    FDA, MHRA, UAE MOHAP, SFDA, Health Canada, TGA, EU/national authorities, ANVISA, SAHPRA, NAFDAC, TMDA, NDA, BPOM, NPRA, PMDA/MHLW and corresponding national authorities.
  15. Registration / Marketing Authorization Requirements
    Usually requires quality dossier, manufacturing information, stability data, specifications, labeling and country-specific registration.
  16. Export Requirements & Special Restrictions
    The exporter must distinguish immediate-release from extended-release products. Combination products containing metformin with another antidiabetic are separate registered products and should not automatically be treated as equivalent to metformin alone.
  17. Buyer Type
    Licensed pharmaceutical importers, generic distributors, pharmacy wholesalers, hospital suppliers and government/institutional procurement organizations.
  18. Required Export / Regulatory Documentation
    Commercial invoice, packing list, certificate of origin where required, COA, GMP evidence, product registration documents, manufacturing licence and shipping documentation.
  19. Commercial Considerations
    Very large global generic market with strong competition. Commercial differentiation can come from registration status, reliable supply, formulation, packaging, private-label capability and competitive landed cost.
  20. Exporter Decision / Verification Checklist
    ☐ API/formulation confirmed
    ☐ IR/ER formulation identified
    ☐ Strength confirmed
    ☐ Manufacturer verified
    ☐ GMP verified
    ☐ Destination registration checked
    ☐ Importer licence verified
    ☐ Stability data available
    ☐ COA available
    ☐ Shelf life confirmed
    ☐ HS code verified
    ☐ Buyer payment/creditworthiness checked

Top Pharma Export Products from India Manufacturers Sellers Pharmaceutical Companies Medicine Buyers

 

 

 

26-Country Regulatory Screening Matrix

Country

Authority

Preliminary export status

USA

FDA

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

UK

MHRA

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

UAE

MOHAP / UAE authority

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Saudi Arabia

SFDA

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Canada

Health Canada

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Australia

TGA

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Germany

EU/national authority

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

France

EU/national authority

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Netherlands

EU/national authority

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Brazil

ANVISA

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

South Africa

SAHPRA

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Nigeria

NAFDAC

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Kenya

Pharmacy and Poisons Board

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Tanzania

TMDA

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Uganda

NDA

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Ghana

FDA Ghana

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Egypt

Egyptian Drug Authority

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Turkey

TITCK

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Russia

Russian regulator

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Bangladesh

DGDA

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Indonesia

BPOM

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Malaysia

NPRA

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Philippines

Philippines FDA

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Vietnam

DAV/MOH

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Japan

PMDA/MHLW

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

New Zealand

Medsafe

🟡 Product registration/marketing authorization and importer authorization normally required; verify exact product/formulation. Controlled/special products may be 🟠/🔴.

Status legend: 🟢 generally permissible pathway; 🟡 registration/approval required; 🟠 special regulatory review; 🔴 controlled/restricted/high-risk; ⚫ formulation-specific investigation required.

36. MODAFINIL

1. Medicine / Product Name

MODAFINIL

2. Generic / API / Composition

MODAFINIL — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

CNS / neurological / psychiatric medicine

5. Pharmacological / Drug Class

Central nervous system active medicine

6. Main Uses / Indications

Indication depends on the active ingredient; verify approved indication.

7. Mechanism / Basic Description

CNS mechanism is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Prescription; controlled/psychotropic status must be checked country by country.

10. Major Warnings / Contraindications / Key Interactions

CNS effects, interactions, dependence/misuse potential where applicable and local controlled-drug status require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority destination-country classification check. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

37. DAPOXETINE HCL

1. Medicine / Product Name

DAPOXETINE HCL

2. Generic / API / Composition

DAPOXETINE HCL — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Sexual-health / serotonergic medicine

5. Pharmacological / Drug Class

Selective serotonin reuptake inhibitor (short-acting)

6. Main Uses / Indications

Used in some markets for premature ejaculation.

7. Mechanism / Basic Description

Increases serotonergic activity through serotonin reuptake inhibition.

8. Dosage Form & Route

Usually oral.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Syncope, dizziness, serotonergic interactions and contraindications must be checked against local labeling.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

38. DICLOFENAC PROLONGED RELEASE

1. Medicine / Product Name

DICLOFENAC PROLONGED RELEASE

2. Generic / API / Composition

DICLOFENAC PROLONGED RELEASE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Analgesic / gastrointestinal medicine

5. Pharmacological / Drug Class

Ingredient-specific analgesic or GI agent

6. Main Uses / Indications

Pain/inflammation or gastrointestinal indication according to ingredient.

7. Mechanism / Basic Description

Ingredient-specific mechanism.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

39. TESTOSTERONE GEL 1 % W/W

1. Medicine / Product Name

TESTOSTERONE GEL 1 % W/W

2. Generic / API / Composition

TESTOSTERONE GEL 1 % W/W — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

40. TESTOSTERONE ENANTHATE INJECTION

1. Medicine / Product Name

TESTOSTERONE ENANTHATE INJECTION

2. Generic / API / Composition

TESTOSTERONE ENANTHATE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

41. TESTOSTERONE ENANTHATE INJECTION USP 250 MG

1. Medicine / Product Name

TESTOSTERONE ENANTHATE INJECTION USP 250 MG

2. Generic / API / Composition

TESTOSTERONE ENANTHATE  USP 250 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

42. ISOTRETINOIN CAPSULES IP 20 MG

1. Medicine / Product Name

ISOTRETINOIN CAPSULES IP 20 MG

2. Generic / API / Composition

ISOTRETINOIN  IP 20 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

43. ISOTRETINOIN CAPSULES IP 320 MG

1. Medicine / Product Name

ISOTRETINOIN CAPSULES IP 320 MG

2. Generic / API / Composition

ISOTRETINOIN  IP 320 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export. Source lists 320 mg isotretinoin; this strength is unusual and must be independently verified before procurement/export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

44. ZOPICLONE

1. Medicine / Product Name

ZOPICLONE

2. Generic / API / Composition

ZOPICLONE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

CNS / neurological / psychiatric medicine

5. Pharmacological / Drug Class

Central nervous system active medicine

6. Main Uses / Indications

Indication depends on the active ingredient; verify approved indication.

7. Mechanism / Basic Description

CNS mechanism is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Prescription; controlled/psychotropic status must be checked country by country.

10. Major Warnings / Contraindications / Key Interactions

CNS effects, interactions, dependence/misuse potential where applicable and local controlled-drug status require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority destination-country classification check. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

45. PRAMIPEXOLE

1. Medicine / Product Name

PRAMIPEXOLE

2. Generic / API / Composition

PRAMIPEXOLE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Neurological medicine

5. Pharmacological / Drug Class

Ingredient-specific CNS agent

6. Main Uses / Indications

Neurological indication according to the approved product.

7. Mechanism / Basic Description

Ingredient-specific CNS mechanism.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

46. PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE

1. Medicine / Product Name

PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE

2. Generic / API / Composition

PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Neurological medicine

5. Pharmacological / Drug Class

Ingredient-specific CNS agent

6. Main Uses / Indications

Neurological indication according to the approved product.

7. Mechanism / Basic Description

Ingredient-specific CNS mechanism.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

47. ES ZOPICLONE USP 3 MG

1. Medicine / Product Name

ES ZOPICLONE USP 3 MG

2. Generic / API / Composition

ES ZOPICLONE USP 3 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

CNS / neurological / psychiatric medicine

5. Pharmacological / Drug Class

Central nervous system active medicine

6. Main Uses / Indications

Indication depends on the active ingredient; verify approved indication.

7. Mechanism / Basic Description

CNS mechanism is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Prescription; controlled/psychotropic status must be checked country by country.

10. Major Warnings / Contraindications / Key Interactions

CNS effects, interactions, dependence/misuse potential where applicable and local controlled-drug status require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority destination-country classification check. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

48. LIOTHYRONINE SODIUM B.P. 25 MCG

1. Medicine / Product Name

LIOTHYRONINE SODIUM B.P. 25 MCG

2. Generic / API / Composition

LIOTHYRONINE SODIUM B.P. 25 MCG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Thyroid hormone

5. Pharmacological / Drug Class

Synthetic triiodothyronine (T3)

6. Main Uses / Indications

Thyroid-hormone replacement in approved indications.

7. Mechanism / Basic Description

Binds thyroid hormone receptors and regulates gene transcription.

8. Dosage Form & Route

Oral; exact formulation must be verified.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

49. NITAZOXANIDE

1. Medicine / Product Name

NITAZOXANIDE

2. Generic / API / Composition

NITAZOXANIDE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Anti-infective / antiparasitic medicine

5. Pharmacological / Drug Class

Antibacterial, antiprotozoal or antiparasitic — ingredient-specific

6. Main Uses / Indications

Treatment of susceptible infections/parasitoses according to the approved indication.

7. Mechanism / Basic Description

Ingredient-specific antimicrobial/antiparasitic mechanism.

8. Dosage Form & Route

Oral or other formulation-specific route.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Allergy, interactions, resistance/appropriate-use restrictions and indication-specific precautions require label review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

50. DOXYCYCLINE

1. Medicine / Product Name

DOXYCYCLINE

2. Generic / API / Composition

DOXYCYCLINE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Anti-infective / antiparasitic medicine

5. Pharmacological / Drug Class

Antibacterial, antiprotozoal or antiparasitic — ingredient-specific

6. Main Uses / Indications

Treatment of susceptible infections/parasitoses according to the approved indication.

7. Mechanism / Basic Description

Ingredient-specific antimicrobial/antiparasitic mechanism.

8. Dosage Form & Route

Oral or other formulation-specific route.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Allergy, interactions, resistance/appropriate-use restrictions and indication-specific precautions require label review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

51. SERTRALINE

1. Medicine / Product Name

SERTRALINE

2. Generic / API / Composition

SERTRALINE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

CNS / neurological / psychiatric medicine

5. Pharmacological / Drug Class

Central nervous system active medicine

6. Main Uses / Indications

Indication depends on the active ingredient; verify approved indication.

7. Mechanism / Basic Description

CNS mechanism is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Prescription; controlled/psychotropic status must be checked country by country.

10. Major Warnings / Contraindications / Key Interactions

CNS effects, interactions, dependence/misuse potential where applicable and local controlled-drug status require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority destination-country classification check.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

52. ISOTRETINOIN

1. Medicine / Product Name

ISOTRETINOIN

2. Generic / API / Composition

ISOTRETINOIN — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

53. PREGABALIN CAPSULES IP 150 MG

1. Medicine / Product Name

PREGABALIN CAPSULES IP 150 MG

2. Generic / API / Composition

PREGABALIN  IP 150 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

CNS / neurological / psychiatric medicine

5. Pharmacological / Drug Class

Central nervous system active medicine

6. Main Uses / Indications

Indication depends on the active ingredient; verify approved indication.

7. Mechanism / Basic Description

CNS mechanism is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Prescription; controlled/psychotropic status must be checked country by country.

10. Major Warnings / Contraindications / Key Interactions

CNS effects, interactions, dependence/misuse potential where applicable and local controlled-drug status require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority destination-country classification check. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

54. PREGABALIN

1. Medicine / Product Name

PREGABALIN

2. Generic / API / Composition

PREGABALIN — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

CNS / neurological / psychiatric medicine

5. Pharmacological / Drug Class

Central nervous system active medicine

6. Main Uses / Indications

Indication depends on the active ingredient; verify approved indication.

7. Mechanism / Basic Description

CNS mechanism is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Prescription; controlled/psychotropic status must be checked country by country.

10. Major Warnings / Contraindications / Key Interactions

CNS effects, interactions, dependence/misuse potential where applicable and local controlled-drug status require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority destination-country classification check. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

55. ANASTROZOLE

1. Medicine / Product Name

ANASTROZOLE

2. Generic / API / Composition

ANASTROZOLE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Hormonal / endocrine medicine

5. Pharmacological / Drug Class

Hormonal pathway modulator

6. Main Uses / Indications

Endocrine or oncology/fertility indication depending on ingredient.

7. Mechanism / Basic Description

Ingredient-specific estrogen-receptor or aromatase pathway modulation.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Hormonal/oncology regulatory review may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

56. METHANDIENONE

1. Medicine / Product Name

METHANDIENONE

2. Generic / API / Composition

METHANDIENONE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

57. DUTASTERIDE

1. Medicine / Product Name

DUTASTERIDE

2. Generic / API / Composition

DUTASTERIDE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Urological / dermatological medicine

5. Pharmacological / Drug Class

5-alpha-reductase inhibitor

6. Main Uses / Indications

Approved indications include benign prostatic hyperplasia and/or androgenetic alopecia depending on strength/formulation.

7. Mechanism / Basic Description

Reduces conversion of testosterone to dihydrotestosterone.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

Top Pharma Export Products from India Manufacturers Sellers Pharmaceutical Companies Medicine Buyers

58. NALTREXONE HYDROCHLORIDE

1. Medicine / Product Name

NALTREXONE HYDROCHLORIDE

2. Generic / API / Composition

NALTREXONE HYDROCHLORIDE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Addiction medicine

5. Pharmacological / Drug Class

Opioid receptor antagonist

6. Main Uses / Indications

Approved indications include alcohol-use disorder and opioid-use-disorder relapse prevention in appropriate settings.

7. Mechanism / Basic Description

Blocks opioid receptors.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

59. TETRACYCLINE

1. Medicine / Product Name

TETRACYCLINE

2. Generic / API / Composition

TETRACYCLINE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Anti-infective / antiparasitic medicine

5. Pharmacological / Drug Class

Antibacterial, antiprotozoal or antiparasitic — ingredient-specific

6. Main Uses / Indications

Treatment of susceptible infections/parasitoses according to the approved indication.

7. Mechanism / Basic Description

Ingredient-specific antimicrobial/antiparasitic mechanism.

8. Dosage Form & Route

Oral or other formulation-specific route.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Allergy, interactions, resistance/appropriate-use restrictions and indication-specific precautions require label review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

60. PREDNISOLONE

1. Medicine / Product Name

PREDNISOLONE

2. Generic / API / Composition

PREDNISOLONE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Immunomodulatory / anti-inflammatory medicine

5. Pharmacological / Drug Class

Ingredient-specific immunosuppressive or anti-inflammatory agent

6. Main Uses / Indications

Inflammatory, autoimmune or transplant-related indications depending on ingredient/formulation.

7. Mechanism / Basic Description

Ingredient-specific immunomodulatory mechanism.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Infection risk, immunosuppression and drug interactions can be important; specialist labeling must be followed.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Higher regulatory and pharmacovigilance scrutiny.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

61. METHYLCOBALAMIN INJECTION 1500 MCG

1. Medicine / Product Name

METHYLCOBALAMIN INJECTION 1500 MCG

2. Generic / API / Composition

METHYLCOBALAMIN  1500 MCG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Nutritional / metabolic supportive product

5. Pharmacological / Drug Class

Vitamin, amino-acid derivative or antioxidant — ingredient-specific

6. Main Uses / Indications

Indication varies by ingredient and approved formulation.

7. Mechanism / Basic Description

Biochemical role is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

62. GLUTATHIONE FOR INJECTION 1200 MG

1. Medicine / Product Name

GLUTATHIONE FOR INJECTION 1200 MG

2. Generic / API / Composition

GLUTATHIONE FOR  1200 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Nutritional / metabolic supportive product

5. Pharmacological / Drug Class

Vitamin, amino-acid derivative or antioxidant — ingredient-specific

6. Main Uses / Indications

Indication varies by ingredient and approved formulation.

7. Mechanism / Basic Description

Biochemical role is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

63. PITAVASTATIN CALCIUM

1. Medicine / Product Name

PITAVASTATIN CALCIUM

2. Generic / API / Composition

PITAVASTATIN CALCIUM — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Cardiometabolic medicine

5. Pharmacological / Drug Class

Ingredient-specific metabolic/cardiovascular agent

6. Main Uses / Indications

Cardiovascular, lipid or glucose-management indication according to the exact ingredient.

7. Mechanism / Basic Description

Ingredient-specific; verify official label.

8. Dosage Form & Route

Usually oral, except formulation-specific products.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

64. NALTREXONE HCL CAPSULE 4.5 MG

1. Medicine / Product Name

NALTREXONE HCL CAPSULE 4.5 MG

2. Generic / API / Composition

NALTREXONE HCL CAPSULE 4.5 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Addiction medicine

5. Pharmacological / Drug Class

Opioid receptor antagonist

6. Main Uses / Indications

Approved indications include alcohol-use disorder and opioid-use-disorder relapse prevention in appropriate settings.

7. Mechanism / Basic Description

Blocks opioid receptors.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

65. SEMAGLUTIDE

1. Medicine / Product Name

SEMAGLUTIDE

2. Generic / API / Composition

SEMAGLUTIDE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Cardiometabolic medicine

5. Pharmacological / Drug Class

Ingredient-specific metabolic/cardiovascular agent

6. Main Uses / Indications

Cardiovascular, lipid or glucose-management indication according to the exact ingredient.

7. Mechanism / Basic Description

Ingredient-specific; verify official label.

8. Dosage Form & Route

Usually oral, except formulation-specific products.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

66. CLOBETASOL PROPIONATE CREAM IP

1. Medicine / Product Name

CLOBETASOL PROPIONATE CREAM IP

2. Generic / API / Composition

CLOBETASOL PROPIONATE CREAM IP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

67. MINOXIDIL TABLETS IP 2.5 MG

1. Medicine / Product Name

MINOXIDIL TABLETS IP 2.5 MG

2. Generic / API / Composition

MINOXIDIL  IP 2.5 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

68. FLUPIRTINE MALEATE CAPSULE 100 MG

1. Medicine / Product Name

FLUPIRTINE MALEATE CAPSULE 100 MG

2. Generic / API / Composition

FLUPIRTINE MALEATE CAPSULE 100 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Analgesic / CNS medicine

5. Pharmacological / Drug Class

Non-opioid analgesic with central action

6. Main Uses / Indications

Historical/limited market-specific analgesic use.

7. Mechanism / Basic Description

Central potassium-channel-related analgesic mechanism; verify current jurisdictional status.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Regulatory status is particularly important because availability has been restricted/withdrawn in some markets.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

69. TRENBOLONE ACETATE INJECTION USP 100 MG / ML

1. Medicine / Product Name

TRENBOLONE ACETATE INJECTION USP 100 MG / ML

2. Generic / API / Composition

TRENBOLONE ACETATE  USP 100 MG / ML — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

70. BACTERIOSTATIC WATER FOR INJECTION

1. Medicine / Product Name

BACTERIOSTATIC WATER FOR INJECTION

2. Generic / API / Composition

BACTERIOSTATIC WATER FOR — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Parenteral diluent

5. Pharmacological / Drug Class

Sterile water with bacteriostatic preservative; not a therapeutic active medicine

6. Main Uses / Indications

Diluent for compatible injectable medicines where specifically permitted.

7. Mechanism / Basic Description

No therapeutic pharmacological mechanism.

8. Dosage Form & Route

Parenteral use only as an approved diluent.

9. Prescription / OTC Status

Healthcare/professional-use product; regulatory classification varies.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Must not be treated as a generic injectable substitute; verify preservative, container, intended use and destination requirements.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

71. BACTERIOSTATIC WATER FOR INJECTION USP 10 ML

1. Medicine / Product Name

BACTERIOSTATIC WATER FOR INJECTION USP 10 ML

2. Generic / API / Composition

BACTERIOSTATIC WATER FOR  USP 10 ML — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Parenteral diluent

5. Pharmacological / Drug Class

Sterile water with bacteriostatic preservative; not a therapeutic active medicine

6. Main Uses / Indications

Diluent for compatible injectable medicines where specifically permitted.

7. Mechanism / Basic Description

No therapeutic pharmacological mechanism.

8. Dosage Form & Route

Parenteral use only as an approved diluent.

9. Prescription / OTC Status

Healthcare/professional-use product; regulatory classification varies.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Must not be treated as a generic injectable substitute; verify preservative, container, intended use and destination requirements.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

72. BACTERIOSTATIC WATER FOR INJECTION USP 30 ML

1. Medicine / Product Name

BACTERIOSTATIC WATER FOR INJECTION USP 30 ML

2. Generic / API / Composition

BACTERIOSTATIC WATER FOR  USP 30 ML — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Parenteral diluent

5. Pharmacological / Drug Class

Sterile water with bacteriostatic preservative; not a therapeutic active medicine

6. Main Uses / Indications

Diluent for compatible injectable medicines where specifically permitted.

7. Mechanism / Basic Description

No therapeutic pharmacological mechanism.

8. Dosage Form & Route

Parenteral use only as an approved diluent.

9. Prescription / OTC Status

Healthcare/professional-use product; regulatory classification varies.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Must not be treated as a generic injectable substitute; verify preservative, container, intended use and destination requirements.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

73. DAPAGLIFLOZIN TABLE 10 MG

1. Medicine / Product Name

DAPAGLIFLOZIN TABLE 10 MG

2. Generic / API / Composition

DAPAGLIFLOZIN TABLE 10 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Cardiometabolic medicine

5. Pharmacological / Drug Class

Ingredient-specific metabolic/cardiovascular agent

6. Main Uses / Indications

Cardiovascular, lipid or glucose-management indication according to the exact ingredient.

7. Mechanism / Basic Description

Ingredient-specific; verify official label.

8. Dosage Form & Route

Usually oral, except formulation-specific products.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

74. ORLISTAT CAPSULE 120 MG

1. Medicine / Product Name

ORLISTAT CAPSULE 120 MG

2. Generic / API / Composition

ORLISTAT CAPSULE 120 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Pharmaceutical medicine

5. Pharmacological / Drug Class

Product-specific pharmacological class — verify against approved label.

6. Main Uses / Indications

Use/indication is formulation- and jurisdiction-specific; verify the approved label.

7. Mechanism / Basic Description

Pharmacology should be stated from the approved product label/official monograph.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

75. LOPERAMIDE HYDROCHLORIDE IP 2 MG

1. Medicine / Product Name

LOPERAMIDE HYDROCHLORIDE IP 2 MG

2. Generic / API / Composition

LOPERAMIDE HYDROCHLORIDE IP 2 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Analgesic / gastrointestinal medicine

5. Pharmacological / Drug Class

Ingredient-specific analgesic or GI agent

6. Main Uses / Indications

Pain/inflammation or gastrointestinal indication according to ingredient.

7. Mechanism / Basic Description

Ingredient-specific mechanism.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

76. CANDESARTAN CILEXETIL TABLES USP

1. Medicine / Product Name

CANDESARTAN CILEXETIL TABLES USP

2. Generic / API / Composition

CANDESARTAN CILEXETIL TABLES USP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Cardiometabolic medicine

5. Pharmacological / Drug Class

Ingredient-specific metabolic/cardiovascular agent

6. Main Uses / Indications

Cardiovascular, lipid or glucose-management indication according to the exact ingredient.

7. Mechanism / Basic Description

Ingredient-specific; verify official label.

8. Dosage Form & Route

Usually oral, except formulation-specific products.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

77. ESTRIOL CREAM BP

1. Medicine / Product Name

ESTRIOL CREAM BP

2. Generic / API / Composition

ESTRIOL CREAM BP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

78. ANASTROZOLE TABLETS 1 MG

1. Medicine / Product Name

ANASTROZOLE TABLETS 1 MG

2. Generic / API / Composition

ANASTROZOLE  1 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Hormonal / endocrine medicine

5. Pharmacological / Drug Class

Hormonal pathway modulator

6. Main Uses / Indications

Endocrine or oncology/fertility indication depending on ingredient.

7. Mechanism / Basic Description

Ingredient-specific estrogen-receptor or aromatase pathway modulation.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Hormonal/oncology regulatory review may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

79. MEMANTINE HYDROCHLORIDE TABLETS I P 5 MG

1. Medicine / Product Name

MEMANTINE HYDROCHLORIDE TABLETS I P 5 MG

2. Generic / API / Composition

MEMANTINE HYDROCHLORIDE  I P 5 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Neurological medicine

5. Pharmacological / Drug Class

Ingredient-specific CNS agent

6. Main Uses / Indications

Neurological indication according to the approved product.

7. Mechanism / Basic Description

Ingredient-specific CNS mechanism.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

80. MODAFINIL TABLETS USP 400 MG

1. Medicine / Product Name

MODAFINIL TABLETS USP 400 MG

2. Generic / API / Composition

MODAFINIL  USP 400 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

CNS / neurological / psychiatric medicine

5. Pharmacological / Drug Class

Central nervous system active medicine

6. Main Uses / Indications

Indication depends on the active ingredient; verify approved indication.

7. Mechanism / Basic Description

CNS mechanism is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Prescription; controlled/psychotropic status must be checked country by country.

10. Major Warnings / Contraindications / Key Interactions

CNS effects, interactions, dependence/misuse potential where applicable and local controlled-drug status require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority destination-country classification check. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

81. HYDROXYZINE HYDROCHLORIDE SUSTAINED RELEASE TABLETS 50 MG

1. Medicine / Product Name

HYDROXYZINE HYDROCHLORIDE SUSTAINED RELEASE TABLETS 50 MG

2. Generic / API / Composition

HYDROXYZINE HYDROCHLORIDE SUSTAINED RELEASE  50 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Antihistamine / allergy medicine

5. Pharmacological / Drug Class

Antihistamine; ingredient-specific additional activity

6. Main Uses / Indications

Allergic or other approved indications.

7. Mechanism / Basic Description

Primarily H1-histamine receptor antagonism.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

82. MELATONIN 20 MG TABLETS

1. Medicine / Product Name

MELATONIN 20 MG TABLETS

2. Generic / API / Composition

MELATONIN 20 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Sleep/circadian medicine

5. Pharmacological / Drug Class

Melatonin receptor agonist/hormone

6. Main Uses / Indications

Sleep/circadian indications vary substantially by jurisdiction.

7. Mechanism / Basic Description

Acts at melatonin receptors involved in circadian regulation.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

OTC, supplement or prescription status varies by country and dose.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

83. BUSPIRONE HYDROCHLORIDE TABLES I P 10 MG

1. Medicine / Product Name

BUSPIRONE HYDROCHLORIDE TABLES I P 10 MG

2. Generic / API / Composition

BUSPIRONE HYDROCHLORIDE TABLES I P 10 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

CNS / neurological / psychiatric medicine

5. Pharmacological / Drug Class

Central nervous system active medicine

6. Main Uses / Indications

Indication depends on the active ingredient; verify approved indication.

7. Mechanism / Basic Description

CNS mechanism is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Prescription; controlled/psychotropic status must be checked country by country.

10. Major Warnings / Contraindications / Key Interactions

CNS effects, interactions, dependence/misuse potential where applicable and local controlled-drug status require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority destination-country classification check.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

84. SILDENAFIL ORAL JELLY 100 MG

1. Medicine / Product Name

SILDENAFIL ORAL JELLY 100 MG

2. Generic / API / Composition

SILDENAFIL ORAL JELLY 100 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Genitourinary / erectile-dysfunction medicine

5. Pharmacological / Drug Class

PDE-5 inhibitor

6. Main Uses / Indications

Treatment of erectile dysfunction; exact indications vary by product and market.

7. Mechanism / Basic Description

Inhibits PDE-5, increasing cGMP-mediated smooth-muscle relaxation.

8. Dosage Form & Route

Oral; exact formulation (tablet/jelly/etc.) must be verified.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Nitrates/riociguat and cardiovascular conditions require particular attention; formulation and local labeling must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

85. SILDENAFIL 100 MG AND DAPOXETINE 60 MG ORAL JELLY

1. Medicine / Product Name

SILDENAFIL 100 MG AND DAPOXETINE 60 MG ORAL JELLY

2. Generic / API / Composition

SILDENAFIL 100 MG AND DAPOXETINE 60 MG ORAL JELLY — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Genitourinary / erectile-dysfunction medicine

5. Pharmacological / Drug Class

PDE-5 inhibitor

6. Main Uses / Indications

Treatment of erectile dysfunction; exact indications vary by product and market.

7. Mechanism / Basic Description

Inhibits PDE-5, increasing cGMP-mediated smooth-muscle relaxation.

8. Dosage Form & Route

Oral; exact formulation (tablet/jelly/etc.) must be verified.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Nitrates/riociguat and cardiovascular conditions require particular attention; formulation and local labeling must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

86. ROSUVASTATIN TABLESTS IP

1. Medicine / Product Name

ROSUVASTATIN TABLESTS IP

2. Generic / API / Composition

ROSUVASTATIN TABLESTS IP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Cardiometabolic medicine

5. Pharmacological / Drug Class

Ingredient-specific metabolic/cardiovascular agent

6. Main Uses / Indications

Cardiovascular, lipid or glucose-management indication according to the exact ingredient.

7. Mechanism / Basic Description

Ingredient-specific; verify official label.

8. Dosage Form & Route

Usually oral, except formulation-specific products.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

87. LEVOCARNITINE INJECTION USP

1. Medicine / Product Name

LEVOCARNITINE INJECTION USP

2. Generic / API / Composition

LEVOCARNITINE  USP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Nutritional / metabolic supportive product

5. Pharmacological / Drug Class

Vitamin, amino-acid derivative or antioxidant — ingredient-specific

6. Main Uses / Indications

Indication varies by ingredient and approved formulation.

7. Mechanism / Basic Description

Biochemical role is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

88. SEMAGLUTIDE TABLETS ORAL USE

1. Medicine / Product Name

SEMAGLUTIDE TABLETS ORAL USE

2. Generic / API / Composition

SEMAGLUTIDE  ORAL USE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Cardiometabolic medicine

5. Pharmacological / Drug Class

Ingredient-specific metabolic/cardiovascular agent

6. Main Uses / Indications

Cardiovascular, lipid or glucose-management indication according to the exact ingredient.

7. Mechanism / Basic Description

Ingredient-specific; verify official label.

8. Dosage Form & Route

Usually oral, except formulation-specific products.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

Top Pharma Export Products from India Manufacturers Sellers Pharmaceutical Companies Medicine Buyers

89. DAPAGLIFLOZIN AND METFORMIN EXTENDED REALASE TABLETS 10 / 1000

1. Medicine / Product Name

DAPAGLIFLOZIN AND METFORMIN EXTENDED REALASE TABLETS 10 / 1000

2. Generic / API / Composition

DAPAGLIFLOZIN AND METFORMIN EXTENDED REALASE  10 / 1000 — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Cardiometabolic medicine

5. Pharmacological / Drug Class

Ingredient-specific metabolic/cardiovascular agent

6. Main Uses / Indications

Cardiovascular, lipid or glucose-management indication according to the exact ingredient.

7. Mechanism / Basic Description

Ingredient-specific; verify official label.

8. Dosage Form & Route

Usually oral, except formulation-specific products.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

90. EPLERENONE TABLETS IP 25 MG

1. Medicine / Product Name

EPLERENONE TABLETS IP 25 MG

2. Generic / API / Composition

EPLERENONE  IP 25 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Cardiometabolic medicine

5. Pharmacological / Drug Class

Ingredient-specific metabolic/cardiovascular agent

6. Main Uses / Indications

Cardiovascular, lipid or glucose-management indication according to the exact ingredient.

7. Mechanism / Basic Description

Ingredient-specific; verify official label.

8. Dosage Form & Route

Usually oral, except formulation-specific products.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

91. METFORMIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS IP

1. Medicine / Product Name

METFORMIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS IP

2. Generic / API / Composition

METFORMIN HYDROCHLORIDE SUSTAINED RELEASE  IP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Cardiometabolic medicine

5. Pharmacological / Drug Class

Ingredient-specific metabolic/cardiovascular agent

6. Main Uses / Indications

Cardiovascular, lipid or glucose-management indication according to the exact ingredient.

7. Mechanism / Basic Description

Ingredient-specific; verify official label.

8. Dosage Form & Route

Usually oral, except formulation-specific products.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

92. MEBENDAZOLE TABLETS USP 500 MG

1. Medicine / Product Name

MEBENDAZOLE TABLETS USP 500 MG

2. Generic / API / Composition

MEBENDAZOLE  USP 500 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Anti-infective / antiparasitic medicine

5. Pharmacological / Drug Class

Antibacterial, antiprotozoal or antiparasitic — ingredient-specific

6. Main Uses / Indications

Treatment of susceptible infections/parasitoses according to the approved indication.

7. Mechanism / Basic Description

Ingredient-specific antimicrobial/antiparasitic mechanism.

8. Dosage Form & Route

Oral or other formulation-specific route.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Allergy, interactions, resistance/appropriate-use restrictions and indication-specific precautions require label review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

93. SELEGILINE HYDROCHLORIDE TABLETS IP 5 MG

1. Medicine / Product Name

SELEGILINE HYDROCHLORIDE TABLETS IP 5 MG

2. Generic / API / Composition

SELEGILINE HYDROCHLORIDE  IP 5 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

CNS / neurological / psychiatric medicine

5. Pharmacological / Drug Class

Central nervous system active medicine

6. Main Uses / Indications

Indication depends on the active ingredient; verify approved indication.

7. Mechanism / Basic Description

CNS mechanism is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Prescription; controlled/psychotropic status must be checked country by country.

10. Major Warnings / Contraindications / Key Interactions

CNS effects, interactions, dependence/misuse potential where applicable and local controlled-drug status require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority destination-country classification check.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

94. FENBENDAZOLE TABLETS 1000 MG

1. Medicine / Product Name

FENBENDAZOLE TABLETS 1000 MG

2. Generic / API / Composition

FENBENDAZOLE  1000 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Veterinary anthelmintic

5. Pharmacological / Drug Class

Benzimidazole anthelmintic

6. Main Uses / Indications

Veterinary parasite control; human use is not automatically authorized.

7. Mechanism / Basic Description

Disrupts parasite microtubule function.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Veterinary/animal-health regulatory status depends on country.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Do not present as a human pharmaceutical without explicit human authorization.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

95. FENBENDAZOLE TABLETS 500 MG

1. Medicine / Product Name

FENBENDAZOLE TABLETS 500 MG

2. Generic / API / Composition

FENBENDAZOLE  500 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Veterinary anthelmintic

5. Pharmacological / Drug Class

Benzimidazole anthelmintic

6. Main Uses / Indications

Veterinary parasite control; human use is not automatically authorized.

7. Mechanism / Basic Description

Disrupts parasite microtubule function.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Veterinary/animal-health regulatory status depends on country.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Do not present as a human pharmaceutical without explicit human authorization.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

96. PENTOXIFYLLINES SUSTAINED RELEASE TABLETS IP

1. Medicine / Product Name

PENTOXIFYLLINES SUSTAINED RELEASE TABLETS IP

2. Generic / API / Composition

PENTOXIFYLLINES SUSTAINED RELEASE  IP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Peripheral vascular medicine

5. Pharmacological / Drug Class

Methylxanthine derivative / hemorheologic agent

6. Main Uses / Indications

Indication varies by jurisdiction.

7. Mechanism / Basic Description

Pharmacology should be stated from the approved product label/official monograph.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

97. FENBENDAZOLE TABLETS 222 MG

1. Medicine / Product Name

FENBENDAZOLE TABLETS 222 MG

2. Generic / API / Composition

FENBENDAZOLE  222 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Veterinary anthelmintic

5. Pharmacological / Drug Class

Benzimidazole anthelmintic

6. Main Uses / Indications

Veterinary parasite control; human use is not automatically authorized.

7. Mechanism / Basic Description

Disrupts parasite microtubule function.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Veterinary/animal-health regulatory status depends on country.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Do not present as a human pharmaceutical without explicit human authorization.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

98. NICLOSAMIDE TABLETS IP 500 MG

1. Medicine / Product Name

NICLOSAMIDE TABLETS IP 500 MG

2. Generic / API / Composition

NICLOSAMIDE  IP 500 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Anti-infective / antiparasitic medicine

5. Pharmacological / Drug Class

Antibacterial, antiprotozoal or antiparasitic — ingredient-specific

6. Main Uses / Indications

Treatment of susceptible infections/parasitoses according to the approved indication.

7. Mechanism / Basic Description

Ingredient-specific antimicrobial/antiparasitic mechanism.

8. Dosage Form & Route

Oral or other formulation-specific route.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Allergy, interactions, resistance/appropriate-use restrictions and indication-specific precautions require label review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

99. UDENAFIL TABLETS 200 MG

1. Medicine / Product Name

UDENAFIL TABLETS 200 MG

2. Generic / API / Composition

UDENAFIL  200 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Genitourinary / erectile-dysfunction medicine

5. Pharmacological / Drug Class

PDE-5 inhibitor

6. Main Uses / Indications

Treatment of erectile dysfunction; exact indications vary by product and market.

7. Mechanism / Basic Description

Inhibits PDE-5, increasing cGMP-mediated smooth-muscle relaxation.

8. Dosage Form & Route

Oral; exact formulation (tablet/jelly/etc.) must be verified.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Nitrates/riociguat and cardiovascular conditions require particular attention; formulation and local labeling must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

100. RIFAXIMIN TABLETS IP 400 MG

1. Medicine / Product Name

RIFAXIMIN TABLETS IP 400 MG

2. Generic / API / Composition

RIFAXIMIN  IP 400 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Anti-infective / antiparasitic medicine

5. Pharmacological / Drug Class

Antibacterial, antiprotozoal or antiparasitic — ingredient-specific

6. Main Uses / Indications

Treatment of susceptible infections/parasitoses according to the approved indication.

7. Mechanism / Basic Description

Ingredient-specific antimicrobial/antiparasitic mechanism.

8. Dosage Form & Route

Oral or other formulation-specific route.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Allergy, interactions, resistance/appropriate-use restrictions and indication-specific precautions require label review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

101. PREGABALIN CAPSULES IP

1. Medicine / Product Name

PREGABALIN CAPSULES IP

2. Generic / API / Composition

PREGABALIN  IP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

CNS / neurological / psychiatric medicine

5. Pharmacological / Drug Class

Central nervous system active medicine

6. Main Uses / Indications

Indication depends on the active ingredient; verify approved indication.

7. Mechanism / Basic Description

CNS mechanism is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Prescription; controlled/psychotropic status must be checked country by country.

10. Major Warnings / Contraindications / Key Interactions

CNS effects, interactions, dependence/misuse potential where applicable and local controlled-drug status require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority destination-country classification check. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

102. HYDROCHLOROTHIAZIDE TABLETS IP 12.5 MG

1. Medicine / Product Name

HYDROCHLOROTHIAZIDE TABLETS IP 12.5 MG

2. Generic / API / Composition

HYDROCHLOROTHIAZIDE  IP 12.5 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Cardiometabolic medicine

5. Pharmacological / Drug Class

Ingredient-specific metabolic/cardiovascular agent

6. Main Uses / Indications

Cardiovascular, lipid or glucose-management indication according to the exact ingredient.

7. Mechanism / Basic Description

Ingredient-specific; verify official label.

8. Dosage Form & Route

Usually oral, except formulation-specific products.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

103. SALBUTAMOL SULPHATE TABLETS IP

1. Medicine / Product Name

SALBUTAMOL SULPHATE TABLETS IP

2. Generic / API / Composition

SALBUTAMOL SULPHATE  IP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Respiratory medicine

5. Pharmacological / Drug Class

Beta-2 adrenergic agonist

6. Main Uses / Indications

Bronchodilator therapy in approved respiratory conditions.

7. Mechanism / Basic Description

Relaxes bronchial smooth muscle through beta-2 receptor stimulation.

8. Dosage Form & Route

Oral or inhaled depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

104. DOXYCYCLINE HYDOCHLORIDE AND LACTIC ACID BACILLUS CAPSULE

1. Medicine / Product Name

DOXYCYCLINE HYDOCHLORIDE AND LACTIC ACID BACILLUS CAPSULE

2. Generic / API / Composition

DOXYCYCLINE HYDOCHLORIDE AND LACTIC ACID BACILLUS CAPSULE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Anti-infective / antiparasitic medicine

5. Pharmacological / Drug Class

Antibacterial, antiprotozoal or antiparasitic — ingredient-specific

6. Main Uses / Indications

Treatment of susceptible infections/parasitoses according to the approved indication.

7. Mechanism / Basic Description

Ingredient-specific antimicrobial/antiparasitic mechanism.

8. Dosage Form & Route

Oral or other formulation-specific route.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Allergy, interactions, resistance/appropriate-use restrictions and indication-specific precautions require label review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

105. NEBIVOLOL HYDROCHLORIDE TABLETS IP 5 MG

1. Medicine / Product Name

NEBIVOLOL HYDROCHLORIDE TABLETS IP 5 MG

2. Generic / API / Composition

NEBIVOLOL HYDROCHLORIDE  IP 5 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Cardiometabolic medicine

5. Pharmacological / Drug Class

Ingredient-specific metabolic/cardiovascular agent

6. Main Uses / Indications

Cardiovascular, lipid or glucose-management indication according to the exact ingredient.

7. Mechanism / Basic Description

Ingredient-specific; verify official label.

8. Dosage Form & Route

Usually oral, except formulation-specific products.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

106. METRONIDAZOLE

1. Medicine / Product Name

METRONIDAZOLE

2. Generic / API / Composition

METRONIDAZOLE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Anti-infective / antiparasitic medicine

5. Pharmacological / Drug Class

Antibacterial, antiprotozoal or antiparasitic — ingredient-specific

6. Main Uses / Indications

Treatment of susceptible infections/parasitoses according to the approved indication.

7. Mechanism / Basic Description

Ingredient-specific antimicrobial/antiparasitic mechanism.

8. Dosage Form & Route

Oral or other formulation-specific route.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Allergy, interactions, resistance/appropriate-use restrictions and indication-specific precautions require label review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

107. ATOMOXETINE TABLETS 40 MG

1. Medicine / Product Name

ATOMOXETINE TABLETS 40 MG

2. Generic / API / Composition

ATOMOXETINE  40 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

CNS / neurological / psychiatric medicine

5. Pharmacological / Drug Class

Central nervous system active medicine

6. Main Uses / Indications

Indication depends on the active ingredient; verify approved indication.

7. Mechanism / Basic Description

CNS mechanism is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Prescription; controlled/psychotropic status must be checked country by country.

10. Major Warnings / Contraindications / Key Interactions

CNS effects, interactions, dependence/misuse potential where applicable and local controlled-drug status require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority destination-country classification check. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

108. CEREBROPROTEIN HYDOLYSATE TABLETS 90 MG

1. Medicine / Product Name

CEREBROPROTEIN HYDOLYSATE TABLETS 90 MG

2. Generic / API / Composition

CEREBROPROTEIN HYDOLYSATE  90 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Neurological peptide preparation

5. Pharmacological / Drug Class

Peptide mixture / biological-derived preparation

6. Main Uses / Indications

Indications are jurisdiction- and evidence-specific.

7. Mechanism / Basic Description

Product-specific; verify official product monograph.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority evidence and regulatory classification verification.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

109. HYDROCHLOROTHIAZIDE TABLETS 12.5 MG IP

1. Medicine / Product Name

HYDROCHLOROTHIAZIDE TABLETS 12.5 MG IP

2. Generic / API / Composition

HYDROCHLOROTHIAZIDE  12.5 MG IP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Cardiometabolic medicine

5. Pharmacological / Drug Class

Ingredient-specific metabolic/cardiovascular agent

6. Main Uses / Indications

Cardiovascular, lipid or glucose-management indication according to the exact ingredient.

7. Mechanism / Basic Description

Ingredient-specific; verify official label.

8. Dosage Form & Route

Usually oral, except formulation-specific products.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

110. CYPROHEPTADINE HYDROCHLORIDE TABLETS I P 4 MG

1. Medicine / Product Name

CYPROHEPTADINE HYDROCHLORIDE TABLETS I P 4 MG

2. Generic / API / Composition

CYPROHEPTADINE HYDROCHLORIDE  I P 4 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Antihistamine / allergy medicine

5. Pharmacological / Drug Class

Antihistamine; ingredient-specific additional activity

6. Main Uses / Indications

Allergic or other approved indications.

7. Mechanism / Basic Description

Primarily H1-histamine receptor antagonism.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

111. IVERMECTIN TABLETS USP 12 MG

1. Medicine / Product Name

IVERMECTIN TABLETS USP 12 MG

2. Generic / API / Composition

IVERMECTIN  USP 12 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Anti-infective / antiparasitic medicine

5. Pharmacological / Drug Class

Antibacterial, antiprotozoal or antiparasitic — ingredient-specific

6. Main Uses / Indications

Treatment of susceptible infections/parasitoses according to the approved indication.

7. Mechanism / Basic Description

Ingredient-specific antimicrobial/antiparasitic mechanism.

8. Dosage Form & Route

Oral or other formulation-specific route.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Allergy, interactions, resistance/appropriate-use restrictions and indication-specific precautions require label review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

112. IVERMECTIN TABLETS USP 15 MG

1. Medicine / Product Name

IVERMECTIN TABLETS USP 15 MG

2. Generic / API / Composition

IVERMECTIN  USP 15 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Anti-infective / antiparasitic medicine

5. Pharmacological / Drug Class

Antibacterial, antiprotozoal or antiparasitic — ingredient-specific

6. Main Uses / Indications

Treatment of susceptible infections/parasitoses according to the approved indication.

7. Mechanism / Basic Description

Ingredient-specific antimicrobial/antiparasitic mechanism.

8. Dosage Form & Route

Oral or other formulation-specific route.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Allergy, interactions, resistance/appropriate-use restrictions and indication-specific precautions require label review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

113. IVERMECTIN TABLETS USP 80 MG

1. Medicine / Product Name

IVERMECTIN TABLETS USP 80 MG

2. Generic / API / Composition

IVERMECTIN  USP 80 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Anti-infective / antiparasitic medicine

5. Pharmacological / Drug Class

Antibacterial, antiprotozoal or antiparasitic — ingredient-specific

6. Main Uses / Indications

Treatment of susceptible infections/parasitoses according to the approved indication.

7. Mechanism / Basic Description

Ingredient-specific antimicrobial/antiparasitic mechanism.

8. Dosage Form & Route

Oral or other formulation-specific route.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Allergy, interactions, resistance/appropriate-use restrictions and indication-specific precautions require label review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

114. IVERMECTIN TABLETS USP 24 MG

1. Medicine / Product Name

IVERMECTIN TABLETS USP 24 MG

2. Generic / API / Composition

IVERMECTIN  USP 24 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Anti-infective / antiparasitic medicine

5. Pharmacological / Drug Class

Antibacterial, antiprotozoal or antiparasitic — ingredient-specific

6. Main Uses / Indications

Treatment of susceptible infections/parasitoses according to the approved indication.

7. Mechanism / Basic Description

Ingredient-specific antimicrobial/antiparasitic mechanism.

8. Dosage Form & Route

Oral or other formulation-specific route.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Allergy, interactions, resistance/appropriate-use restrictions and indication-specific precautions require label review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

115. IVERMECTIN TABLETS USP 40 MG

1. Medicine / Product Name

IVERMECTIN TABLETS USP 40 MG

2. Generic / API / Composition

IVERMECTIN  USP 40 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Anti-infective / antiparasitic medicine

5. Pharmacological / Drug Class

Antibacterial, antiprotozoal or antiparasitic — ingredient-specific

6. Main Uses / Indications

Treatment of susceptible infections/parasitoses according to the approved indication.

7. Mechanism / Basic Description

Ingredient-specific antimicrobial/antiparasitic mechanism.

8. Dosage Form & Route

Oral or other formulation-specific route.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Allergy, interactions, resistance/appropriate-use restrictions and indication-specific precautions require label review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

116. SILDENAFIL CITRATE AND DAPOXETINE TABLETS

1. Medicine / Product Name

SILDENAFIL CITRATE AND DAPOXETINE TABLETS

2. Generic / API / Composition

SILDENAFIL CITRATE AND DAPOXETINE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Genitourinary / erectile-dysfunction medicine

5. Pharmacological / Drug Class

PDE-5 inhibitor

6. Main Uses / Indications

Treatment of erectile dysfunction; exact indications vary by product and market.

7. Mechanism / Basic Description

Inhibits PDE-5, increasing cGMP-mediated smooth-muscle relaxation.

8. Dosage Form & Route

Oral; exact formulation (tablet/jelly/etc.) must be verified.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Nitrates/riociguat and cardiovascular conditions require particular attention; formulation and local labeling must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

117. KETOROLAC TROMETHAMINE INJECTION IP

1. Medicine / Product Name

KETOROLAC TROMETHAMINE INJECTION IP

2. Generic / API / Composition

KETOROLAC TROMETHAMINE  IP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Analgesic / gastrointestinal medicine

5. Pharmacological / Drug Class

Ingredient-specific analgesic or GI agent

6. Main Uses / Indications

Pain/inflammation or gastrointestinal indication according to ingredient.

7. Mechanism / Basic Description

Ingredient-specific mechanism.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

118. SOMATROPIN FOR INJECTION IP RECOMBINANT HUMAN GROWTH HORMONE FOR INJECTION

1. Medicine / Product Name

SOMATROPIN FOR INJECTION IP RECOMBINANT HUMAN GROWTH HORMONE FOR INJECTION

2. Generic / API / Composition

SOMATROPIN FOR  IP RECOMBINANT HUMAN GROWTH HORMONE FOR — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Biologic / growth hormone

5. Pharmacological / Drug Class

Recombinant human growth hormone

6. Main Uses / Indications

Approved growth-hormone deficiency and other indication-specific uses.

7. Mechanism / Basic Description

Activates growth-hormone receptors and downstream IGF-1 pathways.

8. Dosage Form & Route

Parenteral injection.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Growth-related, metabolic and endocrine precautions; cold-chain/storage requirements must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Biologic/cold-chain and destination registration requirements. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

119. IVABRADINE TABLETS 5 MG

1. Medicine / Product Name

IVABRADINE TABLETS 5 MG

2. Generic / API / Composition

IVABRADINE  5 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Cardiometabolic medicine

5. Pharmacological / Drug Class

Ingredient-specific metabolic/cardiovascular agent

6. Main Uses / Indications

Cardiovascular, lipid or glucose-management indication according to the exact ingredient.

7. Mechanism / Basic Description

Ingredient-specific; verify official label.

8. Dosage Form & Route

Usually oral, except formulation-specific products.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

120. DROSTANOLONE ENANTHATE 200 MG

1. Medicine / Product Name

DROSTANOLONE ENANTHATE 200 MG

2. Generic / API / Composition

DROSTANOLONE ENANTHATE 200 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

121. SALBUTAMOL INHALATION IP 100 MCG / DOSE

1. Medicine / Product Name

SALBUTAMOL INHALATION IP 100 MCG / DOSE

2. Generic / API / Composition

SALBUTAMOL INHALATION IP 100 MCG / DOSE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Respiratory medicine

5. Pharmacological / Drug Class

Beta-2 adrenergic agonist

6. Main Uses / Indications

Bronchodilator therapy in approved respiratory conditions.

7. Mechanism / Basic Description

Relaxes bronchial smooth muscle through beta-2 receptor stimulation.

8. Dosage Form & Route

Oral or inhaled depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

122. TESTOSTERONE ENANTHATE USP 250 MG / ML

1. Medicine / Product Name

TESTOSTERONE ENANTHATE USP 250 MG / ML

2. Generic / API / Composition

TESTOSTERONE ENANTHATE USP 250 MG / ML — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

123. EXEMESTANE TABLETS IP 25 MG

1. Medicine / Product Name

EXEMESTANE TABLETS IP 25 MG

2. Generic / API / Composition

EXEMESTANE  IP 25 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Hormonal / endocrine medicine

5. Pharmacological / Drug Class

Hormonal pathway modulator

6. Main Uses / Indications

Endocrine or oncology/fertility indication depending on ingredient.

7. Mechanism / Basic Description

Ingredient-specific estrogen-receptor or aromatase pathway modulation.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Hormonal/oncology regulatory review may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

124. CYCLOSPORINE EYE DROPS 0.05% W/V ( CIPVISION )

1. Medicine / Product Name

CYCLOSPORINE EYE DROPS 0.05% W/V ( CIPVISION )

2. Generic / API / Composition

CYCLOSPORINE EYE DROPS 0.05% W/V ( CIPVISION ) — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Immunomodulatory / anti-inflammatory medicine

5. Pharmacological / Drug Class

Ingredient-specific immunosuppressive or anti-inflammatory agent

6. Main Uses / Indications

Inflammatory, autoimmune or transplant-related indications depending on ingredient/formulation.

7. Mechanism / Basic Description

Ingredient-specific immunomodulatory mechanism.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Infection risk, immunosuppression and drug interactions can be important; specialist labeling must be followed.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Higher regulatory and pharmacovigilance scrutiny. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

125. FLUOXYMESTERONE 5 MG

1. Medicine / Product Name

FLUOXYMESTERONE 5 MG

2. Generic / API / Composition

FLUOXYMESTERONE 5 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

126. TRETINOIN CREAM USP 0.025 % W/W

1. Medicine / Product Name

TRETINOIN CREAM USP 0.025 % W/W

2. Generic / API / Composition

TRETINOIN CREAM USP 0.025 % W/W — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

127. OXYMETHOLONE U S P 50 MG

1. Medicine / Product Name

OXYMETHOLONE U S P 50 MG

2. Generic / API / Composition

OXYMETHOLONE U S P 50 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

128. FLUOXYMESTERONE TABLETS U S P

1. Medicine / Product Name

FLUOXYMESTERONE TABLETS U S P

2. Generic / API / Composition

FLUOXYMESTERONE  U S P — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

129. TAMOXIFEN TABLETS IP 10 MG

1. Medicine / Product Name

TAMOXIFEN TABLETS IP 10 MG

2. Generic / API / Composition

TAMOXIFEN  IP 10 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Hormonal / endocrine medicine

5. Pharmacological / Drug Class

Hormonal pathway modulator

6. Main Uses / Indications

Endocrine or oncology/fertility indication depending on ingredient.

7. Mechanism / Basic Description

Ingredient-specific estrogen-receptor or aromatase pathway modulation.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Hormonal/oncology regulatory review may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

130. CLOMIPHENE CITRATE TABLETS USP 50 MG

1. Medicine / Product Name

CLOMIPHENE CITRATE TABLETS USP 50 MG

2. Generic / API / Composition

CLOMIPHENE CITRATE  USP 50 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Hormonal / endocrine medicine

5. Pharmacological / Drug Class

Hormonal pathway modulator

6. Main Uses / Indications

Endocrine or oncology/fertility indication depending on ingredient.

7. Mechanism / Basic Description

Ingredient-specific estrogen-receptor or aromatase pathway modulation.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Hormonal/oncology regulatory review may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

131. L CARNITINE HCL 2000 MG / 5 ML

1. Medicine / Product Name

L CARNITINE HCL 2000 MG / 5 ML

2. Generic / API / Composition

L CARNITINE HCL 2000 MG / 5 ML — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Nutritional / metabolic supportive product

5. Pharmacological / Drug Class

Vitamin, amino-acid derivative or antioxidant — ingredient-specific

6. Main Uses / Indications

Indication varies by ingredient and approved formulation.

7. Mechanism / Basic Description

Biochemical role is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

132. TESTOSTERONE ENANTHATE FOR INJECTION USP

1. Medicine / Product Name

TESTOSTERONE ENANTHATE FOR INJECTION USP

2. Generic / API / Composition

TESTOSTERONE ENANTHATE FOR  USP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

133. AZELAIC ACID CREAM 20 % W/W

1. Medicine / Product Name

AZELAIC ACID CREAM 20 % W/W

2. Generic / API / Composition

AZELAIC ACID CREAM 20 % W/W — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

134. SILDENAFIL CUTRATE

1. Medicine / Product Name

SILDENAFIL CUTRATE

2. Generic / API / Composition

SILDENAFIL CUTRATE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Genitourinary / erectile-dysfunction medicine

5. Pharmacological / Drug Class

PDE-5 inhibitor

6. Main Uses / Indications

Treatment of erectile dysfunction; exact indications vary by product and market.

7. Mechanism / Basic Description

Inhibits PDE-5, increasing cGMP-mediated smooth-muscle relaxation.

8. Dosage Form & Route

Oral; exact formulation (tablet/jelly/etc.) must be verified.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Nitrates/riociguat and cardiovascular conditions require particular attention; formulation and local labeling must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

135. SIROLIMUS

1. Medicine / Product Name

SIROLIMUS

2. Generic / API / Composition

SIROLIMUS — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Immunomodulatory / anti-inflammatory medicine

5. Pharmacological / Drug Class

Ingredient-specific immunosuppressive or anti-inflammatory agent

6. Main Uses / Indications

Inflammatory, autoimmune or transplant-related indications depending on ingredient/formulation.

7. Mechanism / Basic Description

Ingredient-specific immunomodulatory mechanism.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Infection risk, immunosuppression and drug interactions can be important; specialist labeling must be followed.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Higher regulatory and pharmacovigilance scrutiny.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

136. TESTOSTERONE PROPIONATE INJECTION USP

1. Medicine / Product Name

TESTOSTERONE PROPIONATE INJECTION USP

2. Generic / API / Composition

TESTOSTERONE PROPIONATE  USP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

137. TRICLABENDAZOLE TABLETS 250 MG

1. Medicine / Product Name

TRICLABENDAZOLE TABLETS 250 MG

2. Generic / API / Composition

TRICLABENDAZOLE  250 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Anti-infective / antiparasitic medicine

5. Pharmacological / Drug Class

Antibacterial, antiprotozoal or antiparasitic — ingredient-specific

6. Main Uses / Indications

Treatment of susceptible infections/parasitoses according to the approved indication.

7. Mechanism / Basic Description

Ingredient-specific antimicrobial/antiparasitic mechanism.

8. Dosage Form & Route

Oral or other formulation-specific route.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Allergy, interactions, resistance/appropriate-use restrictions and indication-specific precautions require label review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

138. MESTEROLONE TABLETS 25 MG

1. Medicine / Product Name

MESTEROLONE TABLETS 25 MG

2. Generic / API / Composition

MESTEROLONE  25 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

139. TESTOSTERONE CYPIONATE INJ USP 250 MG /ML

1. Medicine / Product Name

TESTOSTERONE CYPIONATE INJ USP 250 MG /ML

2. Generic / API / Composition

TESTOSTERONE CYPIONATE INJ USP 250 MG /ML — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

140. LIDOCAINE AND PRILOCAINE CREAM IP

1. Medicine / Product Name

LIDOCAINE AND PRILOCAINE CREAM IP

2. Generic / API / Composition

LIDOCAINE AND PRILOCAINE CREAM IP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Local anesthetic

5. Pharmacological / Drug Class

Amide local anesthetic

6. Main Uses / Indications

Topical/local anesthesia according to formulation.

7. Mechanism / Basic Description

Blocks voltage-gated sodium channels and local nerve conduction.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

141. NANDROLONE PHENYLPROPIONATE INJECTION USP

1. Medicine / Product Name

NANDROLONE PHENYLPROPIONATE INJECTION USP

2. Generic / API / Composition

NANDROLONE PHENYLPROPIONATE  USP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

142. TOFACITINIB TABLETS 5 MG

1. Medicine / Product Name

TOFACITINIB TABLETS 5 MG

2. Generic / API / Composition

TOFACITINIB  5 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Immunomodulatory / anti-inflammatory medicine

5. Pharmacological / Drug Class

Ingredient-specific immunosuppressive or anti-inflammatory agent

6. Main Uses / Indications

Inflammatory, autoimmune or transplant-related indications depending on ingredient/formulation.

7. Mechanism / Basic Description

Ingredient-specific immunomodulatory mechanism.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Infection risk, immunosuppression and drug interactions can be important; specialist labeling must be followed.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Higher regulatory and pharmacovigilance scrutiny.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

143. TESTOSTERONE MIX COMPOUND

1. Medicine / Product Name

TESTOSTERONE MIX COMPOUND

2. Generic / API / Composition

TESTOSTERONE MIX COMPOUND — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

144. ESTRADIOL GEL 0.06 % W/W

1. Medicine / Product Name

ESTRADIOL GEL 0.06 % W/W

2. Generic / API / Composition

ESTRADIOL GEL 0.06 % W/W — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

145. TRETINOIN MICROSPHERE GEL USP 0.1 % W/W

1. Medicine / Product Name

TRETINOIN MICROSPHERE GEL USP 0.1 % W/W

2. Generic / API / Composition

TRETINOIN MICROSPHERE GEL USP 0.1 % W/W — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

146. FENBENDAZOLE CAPSULES 444 MG

1. Medicine / Product Name

FENBENDAZOLE CAPSULES 444 MG

2. Generic / API / Composition

FENBENDAZOLE  444 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Veterinary anthelmintic

5. Pharmacological / Drug Class

Benzimidazole anthelmintic

6. Main Uses / Indications

Veterinary parasite control; human use is not automatically authorized.

7. Mechanism / Basic Description

Disrupts parasite microtubule function.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Veterinary/animal-health regulatory status depends on country.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Do not present as a human pharmaceutical without explicit human authorization.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

147. ADAPALENE GEL IP 0.1 %

1. Medicine / Product Name

ADAPALENE GEL IP 0.1 %

2. Generic / API / Composition

ADAPALENE GEL IP 0.1 % — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

148. ADAPALENE GEL IP 0.1 % AND BENZOYL PEROXIDE 2.5 % W/W GEL

1. Medicine / Product Name

ADAPALENE GEL IP 0.1 % AND BENZOYL PEROXIDE 2.5 % W/W GEL

2. Generic / API / Composition

ADAPALENE GEL IP 0.1 % AND BENZOYL PEROXIDE 2.5 % W/W GEL — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

149. ADAPALENE GEL IP 0.3 % AND BENZOYL PEROXIDE 2.5 % W/W GEL

1. Medicine / Product Name

ADAPALENE GEL IP 0.3 % AND BENZOYL PEROXIDE 2.5 % W/W GEL

2. Generic / API / Composition

ADAPALENE GEL IP 0.3 % AND BENZOYL PEROXIDE 2.5 % W/W GEL — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

150. 4 CHLORODEHYDROMETHYLTESTOSTERONE TABLET USP 10 MG

1. Medicine / Product Name

4 CHLORODEHYDROMETHYLTESTOSTERONE TABLET USP 10 MG

2. Generic / API / Composition

4 CHLORODEHYDROMETHYLTESTOSTERONE TABLET USP 10 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination. Sterile/injectable or biologic quality, storage and manufacturing controls may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

151. VORTIOXETINE HYDROBROMIDE TABLETS 10 MG

1. Medicine / Product Name

VORTIOXETINE HYDROBROMIDE TABLETS 10 MG

2. Generic / API / Composition

VORTIOXETINE HYDROBROMIDE  10 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Pharmaceutical medicine

5. Pharmacological / Drug Class

Product-specific pharmacological class — verify against approved label.

6. Main Uses / Indications

Use/indication is formulation- and jurisdiction-specific; verify the approved label.

7. Mechanism / Basic Description

Pharmacology should be stated from the approved product label/official monograph.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

152. AYURVEDIC PROPRIETARY MEDICINE CAPSULE

1. Medicine / Product Name

AYURVEDIC PROPRIETARY MEDICINE CAPSULE

2. Generic / API / Composition

AYURVEDIC PROPRIETARY MEDICINE CAPSULE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Ayurvedic proprietary medicine

5. Pharmacological / Drug Class

Formula-specific Ayurvedic proprietary product

6. Main Uses / Indications

Cannot be determined from the source name alone.

7. Mechanism / Basic Description

Cannot be determined without complete ingredient/formula details.

8. Dosage Form & Route

Cannot be determined from source alone.

9. Prescription / OTC Status

Depends on formulation and jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Complete composition, licence category, claims and regulatory status must be established before export.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Do not market as a conventional pharmaceutical until classification and composition are verified.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

153. AMBRISENTAN TABLETS IP 5 MG

1. Medicine / Product Name

AMBRISENTAN TABLETS IP 5 MG

2. Generic / API / Composition

AMBRISENTAN  IP 5 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Pharmaceutical medicine

5. Pharmacological / Drug Class

Product-specific pharmacological class — verify against approved label.

6. Main Uses / Indications

Use/indication is formulation- and jurisdiction-specific; verify the approved label.

7. Mechanism / Basic Description

Pharmacology should be stated from the approved product label/official monograph.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

154. OXANDROLONE TABLETS USP 10 MG

1. Medicine / Product Name

OXANDROLONE TABLETS USP 10 MG

2. Generic / API / Composition

OXANDROLONE  USP 10 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Androgen / anabolic-hormonal medicine

5. Pharmacological / Drug Class

Androgenic/anabolic steroid or testosterone preparation

6. Main Uses / Indications

Hormone-replacement or other approved indication depends on the specific substance and formulation.

7. Mechanism / Basic Description

Acts through androgen receptors; exact pharmacology varies by compound.

8. Dosage Form & Route

Oral, topical or injectable depending on formulation.

9. Prescription / OTC Status

Prescription; often subject to additional controlled-substance/hormone rules.

10. Major Warnings / Contraindications / Key Interactions

Hormonal adverse effects, cardiovascular/thrombotic risks, hepatic risks for some oral agents, reproductive effects and local controlled-drug rules require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory verification; some jurisdictions impose controlled-substance or special import restrictions. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

155. FINASTERIDE TABLETS IP 1 MG

1. Medicine / Product Name

FINASTERIDE TABLETS IP 1 MG

2. Generic / API / Composition

FINASTERIDE  IP 1 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Urological / dermatological medicine

5. Pharmacological / Drug Class

5-alpha-reductase inhibitor

6. Main Uses / Indications

Approved indications include benign prostatic hyperplasia and/or androgenetic alopecia depending on strength/formulation.

7. Mechanism / Basic Description

Reduces conversion of testosterone to dihydrotestosterone.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

156. SIDENAFIL AND DEPOXETINE TABLETS

1. Medicine / Product Name

SIDENAFIL AND DEPOXETINE TABLETS

2. Generic / API / Composition

SIDENAFIL AND DEPOXETINE — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Genitourinary / erectile-dysfunction medicine

5. Pharmacological / Drug Class

PDE-5 inhibitor

6. Main Uses / Indications

Treatment of erectile dysfunction; exact indications vary by product and market.

7. Mechanism / Basic Description

Inhibits PDE-5, increasing cGMP-mediated smooth-muscle relaxation.

8. Dosage Form & Route

Oral; exact formulation (tablet/jelly/etc.) must be verified.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Nitrates/riociguat and cardiovascular conditions require particular attention; formulation and local labeling must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

157. SIDENAFIL TABLETS BP

1. Medicine / Product Name

SIDENAFIL TABLETS BP

2. Generic / API / Composition

SIDENAFIL  BP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Genitourinary / erectile-dysfunction medicine

5. Pharmacological / Drug Class

PDE-5 inhibitor

6. Main Uses / Indications

Treatment of erectile dysfunction; exact indications vary by product and market.

7. Mechanism / Basic Description

Inhibits PDE-5, increasing cGMP-mediated smooth-muscle relaxation.

8. Dosage Form & Route

Oral; exact formulation (tablet/jelly/etc.) must be verified.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Nitrates/riociguat and cardiovascular conditions require particular attention; formulation and local labeling must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

158. TADALAFIL AND DAPOXETINE TABLETS USP

1. Medicine / Product Name

TADALAFIL AND DAPOXETINE TABLETS USP

2. Generic / API / Composition

TADALAFIL AND DAPOXETINE  USP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Genitourinary / erectile-dysfunction medicine

5. Pharmacological / Drug Class

PDE-5 inhibitor

6. Main Uses / Indications

Treatment of erectile dysfunction; exact indications vary by product and market.

7. Mechanism / Basic Description

Inhibits PDE-5, increasing cGMP-mediated smooth-muscle relaxation.

8. Dosage Form & Route

Oral; exact formulation (tablet/jelly/etc.) must be verified.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Nitrates/riociguat and cardiovascular conditions require particular attention; formulation and local labeling must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

159. TADALAFIL TABLETS USP

1. Medicine / Product Name

TADALAFIL TABLETS USP

2. Generic / API / Composition

TADALAFIL  USP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Genitourinary / erectile-dysfunction medicine

5. Pharmacological / Drug Class

PDE-5 inhibitor

6. Main Uses / Indications

Treatment of erectile dysfunction; exact indications vary by product and market.

7. Mechanism / Basic Description

Inhibits PDE-5, increasing cGMP-mediated smooth-muscle relaxation.

8. Dosage Form & Route

Oral; exact formulation (tablet/jelly/etc.) must be verified.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Nitrates/riociguat and cardiovascular conditions require particular attention; formulation and local labeling must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

160. ARMODAFINIL TABLETS 250 MG

1. Medicine / Product Name

ARMODAFINIL TABLETS 250 MG

2. Generic / API / Composition

ARMODAFINIL  250 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

CNS / neurological / psychiatric medicine

5. Pharmacological / Drug Class

Central nervous system active medicine

6. Main Uses / Indications

Indication depends on the active ingredient; verify approved indication.

7. Mechanism / Basic Description

CNS mechanism is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Prescription; controlled/psychotropic status must be checked country by country.

10. Major Warnings / Contraindications / Key Interactions

CNS effects, interactions, dependence/misuse potential where applicable and local controlled-drug status require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority destination-country classification check. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

161. MODAFINIL TABLETS I.P

1. Medicine / Product Name

MODAFINIL TABLETS I.P

2. Generic / API / Composition

MODAFINIL  I.P — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

CNS / neurological / psychiatric medicine

5. Pharmacological / Drug Class

Central nervous system active medicine

6. Main Uses / Indications

Indication depends on the active ingredient; verify approved indication.

7. Mechanism / Basic Description

CNS mechanism is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Prescription; controlled/psychotropic status must be checked country by country.

10. Major Warnings / Contraindications / Key Interactions

CNS effects, interactions, dependence/misuse potential where applicable and local controlled-drug status require review.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority destination-country classification check. Controlled/psychotropic/hormonal classification must be checked separately in each destination.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

162. MELOXICAM TABLETS BP 15 MG

1. Medicine / Product Name

MELOXICAM TABLETS BP 15 MG

2. Generic / API / Composition

MELOXICAM  BP 15 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Analgesic / gastrointestinal medicine

5. Pharmacological / Drug Class

Ingredient-specific analgesic or GI agent

6. Main Uses / Indications

Pain/inflammation or gastrointestinal indication according to ingredient.

7. Mechanism / Basic Description

Ingredient-specific mechanism.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

163. SORAFENIB TABLETS IP 200 MG

1. Medicine / Product Name

SORAFENIB TABLETS IP 200 MG

2. Generic / API / Composition

SORAFENIB  IP 200 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Oncology medicine

5. Pharmacological / Drug Class

Targeted anticancer kinase inhibitor

6. Main Uses / Indications

Cancer treatment according to approved indication.

7. Mechanism / Basic Description

Inhibits specified protein kinases involved in tumor growth/angiogenesis.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Serious adverse effects and interactions; oncology registration and pharmacovigilance requirements apply.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

High-priority regulatory review; oncology product dossier requirements.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

164. MELATONIN MOUTH DISSOLVING TABLETS

1. Medicine / Product Name

MELATONIN MOUTH DISSOLVING TABLETS

2. Generic / API / Composition

MELATONIN MOUTH DISSOLVING — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Sleep/circadian medicine

5. Pharmacological / Drug Class

Melatonin receptor agonist/hormone

6. Main Uses / Indications

Sleep/circadian indications vary substantially by jurisdiction.

7. Mechanism / Basic Description

Acts at melatonin receptors involved in circadian regulation.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

OTC, supplement or prescription status varies by country and dose.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

165. TAMOXIFEN TABLETS IP 20 MG

1. Medicine / Product Name

TAMOXIFEN TABLETS IP 20 MG

2. Generic / API / Composition

TAMOXIFEN  IP 20 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Hormonal / endocrine medicine

5. Pharmacological / Drug Class

Hormonal pathway modulator

6. Main Uses / Indications

Endocrine or oncology/fertility indication depending on ingredient.

7. Mechanism / Basic Description

Ingredient-specific estrogen-receptor or aromatase pathway modulation.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Hormonal/oncology regulatory review may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

166. EXEMESTANE TABLETS USP 25 MG

1. Medicine / Product Name

EXEMESTANE TABLETS USP 25 MG

2. Generic / API / Composition

EXEMESTANE  USP 25 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Hormonal / endocrine medicine

5. Pharmacological / Drug Class

Hormonal pathway modulator

6. Main Uses / Indications

Endocrine or oncology/fertility indication depending on ingredient.

7. Mechanism / Basic Description

Ingredient-specific estrogen-receptor or aromatase pathway modulation.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Hormonal/oncology regulatory review may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

167. CYANOCOBALAMIN INJECTION USP

1. Medicine / Product Name

CYANOCOBALAMIN INJECTION USP

2. Generic / API / Composition

CYANOCOBALAMIN  USP — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Nutritional / metabolic supportive product

5. Pharmacological / Drug Class

Vitamin, amino-acid derivative or antioxidant — ingredient-specific

6. Main Uses / Indications

Indication varies by ingredient and approved formulation.

7. Mechanism / Basic Description

Biochemical role is ingredient-specific.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

168. TRETINOIN GEL USP 0.025 % W/W

1. Medicine / Product Name

TRETINOIN GEL USP 0.025 % W/W

2. Generic / API / Composition

TRETINOIN GEL USP 0.025 % W/W — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

169. DUTASTERIDE CAPSULES IP 0.5 MG

1. Medicine / Product Name

DUTASTERIDE CAPSULES IP 0.5 MG

2. Generic / API / Composition

DUTASTERIDE  IP 0.5 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Urological / dermatological medicine

5. Pharmacological / Drug Class

5-alpha-reductase inhibitor

6. Main Uses / Indications

Approved indications include benign prostatic hyperplasia and/or androgenetic alopecia depending on strength/formulation.

7. Mechanism / Basic Description

Reduces conversion of testosterone to dihydrotestosterone.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

170. SODIUM HYALURONATE AND VITAMIN C

1. Medicine / Product Name

SODIUM HYALURONATE AND VITAMIN C

2. Generic / API / Composition

SODIUM HYALURONATE AND VITAMIN C — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Ophthalmic / supportive formulation

5. Pharmacological / Drug Class

Hyaluronic-acid derivative formulation

6. Main Uses / Indications

Product-specific ocular or supportive use.

7. Mechanism / Basic Description

Provides viscoelastic/lubricating effect depending on formulation.

8. Dosage Form & Route

Formulation-specific.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

171. MINOXIDIL TABLETS IP 5 MG

1. Medicine / Product Name

MINOXIDIL TABLETS IP 5 MG

2. Generic / API / Composition

MINOXIDIL  IP 5 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

172. MINOXIDIL TABLETS IP 10 MG

1. Medicine / Product Name

MINOXIDIL TABLETS IP 10 MG

2. Generic / API / Composition

MINOXIDIL  IP 10 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

173. FINASTERIDE AND MINOXIDIL TABLETS

1. Medicine / Product Name

FINASTERIDE AND MINOXIDIL TABLETS

2. Generic / API / Composition

FINASTERIDE AND MINOXIDIL — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

174. DUTASTERIDE AND MINOXIDIL TABLETS

1. Medicine / Product Name

DUTASTERIDE AND MINOXIDIL TABLETS

2. Generic / API / Composition

DUTASTERIDE AND MINOXIDIL — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Dermatology / topical or hormonal medicine

5. Pharmacological / Drug Class

Ingredient-specific dermatologic/hormonal agent

6. Main Uses / Indications

Dermatologic or hormonal indication according to the exact formulation.

7. Mechanism / Basic Description

Ingredient-specific; use approved product labeling.

8. Dosage Form & Route

Topical or oral depending on formulation.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Pregnancy/reproductive warnings, systemic absorption, skin reactions and formulation-specific restrictions must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

175. CLOMIPHENE CITRATE TABLETS IP 25 MG

1. Medicine / Product Name

CLOMIPHENE CITRATE TABLETS IP 25 MG

2. Generic / API / Composition

CLOMIPHENE CITRATE  IP 25 MG — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Hormonal / endocrine medicine

5. Pharmacological / Drug Class

Hormonal pathway modulator

6. Main Uses / Indications

Endocrine or oncology/fertility indication depending on ingredient.

7. Mechanism / Basic Description

Ingredient-specific estrogen-receptor or aromatase pathway modulation.

8. Dosage Form & Route

Route/formulation: verify from the exact product specification.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Check official label for contraindications, interactions, pregnancy warnings, organ-function precautions and formulation-specific risks.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Hormonal/oncology regulatory review may apply.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

176. SILDENAFIL SITRAT TABLETLERI

1. Medicine / Product Name

SILDENAFIL SITRAT TABLETLERI

2. Generic / API / Composition

SILDENAFIL SITRAT TABLETLERI — exact composition/API to be confirmed from manufacturer specification.

3. Salt / Strength

Strength/salt as stated in the source where available; otherwise verify the exact product specification.

4. Therapeutic Category

Genitourinary / erectile-dysfunction medicine

5. Pharmacological / Drug Class

PDE-5 inhibitor

6. Main Uses / Indications

Treatment of erectile dysfunction; exact indications vary by product and market.

7. Mechanism / Basic Description

Inhibits PDE-5, increasing cGMP-mediated smooth-muscle relaxation.

8. Dosage Form & Route

Oral; exact formulation (tablet/jelly/etc.) must be verified.

9. Prescription / OTC Status

Generally prescription/regulated medicine; exact status varies by jurisdiction.

10. Major Warnings / Contraindications / Key Interactions

Nitrates/riociguat and cardiovascular conditions require particular attention; formulation and local labeling must be checked.

11. India Export Considerations

Verify Indian manufacturing licence/product permission, GMP status, formulation authorization, exporter eligibility, labeling and destination-specific export documentation.

12. HS Code / Customs Classification — TO BE VERIFIED

Do not assign a final HS/ITC-HS code from the medicine name alone. Confirm with the exact dosage form, packing and Indian customs classification.

13. 26-Country Regulatory Status

Preliminary screen: 🟡 registration/authorization generally required in all 26 markets. Upgrade to 🟠/🔴/⚫ where the ingredient, formulation or destination law imposes special controls; exact status must be verified.

14. Country Regulatory Authority

See the 26-country matrix at the beginning of this document; the responsible authority varies by destination.

15. Registration / Marketing Authorization Requirements

Typically product dossier/quality data, manufacturing information, stability, labeling, local applicant/importer authorization and any country-specific clinical/bioequivalence or GMP evidence required.

16. Export Requirements & Special Restrictions

Product-specific regulatory review required before export.

17. Buyer Type

Licensed pharmaceutical importer/distributor/wholesaler; hospitals or institutional buyers where appropriate. Veterinary products require appropriately licensed animal-health buyers.

18. Required Export / Regulatory Documentation

Commercial invoice; packing list; transport documents; certificate of origin where required; COA; GMP/manufacturing documents; product registration/authorization documents; import permit or controlled-drug permit where applicable.

19. Commercial Considerations

Confirm MOQ, pack size, shelf life, lead time, private-label/OEM availability, registration ownership, Incoterm, freight, insurance, payment terms and landed cost before quotation.

20. Exporter Decision / Verification Checklist

☐ Exact product/formulation confirmed  ☐ Manufacturer verified  ☐ GMP verified  ☐ Indian authorization verified  ☐ Destination registration checked  ☐ Importer licence checked  ☐ Controlled/special status checked  ☐ COA/stability documents checked  ☐ HS code verified  ☐ Buyer verified

 

 

  1. Top Pharma Export Products from India | Manufacturers & Buyers
  2. Pharma Products Export from India | Suppliers, Manufacturers & Buyers
  3. Indian Pharma Export Products | Manufacturers, Sellers & Global Buyers
  4. Top Pharmaceutical Export Products from India | Buyers & Suppliers
  5. Pharma Export Business from India | Products, Manufacturers & Buyers

Discover top pharma export products from India, pharmaceutical manufacturers, sellers, suppliers and international medicine buyers. Explore products, sourcing and export opportunities.

  • pharma export products from India
  • pharmaceutical export products
  • pharma products export
  • India pharma exporters
  • pharmaceutical manufacturers in India
  • pharma manufacturers India
  • pharmaceutical companies India
  • medicine manufacturers India
  • pharma suppliers India
  • pharmaceutical sellers India
  • medicine buyers
  • pharma buyers
  • pharmaceutical buyers
  • medicine importers
  • pharma importers
  • pharmaceutical distributors
  • Indian pharmaceutical products
  • medicine export from India
  • pharmaceutical export from India
  • pharma export business
  • top pharma export products from India
  • pharmaceutical products exported from India
  • top pharmaceutical manufacturers in India
  • Indian pharmaceutical manufacturers and suppliers
  • medicine exporters and buyers from India
  • pharmaceutical companies for export from India
  • pharma medicine buyers worldwide
  • pharmaceutical importers looking for Indian suppliers
  • Indian medicine manufacturers for export
  • wholesale pharmaceutical products from India
  • pharmaceutical products suppliers in India
  • pharma export companies in India
  • medicines available for export from India
  • pharmaceutical distributors and buyers
  • private label pharma manufacturers India

Pharma Export from India — Complete Terminology & Abbreviations

A. Pharmaceutical & Regulatory Basics

No.TermFull Form / Meaning
1APIActive Pharmaceutical Ingredient
2ANDAAbbreviated New Drug Application
3BLABiologics License Application
4CAPACorrective and Preventive Action
5CDSCOCentral Drugs Standard Control Organisation
6COACertificate of Analysis
7COPPCertificate of Pharmaceutical Product
8CPPCertificate of Pharmaceutical Product
9DMFDrug Master File
10DGFTDirectorate General of Foreign Trade
11FDAFood and Drug Administration
12GMPGood Manufacturing Practice
13IECImporter Exporter Code
14INDInvestigational New Drug
15MHRAMedicines and Healthcare products Regulatory Agency
16MOQMinimum Order Quantity
17NDANew Drug Application
18NDCNational Drug Code
19OEMOriginal Equipment Manufacturer
20PMDAPharmaceuticals and Medical Devices Agency
21QAQuality Assurance
22QCQuality Control
23SAHPRASouth African Health Products Regulatory Authority
24TGATherapeutic Goods Administration
25WDAWholesale Distribution Authorisation

Important: COPP and CPP are often used interchangeably in pharmaceutical export discussions, but the exact terminology/document requirements can depend on the issuing authority and destination market.


B. Indian Pharmaceutical Regulatory Terms

No.TermFull Form / Meaning
26CDSCOCentral Drugs Standard Control Organisation
27DCGIDrugs Controller General of India
28CLACentral Licensing Authority
29SDCState Drug Controller
30D&C ActDrugs and Cosmetics Act
31D&C RulesDrugs and Cosmetics Rules
32NDCT ActNew Drugs and Clinical Trials Act
33NDCT RulesNew Drugs and Clinical Trials Rules
34FSSAIFood Safety and Standards Authority of India
35AYUSHAyurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy
36IPCIndian Pharmacopoeia Commission
37IPIndian Pharmacopoeia
38Schedule MGMP requirements under Indian drug regulations
39Schedule HPrescription medicines category
40Schedule H1Prescription medicines subject to additional controls
41Schedule XSpecified controlled prescription drugs
42Form 20Drug manufacturing licence category
43Form 21Drug manufacturing licence category
44Form 25Manufacturing licence
45Form 28Licence for manufacture of specified categories
46Form 29Licence for manufacture/testing of drugs for examination/test/analysis
47Form 41Registration Certificate
48Form 40Application for Registration Certificate
49Form 10Import licence
50Form 10AImport licence-related application
51SUGAMCDSCO online regulatory portal
52CTClinical Trial
53BA/BEBioavailability/Bioequivalence
54BEBioequivalence
55BABioavailability

C. Export & Foreign Trade Terms — India

No.TermFull Form / Meaning
56IECImporter Exporter Code
57DGFTDirectorate General of Foreign Trade
58FTPForeign Trade Policy
59ITC-HSIndian Trade Classification – Harmonized System
60HS CodeHarmonized System Code
61HSNHarmonized System of Nomenclature
62AD CodeAuthorised Dealer Code
63ICEGATEIndian Customs Electronic Gateway
64EDIElectronic Data Interchange
65GSTGoods and Services Tax
66GSTINGoods and Services Tax Identification Number
67LUTLetter of Undertaking
68RCMCRegistration-Cum-Membership Certificate
69EPCExport Promotion Council
70PHARMEXCILPharmaceuticals Export Promotion Council of India
71RBIReserve Bank of India
72FEMAForeign Exchange Management Act
73EDFExport Declaration Form
74SOFTEXSoftware Export Declaration Form
75BRCBank Realisation Certificate
76e-BRCElectronic Bank Realisation Certificate
77GRNGoods Receipt Note
78SBShipping Bill
79LEOLet Export Order
80Let Export OrderCustoms clearance permission for export
81LUTLetter of Undertaking
82ARNApplication Reference Number
83DSCDigital Signature Certificate
84PANPermanent Account Number
85TANTax Deduction and Collection Account Number

Note: EDF/SOFTEX terminology should not be automatically treated as interchangeable for pharmaceutical goods exports; the applicable RBI/customs documentation depends on the transaction and export structure.


D. Pharmaceutical Manufacturing Terms

No.TermMeaning
86APIActive Pharmaceutical Ingredient
87ExcipientInactive ingredient used in formulation
88FDFFinished Dosage Form
89FPPFinished Pharmaceutical Product
90DMFDrug Master File
91ASMFActive Substance Master File
92CEPCertificate of Suitability
93CTDCommon Technical Document
94eCTDElectronic Common Technical Document
95MAAMarketing Authorisation Application
96MAMarketing Authorisation
97SmPCSummary of Product Characteristics
98PILPatient Information Leaflet
99SPCSummary of Product Characteristics
100INNInternational Nonproprietary Name
101GenericNon-originator medicine marketed under generic name
102Branded GenericGeneric medicine sold under a brand name
103InnovatorOriginal/reference product developer
104Reference ProductComparator/originator product used for regulatory purposes
105BiosimilarBiological medicine highly similar to a reference biological product
106BiologicMedicine produced from biological sources
107VaccineBiological preparation providing immunity
108Sterile ProductProduct manufactured to meet sterility requirements
109OSDOral Solid Dosage
110ODTOrally Disintegrating Tablet
111ERExtended Release
112SRSustained Release
113CRControlled Release
114MRModified Release
115IRImmediate Release
116DRDelayed Release
117XRExtended Release

E. Quality Assurance & Quality Control

No.TermFull Form / Meaning
118QAQuality Assurance
119QCQuality Control
120GMPGood Manufacturing Practice
121cGMPCurrent Good Manufacturing Practice
122GLPGood Laboratory Practice
123GCPGood Clinical Practice
124GDPGood Distribution Practice
125GSPGood Storage Practice
126GVPGood Pharmacovigilance Practice
127SOPStandard Operating Procedure
128CAPACorrective and Preventive Action
129OOSOut of Specification
130OOTOut of Trend
131DeviationDeparture from an approved procedure/specification
132Change ControlFormal process for controlling changes
133QMSQuality Management System
134TQMTotal Quality Management
135IPQCIn-Process Quality Control
136IPCIn-Process Control
137COACertificate of Analysis
138COCCertificate of Conformity
139COTCertificate of Testing
140AQLAcceptable Quality Limit
141RMRaw Material
142PMPackaging Material
143BMRBatch Manufacturing Record
144BPRBatch Packaging Record
145MFRMaster Formula Record
146MBRMaster Batch Record
147SOPStandard Operating Procedure
148ValidationDocumented evidence that a process consistently works
149Process ValidationValidation of manufacturing process
150Cleaning ValidationEvidence that cleaning procedures are effective
151Analytical Method ValidationValidation of laboratory testing methods

F. Regulatory Authorities — Major Export Markets

No.AbbreviationAuthority
152FDAU.S. Food and Drug Administration
153CDERCenter for Drug Evaluation and Research
154CBERCenter for Biologics Evaluation and Research
155DEADrug Enforcement Administration
156MHRAMedicines and Healthcare products Regulatory Agency — UK
157EMAEuropean Medicines Agency
158ECEuropean Commission
159BfArMFederal Institute for Drugs and Medical Devices — Germany
160ANSMFrench National Agency for Medicines Safety
161AIFAItalian Medicines Agency
162AEMPSSpanish Agency of Medicines and Medical Devices
163MEBMedicines Evaluation Board — Netherlands
164PMDAPharmaceuticals and Medical Devices Agency — Japan
165MHLWMinistry of Health, Labour and Welfare — Japan
166TGATherapeutic Goods Administration — Australia
167Health CanadaCanadian federal health regulator
168ANVISABrazilian Health Regulatory Agency
169SAHPRASouth African Health Products Regulatory Authority
170NAFDACNational Agency for Food and Drug Administration and Control — Nigeria
171PPBPharmacy and Poisons Board — Kenya
172TMDATanzania Medicines and Medical Devices Authority
173NDANational Drug Authority — Uganda
174FDA GhanaFood and Drugs Authority — Ghana
175EDAEgyptian Drug Authority
176TİTCKTurkish Medicines and Medical Devices Agency
177MOHMinistry of Health
178SFDASaudi Food and Drug Authority
179MOHAPMinistry of Health and Prevention — UAE
180EDEEmirates Drug Establishment
181MOHMinistry of Health
182DGDADirectorate General of Drug Administration — Bangladesh
183BPOMIndonesia Food and Drug Authority
184NPRANational Pharmaceutical Regulatory Agency — Malaysia
185FDA PhilippinesPhilippine Food and Drug Administration
186DAVDrug Administration of Vietnam
187MHLWMinistry of Health, Labour and Welfare — Japan
188MedsafeNew Zealand medicines regulator

G. United States — FDA Terminology

No.TermMeaning
189FDAFood and Drug Administration
190ANDAAbbreviated New Drug Application
191NDANew Drug Application
192BLABiologics License Application
193INDInvestigational New Drug
194DMFDrug Master File
195NDCNational Drug Code
196Orange BookApproved Drug Products with Therapeutic Equivalence Evaluations
197Purple BookLicensed Biological Products database
198GDUFAGeneric Drug User Fee Amendments
199PDUFAPrescription Drug User Fee Act
200REMSRisk Evaluation and Mitigation Strategy
201cGMPCurrent Good Manufacturing Practice
202US AgentU.S.-based representative for applicable foreign establishments
203FEIFDA Establishment Identifier
204NDA HolderHolder of New Drug Application
205ANDA HolderHolder of Abbreviated New Drug Application
206RLDReference Listed Drug
207RSReference Standard
208TE CodeTherapeutic Equivalence Code
209OTCOver-the-Counter
210RxPrescription
211OTC MonographFDA-established requirements for certain OTC medicines

H. UK / Europe Terminology

No.TermMeaning
212MHRAMedicines and Healthcare products Regulatory Agency
213EMAEuropean Medicines Agency
214EUEuropean Union
215EEAEuropean Economic Area
216EudraGMDPEU database for manufacturing/distribution authorisations and GMP certificates
217MAMarketing Authorisation
218MAAMarketing Authorisation Application
219MRPMutual Recognition Procedure
220DCPDecentralised Procedure
221CAPCentrally Authorised Product
222NAPNationally Authorised Product
223SmPCSummary of Product Characteristics
224PILPatient Information Leaflet
225QPQualified Person
226QP DeclarationQualified Person declaration
227WDA(H)Wholesale Distribution Authorisation for Human medicines
228POMPrescription Only Medicine
229GSLGeneral Sales List
230PPharmacy medicine
231GDPGood Distribution Practice
232PVPharmacovigilance
233PSURPeriodic Safety Update Report
234PBRERPeriodic Benefit-Risk Evaluation Report
235RMPRisk Management Plan
236DSURDevelopment Safety Update Report

I. Clinical & Regulatory Development

No.TermMeaning
237INDInvestigational New Drug
238NDANew Drug Application
239ANDAAbbreviated New Drug Application
240BLABiologics License Application
241CTAClinical Trial Application
242CTClinical Trial
243Phase IFirst-in-human clinical development
244Phase IIDose/efficacy-focused clinical development
245Phase IIILarge confirmatory clinical trials
246Phase IVPost-marketing studies
247CROContract Research Organization
248BABioavailability
249BEBioequivalence
250BA/BEBioavailability/Bioequivalence
251PKPharmacokinetics
252PDPharmacodynamics
253RCTRandomized Controlled Trial
254SAESerious Adverse Event
255AEAdverse Event
256ADRAdverse Drug Reaction
257SUSARSuspected Unexpected Serious Adverse Reaction
258ICHInternational Council for Harmonisation
259GCPGood Clinical Practice
260IRBInstitutional Review Board
261IECIndependent Ethics Committee
262EDCElectronic Data Capture

J. Pharmaceutical Regulatory Documents

No.TermMeaning
263CPPCertificate of Pharmaceutical Product
264COPPCertificate of Pharmaceutical Product
265COACertificate of Analysis
266COCCertificate of Conformity
267GMP CertificateEvidence of GMP compliance
268FSCFree Sale Certificate
269PIC/SPharmaceutical Inspection Co-operation Scheme
270CEPCertificate of Suitability
271DMFDrug Master File
272ASMFActive Substance Master File
273LOALetter of Authorization
274POAPower of Attorney
275MAMarketing Authorisation
276PILPatient Information Leaflet
277SmPCSummary of Product Characteristics
278SPCSummary of Product Characteristics
279CTDCommon Technical Document
280eCTDElectronic Common Technical Document
281ACTDASEAN Common Technical Dossier
282Site Master FileDetailed information about manufacturing site
283Product DossierTechnical/regulatory information about product
284Stability DataEvidence of product stability over time
285Validation ReportDocumented validation results
286Batch Release CertificateDocumentation confirming batch release

K. Pharmaceutical Distribution & Supply Chain

No.TermMeaning
287GDPGood Distribution Practice
288GSPGood Storage Practice
2893PLThird-Party Logistics
2904PLFourth-Party Logistics
291Cold ChainTemperature-controlled supply chain
292Temperature MappingStudy of temperature distribution
293Data LoggerDevice recording environmental conditions
294FEFOFirst Expiry, First Out
295FIFOFirst In, First Out
296BatchDefined quantity manufactured under uniform conditions
297LotIdentified production quantity
298Batch NumberUnique manufacturing batch identifier
299Expiry DateDate beyond which product should not be used
300Shelf LifePeriod during which product remains within specifications
301Retest DateDate after which API/material may require retesting
302SerializationUnique identification of individual saleable units
303Track & TraceTracking products through supply chain
304Tamper EvidencePackaging feature showing unauthorized opening

L. International Trade & Incoterms

No.TermMeaning
305EXWEx Works
306FCAFree Carrier
307FOBFree On Board
308CFRCost and Freight
309CIFCost, Insurance and Freight
310CPTCarriage Paid To
311CIPCarriage and Insurance Paid To
312DAPDelivered at Place
313DPUDelivered at Place Unloaded
314DDPDelivered Duty Paid
315IncotermsInternational Commercial Terms
316Proforma InvoicePreliminary commercial invoice
317Commercial InvoiceFinal invoice for commercial transaction
318Packing ListDetailed shipment packing information
319Purchase OrderBuyer-issued order
320PIProforma Invoice
321POPurchase Order
322BL/BOLBill of Lading
323AWBAir Waybill
324COOCertificate of Origin
325LCLetter of Credit
326TTTelegraphic Transfer
327CADCash Against Documents
328DPDocuments Against Payment
329DADocuments Against Acceptance
330Open AccountCredit-based trade arrangement

M. Shipping & Customs

No.TermMeaning
331HS CodeHarmonized System Code
332HSNHarmonized System of Nomenclature
333Customs DutyGovernment duty imposed on imported goods
334Import DutyDuty charged by importing country
335Export DutyDuty applicable to certain exports
336FOBFree On Board
337CIFCost, Insurance and Freight
338FreightTransportation cost
339DemurrageCharges for delay beyond allowed period
340DetentionCharges for retaining carrier equipment beyond free time
341CHACustoms House Agent
342Customs BrokerLicensed customs clearance intermediary
343Shipping BillExport customs declaration
344Bill of EntryImport customs declaration
345LEOLet Export Order
346IGMImport General Manifest
347EGMExport General Manifest
348Port of LoadingPort where goods are loaded
349Port of DischargePort where goods are unloaded
350ETAEstimated Time of Arrival
351ETDEstimated Time of Departure
352FCLFull Container Load
353LCLLess than Container Load
354ULDUnit Load Device
355DGDangerous Goods
356IATAInternational Air Transport Association
357IMOInternational Maritime Organization

N. Commercial / Buyer / Supplier Terminology

No.TermMeaning
358MOQMinimum Order Quantity
359OEMOriginal Equipment Manufacturer
360ODMOriginal Design Manufacturer
361Private LabelProduct manufactured for another company’s brand
362Contract ManufacturingManufacturing under agreement for another company
363CMOContract Manufacturing Organization
364CDMOContract Development and Manufacturing Organization
365API SupplierSupplier of active pharmaceutical ingredients
366FDF ManufacturerFinished dosage form manufacturer
367ExporterEntity exporting goods
368ImporterEntity importing goods
369DistributorEntity distributing products
370WholesalerBulk commercial seller
371StockistEntity holding inventory for distribution
372AgentRepresentative acting for another party
373PrincipalCompany represented by an agent/distributor
374TenderCompetitive procurement process
375RFQRequest for Quotation
376RFPRequest for Proposal
377RFQ ResponseSupplier’s quotation response
378NDANon-Disclosure Agreement
379MOUMemorandum of Understanding
380SLAService Level Agreement
381TerritoryGeographic market assigned to distributor
382ExclusivityContractual exclusive distribution/manufacturing rights

O. Pricing & Financial Terms

No.TermMeaning
383FOB PricePrice up to loading point under FOB terms
384CIF PriceCost + Insurance + Freight
385EXW PriceEx-works price
386Landed CostTotal cost after delivery/import-related costs
387COGSCost of Goods Sold
388GMGross Margin
389GPGross Profit
390ROIReturn on Investment
391LCLetter of Credit
392TTTelegraphic Transfer
393Advance PaymentPayment made before shipment
394Credit TermsAgreed payment period
395Payment TermsConditions under which buyer pays seller
396Currency RiskRisk from exchange-rate movements
397FXForeign Exchange
398Bank ChargesBanking costs associated with transaction
399InsuranceShipment/product insurance coverage
400Credit RiskRisk that buyer fails to pay

P. Pharmacovigilance & Post-Marketing

No.TermMeaning
401PVPharmacovigilance
402AEAdverse Event
403ADRAdverse Drug Reaction
404SAESerious Adverse Event
405SUSARSuspected Unexpected Serious Adverse Reaction
406PSURPeriodic Safety Update Report
407PBRERPeriodic Benefit-Risk Evaluation Report
408RMPRisk Management Plan
409Signal DetectionIdentification of potential safety signals
410Safety SignalInformation suggesting a new safety concern
411Post-Marketing SurveillanceMonitoring medicine after market launch
412RecallRemoval of product from market
413Product ComplaintCustomer complaint regarding product
414Medical InformationScientific/medical information service
415Adverse Event ReportingReporting suspected adverse events

Q. Pharmaceutical Packaging & Labelling

No.TermMeaning
416Primary PackagingPackaging directly contacting product
417Secondary PackagingOuter packaging containing primary pack
418Tertiary PackagingTransport/shipping packaging
419Label ClaimInformation stated on product label
420Batch No.Manufacturing batch identifier
421MFG DateManufacturing date
422EXP DateExpiry date
423MRPMaximum Retail Price
424GTINGlobal Trade Item Number
425UDIUnique Device Identification
426BarcodeMachine-readable product identification
427Serialization CodeUnique product-level identifier
428PILPatient Information Leaflet
429ArtworkApproved packaging/label design
430LeafletPatient/user information document

R. Pharmacopoeia & Standards

No.TermMeaning
431IPIndian Pharmacopoeia
432USPUnited States Pharmacopeia
433BPBritish Pharmacopoeia
434EPEuropean Pharmacopoeia
435JPJapanese Pharmacopoeia
436Ph. Eur.European Pharmacopoeia
437NFNational Formulary
438WHOWorld Health Organization
439ICHInternational Council for Harmonisation
440ISOInternational Organization for Standardization
441PIC/SPharmaceutical Inspection Co-operation Scheme
442ASTMAmerican Society for Testing and Materials
443Reference StandardStandard used for analytical testing
444MonographOfficial specification for a substance/product

S. API & Raw Material Terminology

No.TermMeaning
445APIActive Pharmaceutical Ingredient
446KSMKey Starting Material
447Starting MaterialMaterial used in API manufacturing
448IntermediateMaterial formed during manufacturing process
449ExcipientInactive pharmaceutical ingredient
450DMFDrug Master File
451CEPCertificate of Suitability
452ASMFActive Substance Master File
453Retest DateDate for reassessment of material quality
454AssayMeasurement of active substance content
455PurityDegree of freedom from impurities
456ImpurityUnwanted component
457Residual SolventSolvent remaining from manufacturing
458NitrosamineClass of potentially concerning impurities
459Genotoxic ImpurityImpurity with potential genetic toxicity
460Elemental ImpurityMetallic/inorganic impurity
461SpecificationDefined quality requirements
462Analytical MethodLaboratory method used to test material/product

T. Regulatory Submission / Dossier Terms

No.TermMeaning
463CTDCommon Technical Document
464eCTDElectronic Common Technical Document
465ACTDASEAN Common Technical Dossier
466Module 1Administrative/regional information
467Module 2CTD summaries
468Module 3Quality information
469Module 4Nonclinical information
470Module 5Clinical information
471DossierComplete regulatory submission
472Regulatory SubmissionApplication submitted to regulator
473MAMarketing Authorisation
474MAAMarketing Authorisation Application
475VariationRegulatory change to an approved product
476RenewalApplication to continue authorisation
477RegistrationRegulatory approval/listing of product
478Product LicenceAuthorisation to market product
479Site RegistrationRegistration/approval of manufacturing site
480Regulatory PathwayRoute used to obtain market authorization

U. Important Business & Export Abbreviations

No.TermMeaning
481B2BBusiness to Business
482B2CBusiness to Consumer
483B2GBusiness to Government
484OEMOriginal Equipment Manufacturer
485ODMOriginal Design Manufacturer
486CMOContract Manufacturing Organization
487CDMOContract Development and Manufacturing Organization
488CROContract Research Organization
489KOLKey Opinion Leader
490CRMCustomer Relationship Management
491ERPEnterprise Resource Planning
492SKUStock Keeping Unit
493UPCUniversal Product Code
494GTINGlobal Trade Item Number
495MOQMinimum Order Quantity
496MPQMinimum Packaging Quantity
497Lead TimeTime required to fulfil an order
498RFQRequest for Quotation
499RFPRequest for Proposal
500POPurchase Order

Complete Pharmaceutical Export Terminology & Glossary

  1. INDIAN PHARMA EXPORT TERMS

No.

Term

Full Form

Detailed Meaning / Use in Pharma Export

1

DGFT

Directorate General of Foreign Trade

Indian government authority responsible for India’s foreign-trade policy, IEC issuance and various export/import procedures.

2

IEC

Importer Exporter Code

Unique code generally required for carrying out import/export activities from India.

3

ICEGATE

Indian Customs Electronic Gateway

Indian Customs’ electronic platform used for customs-related filings and services.

4

AD Code

Authorised Dealer Code

Bank-related code registered with Customs for export/import transactions through an authorised dealer bank.

5

RCMC

Registration-Cum-Membership Certificate

Certificate issued by the relevant Export Promotion Council or authority to eligible exporters.

6

PHARMEXCIL

Pharmaceuticals Export Promotion Council of India

Export promotion body supporting India’s pharmaceutical export sector.

7

GST

Goods and Services Tax

Indian indirect tax system applicable to goods/services; export supplies generally receive specific GST treatment.

8

GSTIN

Goods and Services Tax Identification Number

Identification number issued to a GST-registered business.

9

LUT

Letter of Undertaking

Undertaking used by eligible exporters for exporting without payment of IGST, subject to applicable GST rules.

10

e-BRC

Electronic Bank Realisation Certificate

Electronic evidence related to realization of export proceeds through the banking system.

11

FEMA

Foreign Exchange Management Act

Indian law governing foreign exchange transactions, including export proceeds.

12

RBI

Reserve Bank of India

India’s central bank; regulates foreign-exchange and banking aspects relevant to exports.

13

ITC-HS

Indian Trade Classification – Harmonized System

Indian classification system used for identifying goods for trade/customs purposes.

14

HS Code

Harmonized System Code

International product classification system used for customs and trade.

15

HSN

Harmonized System of Nomenclature

Product classification terminology used particularly in Indian taxation and trade.

16

AD Bank

Authorised Dealer Bank

Bank authorised to handle specified foreign-exchange transactions.

17

Shipping Bill

—

Customs declaration submitted for export of goods from India.

18

EGM

Export General Manifest

Manifest information submitted to Customs concerning exported cargo.

19

LEO

Let Export Order

Customs order permitting goods to be exported after applicable examination/clearance.

20

CHA

Customs House Agent

Common industry term for a customs intermediary; formally, customs broker.

  1. REGISTRATION & REGULATORY COMPLIANCE

No.

Term

Detailed Meaning

21

Marketing Authorisation (MA)

Regulatory authorization allowing a medicinal product to be marketed in a particular jurisdiction.

22

Marketing Authorisation Application (MAA)

Application submitted to a regulatory authority seeking marketing authorization.

23

Product Registration

Regulatory registration/approval of a pharmaceutical product in the destination market.

24

Site Registration

Registration or approval of a manufacturing/testing/distribution site where required by the destination regulator.

25

Establishment Registration

Regulatory registration of a pharmaceutical establishment or facility.

26

Foreign Manufacturer Registration

Registration of a foreign manufacturing establishment with the importing country’s regulator where applicable.

27

Import Licence

Authorization allowing an importer to import specified pharmaceutical products into a country.

28

Export Licence

Authorization required for exporting certain regulated products or controlled substances, where applicable.

29

Wholesale Licence

Authorization allowing an entity to conduct pharmaceutical wholesale activities.

30

Manufacturing Licence

Authorization permitting a company/facility to manufacture specified pharmaceutical products.

31

Controlled Drug Licence

Special authorization applicable to controlled/narcotic/psychotropic or otherwise restricted substances where required.

32

Certificate of Free Sale (CFS/FSC)

Certificate showing that a product is legally marketed or freely sold in the issuing jurisdiction, subject to the issuing authority’s rules.

33

GMP Certificate

Certificate demonstrating compliance with applicable Good Manufacturing Practice requirements.

34

CPP

Certificate of Pharmaceutical Product

35

COPP

Certificate of Pharmaceutical Product

36

CEP

Certificate of Suitability

37

DMF

Drug Master File

38

ASMF

Active Substance Master File

39

Letter of Access (LoA)

Letter of Access

40

Letter of Authorization (LoA)

Letter of Authorization

41

Regulatory Dossier

—

42

Variation

—

43

Renewal

—

44

Pharmacovigilance

PV

45

Recall

—

46

Regulatory Authority

—

47

Product Licence

—

48

Registration Certificate

—

49

Regulatory Pathway

—

50

Regulatory Submission

—

  1. EXPORT DOCUMENTATION

No.

Document / Term

Full Form

Purpose

51

IEC

Importer Exporter Code

Identifies the Indian exporter/importer.

52

DGFT

Directorate General of Foreign Trade

Authority associated with India’s foreign-trade administration.

53

RCMC

Registration-Cum-Membership Certificate

Establishes relevant export-promotion-council membership/status where applicable.

54

Commercial Invoice

—

Final commercial document showing seller, buyer, products, quantities, prices and transaction value.

55

Proforma Invoice

PI

Preliminary quotation/invoice issued before the final commercial invoice.

56

Packing List

—

Provides package-level details such as cartons, quantities, weights and dimensions.

57

Shipping Bill

SB

Customs export declaration filed for shipment from India.

58

Bill of Lading

B/L or BL

Transport document commonly used for sea freight.

59

Air Waybill

AWB

Transport document used for air cargo.

60

Certificate of Origin

COO

Certifies the origin of exported goods.

61

Certificate of Analysis

COA

Shows analytical test results and conformity of a batch/product against specifications.

62

Certificate of Pharmaceutical Product

CPP

Regulatory certificate used in pharmaceutical registration/export processes.

63

Certificate of Free Sale

CFS/FSC

Provides evidence concerning legal sale/marketing status where accepted by the destination authority.

64

Insurance Certificate

—

Evidence of insurance coverage for the shipment where insurance is arranged.

65

Purchase Order

PO

Buyer-issued document specifying products, quantities, prices/terms and other requirements.

66

Letter of Credit

LC

Bank-supported payment mechanism subject to specified documentary conditions.

67

Bank Realisation Certificate

BRC

Evidence relating to realization of export proceeds.

68

e-BRC

Electronic Bank Realisation Certificate

Electronic version/system-record associated with export proceeds realization.

69

LUT

Letter of Undertaking

GST-related undertaking used by eligible exporters in applicable circumstances.

70

GST Documents

—

GST registration/invoice/export-related documents required according to the transaction.

71

Customs Declaration

—

Declaration of goods to Customs for export/import clearance.

72

Certificate of Conformity

COC

Document certifying conformity with specified standards/requirements where applicable.

73

GMP Certificate

—

Evidence of GMP compliance.

74

Batch Release Documentation

—

Documentation demonstrating release/quality approval of a particular batch.

75

Site Master File

SMF

Detailed information describing a manufacturing site’s organization, operations, quality system and facilities.

76

Product Dossier

—

Product-specific technical and regulatory documentation.

77

Stability Data

—

Data demonstrating product quality over its proposed storage period under defined conditions.

78

Certificate of Insurance

—

Evidence of shipment insurance coverage when required.

79

Purchase Contract

—

Contract defining commercial obligations between buyer and seller.

80

Export Declaration

—

Formal declaration submitted to relevant authorities concerning an export transaction.

  1. COMMERCIAL & BUSINESS TERMS

No.

Term

Full Form / Meaning

81

MOQ

Minimum Order Quantity — smallest quantity a supplier agrees to manufacture/sell.

82

OEM

Original Equipment Manufacturer — manufacturer producing a product according to an agreed specification/brand arrangement.

83

ODM

Original Design Manufacturer — manufacturer that may design and manufacture a product for another company.

84

Private Label

Product manufactured by one company and marketed under another company’s brand.

85

Contract Manufacturing

Manufacturing performed by one company on behalf of another under contract.

86

CMO

Contract Manufacturing Organization

87

CDMO

Contract Development and Manufacturing Organization

88

Distributor

Business purchasing/selling/distributing pharmaceutical products within a market or territory.

89

Importer

Entity legally importing products into the destination country.

90

Wholesaler

Business purchasing and selling products in commercial quantities.

91

Stockist

Entity that holds pharmaceutical inventory for supply/distribution.

92

Tender

Formal competitive procurement process.

93

RFQ

Request for Quotation

94

RFP

Request for Proposal

95

FOB

Free On Board

96

CIF

Cost, Insurance and Freight

97

CFR

Cost and Freight

98

EXW

Ex Works

99

FCA

Free Carrier

100

DAP

Delivered at Place

101

DDP

Delivered Duty Paid

102

LC

Letter of Credit

103

TT

Telegraphic Transfer

104

Advance Payment

Payment received before shipment or before specified production stage.

105

Credit Terms

Agreed period/conditions under which buyer pays after invoicing or shipment.

106

Landed Cost

Total cost of product after relevant freight, insurance, duties, taxes, handling and other applicable costs.

107

Gross Margin

Revenue minus relevant cost of goods, usually expressed as a percentage or amount.

108

COGS

Cost of Goods Sold

109

ROI

Return on Investment

110

Territory

Geographic area assigned to a distributor/agent or covered by a commercial agreement.

111

Exclusivity

Contractual right restricting supply/representation to a specified party within a defined scope.

112

Lead Time

Time between order/production initiation and readiness or delivery.

113

Payment Terms

Agreed payment conditions between buyer and seller.

114

Credit Risk

Risk that a buyer does not pay according to agreed terms.

115

FX Risk

Foreign-exchange risk resulting from currency movements.

  1. QUALITY ASSURANCE & QUALITY CONTROL

No.

Term

Full Form

Detailed Meaning

116

QA

Quality Assurance

Systematic activities ensuring pharmaceutical quality is consistently achieved.

117

QC

Quality Control

Testing and controls used to determine whether materials/products meet specifications.

118

GMP

Good Manufacturing Practice

Requirements designed to ensure medicines are consistently manufactured and controlled according to quality standards.

119

cGMP

Current Good Manufacturing Practice

Term emphasizing current applicable GMP requirements, especially in U.S. regulatory usage.

120

GLP

Good Laboratory Practice

Quality system principles for certain nonclinical laboratory studies.

121

GCP

Good Clinical Practice

International ethical and scientific quality standard for clinical trials.

122

GDP

Good Distribution Practice

Standards governing appropriate distribution/storage/handling of medicinal products.

123

GSP

Good Storage Practice

Principles governing proper storage of pharmaceutical products.

124

SOP

Standard Operating Procedure

Approved written procedure describing how an activity is performed.

125

CAPA

Corrective and Preventive Action

System for correcting identified problems and preventing recurrence.

126

OOS

Out of Specification

Test/result that does not meet an approved specification.

127

OOT

Out of Trend

Result that may remain within specification but shows an unexpected trend.

128

Deviation

—

Departure from an approved procedure, process, specification or expected condition.

129

Change Control

—

Formal system for evaluating, approving and documenting proposed changes.

130

Validation

—

Documented evidence demonstrating that a process/system performs consistently as intended.

131

Cleaning Validation

—

Evidence that cleaning procedures consistently remove residues to predetermined acceptable levels.

132

Process Validation

—

Evidence that a manufacturing process consistently produces product meeting predetermined requirements.

133

BMR

Batch Manufacturing Record

Batch-specific record documenting manufacturing operations.

134

BPR

Batch Packaging Record

Batch-specific documentation covering packaging operations.

135

MFR

Master Formula Record

Approved master manufacturing instructions/formula for a product.

136

MBR

Master Batch Record

Master document describing approved batch manufacturing requirements.

137

COA

Certificate of Analysis

Batch/product analytical results against specified standards.

138

COC

Certificate of Conformity

Certificate indicating conformity to specified requirements where applicable.

139

Specification

—

Defined acceptance criteria for material/product quality.

140

Assay

—

Analytical measurement of the quantity/content of a specified substance.

141

Impurity

—

Unwanted component present in a pharmaceutical material/product.

142

Stability

—

Ability of a product to maintain quality within specifications over time under defined conditions.

143

Qualification

—

Documented demonstration that equipment/facility/system is appropriately installed and operates as intended.

144

Audit

—

Systematic examination of records, systems, facilities or activities against defined criteria.

145

Supplier Qualification

—

Formal process for evaluating and approving suppliers.

  1. MEDICINE & PHARMACEUTICAL TERMINOLOGY

No.

Term

Detailed Meaning

146

API

Active Pharmaceutical Ingredient — substance responsible for the pharmacological effect of a medicine.

147

FDF

Finished Dosage Form — final pharmaceutical dosage form ready for use/market supply.

148

FPP

Finished Pharmaceutical Product — finished medicinal product containing active ingredient(s) and excipients in its final form.

149

Generic Medicine

Medicine generally equivalent to a reference product in the relevant regulatory sense and marketed after applicable requirements are met.

150

Branded Generic

Generic medicine marketed under a proprietary/trade brand name.

151

Innovator Product

Original/reference pharmaceutical product developed and authorized by the innovator company.

152

Reference Product

Product used as the regulatory comparator/reference in relevant approval pathways.

153

Biosimilar

Biological product demonstrated to be highly similar to a reference biological product, subject to jurisdiction-specific requirements.

154

Biologic

Medicinal product derived from biological sources.

155

Excipient

Ingredient other than the active ingredient used for formulation, stability, delivery, appearance or other purposes.

156

Salt

Chemical form of an active pharmaceutical substance, often used to achieve suitable pharmaceutical properties.

157

Strength

Amount/concentration of active ingredient in a dosage unit or specified volume.

158

Dosage Form

Physical form in which a medicine is supplied, such as tablet, capsule, injection or cream.

159

Route of Administration

Method by which medicine enters the body, e.g. oral, intravenous, topical or inhaled.

160

Indication

Disease, condition or therapeutic purpose for which a medicine is authorized/recommended.

161

Contraindication

Situation in which a medicine should not be used because of unacceptable risk.

162

Drug Class

Group of medicines categorized according to pharmacological, chemical or therapeutic characteristics.

163

Therapeutic Class

Classification according to therapeutic use or disease/condition treated.

164

Pharmacological Class

Classification according to pharmacological action/mechanism.

165

Prescription Medicine

Medicine supplied under prescription requirements applicable in a jurisdiction.

166

OTC

Over-the-Counter

167

Controlled Substance

Substance subject to special legal controls because of abuse, dependence, diversion or other risks.

168

Dosage

Amount and frequency of medicine administered.

169

Regimen

Overall dosing schedule for a medicine.

170

Half-Life

Time required for the concentration/amount of a substance to decrease by approximately half under defined conditions.

171

Bioavailability

Rate and extent to which an active substance becomes available at the site/systemic circulation as applicable.

172

Bioequivalence

Demonstration that two pharmaceutical products meet specified criteria for equivalence in exposure/availability.

173

Pharmacokinetics

Study of what the body does to a drug — absorption, distribution, metabolism and excretion.

174

Pharmacodynamics

Study of what a drug does to the body and its effects/mechanisms.

175

Therapeutic Index

Relationship between effective and toxic exposure/dose used to characterize safety margin.

  1. INTERNATIONAL REGULATORY AUTHORITIES

No.

Abbreviation

Full Name / Authority

Country/Region

176

FDA

Food and Drug Administration

USA

177

CDER

Center for Drug Evaluation and Research

USA

178

CBER

Center for Biologics Evaluation and Research

USA

179

DEA

Drug Enforcement Administration

USA

180

MHRA

Medicines and Healthcare products Regulatory Agency

UK

181

EMA

European Medicines Agency

European Union

182

EC

European Commission

European Union

183

PMDA

Pharmaceuticals and Medical Devices Agency

Japan

184

MHLW

Ministry of Health, Labour and Welfare

Japan

185

TGA

Therapeutic Goods Administration

Australia

186

Health Canada

Canadian federal health regulator

Canada

187

ANVISA

Agência Nacional de Vigilância Sanitária

Brazil

188

SAHPRA

South African Health Products Regulatory Authority

South Africa

189

NAFDAC

National Agency for Food and Drug Administration and Control

Nigeria

190

PPB

Pharmacy and Poisons Board

Kenya

191

TMDA

Tanzania Medicines and Medical Devices Authority

Tanzania

192

NDA

National Drug Authority

Uganda

193

FDA Ghana

Food and Drugs Authority

Ghana

194

EDA

Egyptian Drug Authority

Egypt

195

SFDA

Saudi Food and Drug Authority

Saudi Arabia

196

MOHAP

Ministry of Health and Prevention

UAE

197

EDE

Emirates Drug Establishment

UAE

198

DGDA

Directorate General of Drug Administration

Bangladesh

199

BPOM

Badan Pengawas Obat dan Makanan

Indonesia

200

NPRA

National Pharmaceutical Regulatory Agency

Malaysia

201

FDA Philippines

Food and Drug Administration

Philippines

202

DAV

Drug Administration of Vietnam

Vietnam

203

Medsafe

New Zealand Medicines and Medical Devices Safety Authority

New Zealand

204

BfArM

Federal Institute for Drugs and Medical Devices

Germany

205

ANSM

French National Agency for Medicines Safety

France

206

AIFA

Italian Medicines Agency

Italy

207

AEMPS

Spanish Agency of Medicines and Medical Devices

Spain

208

MEB

Medicines Evaluation Board

Netherlands

209

TİTCK

Turkish Medicines and Medical Devices Agency

Turkey

  1. DRUG DEVELOPMENT & REGULATORY APPLICATIONS

No.

Term

Full Form / Meaning

210

IND

Investigational New Drug

211

NDA

New Drug Application

212

ANDA

Abbreviated New Drug Application

213

BLA

Biologics License Application

214

DMF

Drug Master File

215

CTD

Common Technical Document

216

eCTD

Electronic Common Technical Document

217

ACTD

ASEAN Common Technical Dossier

218

MAA

Marketing Authorisation Application

219

CTA

Clinical Trial Application

220

CRO

Contract Research Organization

221

CMC

Chemistry, Manufacturing and Controls

222

RLD

Reference Listed Drug

223

TE Code

Therapeutic Equivalence Code

224

Orange Book

Approved Drug Products with Therapeutic Equivalence Evaluations

225

Purple Book

—

226

PDUFA

Prescription Drug User Fee Act

227

GDUFA

Generic Drug User Fee Amendments

228

REMS

Risk Evaluation and Mitigation Strategy

  1. SHIPPING, LOGISTICS & INCOTERMS

No.

Term

Full Form / Meaning

229

EXW

Ex Works

230

FCA

Free Carrier

231

FOB

Free On Board

232

CFR

Cost and Freight

233

CIF

Cost, Insurance and Freight

234

CPT

Carriage Paid To

235

CIP

Carriage and Insurance Paid To

236

DAP

Delivered at Place

237

DPU

Delivered at Place Unloaded

238

DDP

Delivered Duty Paid

239

Incoterms

International Commercial Terms published by the International Chamber of Commerce

240

BL/BOL

Bill of Lading

241

AWB

Air Waybill

242

FCL

Full Container Load

243

LCL

Less than Container Load

244

ETA

Estimated Time of Arrival

245

ETD

Estimated Time of Departure

246

Freight Forwarder

Company arranging transportation/logistics for shipments.

247

Customs Broker

Authorized intermediary assisting with customs clearance.

248

3PL

Third-Party Logistics Provider

249

Cold Chain

Temperature-controlled supply chain.

250

Data Logger

Device recording temperature/humidity or other environmental conditions.

251

Temperature Mapping

Assessment of temperature distribution within a storage/transport area.

252

FEFO

First Expiry, First Out

253

FIFO

First In, First Out

254

Demurrage

Charges associated with exceeding permitted terminal/container time, depending on the applicable arrangement.

255

Detention

Charges associated with retaining carrier equipment beyond permitted free time.

256

Port of Loading

Location where cargo is loaded for transportation.

257

Port of Discharge

Location where cargo is discharged from the transporting vessel.

  1. DOCUMENTATION ABBREVIATIONS — QUICK REFERENCE

No.

Abbreviation

Meaning

258

COA

Certificate of Analysis

259

COC

Certificate of Conformity

260

CPP

Certificate of Pharmaceutical Product

261

COPP

Certificate of Pharmaceutical Product

262

FSC

Free Sale Certificate

263

CFS

Certificate of Free Sale

264

COO

Certificate of Origin

265

PI

Proforma Invoice

266

PO

Purchase Order

267

CI

Commercial Invoice

268

PL

Packing List

269

BL

Bill of Lading

270

BOL

Bill of Lading

271

AWB

Air Waybill

272

LC

Letter of Credit

273

BRC

Bank Realisation Certificate

274

e-BRC

Electronic Bank Realisation Certificate

275

LUT

Letter of Undertaking

276

LOA

Letter of Authorization

277

LOA

Letter of Access — context dependent

278

SMF

Site Master File

279

DMF

Drug Master File

280

ASMF

Active Substance Master File

281

CEP

Certificate of Suitability

  1. PHARMACOVIGILANCE & DRUG SAFETY

No.

Term

Full Form / Meaning

282

PV

Pharmacovigilance

283

AE

Adverse Event

284

ADR

Adverse Drug Reaction

285

SAE

Serious Adverse Event

286

SUSAR

Suspected Unexpected Serious Adverse Reaction

287

PSUR

Periodic Safety Update Report

288

PBRER

Periodic Benefit-Risk Evaluation Report

289

RMP

Risk Management Plan

290

DSUR

Development Safety Update Report

291

Signal Detection

Process of identifying potential safety signals from available data.

292

Safety Signal

Information suggesting a possible new association or safety concern.

293

Post-Marketing Surveillance

Monitoring product safety and performance after authorization.

294

Risk-Benefit Assessment

Evaluation comparing therapeutic benefits with identified/potential risks.

295

Product Recall

Removal of affected product from the market.

296

Medical Information

Scientific/medical information provided regarding a medicinal product.

297

Adverse Event Reporting

Process of receiving, assessing and reporting suspected adverse events.

  1. PACKAGING & LABELLING

No.

Term

Meaning

298

Primary Packaging

Packaging directly in contact with the medicine.

299

Secondary Packaging

Outer packaging surrounding the primary package.

300

Tertiary Packaging

Packaging used primarily for transportation/logistics.

301

Label Claim

Information/statement appearing on the product label.

302

Batch No.

Unique identification number assigned to a manufacturing batch.

303

MFG Date

Manufacturing date.

304

EXP Date

Expiry date.

305

MRP

Maximum Retail Price, where applicable.

306

GTIN

Global Trade Item Number.

307

Barcode

Machine-readable identification code.

308

Serialization

Assignment of unique identifiers to individual saleable units where required.

309

Artwork

Approved design/layout of packaging and labelling.

310

Leaflet

Information document supplied with a medicine.

311

PIL

Patient Information Leaflet.

312

SmPC

Summary of Product Characteristics.

313

Tamper-Evident Packaging

Packaging designed to show visible evidence of unauthorized opening/tampering.

  1. PHARMACOPOEIA & INTERNATIONAL STANDARDS

No.

Term

Full Form / Meaning

314

IP

Indian Pharmacopoeia

315

USP

United States Pharmacopeia

316

BP

British Pharmacopoeia

317

Ph. Eur.

European Pharmacopoeia

318

EP

European Pharmacopoeia

319

JP

Japanese Pharmacopoeia

320

NF

National Formulary

321

WHO

World Health Organization

322

ICH

International Council for Harmonisation

323

ISO

International Organization for Standardization

324

PIC/S

Pharmaceutical Inspection Co-operation Scheme

325

ASTM

ASTM International

326

Monograph

Official standard/specification for a substance or pharmaceutical product.

327

Reference Standard

Material of established quality used for analytical comparison/testing.

  1. API, RAW MATERIAL & EXCIPIENT TERMINOLOGY

No.

Term

Meaning

328

API

Active Pharmaceutical Ingredient

329

KSM

Key Starting Material

330

Starting Material

Material used in the manufacturing process of an API/product.

331

Intermediate

Substance produced during manufacturing and subsequently processed.

332

Excipient

Non-active ingredient used in pharmaceutical formulation.

333

DMF

Drug Master File

334

ASMF

Active Substance Master File

335

CEP

Certificate of Suitability

336

Assay

Quantitative measurement of a specified substance.

337

Purity

Degree to which a material is free from unwanted substances.

338

Impurity

Unwanted component present in a material/product.

339

Residual Solvent

Solvent remaining from manufacturing processes.

340

Elemental Impurity

Elemental/metallic impurity requiring control according to applicable standards.

341

Nitrosamine

A class of compounds subject to regulatory risk assessment/control in pharmaceuticals.

342

Genotoxic Impurity

Impurity with potential to cause genetic damage.

343

Retest Date

Date by which an API/material should be retested to confirm continued suitability where applicable.

344

Specification

Defined set of tests, analytical procedures and acceptance criteria.

345

Analytical Method

Procedure used to test and characterize pharmaceutical materials/products.

  1. REGULATORY DOSSIER STRUCTURE

No.

Term

Meaning

346

CTD

Common Technical Document

347

eCTD

Electronic Common Technical Document

348

ACTD

ASEAN Common Technical Dossier

349

Module 1

Administrative/regional information.

350

Module 2

CTD summaries and overviews.

351

Module 3

Quality/CMC information.

352

Module 4

Nonclinical study information.

353

Module 5

Clinical study information.

354

Dossier

Complete collection of regulatory documentation.

355

CMC

Chemistry, Manufacturing and Controls

356

Quality Overall Summary

Summary of the quality portion of a regulatory submission.

357

Clinical Overview

Summary/assessment of clinical evidence.

358

Nonclinical Overview

Summary/assessment of nonclinical evidence.

359

Regulatory Submission

Formal submission made to a regulatory authority.

360

Variation

Change to an approved product/authorization.

361

Renewal

Process for continuation of an authorization where applicable.

  1. BUYER, SUPPLIER & CONTRACT TERMINOLOGY

No.

Term

Meaning

362

Manufacturer

Company producing pharmaceutical products.

363

Supplier

Company supplying goods/materials to another business.

364

Trader

Entity buying and reselling products rather than necessarily manufacturing them.

365

Exporter

Entity exporting products from the origin country.

366

Importer

Entity importing products into destination country.

367

Distributor

Entity distributing products within a market.

368

Wholesaler

Entity dealing in products in wholesale quantities.

369

Stockist

Entity holding stock for onward distribution/sale.

370

Agent

Representative acting on behalf of another company.

371

Principal

Company represented by an agent/distributor.

372

OEM

Original Equipment Manufacturer.

373

ODM

Original Design Manufacturer.

374

CMO

Contract Manufacturing Organization.

375

CDMO

Contract Development and Manufacturing Organization.

376

Private Label

Product marketed under customer’s own brand.

377

Contract Manufacturing

Manufacturing under a contractual arrangement.

378

Tender

Competitive procurement process.

379

RFQ

Request for Quotation.

380

RFP

Request for Proposal.

381

NDA

Non-Disclosure Agreement.

382

MOU

Memorandum of Understanding.

383

SLA

Service Level Agreement.

384

KOL

Key Opinion Leader.

  1. FINANCE & EXPORT PAYMENT TERMS

No.

Term

Meaning

385

LC

Letter of Credit

386

TT

Telegraphic Transfer

387

DP

Documents Against Payment

388

DA

Documents Against Acceptance

389

CAD

Cash Against Documents

390

Advance Payment

Payment received before shipment/production as agreed.

391

Open Account

Buyer pays after shipment according to agreed credit terms.

392

Credit Period

Agreed number of days before payment becomes due.

393

Credit Risk

Risk of non-payment by buyer.

394

FX

Foreign Exchange

395

FX Risk

Risk arising from currency fluctuations.

396

Landed Cost

Total delivered/imported cost after relevant charges.

397

COGS

Cost of Goods Sold

398

Gross Profit

Revenue less applicable cost of goods.

399

Gross Margin

Gross profit expressed as a percentage of revenue.

400

ROI

Return on Investment.

  1. IMPORTANT GENERAL PHARMA TERMS

No.

Term

Meaning

401

Rx

Prescription

402

OTC

Over-the-Counter

403

Rx-only

Prescription-only medicine under applicable jurisdictional rules.

404

Controlled Drug

Medicine/substance subject to special legal controls.

405

Narcotic

Substance subject to specific legal controls and classification.

406

Psychotropic

Substance affecting the central nervous system and potentially subject to special controls.

407

Orphan Drug

Medicine intended for a rare disease/condition under applicable regulatory definitions.

408

Combination Product

Product containing two or more active ingredients or combining different therapeutic components.

409

Fixed-Dose Combination

Product containing specified active ingredients in fixed proportions.

410

Dosage Strength

Quantity/concentration of active ingredient in a dosage unit.

411

Route

Route by which the product is administered.

412

Oral

Administered through the mouth.

413

Parenteral

Administration that generally bypasses the gastrointestinal tract, such as injection.

414

Topical

Applied to a body surface/skin.

415

Ophthalmic

Intended for administration to/around the eye.

416

Inhalation

Administration through the respiratory tract.

417

Injectable

Pharmaceutical product administered by injection.

418

Tablet

Solid dosage form generally intended for oral administration.

419

Capsule

Dosage form containing drug substance/formulation within a shell.

420

Cream

Semisolid topical preparation.

421

Ointment

Semisolid preparation generally intended for application to skin.

422

Gel

Semisolid formulation with a gel structure.

423

Syrup

Liquid oral formulation, often containing dissolved ingredients.

424

Suspension

Liquid preparation containing dispersed insoluble particles.

425

Solution

Homogeneous liquid preparation in which ingredients are dissolved.

  1. 26-COUNTRY REGULATORY TERMINOLOGY FOR YOUR NAWINZA BOOK

For your 26-country medicine export database, I recommend maintaining the following country-specific terminology.

No.

Country

Main Regulatory Authority / Terms to Track

426

USA

FDA, CDER, CBER, ANDA, NDA, BLA, IND, NDC, DMF, cGMP, DEA

427

UK

MHRA, Marketing Authorisation, WDA(H), GDP, POM, GSL, Pharmacovigilance

428

UAE

EDE/MOHAP, product registration, importer/manufacturer requirements, controlled medicines requirements

429

Saudi Arabia

SFDA, drug registration, importer/establishment requirements

430

Canada

Health Canada, DIN, NOC, Drug Submission, GMP, Drug Establishment Licence

431

Australia

TGA, ARTG, AUST-R, AUST-L, GMP, sponsor

432

Germany

BfArM/EMA, Marketing Authorisation, EU GMP, QP

433

France

ANSM/EMA, Marketing Authorisation, pharmacovigilance

434

Netherlands

MEB/EMA, Marketing Authorisation, GDP/GMP

435

Brazil

ANVISA, product registration, GMP, importer requirements

436

South Africa

SAHPRA, product registration, GMP, applicant/importer requirements

437

Nigeria

NAFDAC, product registration, import/registration requirements

438

Kenya

PPB, product registration, import/wholesale requirements

439

Tanzania

TMDA, registration, import permits, GMP

440

Uganda

NDA, product registration, import requirements

441

Ghana

FDA Ghana, product registration, importer requirements

442

Egypt

EDA, product registration, import/manufacturing requirements

443

Turkey

TİTCK, marketing authorization, product registration

444

Russia

Russian/EAEU registration framework, GMP and marketing authorization

445

Bangladesh

DGDA, product registration/import requirements

446

Indonesia

BPOM, product registration, importer/marketing authorization requirements

447

Malaysia

NPRA, product registration, importer/PRH requirements

448

Philippines

FDA Philippines, product registration, LTO/CPR-related requirements

449

Vietnam

Drug Administration of Vietnam, marketing authorization, import requirements

450

Japan

PMDA, MHLW, marketing authorization, MAH, GMP

451

New Zealand

Medsafe, medicine classification, product approval/notification requirements

 

Professional Master Glossary of Pharmaceutical Export Terminology

This section is designed to function as a book-ready reference chapter for an Indian pharmaceutical exporter. The objective is not merely to give abbreviations, but to explain what each term means, why it matters, when it is used, and how it differs from related terminology.

Regulatory principle: A pharmaceutical product is not automatically exportable merely because it is legally manufactured in India. Exportability can depend on the product’s composition, dosage form, strength, controlled-substance status, manufacturing site, destination-country registration, importer licence, product authorization, labelling, documentation and applicable customs requirements.

PART I — INDIAN EXPORT & FOREIGN-TRADE TERMS

  1. DGFT

Full Form: Directorate General of Foreign Trade

Meaning

DGFT is the Indian government authority responsible for administering important aspects of India’s foreign-trade framework.

Importance to pharma exporters

An Indian pharmaceutical exporter may interact with DGFT for matters such as:

  • Importer Exporter Code (IEC)
  • Foreign Trade Policy
  • export/import policy conditions
  • restricted goods
  • authorisations
  • trade-related notifications
  • export incentives or schemes where applicable

Difference

DGFT ≠ CDSCO.

  • DGFT → foreign trade/export-import framework
  • CDSCO → regulation of drugs and medical products in India

A pharma exporter may therefore need to satisfy both trade requirements and pharmaceutical regulatory requirements.

  1. IEC

Full Form: Importer Exporter Code

Meaning

IEC is the identification code associated with an Indian entity carrying out import/export activities, subject to applicable exemptions and rules.

Importance

For an Indian company exporting pharmaceutical products, IEC is one of the fundamental business/trade identifiers.

Example

An Indian pharmaceutical company may have:

Company → IEC → Customs/Trade documentation → Foreign buyer

Difference

IEC ≠ GSTIN

  • IEC → foreign trade identification
  • GSTIN → GST/tax identification
  1. ICEGATE

Full Form: Indian Customs Electronic Gateway

Meaning

ICEGATE is the electronic interface used for various Indian Customs-related activities and filings.

Importance

It is relevant to exporters because pharmaceutical shipments must pass through customs procedures.

Difference

DGFT deals primarily with foreign-trade administration.

ICEGATE/Customs systems deal with customs-related processing and electronic transactions.

  1. AD Code

Full Form: Authorised Dealer Code

Meaning

An AD Code is associated with an authorised dealer bank handling foreign-exchange transactions for an exporter/importer.

Importance

It is important for connecting export transactions with the appropriate banking/customs framework.

Related term

AD Bank = Authorised Dealer Bank

Difference

  • IEC identifies the exporter/importer for foreign trade.
  • AD Code relates to the authorised banking channel.
  • GSTIN relates to GST taxation.
  1. RCMC

Full Form: Registration-Cum-Membership Certificate

Meaning

RCMC is issued by the relevant Export Promotion Council or competent organization to eligible exporters.

Pharma relevance

For pharmaceutical exporters, PHARMEXCIL may be relevant depending on the nature of the exporter’s business and applicable membership requirements.

Importance

It can support participation in export-promotion activities, trade facilitation and certain schemes/processes.

  1. PHARMEXCIL

Full Form: Pharmaceuticals Export Promotion Council of India

Meaning

PHARMEXCIL is India’s pharmaceutical export promotion council.

Importance

It is particularly relevant for companies involved in:

  • pharmaceutical exports
  • APIs
  • formulations
  • biotechnology products
  • herbal/related healthcare products, depending on category

Difference

PHARMEXCIL ≠ CDSCO

  • PHARMEXCIL → export promotion/trade support
  • CDSCO → drug regulatory authority
  1. GST

Full Form: Goods and Services Tax

Meaning

GST is India’s indirect tax system covering supplies of goods and services.

Pharma export importance

Exports can receive specific GST treatment, including zero-rated supply mechanisms subject to applicable law and compliance.

Important distinction

Zero-rated export ≠ automatically tax-free in every procedural sense.

The exporter still has documentation and compliance obligations.

  1. GSTIN

Full Form: Goods and Services Tax Identification Number

Meaning

GSTIN identifies a GST-registered business.

Difference

Term

Purpose

IEC

Foreign trade

GSTIN

GST

PAN

Income-tax/business identity

AD Code

Banking/customs-related export framework

  1. LUT

Full Form: Letter of Undertaking

Meaning

In GST export practice, an eligible exporter can use an LUT for exporting without payment of IGST, subject to applicable GST provisions.

Importance

It can improve export cash flow by avoiding payment of IGST upfront where the exporter is eligible to use the LUT route.

Difference

LUT is not an export licence.

It is a GST-related undertaking.

  1. e-BRC

Full Form: Electronic Bank Realisation Certificate

Meaning

e-BRC is an electronic record/certificate associated with realization of export proceeds.

Importance

It provides evidence relevant to:

  • export proceeds realization
  • banking records
  • foreign-trade compliance
  • certain export-related claims/benefits where applicable

Difference

Shipping Bill proves/records export customs declaration.

e-BRC relates to realization of export proceeds.

  1. RBI

Full Form: Reserve Bank of India

Meaning

RBI is India’s central bank.

Pharma-export relevance

Its importance to exporters arises particularly through:

  • foreign exchange
  • export proceeds
  • banking channels
  • authorized dealer banks
  • reporting requirements

Difference

RBI does not approve pharmaceutical medicines for sale in foreign markets.

  1. FEMA

Full Form: Foreign Exchange Management Act, 1999

Meaning

FEMA provides India’s legal framework for foreign-exchange management.

Importance

Pharma exporters receiving foreign currency and conducting international transactions must understand the applicable FEMA/banking framework.

Difference

FEMA → foreign exchange

Drugs and Cosmetics framework → pharmaceutical regulation

  1. ITC-HS

Full Form: Indian Trade Classification based on Harmonized System

Meaning

ITC-HS is India’s trade classification system used for goods.

Importance

Correct classification affects:

  • customs declarations
  • export/import policy
  • trade statistics
  • applicable duties
  • restrictions/conditions

Critical point

An HS code should not be guessed merely from the medicine’s brand name.

  1. HSN

Full Form: Harmonized System of Nomenclature

Meaning

HS/HSN terminology refers to internationally structured goods classification.

Difference

HS Code → international customs classification framework.

ITC-HS → India’s implementation/classification structure.

PART II — REGISTRATION & REGULATORY COMPLIANCE

  1. MA

Full Form: Marketing Authorisation

Meaning

Marketing Authorisation is regulatory authorization allowing a medicinal product to be marketed in a particular jurisdiction, subject to that jurisdiction’s law.

Importance

This is one of the most important concepts in pharmaceutical exports.

A medicine manufactured legally in India may still require separate authorization in the destination country before commercial marketing.

Difference

Manufacturing Licence → permission to manufacture.

Marketing Authorisation → permission to market/supply the product in the relevant jurisdiction.

  1. MAA

Full Form: Marketing Authorisation Application

Meaning

The application submitted to a regulatory authority seeking marketing authorization.

Relationship

MAA → regulatory review → MA

An MAA is an application.

MA is the authorization.

  1. Product Registration

Meaning

Formal registration/authorization of a pharmaceutical product with the destination country’s regulator.

Importance

It establishes the legal regulatory status of the specific product in that market.

Example

A company may manufacture:

Paracetamol 500 mg tablets

in India, but the product may still need to be registered with the relevant regulator before commercial sale in another country.

  1. Site Registration

Meaning

Registration or approval of a manufacturing, testing or other relevant site by a regulatory authority where required.

Importance

Regulators often need to know:

  • where the medicine is manufactured
  • who manufactures it
  • whether the site complies with GMP
  • what products/processes are performed there

Difference

Product registration concerns the product.

Site registration concerns the facility/site.

  1. Establishment Registration

Meaning

Registration of a pharmaceutical establishment/facility with the relevant authority.

Importance

It allows regulators to identify and oversee businesses involved in regulated pharmaceutical activities.

Difference

A company may have:

Company registration + establishment registration + product registration

These are not necessarily the same thing.

  1. Foreign Manufacturer Registration

Meaning

Registration of a manufacturer located outside the destination country, where required by the destination regulator.

Importance

An Indian manufacturer exporting medicines may need to be recognized by the destination country’s regulatory system.

Example

Indian manufacturer → foreign regulator → foreign establishment requirements

  1. Import Licence

Meaning

Authorization permitting an entity to import specified pharmaceutical products into a country.

Importance

The foreign buyer/importer may need an import authorization.

Key point

The Indian exporter should not assume that obtaining an Indian export document automatically gives the foreign buyer permission to import.

  1. Export Licence

Meaning

Authorization required for exporting certain goods/products where the law imposes such a requirement.

Pharma relevance

Particularly important for products that are:

  • controlled
  • narcotic/psychotropic
  • restricted
  • subject to special export controls

Difference

Export licence controls export from the exporting jurisdiction.

Import licence controls import into the destination jurisdiction.

  1. Wholesale Licence

Meaning

Authorization allowing an entity to conduct pharmaceutical wholesale activities under applicable law.

Importance

The foreign distributor/importer may require appropriate wholesale authorization.

Difference

Importer → legally brings product into country.

Wholesaler/distributor → distributes/sells within the market.

One organization can sometimes perform multiple roles if legally authorized.

  1. Manufacturing Licence

Meaning

Government authorization permitting manufacturing of specified pharmaceutical products at an approved facility.

Importance

It demonstrates that manufacturing is taking place under an authorized regulatory framework.

Difference

Manufacturing licence ≠ GMP certificate.

  • Licence → legal authorization to manufacture.
  • GMP certificate → evidence of compliance with applicable GMP requirements.
  1. Controlled Drug Licence

Meaning

Special authorization associated with controlled, narcotic, psychotropic or otherwise restricted substances where required.

Importance

Controlled products can have substantially stricter requirements for:

  • manufacture
  • storage
  • possession
  • distribution
  • import
  • export
  • record keeping

Critical distinction

A product should not be labelled “controlled” merely because it is prescription-only.

Prescription status and controlled-drug status are different regulatory concepts.

  1. CFS / FSC

Full Form: Certificate of Free Sale / Free Sale Certificate

Meaning

A certificate providing evidence about a product’s legal sale/marketing status in the issuing jurisdiction, where the issuing authority uses such a certificate.

Importance

Some destination markets may request it as part of product registration.

Difference

GMP Certificate → manufacturing quality compliance.

CFS/FSC → evidence concerning free/legal sale or marketing status.

  1. GMP Certificate

Full Form: Good Manufacturing Practice Certificate

Meaning

A certificate or official evidence showing that a manufacturing facility complies with applicable GMP requirements, according to the issuing authority and scope.

Importance

GMP is fundamental to pharmaceutical manufacturing and international regulatory confidence.

Difference

GMP → standard/requirements.

GMP Certificate → evidence issued/recognized by an authority or competent body.

  1. CPP

Full Form: Certificate of Pharmaceutical Product

Meaning

A pharmaceutical regulatory certificate based on the WHO Certification Scheme for pharmaceutical products, used by participating authorities as applicable.

Importance

It can support registration of pharmaceutical products in importing countries.

Difference

CPP is a regulatory certificate, not a commercial invoice and not a manufacturing licence.

  1. COPP

Commonly used as: Certificate of Pharmaceutical Product

Meaning

COPP is frequently used in pharmaceutical-export terminology for a Certificate of Pharmaceutical Product.

Important distinction

Do not automatically create two completely separate concepts:

CPP ≠ COPP

In many contexts, they refer to the same general pharmaceutical certificate, with terminology varying according to authority/country/practice.

For your book, write:

CPP/COPP — Certificate of Pharmaceutical Product

and then explain the exact format/issuing authority applicable to the target country.

  1. CEP

Full Form: Certificate of Suitability

Meaning

A CEP is associated with demonstrating suitability of a substance with respect to relevant European Pharmacopoeia standards.

Importance

Particularly relevant to API manufacturers and regulatory submissions involving European markets.

Difference

CEP ≠ DMF

Both may contain technical information, but they are different regulatory mechanisms/documents.

  1. DMF

Full Form: Drug Master File

Meaning

A confidential technical file containing detailed information about manufacturing, processing, quality and controls of a substance or other regulated material, depending on the regulatory system.

Importance

It allows regulators to review confidential manufacturing information without necessarily disclosing it to the finished-product applicant.

Difference

DMF → confidential technical information

Marketing Authorisation → permission to market finished product

  1. ASMF

Full Form: Active Substance Master File

Meaning

ASMF is a European regulatory mechanism for protecting confidential information concerning an active substance while allowing regulators access to the necessary information.

Difference

DMF is a broader term used in several regulatory systems.

ASMF is particularly associated with the European regulatory framework for active substances.

  1. Letter of Access

Meaning

A Letter of Access authorizes a regulatory authority or relevant party to access/refer to confidential information contained in a technical file.

Example

An API manufacturer may permit a finished-product applicant to reference confidential API information held in a regulatory file.

Difference

Letter of Access ≠ Letter of Authorization.

  1. Letter of Authorization

Meaning

A formal document authorizing another party to perform an action, represent a company, submit information or act on behalf of the authorization holder, depending on the context.

Difference

Letter

Purpose

Letter of Access

Access/reference confidential regulatory information

Letter of Authorization

Authorize a person/company to perform specified actions

  1. Regulatory Dossier

Meaning

A structured collection of regulatory, technical, quality, administrative, nonclinical and/or clinical information submitted to a regulatory authority.

Importance

A pharmaceutical product cannot normally be evaluated for authorization merely from a commercial brochure.

The regulator requires evidence.

Typical areas

  • administrative information
  • quality/CMC
  • manufacturing
  • specifications
  • stability
  • nonclinical information
  • clinical information
  • labelling
  1. Variation

Meaning

A regulatory change to an already authorized product, site, manufacturing process, documentation or other approved element.

Examples

  • manufacturing-site change
  • formulation change
  • specification change
  • packaging change
  • manufacturing-process change

Difference

Variation = change to an existing authorization.

New application = authorization for a new product/pathway.

  1. Renewal

Meaning

Process through which a regulatory authorization is continued after a specified validity period, where applicable.

Difference

Renewal → continuation

Variation → change

New application → new authorization/pathway

  1. Pharmacovigilance

Abbreviation: PV

Meaning

The science and activities concerned with detecting, assessing, understanding and preventing adverse effects and other medicine-related safety problems.

Importance

Pharmacovigilance continues after the medicine reaches the market.

Difference

Clinical development studies safety before/around approval.

Pharmacovigilance monitors safety throughout the product lifecycle.

  1. Recall

Meaning

A process through which affected pharmaceutical products are removed from the market/supply chain because of a quality, safety, regulatory or other significant issue.

Possible triggers

  • contamination
  • incorrect strength
  • labelling error
  • stability problem
  • manufacturing defect
  • regulatory non-compliance

Difference

Recall ≠ routine product return.

A recall is a controlled corrective action addressing an identified risk/problem.

PART III — EXPORT DOCUMENTATION

  1. Commercial Invoice

Meaning

The principal commercial document describing the sale transaction.

Usually contains

  • exporter
  • buyer
  • product
  • quantity
  • unit price
  • total value
  • currency
  • Incoterm
  • shipment details

Importance

Used by commercial, customs, banking and logistics parties.

  1. Proforma Invoice — PI

Meaning

A preliminary invoice/quotation issued before the final commercial transaction/shipment.

Uses

  • quotation
  • buyer approval
  • advance payment
  • LC arrangements
  • order confirmation

Difference

PI → before/facilitates transaction

Commercial Invoice → final commercial transaction document

  1. Packing List

Meaning

Document describing how goods are physically packed.

Typical information

  • number of cartons
  • package type
  • quantity
  • gross weight
  • net weight
  • dimensions
  • batch information where appropriate

Difference

Commercial Invoice → money/value

Packing List → physical shipment

  1. Shipping Bill

Meaning

Indian Customs export declaration for goods being exported.

Importance

Essential to customs clearance of the shipment.

  1. Bill of Lading — BL/BOL

Meaning

A transport document used mainly in sea freight.

Functions

Depending on the type and circumstances, it can serve as:

  • evidence of carriage contract
  • receipt for goods
  • document with title functions in appropriate cases

Difference

B/L → sea transport

AWB → air transport

  1. Air Waybill — AWB

Meaning

Transport document for air cargo.

Difference

B/L

AWB

Primarily sea freight

Air freight

Can have negotiable/title characteristics depending on type

Generally non-negotiable

Used by ocean carrier

Used by airline/air cargo carrier

  1. Certificate of Origin — COO

Meaning

Certificate establishing the origin of goods for purposes determined by the destination country’s rules.

Importance

May be required for:

  • customs
  • preferential tariffs
  • trade agreements
  • buyer requirements

Difference

COO → origin of goods

COA → quality/test results

  1. Certificate of Analysis — COA

Meaning

A document showing analytical test results for a particular batch/product against specified standards.

Typical information

  • product name
  • batch number
  • test parameters
  • specifications
  • actual results
  • release status
  • dates/signatures as applicable

Importance

Extremely important in pharmaceutical B2B transactions.

Difference

COA → product quality/test results

COO → country of origin

CPP → pharmaceutical regulatory status/product information

  1. Insurance Certificate

Meaning

Evidence that shipment insurance has been arranged.

Importance

Particularly relevant where the applicable Incoterm or sales contract requires the seller to arrange insurance.

  1. Purchase Order — PO

Meaning

Formal order issued by the buyer.

Typical details

  • product
  • quantity
  • price
  • delivery terms
  • destination
  • payment terms
  • specifications

Difference

PO → buyer’s order

PI → seller’s preliminary commercial document

  1. Letter of Credit — LC

Meaning

A bank-based payment mechanism under which payment is made subject to specified terms and documentary conditions.

Importance

Can reduce certain payment risks, but documentary compliance is critical.

Difference

LC ≠ advance payment

With advance payment, seller receives funds before shipment.

With an LC, payment depends on the LC’s terms and compliant presentation.

PART IV — COMMERCIAL TERMS

  1. MOQ

Full Form: Minimum Order Quantity

Meaning

Smallest quantity a manufacturer/supplier agrees to supply or produce.

Example

MOQ = 10,000 tablets

Importance

Affects:

  • working capital
  • production economics
  • packaging
  • private-label viability
  • inventory risk

Difference

MOQ → minimum quantity

Lead Time → time required

  1. OEM

Full Form: Original Equipment Manufacturer

Pharma context

A pharmaceutical manufacturer produces a product according to an agreed arrangement/specification for another company.

Importance

Useful when an exporter wants products manufactured under its own commercial brand or customer’s requirements.

  1. ODM

Full Form: Original Design Manufacturer

Meaning

An organization that may provide product design/development together with manufacturing.

Difference

OEM → manufacturing focus

ODM → design/development + manufacturing

The terminology is less standardized in pharmaceuticals than in electronics, so contracts should clearly define responsibilities.

  1. Private Label

Meaning

A product manufactured by one company and sold under another company’s brand.

Example

Manufacturer:

ABC Pharma Pvt. Ltd.

Brand:

NAWINZA

The commercial arrangement may be private-label manufacturing, subject to regulatory/legal requirements.

Important

Private labelling does not eliminate regulatory responsibilities.

  1. Contract Manufacturing

Meaning

A manufacturer produces pharmaceutical products for another company under a contractual arrangement.

Importance

Allows a company to enter markets without owning a complete manufacturing facility.

  1. CMO

Full Form: Contract Manufacturing Organization

Meaning

Organization providing manufacturing services to another company.

  1. CDMO

Full Form: Contract Development and Manufacturing Organization

Meaning

Organization providing development and manufacturing services.

Difference

CMO → primarily manufacturing

CDMO → development + manufacturing

  1. Distributor

Meaning

A company that purchases/receives pharmaceutical products and distributes them within a market or territory.

Importance

Often becomes the key commercial partner in foreign markets.

  1. Importer

Meaning

Entity responsible for importing goods into the destination country.

Importance

The importer may need:

  • import authorization
  • establishment authorization
  • product registration
  • customs capability
  • storage/distribution authorization

depending on the jurisdiction.

  1. Wholesaler

Meaning

Business involved in buying and selling products in wholesale quantities.

Difference

Importer → brings goods into country

Wholesaler → sells/distributes in wholesale channel

One company can legally perform both functions where authorized.

  1. Stockist

Meaning

A business that holds pharmaceutical inventory for onward distribution.

Difference

A stockist is primarily characterized by its inventory/distribution role, while an importer is characterized by its import role.

  1. Tender

Meaning

Formal competitive procurement process.

Common buyers

  • governments
  • hospitals
  • public procurement agencies
  • international organizations
  • large healthcare groups

Importance

Tender business can involve large volumes but generally has strict:

  • technical specifications
  • registration requirements
  • pricing requirements
  • documentation
  • delivery conditions
  1. RFQ

Full Form: Request for Quotation

Meaning

Buyer asks suppliers to provide pricing and commercial terms.

Typical RFQ information

  • product
  • strength
  • dosage form
  • quantity
  • destination
  • packaging
  • Incoterm
  • required documents
  1. RFP

Full Form: Request for Proposal

Difference from RFQ

RFQ → mainly asks “What is your price/quotation?”

RFP → asks for a broader technical + commercial proposal.

  1. NDA

This abbreviation has two important meanings.

Pharmaceutical regulatory meaning

New Drug Application

Used particularly in the U.S. regulatory system.

Commercial/legal meaning

Non-Disclosure Agreement

Contract protecting confidential information.

Important rule

Never write simply “NDA” in a document where ambiguity is possible.

Write:

NDA — New Drug Application

or

NDA — Non-Disclosure Agreement

PART V — INCOTERMS & SHIPPING

  1. Incoterms®

Meaning: International Commercial Terms

Meaning

Incoterms are standardized international trade rules published by the International Chamber of Commerce.

They establish important responsibilities regarding:

  • delivery
  • costs
  • risks
  • transport
  • insurance in specified terms
  • customs responsibilities

Critical point

Incoterms do not by themselves determine:

  • ownership/title transfer in every transaction
  • payment terms
  • product registration
  • pharmaceutical regulatory authorization
  1. EXW

Full Form: Ex Works

Meaning

Seller makes goods available at the named place, generally with relatively limited seller responsibility for transportation.

Exporter consideration

Although commercially attractive for the seller, EXW can create practical difficulties where the buyer is expected to handle export formalities from another country.

  1. FCA

Full Form: Free Carrier

Meaning

Seller delivers goods to the carrier/person at the agreed place under the applicable Incoterms rule.

Use

Often useful where organized international transport is handled by the buyer.

  1. FOB

Full Form: Free On Board

Meaning

Under FOB, seller delivers goods on board the vessel at the named port of shipment, with risk transfer according to the Incoterms rule.

Important

FOB is designed for sea/inland waterway transport, not as a generic term for every shipment.

  1. CFR

Full Form: Cost and Freight

Meaning

Seller pays cost and freight to the named port of destination, with risk transferring according to the applicable Incoterms rule.

Difference from CIF

CIF additionally includes insurance arranged by the seller under the Incoterms rule.

  1. CIF

Full Form: Cost, Insurance and Freight

Meaning

Seller arranges cost, freight and the required insurance to the named port of destination according to the applicable Incoterms rule.

Difference

CFR = Cost + Freight

CIF = Cost + Insurance + Freight

  1. CPT

Full Form: Carriage Paid To

Meaning

Seller pays carriage to the named destination.

Difference from CIP

CIP additionally requires seller-arranged insurance according to the applicable Incoterms rule.

  1. CIP

Full Form: Carriage and Insurance Paid To

Meaning

Seller pays carriage and arranges insurance to the named destination according to the applicable Incoterms rule.

  1. DAP

Full Form: Delivered at Place

Meaning

Seller delivers goods to the named destination, ready for unloading.

Difference from DDP

Under DAP, import clearance/duties generally remain with the buyer.

  1. DPU

Full Form: Delivered at Place Unloaded

Meaning

Seller delivers and unloads goods at the named destination.

Difference

DAP → ready for unloading

DPU → unloaded

  1. DDP

Full Form: Delivered Duty Paid

Meaning

Seller assumes extensive responsibilities, including import formalities/duties where legally possible under the applicable rule.

Important pharma-export warning

DDP should not be selected casually for pharmaceutical exports because import-country regulatory and tax responsibilities may require the importer or locally established entity to perform certain functions.

PART VI — QUALITY

  1. QA

Full Form: Quality Assurance

Meaning

The overall system ensuring quality is built into pharmaceutical operations.

Focus

Prevention and systems.

  1. QC

Full Form: Quality Control

Meaning

Testing and analytical activities used to determine whether materials/products meet specifications.

Focus

Testing and verification.

Key difference

QA builds the quality system. QC tests the product/material against requirements.

  1. GMP

Full Form: Good Manufacturing Practice

Meaning

Requirements governing pharmaceutical manufacturing and quality systems.

Core objective

Ensure medicines are consistently:

  • manufactured
  • controlled
  • documented
  • tested
  • stored

according to applicable requirements.

  1. cGMP

Full Form: Current Good Manufacturing Practice

Meaning

Emphasizes compliance with currently applicable GMP requirements.

Difference

GMP is the general concept.

cGMP is particularly common in U.S. regulatory terminology emphasizing current requirements.

  1. GLP

Full Form: Good Laboratory Practice

Meaning

Quality system principles for certain nonclinical laboratory studies.

Difference

GLP → laboratory/nonclinical studies

GCP → clinical trials

GMP → manufacturing

  1. GCP

Full Form: Good Clinical Practice

Meaning

International ethical and scientific quality standards for clinical trials involving human participants.

  1. GDP

Full Form: Good Distribution Practice

Meaning

Requirements governing proper distribution and handling of medicinal products.

Focus

  • storage
  • transportation
  • traceability
  • handling
  • distribution quality

Important

In a pharmaceutical context:

GDP = Good Distribution Practice

not Gross Domestic Product.

  1. GSP

Full Form: Good Storage Practice

Meaning

Principles governing proper storage conditions for pharmaceutical products.

Difference

GSP → storage

GDP → broader distribution chain

  1. SOP

Full Form: Standard Operating Procedure

Meaning

Controlled written procedure describing how a particular activity must be performed.

Example

  • warehouse SOP
  • sampling SOP
  • deviation SOP
  • export documentation SOP
  1. CAPA

Full Form: Corrective and Preventive Action

Meaning

System for:

Corrective Action → fixing the existing problem

Preventive Action → preventing recurrence/potential recurrence

Example

Repeated packaging errors:

  1. identify root cause
  2. correct affected process
  3. implement preventive controls
  4. monitor effectiveness
  1. OOS

Full Form: Out of Specification

Meaning

A test result falls outside an approved specification.

Example

Specification:

Assay: 95–105%

Actual result:

92%

This may constitute an OOS result requiring formal investigation.

  1. OOT

Full Form: Out of Trend

Meaning

A result may remain within specification but shows an unusual or unexpected trend.

Difference

OOS → outside specification

OOT → potentially abnormal trend even within specification

  1. Deviation

Meaning

Departure from an approved procedure, specification, process or expected condition.

Example

A manufacturing step was performed outside the approved time range.

  1. Change Control

Meaning

Formal process for evaluating and approving changes before implementation.

Examples

  • supplier change
  • equipment change
  • manufacturing-site change
  • formulation change
  • packaging change

Difference

Deviation → something departed from approved procedure.

Change control → planned/proposed change is evaluated before implementation.

  1. Validation

Meaning

Documented evidence demonstrating that a process/system consistently produces the intended result.

Difference from qualification

Qualification → equipment/system/facility

Validation → process/method/system performance

The terms can overlap depending on the context, so the applicable regulatory framework should be followed.

  1. Cleaning Validation

Meaning

Evidence that cleaning procedures consistently remove residues/contaminants to predetermined acceptable levels.

Importance

Critical for preventing:

  • cross-contamination
  • carryover
  • microbial contamination
  1. Process Validation

Meaning

Evidence that a manufacturing process consistently produces product meeting predetermined requirements.

  1. BMR

Full Form: Batch Manufacturing Record

Meaning

Batch-specific documentation showing how a particular batch was manufactured.

Importance

Provides traceability of:

  • materials
  • equipment
  • manufacturing steps
  • quantities
  • operators
  • in-process checks
  1. BPR

Full Form: Batch Packaging Record

Meaning

Batch-specific documentation describing packaging operations.

  1. MFR

Full Form: Master Formula Record

Meaning

Approved master manufacturing instructions/formula for producing a pharmaceutical product.

  1. MBR

Full Form: Master Batch Record

Meaning

Master document containing approved instructions and requirements for batch manufacture.

Important

Terminology can vary between companies and regulatory systems. Your book should define the company’s/regulator’s specific usage when applicable.

PART VII — MEDICINE TERMINOLOGY

  1. API

Full Form: Active Pharmaceutical Ingredient

Meaning

The pharmacologically active substance responsible for the intended therapeutic effect.

Example

In a tablet containing paracetamol:

Paracetamol = API

Other ingredients are generally excipients.

  1. FDF

Full Form: Finished Dosage Form

Meaning

Final pharmaceutical dosage form presented for use.

Examples

  • tablet
  • capsule
  • injection
  • cream
  • oral solution
  1. FPP

Full Form: Finished Pharmaceutical Product

Meaning

Finished pharmaceutical product containing the active pharmaceutical ingredient(s) together with appropriate excipients and presented in its final form.

Difference

API → active substance

FPP/FDF → finished medicine

  1. Generic Medicine

Meaning

A medicine that follows the relevant regulatory requirements for a generic product and is generally associated with the same active substance as a reference product.

Important

“Generic” does not mean:

“unregulated” or “lower quality.”

A legally approved generic must satisfy the applicable quality and regulatory requirements.

  1. Branded Generic

Meaning

A generic medicine marketed under a proprietary brand/trade name.

Example

Instead of marketing only by generic name, a company sells the product under its own brand.

  1. Innovator Product

Meaning

Original/reference medicinal product developed and brought to market by the innovator company.

Difference

Innovator → original/reference product

Generic → subsequent product using the relevant regulatory pathway

  1. Reference Product

Meaning

Product used as the comparator/reference in a regulatory pathway.

Importance

Particularly important in generic and bioequivalence development.

  1. Biosimilar

Meaning

A biological medicinal product demonstrated to be highly similar to a reference biological product, with no clinically meaningful differences in the relevant aspects under the applicable regulatory framework.

Difference

Generic → generally small-molecule pharmaceutical products

Biosimilar → biological products

  1. Biologic

Meaning

Medicinal product derived from biological sources.

Examples

Depending on regulatory classification:

  • monoclonal antibodies
  • recombinant proteins
  • vaccines
  • certain blood-derived products
  1. Excipient

Meaning

Ingredient other than the API used to formulate the medicine.

Functions

  • tablet formation
  • stability
  • taste
  • dissolution
  • preservation
  • colour
  • delivery
  1. Salt

Meaning

A particular chemical form of an active substance created by combining it with an appropriate counter-ion.

Example

A medicine may contain:

Drug X hydrochloride

rather than the free-base form.

Export importance

The exact salt can affect:

  • product identity
  • specifications
  • regulatory registration
  • HS classification
  • formulation
  • documentation
  1. Strength

Meaning

Amount/concentration of active ingredient in a defined dosage unit or volume.

Example

Paracetamol 500 mg tablet

500 mg = strength per tablet.

Difference

Strength ≠ dosage

Strength is what the product contains per unit.

Dosage is how much/how often the patient takes it.

  1. Dosage Form

Meaning

Physical pharmaceutical form.

Examples

  • tablet
  • capsule
  • injection
  • cream
  • ointment
  • syrup
  • suspension
  • eye drops
  1. Route of Administration

Meaning

How a medicine is administered.

Examples

  • oral
  • intravenous
  • intramuscular
  • subcutaneous
  • topical
  • ophthalmic
  • inhalation

Importance

The same API can have different regulatory and clinical characteristics depending on its route.

  1. Indication

Meaning

The disease/condition or therapeutic purpose for which a medicine is authorized or recommended.

Example

A medicine may be indicated for:

hypertension

or

type 2 diabetes

depending on its authorized use.

  1. Contraindication

Meaning

A circumstance in which a medicine should not be used because the potential risk is unacceptable.

Difference

Indication → when to use

Contraindication → when not to use

  1. Drug Class

Meaning

Group of medicines categorized according to pharmacological/chemical characteristics.

Example

ACE inhibitors, beta blockers, statins, etc.

  1. Therapeutic Class

Meaning

Classification according to the therapeutic condition or purpose.

Example

Antihypertensive medicines.

  1. Pharmacological Class

Meaning

Classification based primarily on pharmacological action/mechanism.

Important distinction

Therapeutic class → what condition it treats

Pharmacological class → how it acts/group of pharmacological action

  1. Rx

Meaning: Prescription medicine / prescription status

Meaning

Indicates that supply/use is subject to prescription requirements under the relevant jurisdiction.

Important

Rx status differs between countries.

  1. OTC

Full Form: Over-the-Counter

Meaning

Medicine that can be obtained without a prescription under the applicable country’s legal framework.

Important

A product may be OTC in one country and prescription-only in another.

  1. Controlled Substance

Meaning

A substance subject to special legal controls because of risks such as abuse, dependence, diversion or public-health concerns.

Critical difference

Prescription-only ≠ automatically controlled substance.

A controlled substance normally has an additional layer of legal control.

PART VIII — INTERNATIONAL REGULATORY AUTHORITIES

  1. FDA

Full Form: U.S. Food and Drug Administration

Role

U.S. federal regulator responsible for numerous products, including human drugs and biologics.

Pharma relevance

FDA regulates areas including:

  • drug approval
  • manufacturing
  • labelling
  • safety
  • quality
  • establishment requirements
  • imports

Difference

FDA is the U.S. regulator; CDSCO is India’s principal central drug regulator.

  1. CDER

Full Form: Center for Drug Evaluation and Research

Meaning

FDA center primarily responsible for human drug evaluation and regulation.

Difference

FDA → overall agency

CDER → FDA center focused primarily on drugs

  1. CBER

Full Form: Center for Biologics Evaluation and Research

Meaning

FDA center responsible for many biological products.

Difference

CDER → many drugs

CBER → many biological products

The precise regulatory division depends on the product.

  1. DEA

Full Form: Drug Enforcement Administration

Meaning

U.S. federal agency responsible for enforcement relating to controlled substances.

Pharma relevance

Relevant when products/substances fall under U.S. controlled-substance laws.

Critical distinction

FDA approval does not mean DEA authorization where controlled-substance requirements apply.

  1. MHRA

Full Form: Medicines and Healthcare products Regulatory Agency

Country

United Kingdom.

Role

Regulates medicines, medical devices and other healthcare products within its statutory responsibilities.

  1. EMA

Full Form: European Medicines Agency

Region

European Union.

Role

Scientific/regulatory role within the EU medicines system.

Important

EMA is not simply the “FDA of Europe.”

The EU regulatory system involves:

  • EMA
  • European Commission
  • national competent authorities

with different responsibilities.

  1. PMDA

Full Form: Pharmaceuticals and Medical Devices Agency

Country

Japan.

Role

Japan’s regulatory system includes PMDA and the Ministry of Health, Labour and Welfare.

  1. MHLW

Full Form: Ministry of Health, Labour and Welfare

Country

Japan.

Difference

PMDA → scientific/review/assessment functions

MHLW → governmental regulatory decision/policy functions

The exact division depends on the regulatory process.

  1. TGA

Full Form: Therapeutic Goods Administration

Country

Australia.

Role

Australian regulator for therapeutic goods.

Pharma relevance

Medicines may need appropriate Australian regulatory authorization/listing/registration depending on product classification.

  1. Health Canada

Meaning

Federal Canadian health regulator responsible for regulation of medicines and other health products.

Important Canadian term

DIN — Drug Identification Number

This should be added to your final glossary because it is important in the Canadian pharmaceutical market.

  1. ANVISA

Full Form: Agência Nacional de Vigilância Sanitária

Country

Brazil.

Role

Brazilian health regulatory authority.

Pharma relevance

Brazil has significant pharmaceutical registration and local regulatory requirements.

  1. SAHPRA

Full Form: South African Health Products Regulatory Authority

Country

South Africa.

Role

Regulates medicines and other health products.

  1. NAFDAC

Full Form: National Agency for Food and Drug Administration and Control

Country

Nigeria.

Pharma relevance

Important authority for pharmaceutical product registration and related regulatory requirements in Nigeria.

  1. PPB

Full Form: Pharmacy and Poisons Board

Country

Kenya.

Role

Regulatory authority for medicines/pharmaceutical products and related matters.

  1. TMDA

Full Form: Tanzania Medicines and Medical Devices Authority

Country

Tanzania.

  1. SFDA

Full Form: Saudi Food and Drug Authority

Country

Saudi Arabia.

Pharma relevance

Important for pharmaceutical registration, importation and related regulatory controls in Saudi Arabia.

  1. EDE

Full Form: Emirates Drug Establishment

Country

United Arab Emirates.

Importance

Important UAE federal pharmaceutical regulatory institution.

Note

UAE regulatory structures and responsibilities should always be checked against the current authority and product-specific pathway when your book is updated.

  1. DGDA

Full Form: Directorate General of Drug Administration

Country

Bangladesh.

  1. BPOM

Meaning: Indonesia’s Food and Drug Authority

Country

Indonesia.

Pharma relevance

Responsible for regulatory oversight of medicines and other regulated products.

  1. NPRA

Full Form: National Pharmaceutical Regulatory Agency

Country

Malaysia.

  1. FDA Philippines

Full Form: Food and Drug Administration

Country

Philippines.

  1. DAV

Full Form: Drug Administration of Vietnam

Country

Vietnam.

  1. Medsafe

Meaning: New Zealand’s medicines and medical devices safety/regulatory authority within the Ministry of Health framework.

Country

New Zealand.

PART IX — DRUG DEVELOPMENT & REGULATORY APPLICATIONS

  1. IND

Full Form: Investigational New Drug

Meaning

In the U.S., IND refers to the regulatory framework/application allowing investigation of a drug in humans, subject to applicable requirements.

Importance

Relevant primarily to clinical development rather than routine commercial export.

  1. NDA

Full Form: New Drug Application

Meaning

U.S. application for approval to market a new drug.

Difference

IND → investigate

NDA → seek marketing approval

  1. ANDA

Full Form: Abbreviated New Drug Application

Meaning

U.S. application pathway for qualifying generic drugs.

Difference

NDA → generally new drug approval pathway

ANDA → qualifying generic drug pathway

  1. BLA

Full Form: Biologics License Application

Meaning

U.S. application seeking approval for specified biological products.

Difference

ANDA → generic-drug pathway

BLA → biological products covered by the BLA framework

  1. CTD

Full Form: Common Technical Document

Meaning

Internationally harmonized format for organizing pharmaceutical regulatory information.

Five modules

  1. Administrative information
  2. Summaries
  3. Quality
  4. Nonclinical
  5. Clinical

Importance

Allows regulatory dossiers to be organized consistently across participating markets.

  1. eCTD

Full Form: Electronic Common Technical Document

Meaning

Electronic implementation of CTD submission architecture.

Difference

CTD → content/structure

eCTD → electronic submission format/technical framework

  1. ACTD

Full Form: ASEAN Common Technical Dossier

Meaning

Common technical dossier structure used in ASEAN regulatory submissions.

Importance

Particularly relevant to pharmaceutical registration in ASEAN markets.

  1. CMC

Full Form: Chemistry, Manufacturing and Controls

Meaning

Technical information describing:

  • composition
  • manufacturing process
  • specifications
  • analytical controls
  • quality
  • stability
  • manufacturing consistency

Importance

CMC is central to demonstrating pharmaceutical product quality.

  1. CRO

Full Form: Contract Research Organization

Meaning

External organization contracted to perform research/clinical development services.

Difference

CRO → research

CMO → manufacturing

CDMO → development + manufacturing

  1. RLD

Full Form: Reference Listed Drug

Meaning

FDA terminology referring to the reference product used in certain generic drug approval pathways.

  1. NDC

Full Form: National Drug Code

Country

United States.

Meaning

FDA-associated product identification system/code structure for marketed drugs.

Important

NDC is not the same as FDA approval.

  1. Orange Book

Full Name: Approved Drug Products with Therapeutic Equivalence Evaluations

Meaning

FDA publication/database containing information about approved drug products and therapeutic-equivalence evaluations.

Importance

Important for understanding U.S. generic-drug regulatory relationships.

  1. Purple Book

Meaning

FDA resource containing information on licensed biological products, including relevant biosimilar/interchangeability information.

Difference

Orange Book → certain drug products

Purple Book → biological products

  1. PDUFA

Full Form: Prescription Drug User Fee Act

Meaning

U.S. legislation establishing user-fee mechanisms supporting FDA review activities for certain prescription drug applications.

  1. GDUFA

Full Form: Generic Drug User Fee Amendments

Meaning

U.S. user-fee framework associated with generic-drug application review.

PART X — PHARMACOVIGILANCE & SAFETY

  1. PV

Full Form: Pharmacovigilance

Meaning

System for monitoring medicine safety.

  1. AE

Full Form: Adverse Event

Meaning

Any untoward medical occurrence associated with use of a medicine, without necessarily establishing causation.

Important

AE does not automatically mean the medicine caused the event.

  1. ADR

Full Form: Adverse Drug Reaction

Meaning

A harmful/unintended response to a medicinal product where a causal relationship is at least a reasonable possibility under the applicable definition.

Difference

AE → occurrence associated with medicine use

ADR → stronger causal relationship concept

  1. SAE

Full Form: Serious Adverse Event

Meaning

An adverse event meeting defined seriousness criteria.

Important

Serious ≠ severe.

“Serious” is a regulatory classification; “severe” describes intensity.

  1. SUSAR

Full Form: Suspected Unexpected Serious Adverse Reaction

Meaning

A suspected adverse reaction that is:

  • serious
  • unexpected
  • associated with a medicinal product

according to the applicable clinical-trial regulatory definitions.

  1. PSUR

Full Form: Periodic Safety Update Report

Meaning

Periodic regulatory safety report evaluating safety information and benefit-risk balance.

  1. PBRER

Full Form: Periodic Benefit-Risk Evaluation Report

Meaning

ICH-based periodic report assessing cumulative safety and benefit-risk information.

Difference

PSUR and PBRER are closely related regulatory safety-reporting concepts, with PBRER representing the harmonized ICH approach.

  1. RMP

Full Form: Risk Management Plan

Meaning

Document describing known/potential risks and planned activities to monitor/manage those risks.

  1. DSUR

Full Form: Development Safety Update Report

Meaning

Periodic safety report used during clinical development.

Difference

DSUR → development/clinical-trial stage

PBRER/PSUR → generally post-authorization safety reporting

  1. Signal Detection

Meaning

Process of identifying information that may indicate a new or changed safety concern.

Example

Unexpected pattern of adverse-event reports.

  1. Post-Marketing Surveillance

Meaning

Monitoring medicine safety, quality and performance after commercialization.

Importance

Regulatory responsibility does not necessarily end after product approval.

PART XI — PHARMACOPOEIA & STANDARDS

  1. IP

Full Form: Indian Pharmacopoeia

Meaning

Official pharmacopoeial standards applicable in India for relevant pharmaceutical substances/products.

  1. USP

Full Form: United States Pharmacopeia

Country

United States.

Importance

Contains recognized pharmaceutical quality standards/monographs.

  1. BP

Full Form: British Pharmacopoeia

Country

United Kingdom.

  1. Ph. Eur.

Full Form: European Pharmacopoeia

Region

Europe.

Difference

Ph. Eur. is the standard abbreviation for European Pharmacopoeia.

  1. EP

Meaning: European Pharmacopoeia

Important

In professional regulatory writing, Ph. Eur. is generally the clearer abbreviation for European Pharmacopoeia.

  1. JP

Full Form: Japanese Pharmacopoeia

Country

Japan.

  1. NF

Full Form: National Formulary

Importance

In pharmaceutical contexts, NF is particularly associated with the U.S. compendial system and should not be confused with an arbitrary national formulary in another country.

  1. WHO

Full Form: World Health Organization

Pharma relevance

WHO develops international standards, guidance and frameworks relevant to medicines, quality, public health and pharmaceutical regulation.

  1. ICH

Full Form: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use

Importance

ICH develops harmonized technical guidelines covering areas such as:

  • quality
  • safety
  • efficacy
  • multidisciplinary regulatory topics
  1. ISO

Full Form: International Organization for Standardization

Meaning

International standards organization.

Important

ISO certification is not automatically equivalent to pharmaceutical GMP approval.

  1. PIC/S

Full Form: Pharmaceutical Inspection Co-operation Scheme

Meaning

International cooperation framework among participating pharmaceutical inspectorates.

Importance

Promotes harmonized GMP inspection and standards.

  1. ASTM

Full Form: ASTM International

Meaning

International standards organization developing technical standards across numerous industries.

Important

An ASTM standard should not automatically be described as a pharmaceutical regulatory approval.

  1. Monograph

Meaning

An official or recognized specification describing requirements for a particular substance/product.

Typically includes

  • identity
  • purity
  • assay
  • tests
  • impurities
  • analytical requirements
  1. Reference Standard

Meaning

A material of established quality used as a benchmark for analytical testing.

Example

A laboratory may compare a sample against a qualified reference standard.

PART XII — API & RAW MATERIAL TERMINOLOGY

  1. KSM

Full Form: Key Starting Material

Meaning

Important starting material used in API manufacturing.

Importance

Its control and qualification can affect API quality and regulatory compliance.

  1. Starting Material

Meaning

Material introduced into the manufacturing process at a defined stage.

Difference

A starting material is not necessarily the same thing as an API or finished product.

  1. Intermediate

Meaning

Material produced during a manufacturing process and subsequently processed further.

  1. Assay

Meaning

Quantitative determination of the amount/content of a specified substance.

Example

API assay:

99.2%

This indicates measured content according to the applicable analytical method.

  1. Purity

Meaning

Degree to which a substance is free from unwanted substances/impurities.

Difference

Assay → quantity of specified substance

Purity → broader assessment of absence/level of unwanted components

  1. Residual Solvent

Meaning

Solvent remaining in a pharmaceutical material after manufacturing.

Importance

Residual solvents must be appropriately controlled according to applicable quality standards.

  1. Elemental Impurity

Meaning

Unwanted elemental/metallic substances present in pharmaceutical materials/products.

Importance

Certain elements may pose toxicity risks and require risk-based control.

  1. Nitrosamine

Meaning

A class of compounds that has received significant pharmaceutical regulatory attention because some nitrosamines can pose carcinogenic risks.

Importance

Risk assessment and control may be required for affected products/processes.

  1. Genotoxic Impurity

Meaning

Impurity with potential to damage genetic material.

Importance

Such impurities can require particularly stringent assessment and control.

  1. Retest Date

Meaning

Date by which an API/material should be retested to confirm it continues to meet specifications, where applicable.

Difference

Expiry date → generally associated with finished product

Retest date → commonly associated with APIs/raw materials

PART XIII — REGULATORY DOSSIER

  1. Module 1

Meaning

Administrative and region-specific information.

May include

  • application forms
  • legal information
  • labelling
  • administrative documents
  1. Module 2

Meaning

CTD summaries and overviews.

  1. Module 3

Meaning

Quality information.

Major content

  • API
  • formulation
  • manufacturing
  • specifications
  • analytical methods
  • validation
  • stability
  1. Module 4

Meaning

Nonclinical information.

Examples

  • pharmacology
  • toxicology
  1. Module 5

Meaning

Clinical information.

Examples

  • clinical studies
  • efficacy
  • safety
  • bioequivalence studies where applicable

PART XIV — BUYER, SUPPLIER & CONTRACT TERMINOLOGY

  1. Manufacturer

Meaning

Entity that actually manufactures the pharmaceutical product.

Important

Do not assume that every “supplier” is the manufacturer.

  1. Supplier

Meaning

Entity that supplies the product/material.

Difference

Manufacturer → makes product

Supplier/trader → may purchase and resell

  1. Trader

Meaning

Commercial intermediary that buys and sells products.

Importance

A trader may not own the manufacturing facility.

Due diligence

For pharma exports, verify:

  • actual manufacturer
  • manufacturing licence
  • GMP status
  • product authorization
  • supply chain
  • documentation
  1. Exporter

Meaning

Entity exporting goods from the origin country.

Important

Exporter and manufacturer can be different companies.

  1. Importer

Meaning

Entity bringing the product into the destination country.

Important

The importer often has country-specific legal/regulatory responsibilities.

  1. Agent

Meaning

Representative acting on behalf of another party.

Difference

Agent → represents

Distributor → normally purchases/distributes

The actual contractual structure determines the legal relationship.

  1. Principal

Meaning

The company on whose behalf an agent/distributor acts.

  1. NDA — Non-Disclosure Agreement

Meaning

Legal agreement protecting confidential information.

Pharma use

Can cover:

  • formulation
  • pricing
  • customer information
  • manufacturing information
  • regulatory documents
  • business plans
  1. MOU

Full Form: Memorandum of Understanding

Meaning

Document recording an understanding between parties.

Important

An MOU is not automatically a legally binding commercial contract in every respect. Its legal effect depends on its wording and applicable law.

  1. SLA

Full Form: Service Level Agreement

Meaning

Agreement defining service expectations and performance standards.

Example

A logistics provider may commit to defined delivery or reporting standards.

PART XV — FINANCE & PAYMENT

  1. TT

Full Form: Telegraphic Transfer

Meaning

Electronic bank transfer.

Common pharma-export practice

  • 100% advance
  • partial advance + balance before shipment
  • other negotiated arrangements

The actual terms depend on commercial risk.

  1. DP

Full Form: Documents Against Payment

Meaning

Banking arrangement where documents are released against payment according to the agreed collection terms.

  1. DA

Full Form: Documents Against Acceptance

Meaning

Documents are released against buyer’s acceptance of a time draft/bill under the applicable collection arrangement.

Difference

DP → payment

DA → acceptance/credit arrangement

  1. CAD

Full Form: Cash Against Documents

Meaning

Commercial/banking expression referring to payment against presentation/release of documents, with exact structure defined by the transaction.

  1. Open Account

Meaning

Exporter ships goods and buyer pays later according to agreed credit terms.

Risk

Higher seller credit exposure than advance payment.

  1. Landed Cost

Meaning

Total cost of getting the product to the relevant destination, including applicable costs such as:

  • product cost
  • freight
  • insurance
  • duties
  • taxes
  • handling
  • clearance
  • other charges

Importance

A product can have a low FOB price but a high landed cost.

  1. COGS

Full Form: Cost of Goods Sold

Meaning

Direct costs associated with products sold.

  1. Gross Profit

Formula

Gross Profit = Sales Revenue − COGS

  1. Gross Margin

Formula

Gross Margin % = Gross Profit ÷ Sales Revenue × 100

Example

Sales = ₹10 lakh
COGS = ₹7 lakh

Gross Profit = ₹3 lakh

Gross Margin = 30%

  1. ROI

Full Form: Return on Investment

Meaning

Measures return relative to investment.

Importance

A pharmaceutical export business should not evaluate an opportunity only on sales value.

Also examine:

  • margin
  • working capital
  • regulatory cost
  • registration cost
  • inventory
  • payment risk
  • logistics
  • buyer risk

PART XVI — IMPORTANT DISTINCTIONS EVERY PHARMA EXPORTER MUST UNDERSTAND

  1. Approved vs Registered

Approved

A regulator has formally evaluated/authorized something under its legal framework.

Registered

A product/company/site has been entered into the applicable regulatory registration system.

Important

The exact meaning differs between jurisdictions.

Do not automatically treat “registered” and “approved” as identical legal terms.

  1. Permitted vs Approved

Permitted

An activity/product may legally be allowed under a particular condition.

Approved

A specific regulatory authorization has been granted.

Example

A product might be legally importable under certain circumstances but still not be authorized for commercial marketing.

  1. Restricted vs Banned

Restricted

Allowed subject to specified conditions.

Examples could include:

  • licence
  • quantity limit
  • approved importer
  • special documentation
  • controlled-substance authorization

Banned

Prohibited by law for the relevant activity/use.

Critical rule

Never write “BANNED” in the Nawinza medicine database merely because a product is not approved or because registration is difficult.

Use the correct status:

  • Not approved
  • Registration required
  • Restricted
  • Controlled
  • Not authorized for specified use
  • Prohibited
  • Product-specific review required
  1. Prescription vs Controlled

These are not the same.

Prescription

Requires a prescription.

Controlled

Subject to special legal controls.

A medicine can be:

Prescription-only but not controlled.

Some controlled medicines may also be prescription medicines, but the concepts remain distinct.

  1. GMP vs GMP Certificate

GMP

The quality/manufacturing standard.

GMP Certificate

Evidence issued/recognized by an appropriate authority/body regarding compliance with applicable GMP requirements.

  1. QA vs QC

QA

QC

Quality Assurance

Quality Control

System-oriented

Testing-oriented

Prevention

Detection/verification

Processes

Materials/products/test results

Builds quality system

Checks conformity

  1. OOS vs OOT

OOS

OOT

Out of Specification

Out of Trend

Result outside approved specification

Unexpected trend

Clear specification failure

May still be within specification

Formal investigation generally required

Trend evaluation/investigation may be required

  1. CAPA vs Change Control

CAPA

Used to correct/prevent problems.

Change Control

Used to evaluate and control planned changes.

Example

Repeated tablet weight deviation:

Investigation → Root cause → CAPA

Changing manufacturing equipment:

Change Control

  1. DMF vs Regulatory Dossier

DMF

Focused confidential technical information.

Regulatory Dossier

Complete submission for regulatory approval/registration.

Relationship

A DMF can support a regulatory dossier without being the entire dossier.

  1. API vs FPP

API

Active ingredient.

FPP

Finished medicine.

Supply chain

API manufacturer → formulation manufacturer → finished product → exporter → importer/distributor → market

  1. Generic vs Branded Generic

Generic

Usually marketed using generic/non-proprietary name, depending on market.

Branded Generic

Generic product marketed under a proprietary brand.

Export importance

A branded generic strategy may require:

  • trademark
  • brand registration
  • product registration
  • local marketing authorization
  • labelling compliance
  1. Manufacturer vs Supplier

Manufacturer

Actually produces the product.

Supplier

Provides the product.

Critical due-diligence question

“Are you the actual manufacturer? If not, who is the licensed manufacturer?”

This question is particularly important when sourcing from online B2B platforms.

  1. OEM vs Private Label

These terms overlap in commercial practice but are not identical.

OEM

Focuses on manufacturing according to another company’s requirements.

Private Label

Focuses on selling the manufactured product under another company’s brand.

A single pharmaceutical arrangement can therefore involve:

OEM manufacturing + Private Label branding.

  1. FOB vs CIF

FOB

Seller delivers goods on board vessel at named port of shipment.

CIF

Seller also arranges cost, freight and insurance to named destination port under the applicable rule.

Commercial consequence

CIF generally produces a higher seller quotation than FOB because additional transport/insurance costs are included.

  1. CIF vs CFR

CFR

Cost + Freight.

CIF

Cost + Freight + Insurance.

  1. DAP vs DDP

DAP

Seller delivers to destination; buyer generally handles import clearance/duties.

DDP

Seller takes on extensive import responsibilities, including duties, subject to legal feasibility.

Pharma caution

DDP can be problematic if the exporter cannot legally act as importer of record or perform required local regulatory obligations.

  1. COA vs CPP vs COO

Document

Main purpose

COA

Batch/product analytical quality

CPP/COPP

Pharmaceutical regulatory/product information

COO

Country of origin

These documents cannot normally substitute for one another.

  1. CPP vs GMP Certificate

CPP

Information about the pharmaceutical product and its regulatory/manufacturing status under the applicable certification scheme.

GMP Certificate

Evidence regarding GMP compliance of a manufacturing site.

  1. CFS vs CPP

CFS/FSC

Evidence concerning free/legal sale or marketing status, depending on issuing authority.

CPP

Pharmaceutical product certificate used for regulatory purposes.

  1. IND vs NDA vs ANDA

Term

Main purpose

IND

Clinical investigation

NDA

New drug marketing application

ANDA

Qualifying generic drug application

Think:

IND → Investigate

NDA → New drug approval

ANDA → Generic approval

  1. NDA vs BLA

NDA

Application for drugs within the NDA framework.

BLA

Application for biological products covered by the BLA framework.

  1. CTD vs eCTD

CTD

Common technical dossier structure.

eCTD

Electronic technical submission implementation.

  1. GMP vs GDP vs GSP

Term

Focus

GMP

Manufacturing

GDP

Distribution

GSP

Storage

  1. GLP vs GCP vs GMP

Term

Area

GLP

Certain nonclinical laboratory studies

GCP

Clinical trials

GMP

Manufacturing

  1. Pharmacovigilance vs Quality Control

Pharmacovigilance

Focuses primarily on medicine safety and risk after/during development and commercialization.

QC

Focuses on analytical/product/material quality testing.

  1. Recall vs Withdrawal

Recall

Removal of product because of an identified problem/risk, generally under a controlled corrective process.

Withdrawal

A broader term that can refer to removing/suspending a product from the market for various reasons.

The exact legal distinction depends on the jurisdiction.

  1. Importer vs Distributor

Importer

Legally brings product into the country.

Distributor

Distributes product within the market.

One company can potentially perform both roles if appropriately authorized.

  1. Wholesaler vs Stockist

Wholesaler

Commercial wholesale seller.

Stockist

Entity primarily characterized by holding inventory for distribution.

The terminology varies by market.

  1. RFQ vs RFP

RFQ

Primarily asks for price/quotation.

RFP

Requests a broader technical and commercial proposal.

  1. PO vs PI

PO

Issued by buyer.

PI

Issued by seller.

  1. Advance Payment vs LC

Advance

Seller receives money before shipment/production as agreed.

LC

Payment depends on compliance with the LC’s terms and documentary conditions.

  1. B/L vs AWB

B/L

Primarily sea freight.

AWB

Air freight.

  1. HS Code vs HSN

HS Code

International harmonized classification concept.

HSN

Harmonized System of Nomenclature terminology commonly used in India.

  1. PHARMEXCIL vs CDSCO

PHARMEXCIL

Export promotion/trade support.

CDSCO

Drug regulatory authority.

  1. DGFT vs CDSCO

DGFT

Foreign trade.

CDSCO

Drugs/regulatory control.

Example

For an Indian pharmaceutical export:

DGFT/Customs side
→ Can the goods legally be exported and properly declared?

Drug regulatory side
→ Does the product/manufacturer satisfy applicable pharmaceutical requirements?

Destination regulator
→ Can the product legally be imported/marketed there?

All three questions can matter.

PART XVII — A PROFESSIONAL WAY TO THINK ABOUT PHARMA EXPORT

For every medicine that Nawinza evaluates for export, use this sequence:

STEP 1 — Identify the product

Brand → Generic → API → Salt → Strength → Dosage Form → Route

STEP 2 — Identify the manufacturer

Manufacturer → Manufacturing licence → GMP → Site → Certifications

STEP 3 — Identify Indian export requirements

IEC → DGFT → Customs → HS Code → Banking → Export documentation

STEP 4 — Identify destination-country requirements

Importer → Establishment → Product registration → Marketing Authorisation → Import licence → Labelling

STEP 5 — Determine medicine status

OTC / Prescription / Controlled / Restricted / Special regulatory category

STEP 6 — Prepare technical documentation

COA → GMP → CPP/COPP → CFS/FSC → DMF/CEP/ASMF → Dossier

STEP 7 — Determine commercial model

Distributor / Importer / Wholesaler / Tender / Private Label / OEM / CDMO

STEP 8 — Determine logistics

EXW / FCA / FOB / CFR / CIF / CPT / CIP / DAP / DDP

STEP 9 — Determine payment risk

Advance / TT / LC / DP / DA / Open Account

STEP 10 — Verify before shipment

Product + Manufacturer + Buyer + Registration + Documentation + Customs + Payment + Logistics

PART XVIII — THE MOST IMPORTANT 25 TERMS FOR A NEW INDIAN PHARMA EXPORTER

If someone is completely new to pharma exports, I would make these the “First 25 Terms You Must Know” box in the Nawinza book:

Priority

Term

Why it matters

1

API

Identifies active pharmaceutical substance

2

FPP

Identifies finished medicine

3

CDSCO

Indian drug regulatory authority

4

DGFT

Indian foreign-trade authority

5

IEC

Core foreign-trade identification

6

GMP

Manufacturing quality requirement

7

COA

Batch quality evidence

8

CPP/COPP

Pharmaceutical regulatory certificate

9

DMF

Confidential technical information

10

MA

Permission to market

11

Product Registration

Destination-market regulatory status

12

Import Licence

Destination-country import authorization

13

MOQ

Minimum commercial quantity

14

OEM

Manufacturing arrangement

15

Private Label

Selling under another brand

16

CMO/CDMO

Contract manufacturing/development

17

Distributor

Foreign commercial partner

18

HS Code

Customs classification

19

FOB

Major shipping term

20

CIF

Shipping + insurance term

21

LC

Trade payment mechanism

22

QA/QC

Pharmaceutical quality system/testing

23

CAPA

Corrective/preventive quality action

24

Pharmacovigilance

Medicine safety monitoring

25

Recall

Controlled removal of affected product

Additional Indian Export & Trade Terms

Term

Full Form

Meaning / Importance

ICEGATE

Indian Customs Electronic Gateway

Indian Customs electronic portal used for customs filings, shipping bills, electronic communication and related processes.

AD Code

Authorized Dealer Code

Bank-linked code used in export transactions and customs processes. It connects the exporter’s bank account with customs/export operations.

RCMC

Registration-Cum-Membership Certificate

Exporter registration with the relevant Export Promotion Council; PHARMEXCIL is relevant for many pharmaceutical exporters.

PHARMEXCIL

Pharmaceuticals Export Promotion Council of India

Government-recognized export promotion body for the Indian pharmaceutical sector.

e-BRC

Electronic Bank Realisation Certificate

Electronic evidence that export proceeds have been realized through the banking system.

LUT

Letter of Undertaking

GST mechanism allowing eligible exporters to export without payment of IGST, subject to applicable conditions.

ITC-HS

Indian Trade Classification – Harmonized System

India’s classification system used for import/export policy and customs purposes.

HS Code

Harmonized System Code

International product classification system used by customs; exact classification must be verified for the product and destination.

LEO

Let Export Order

Customs authorization permitting goods to be exported after applicable examination/compliance.

EGM

Export General Manifest

Carrier-level export manifest filed with Customs after shipment, subject to the applicable process.

Additional Regulatory Terms

Term

Full Form

Meaning / Importance

MAH

Marketing Authorisation Holder

Entity legally responsible for a medicinal product’s marketing authorization in a particular jurisdiction.

MIA

Manufacturing Import Authorization / context-dependent

Must be interpreted according to the jurisdiction; do not use as a universal abbreviation.

NRA

National Regulatory Authority

Government body responsible for regulating medicines in a country.

NOC

No Objection Certificate

Official authorization/clearance issued where a particular regulatory or administrative process requires it.

GMP Inspection

Good Manufacturing Practice Inspection

Regulatory inspection to assess whether manufacturing operations comply with applicable GMP requirements.

Prequalification

Regulatory/quality prequalification

Formal assessment showing that a product, manufacturer or supplier meets specified requirements, often relevant to institutional/international procurement.

Regulatory Reliance

—

A regulator uses or considers assessments performed by another trusted regulatory authority to improve efficiency.

Reference Authority

—

A regulatory authority whose assessment may be relied upon or considered by another jurisdiction.

Good Regulatory Practices (GRP)

Good Regulatory Practices

Principles intended to make regulatory decision-making consistent, transparent, risk-based and predictable.

Additional Registration & Dossier Terms

Term

Full Form

Meaning / Difference

MA

Marketing Authorization

Legal authorization allowing a medicinal product to be marketed in a jurisdiction.

MAA

Marketing Authorisation Application

Application submitted to obtain marketing authorization.

MA Number

Marketing Authorization Number

Identification number assigned to an approved product, where the jurisdiction uses such a system.

Site Master File (SMF)

Site Master File

Document describing a manufacturing site’s organization, facilities, quality system and operations.

PIL

Patient Information Leaflet

Patient-facing information supplied with a medicine in applicable markets.

PI

Prescribing Information

Professional prescribing information; exact format and terminology vary by country.

SmPC

Summary of Product Characteristics

UK/EU professional product information describing approved indications, dosage, warnings, pharmacology and other information.

Package Insert (PI)

Package Insert

Information accompanying the medicine; terminology and legal requirements vary by market.

Labeling

—

Legally regulated information appearing on the container, package and/or accompanying documentation.

Artwork

—

Approved packaging/label design used for a specific market.

Mock-up

—

Representative visual version of proposed packaging/labeling submitted for regulatory review where required.

Additional Pharmaceutical Development Terms

Term

Full Form

Meaning / Importance

QTPP

Quality Target Product Profile

Defines the desired quality characteristics of a pharmaceutical product.

CQA

Critical Quality Attribute

Physical, chemical, biological or microbiological property that must remain within an appropriate limit/range.

CPP

Critical Process Parameter

Process parameter whose variability can affect a CQA.

QbD

Quality by Design

Systematic development approach based on predefined objectives, risk management and scientific understanding.

QRM

Quality Risk Management

Systematic assessment, control, communication and review of pharmaceutical quality risks.

DoE

Design of Experiments

Statistical method used to study process/product variables efficiently.

PAT

Process Analytical Technology

Framework for monitoring and controlling pharmaceutical manufacturing processes.

Bioavailability

—

Rate and extent to which an active ingredient becomes available at the site of action/systemic circulation.

Bioequivalence

—

Demonstration that two medicinal products have sufficiently comparable bioavailability/exposure under specified conditions.

BE Study

Bioequivalence Study

Study used to establish bioequivalence, commonly important for generic medicines.

BA/BE

Bioavailability/Bioequivalence

Regulatory evidence frequently relevant to generic drug applications.

Pharmaceutical Equivalence

—

Products contain the same active ingredient(s), strength and dosage form, subject to the applicable regulatory definition.

Therapeutic Equivalence

—

Broader regulatory concept involving pharmaceutical equivalence plus evidence required to establish comparable therapeutic performance.

Additional Quality-Control Terms

Term

Full Form

Meaning

IPC

In-Process Control

Checks performed during manufacturing rather than only on the finished product.

IPQC

In-Process Quality Control

Quality-control activities conducted during manufacturing.

FP

Finished Product

Completed medicinal product ready for release after applicable testing and quality review.

RM

Raw Material

Material used in pharmaceutical manufacturing.

PM

Packaging Material

Material used to package a pharmaceutical product.

AMV

Analytical Method Validation

Demonstration that an analytical method is suitable for its intended purpose.

AMT

Analytical Method Transfer

Transfer of an analytical method from one laboratory/site to another.

Stability Study

—

Study determining how product quality changes over time under defined environmental conditions.

Accelerated Stability

—

Stability testing under stressed conditions to support development and regulatory assessment.

Long-Term Stability

—

Stability testing under recommended storage conditions over the intended shelf-life period.

Shelf Life

—

Period during which the product is expected to remain within approved specifications when stored as directed.

Retest Period

—

Period after which an API/material should be retested before use, where applicable.

Specification

—

Set of tests, references to analytical procedures and acceptance criteria defining product/material quality.

Acceptance Criteria

—

Numerical or qualitative limits used to determine whether a test result passes.

Additional Pharmacovigilance Terms

Term

Full Form

Meaning

ICSR

Individual Case Safety Report

Report containing information about an individual suspected adverse reaction/event case.

MedDRA

Medical Dictionary for Regulatory Activities

Standardized medical terminology widely used for coding regulatory safety information.

PV Agreement / PVA

Pharmacovigilance Agreement

Agreement defining pharmacovigilance responsibilities between companies/partners.

Safety Database

—

System used to collect, manage and evaluate safety information.

Benefit-Risk Assessment

—

Evaluation comparing a medicine’s therapeutic benefits against identified or potential risks.

Risk Minimization

—

Measures intended to prevent or reduce medicine-related risks.

PASS

Post-Authorization Safety Study

Study conducted after authorization to obtain additional safety information.

PAES

Post-Authorization Efficacy Study

Study performed after authorization to collect additional efficacy information.

Additional Supply-Chain & Export Terms

Term

Full Form

Meaning

GDP

Good Distribution Practice

Standards governing proper storage, transportation and distribution of medicinal products. Do not confuse with Gross Domestic Product.

GSP

Good Storage Practice

Principles for maintaining appropriate storage conditions for medicines.

FEFO

First Expiry, First Out

Inventory method where products with the earliest expiry are dispatched first.

FIFO

First In, First Out

Inventory method based on earliest receipt date.

Temperature Excursion

—

Situation where a product is exposed to temperatures outside its specified range.

Data Logger

—

Device used to record environmental conditions such as temperature during storage or transportation.

GDP Certificate

Good Distribution Practice Certificate

Evidence of compliance where the relevant authority/certification system issues such a certificate.

CoA / COA

Certificate of Analysis

Document showing test results against specified quality requirements.

CoC / COC

Certificate of Conformity

Certificate confirming conformity with specified requirements; exact meaning depends on the transaction/regulatory context.

POD

Proof of Delivery

Evidence that shipment was delivered to the consignee/customer.

Additional Commercial Terms

Term

Full Form

Meaning

SKU

Stock Keeping Unit

Unique inventory/product identifier used commercially.

RFQ

Request for Quotation

Buyer request asking suppliers for price and commercial terms.

RFI

Request for Information

Preliminary request used to gather supplier/product information.

RFP

Request for Proposal

Formal request seeking a detailed commercial/technical proposal.

PO

Purchase Order

Buyer’s formal order specifying products, quantities and commercial terms.

PI

Proforma Invoice

Preliminary commercial invoice used before shipment/payment; PI can also mean Prescribing Information, so context matters.

CI

Commercial Invoice

Final commercial invoice used for customs and commercial purposes.

PL

Packing List

Document showing package-level shipment details.

DN

Delivery Note

Document accompanying/confirming delivery, depending on the transaction.

Credit Limit

—

Maximum credit exposure permitted for a buyer.

Due Diligence

—

Systematic verification of a supplier, buyer, product, licence, financial position or regulatory status.

KYC

Know Your Customer

Process of identifying and verifying a business/customer.

KYB

Know Your Business

Business-level verification of a company and its legitimacy.

Critical Legal/Regulatory Distinctions to Add to the Book

These deserve their own glossary box, because exporters frequently confuse them:

Approved ≠ Registered ≠ Permitted ≠ Marketed ≠ Exportable ≠ Importable ≠ Banned

  • Approved — regulator has granted the relevant approval.
  • Registered — product/company/site has been entered into the applicable regulatory registration system.
  • Permitted — activity/product is legally allowed under the relevant rules.
  • Not approved — approval has not been granted; this does not automatically mean banned.
  • Restricted — additional conditions or controls apply.
  • Controlled — subject to specific legal controls, often including narcotic/psychotropic or other special regulatory requirements.
  • Banned/Prohibited — law specifically prohibits the product/activity in the relevant context.
  • Exportable from India — does not automatically mean legally importable or marketable in the destination country.
  • Registered in India — does not automatically mean registered in the destination country.
  • Manufactured in a GMP-compliant facility — does not automatically mean the product is approved for sale in another country.

Important Abbreviation Conflicts

These should be explicitly explained in the glossary:

Abbreviation

Possible Meaning

How to Interpret

NDA

New Drug Application / Non-Disclosure Agreement

Regulatory context = New Drug Application; commercial/legal context = Non-Disclosure Agreement.

IEC

Importer Exporter Code / Independent Ethics Committee

Indian trade context = Importer Exporter Code; clinical research context may mean Independent Ethics Committee.

GDP

Good Distribution Practice / Gross Domestic Product

Pharma logistics = Good Distribution Practice; economics = Gross Domestic Product.

PI

Proforma Invoice / Prescribing Information / Package Insert

Commercial, regulatory and medical contexts differ.

MA

Marketing Authorization / other context-specific meanings

Pharma regulatory context normally refers to Marketing Authorization.

LOA

Letter of Authorization / Letter of Access

Meaning depends on regulatory/commercial context.

CPP

Certificate of Pharmaceutical Product / Critical Process Parameter

Regulatory export certificate vs pharmaceutical manufacturing terminology.

BPR

Batch Packaging Record / other organization-specific terminology

Always check the company’s SOP/document-control terminology.

BL/BOL

Bill of Lading

Usually the same shipping-document concept; terminology may vary by organization.

EP/Ph. Eur.

European Pharmacopoeia

“Ph. Eur.” is the formal abbreviation commonly used for European Pharmacopoeia.

One more section I strongly recommend for your book

26-Country Regulatory Authority Quick Reference

Country

Principal Authority / Regulatory Reference

🇺🇸 USA

FDA — Food and Drug Administration

🇬🇧 UK

MHRA — Medicines and Healthcare products Regulatory Agency

🇦🇪 UAE

EDE — Emirates Drug Establishment

🇸🇦 Saudi Arabia

SFDA — Saudi Food and Drug Authority

🇨🇦 Canada

Health Canada

🇦🇺 Australia

TGA — Therapeutic Goods Administration

🇩🇪 Germany

BfArM / PEI, depending on product; EU framework also applies

🇫🇷 France

ANSM; EU framework also applies

🇳🇱 Netherlands

MEB; EU framework also applies

🇧🇷 Brazil

ANVISA

🇿🇦 South Africa

SAHPRA

🇳🇬 Nigeria

NAFDAC

🇰🇪 Kenya

Pharmacy and Poisons Board (PPB)

🇹🇿 Tanzania

TMDA

🇺🇬 Uganda

National Drug Authority (NDA)

🇬🇭 Ghana

FDA Ghana

🇪🇬 Egypt

Egyptian Drug Authority (EDA)

🇹🇷 Türkiye

TITCK

🇷🇺 Russia

Ministry of Health / Roszdravnadzor framework

🇧🇩 Bangladesh

DGDA

🇮🇩 Indonesia

BPOM

🇲🇾 Malaysia

NPRA

🇵🇭 Philippines

FDA Philippines

🇻🇳 Vietnam

Drug Administration of Vietnam (DAV)

🇯🇵 Japan

PMDA / MHLW

🇳🇿 New Zealand

Medsafe

Important: For Germany, France and the Netherlands, do not describe EMA as simply “the national regulator.” EMA is an EU-level agency and the applicable authorization route can involve EU centralized or national/mutual-recognition/decentralized procedures.

Final glossary addition: “Verification Required”

 Regulatory terminology is jurisdiction-specific. An abbreviation, certificate, licence or regulatory pathway may have different meanings or legal effects in different countries. Exporters should verify the current requirement with the applicable national regulator, customs authority, importing-country authority and, where necessary, qualified regulatory counsel before shipment.

 

NAWINZA OPC PVT. LTD. — EDUCATIONAL & REGULATORY DISCLAIMER

Disclaimer — Educational, Informational & Reference Use Only

The information, articles, pharmaceutical terminology, medicine descriptions, regulatory information, country-specific guidance, export procedures, documentation requirements, product classifications, examples, tables, databases, and other materials published on this website by Nawinza OPC Pvt. Ltd. are provided solely for educational, informational, academic, research, training, and general reference purposes.

This website and its content are intended to help students, researchers, exporters, importers, pharmaceutical professionals, business learners, and other interested persons understand general concepts relating to pharmaceutical products, international pharmaceutical trade, regulatory terminology, export procedures, documentation, quality requirements, logistics, and global pharmaceutical markets.

No Offer or Intention to Sell

Nawinza OPC Pvt. Ltd. does not intend this educational content, by itself, to constitute an offer, solicitation, invitation, advertisement, quotation, commitment, or representation to sell or supply any pharmaceutical medicine, drug, API, formulation, controlled substance, medical product, or other regulated product.

The appearance of a medicine, pharmaceutical product, manufacturer, supplier, buyer, country, regulatory category, product example, trade term, HS code, or commercial reference on this website does not mean that Nawinza OPC Pvt. Ltd. is offering that product for sale or confirming its availability, legality, registration, approval, importability, exportability, or marketability in any particular country.

Regulatory Requirements May Differ

Pharmaceutical laws and regulatory requirements vary significantly between countries and may also vary according to:

  • active ingredient/API;
  • salt, strength and formulation;
  • dosage form and route of administration;
  • intended indication/use;
  • prescription or OTC classification;
  • controlled-substance status;
  • product registration status;
  • manufacturer and manufacturing site;
  • importing country;
  • intended buyer/importer;
  • quantity and shipment purpose;
  • clinical, commercial, research or other intended use; and
  • applicable national, regional and international regulations.

Regulatory terminology is jurisdiction-specific. An abbreviation, certificate, licence, approval, registration, regulatory pathway or document may have different meanings or legal effects in different countries.

Accordingly, information presented on this website should not be interpreted as a guarantee that a particular pharmaceutical product is approved, registered, permitted, freely exportable, freely importable, or legally marketable in any particular jurisdiction.

No Legal, Regulatory or Professional Advice

The information provided is not intended to constitute legal, regulatory, medical, pharmaceutical, customs, tax, accounting, financial, investment, clinical, pharmacovigilance, or other professional advice.

Users should not rely solely on website content when making decisions involving pharmaceutical manufacturing, registration, importation, exportation, distribution, marketing, prescribing, procurement, customs clearance, licensing, or commercial transactions.

Where appropriate, users should obtain independent advice from:

  • the relevant national medicines regulatory authority;
  • customs authorities;
  • DGFT and other applicable Indian authorities;
  • the importing-country authority;
  • qualified regulatory professionals;
  • customs brokers or trade professionals;
  • qualified legal professionals;
  • licensed healthcare/pharmaceutical professionals; and
  • other appropriately qualified advisers.

Verification of Current Information

Regulations, policies, licences, registration procedures, tariffs, customs requirements, regulatory classifications, product approvals and government procedures may change without notice.

Users are therefore responsible for independently verifying the latest applicable requirements before relying on any information or undertaking any transaction.

For pharmaceutical exports from India, verification may involve the relevant Indian authorities as well as the regulatory and customs authorities of the destination country.

Product-Specific Verification

The inclusion of a medicine or pharmaceutical product in an educational database does not constitute an endorsement, recommendation, approval, certification, or authorization of that product.

Product-specific information should be independently verified against the applicable official regulatory source before:

  • manufacturing;
  • purchasing;
  • exporting;
  • importing;
  • registering;
  • distributing;
  • marketing;
  • advertising; or
  • otherwise dealing with the product.

Particular caution should be exercised for controlled substances, narcotic and psychotropic substances, hormones, anabolic steroids, prescription medicines, biologics, investigational products, veterinary medicines, products with special import restrictions, and other regulated or high-risk products.

No Guarantee of Accuracy or Completeness

Although reasonable efforts may be made to present useful and accurate educational information, Nawinza OPC Pvt. Ltd. does not warrant or guarantee that the information is complete, current, error-free, universally applicable, or suitable for a particular transaction or jurisdiction.

Examples, classifications, regulatory references, commercial information, supplier/buyer information, HS codes, prices, MOQs, timelines and other data may require independent verification.

Where information is marked “to be verified,” “indicative,” “example,” “preliminary,” “subject to confirmation,” or similar wording, users should treat it accordingly and should not consider it confirmed regulatory or commercial advice.

Website and Student Reference Use

Certain materials may be provided specifically to support students, researchers, trainees, exporters and educational users in understanding pharmaceutical export concepts.

Such material may be used as a learning and reference resource, but users should not treat educational examples as instructions to conduct a regulated pharmaceutical transaction without completing the appropriate independent regulatory and legal checks.

Third-Party Information

References to third-party companies, manufacturers, suppliers, buyers, distributors, websites, organizations, regulatory authorities, databases or commercial platforms are provided where applicable for identification, research or reference purposes only.

Such references do not necessarily constitute an endorsement, partnership, certification, recommendation, guarantee, or commercial relationship with Nawinza OPC Pvt. Ltd., unless expressly stated.

No Guarantee of Commercial Transaction

Nawinza OPC Pvt. Ltd. does not guarantee:

  • product availability;
  • supplier availability;
  • buyer availability;
  • product pricing;
  • minimum order quantities;
  • regulatory approval;
  • registration;
  • import permission;
  • export permission;
  • customs clearance;
  • shipment acceptance;
  • delivery timelines;
  • payment;
  • commercial profitability; or
  • successful completion of any proposed transaction.

All commercial terms and regulatory requirements must be independently confirmed before entering into a transaction.

User Responsibility

By using this website, the user acknowledges that the responsibility for verifying applicable laws, regulations, licences, approvals, registrations, documentation and commercial requirements rests with the user and the relevant parties to the transaction.

Users should not use the information on this website as a substitute for professional regulatory or legal due diligence.

Final Statement

Nawinza OPC Pvt. Ltd. provides this material in good faith as an educational, informational and research resource. Nothing contained on this website should be interpreted as an offer to sell, a solicitation to purchase, a medical prescription, regulatory approval, legal advice, or a guarantee that any pharmaceutical product or transaction is lawful, approved, registered, importable, exportable or marketable in a particular jurisdiction.

Always verify the latest requirements directly with the applicable government authority, regulatory authority, customs authority and qualified professional before taking any regulatory, medical, export, import or commercial action.

© Nawinza OPC Pvt. Ltd. — All Rights Reserved.

Shopping Cart
Translate »